
<html lang="en"     class="pb-page"  data-request-id="4fb3f2c1-3fa7-4b92-aedc-5556ee9e3b9d"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/acs.jmedchem.8b00420;requestedJournal:journal:jmcmar;issue:issue:10.1021/jmcmar.2018.61.issue-11;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Discovery of Novel Nonsteroidal Anti-Inflammatory Drugs and Carbonic Anhydrase Inhibitors Hybrids (NSAIDs–CAIs) for the Management of Rheumatoid Arthritis" /></meta><meta name="dc.Creator" content="Ozlem  Akgul" /></meta><meta name="dc.Creator" content="Lorenzo  Di Cesare Mannelli" /></meta><meta name="dc.Creator" content="Daniela  Vullo" /></meta><meta name="dc.Creator" content="Andrea  Angeli" /></meta><meta name="dc.Creator" content="Carla  Ghelardini" /></meta><meta name="dc.Creator" content="Gianluca  Bartolucci" /></meta><meta name="dc.Creator" content="Abdulmalik Saleh  Alfawaz Altamimi" /></meta><meta name="dc.Creator" content="Andrea  Scozzafava" /></meta><meta name="dc.Creator" content="Claudiu T.  Supuran" /></meta><meta name="dc.Creator" content="Fabrizio  Carta" /></meta><meta name="dc.Description" content="Herein we report the design as well as the synthesis of a new series of dual hybrid compounds consisting of the therapeutically used nonsteroidal-anti-inflammatory drugs (NSAIDs; i.e., indometacin,..." /></meta><meta name="Description" content="Herein we report the design as well as the synthesis of a new series of dual hybrid compounds consisting of the therapeutically used nonsteroidal-anti-inflammatory drugs (NSAIDs; i.e., indometacin,..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 10, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b00420" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00420" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b00420" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00420" /></link>
        
    
    

<title>Discovery of Novel Nonsteroidal Anti-Inflammatory Drugs and Carbonic Anhydrase Inhibitors Hybrids (NSAIDs–CAIs) for the Management of Rheumatoid Arthritis | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b00420" /></meta><meta property="og:title" content="Discovery of Novel Nonsteroidal Anti-Inflammatory Drugs and Carbonic Anhydrase Inhibitors Hybrids (NSAIDs–CAIs) for the Management of Rheumatoid Arthritis" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00420/20180608/images/large/jm-2018-004205_0006.jpeg" /></meta><meta property="og:description" content="Herein we report the design as well as the synthesis of a new series of dual hybrid compounds consisting of the therapeutically used nonsteroidal-anti-inflammatory drugs (NSAIDs; i.e., indometacin, sulindac, ketoprofen, ibuprofen, diclofenac, ketorolac, etc., cyclooxygenase inhibitors) and the carbonic anhydrase inhibitor (CAIs) fragments of the sulfonamide type. Such compounds are proposed as new tools for the management of ache symptoms associated with rheumatoid arthritis (RA) and related inflammation diseases. The majority of the hybrids reported were effective in inhibiting the ubiquitous human (h) CA I and II as well as the RA overexpressed hCAs IX and XII isoforms, with KI values comprised of the low-medium nanomolar ranges. The antihyperalgesic activity of selected compounds was assessed by means of the paw-pressure and incapacitance tests using an in vivo RA model, and among them the hybrids 6B and 8B showed potent antinociceptive effects lasting up to 60 min after administration." /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta><meta name="twitter:description" content="Herein we report the design as well as the synthesis of a new series of dual hybrid compounds consisting of the therapeutically used nonsteroidal-anti-inflammatory drugs (NSAIDs; i.e., indometacin, sulindac, ketoprofen, ibuprofen, diclofenac, ketorolac, etc., cyclooxygenase inhibitors) and the carbonic anhydrase inhibitor (CAIs) fragments of the sulfonamide type. Such compounds are proposed as new tools for the management of ache symptoms associated with rheumatoid arthritis (RA) and related inflammation diseases. The majority of the hybrids reported were effective in inhibiting the ubiquitous human (h) CA I and II as well as the RA overexpressed hCAs IX and XII isoforms, with KI values comprised of the low-medium nanomolar ranges. The antihyperalgesic activity of selected compounds was assessed by means of the paw-pressure and incapacitance tests using an in vivo RA model, and among them the hybrids 6B and 8B showed potent antinociceptive effects lasting up to 60 min after administration." /></meta><meta name="twitter:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00420/20180608/images/large/jm-2018-004205_0006.jpeg" /></meta><meta name="twitter:title" content="Discovery of Novel Nonsteroidal Anti-Inflammatory Drugs and Carbonic Anhydrase Inhibitors Hybrids (NSAIDs–CAIs) for the Management of Rheumatoid Arthritis" /></meta>
        
            <meta property="og:type" content="Article" /></meta>
        

        
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b00420"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/ke1q~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-6ee29527b3d8ff00a106.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b00420">
            
        





































    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-12/achre4.2021.54.issue-12/20210615/achre4.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-6/amrcda.2021.2.issue-6/20210625/amrcda.2021.2.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-6/aabmcb.2021.4.issue-6/20210621/aabmcb.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-6/aaembp.2021.3.issue-6/20210622/aaembp.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-6/aaemcq.2021.4.issue-6/20210628/aaemcq.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-25/aamick.2021.13.issue-25/20210630/aamick.2021.13.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-6/aanmf6.2021.4.issue-6/20210625/aanmf6.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-6/aapmcd.2021.3.issue-6/20210611/aapmcd.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-6/abseba.2021.7.issue-6/20210614/abseba.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-12/accacs.2021.11.issue-12/20210618/accacs.2021.11.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-6/acscii.2021.7.issue-6/20210623/acscii.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-6/acbcct.2021.16.issue-6/20210618/acbcct.2021.16.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-3/achsc5.2021.28.issue-3/20210524/achsc5.2021.28.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-12/acncdm.2021.12.issue-12/20210616/acncdm.2021.12.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-6/aesccq.2021.5.issue-6/20210617/aesccq.2021.5.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-6/aelccp.2021.6.issue-6/20210611/aelccp.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-6/aeecco.2021.1.issue-6/20210611/aeecco.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-6/aewcaa.2021.1.issue-6/20210611/aewcaa.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-5/afsthl.2021.1.issue-5/20210618/afsthl.2021.1.issue-5.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-6/aidcbc.2021.7.issue-6/20210611/aidcbc.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-6/amlccd.2021.10.issue-6/20210615/amlccd.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-6/amlcef.2021.3.issue-6/20210607/amlcef.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-6/amclct.2021.12.issue-6/20210610/amclct.2021.12.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-6/ancac3.2021.15.issue-6/20210622/ancac3.2021.15.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-25/acsodf.2021.6.issue-25/20210629/acsodf.2021.6.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-6/apchd5.2021.8.issue-6/20210616/apchd5.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-6/ascefj.2021.6.issue-6/20210625/ascefj.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-25/ascecg.2021.9.issue-25/20210628/ascecg.2021.9.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-6/asbcd6.2021.10.issue-6/20210618/asbcd6.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-25/ancham.2021.93.issue-25/20210629/ancham.2021.93.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-25/bichaw.2021.60.issue-25/20210629/bichaw.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-6/bcches.2021.32.issue-6/20210616/bcches.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-6/bomaf6.2021.22.issue-6/20210614/bomaf6.2021.22.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-24/cgeabj.2021.99.issue-24/20210628-01/cgeabj.2021.99.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-6/crtoec.2021.34.issue-6/20210621/crtoec.2021.34.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-12/chreay.2021.121.issue-12/20210623/chreay.2021.121.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-12/cmatex.2021.33.issue-12/20210622/cmatex.2021.33.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-6/cgdefu.2021.21.issue-6/20210602/cgdefu.2021.21.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-12/enfuem.2021.35.issue-12/20210617/enfuem.2021.35.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-12/esthag.2021.55.issue-12/20210615/esthag.2021.55.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-6/estlcu.2021.8.issue-6/20210608/estlcu.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-25/iecred.2021.60.issue-25/20210630/iecred.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-12/inocaj.2021.60.issue-12/20210621/inocaj.2021.60.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-6/jaaucr.2021.1.issue-6/20210628/jaaucr.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-25/jafcau.2021.69.issue-25/20210630/jafcau.2021.69.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-6/jceaax.2021.66.issue-6/20210610/jceaax.2021.66.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-6/jceda8.2021.98.issue-6/20210608/jceda8.2021.98.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-6/jcisd8.2021.61.issue-6/20210628/jcisd8.2021.61.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-6/jctcce.2021.17.issue-6/20210608/jctcce.2021.17.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/jmcmar.2021.64.issue-12/20210624/jmcmar.2021.64.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-6/jnprdf.2021.84.issue-6/20210625/jnprdf.2021.84.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-12/joceah.2021.86.issue-12/20210618/joceah.2021.86.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-24/jpcafh.2021.125.issue-24/20210624/jpcafh.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-24/jpcbfk.2021.125.issue-24/20210624/jpcbfk.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-24/jpccck.2021.125.issue-24/20210624/jpccck.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-24/jpclcd.2021.12.issue-24/20210624/jpclcd.2021.12.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-6/jprobs.2021.20.issue-6/20210604/jprobs.2021.20.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-25/jacsat.2021.143.issue-25/20210630/jacsat.2021.143.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-6/jamsef.2021.32.issue-6/20210602/jamsef.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-25/langd5.2021.37.issue-25/20210629/langd5.2021.37.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-12/mamobx.2021.54.issue-12/20210622/mamobx.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-6/mpohbp.2021.18.issue-6/20210607/mpohbp.2021.18.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-12/nalefd.2021.21.issue-12/20210623/nalefd.2021.21.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-12/orlef7.2021.23.issue-12/20210618/orlef7.2021.23.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-6/oprdfk.2021.25.issue-6/20210618/oprdfk.2021.25.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-12/orgnd7.2021.40.issue-12/20210628/orgnd7.2021.40.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b00420&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b00420&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b00420&amp;href=/doi/10.1021/acs.jmedchem.8b00420" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 11</span><span class="cit-fg-pageRange">, 4961-4977</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/11" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b00419" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b00421" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of Novel Nonsteroidal Anti-Inflammatory Drugs and Carbonic Anhydrase Inhibitors Hybrids (NSAIDs–CAIs) for the Management of Rheumatoid Arthritis</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Ozlem Akgul</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ozlem Akgul</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Ege University Bornova, İzmir, Turkey 35100</div><div class="loa-info-affiliations-info">NEUROFARBA Department, Sezione di Scienze Farmaceutiche, University of Florence, Via Ugo Schiff 6, 50019 Sesto Fiorentino, Florence, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ozlem++Akgul">Ozlem Akgul</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lorenzo Di Cesare Mannelli</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lorenzo Di Cesare Mannelli</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Neuroscience, Psychology, Drug Research and Child Health-NEUROFARBA-Pharmacology and Toxicology Section, University of Florence, 50139 Florence, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lorenzo++Di+Cesare+Mannelli">Lorenzo Di Cesare Mannelli</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Daniela Vullo</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Daniela Vullo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratorio di Chimica Bioinorganica, University of Florence, Polo Scientifico, Rm. 188, Via della Lastruccia 3, 50019 Sesto Fiorentino, Florence, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Daniela++Vullo">Daniela Vullo</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Andrea Angeli</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Andrea Angeli</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">NEUROFARBA Department, Sezione di Scienze Farmaceutiche, University of Florence, Via Ugo Schiff 6, 50019 Sesto Fiorentino, Florence, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Andrea++Angeli">Andrea Angeli</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Carla Ghelardini</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Carla Ghelardini</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Neuroscience, Psychology, Drug Research and Child Health-NEUROFARBA-Pharmacology and Toxicology Section, University of Florence, 50139 Florence, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Carla++Ghelardini">Carla Ghelardini</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Gianluca Bartolucci</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gianluca Bartolucci</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">NEUROFARBA Department, Sezione di Scienze Farmaceutiche, University of Florence, Via Ugo Schiff 6, 50019 Sesto Fiorentino, Florence, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gianluca++Bartolucci">Gianluca Bartolucci</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5631-8769" title="Orcid link">http://orcid.org/0000-0002-5631-8769</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Abdulmalik Saleh Alfawaz Altamimi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Abdulmalik Saleh Alfawaz Altamimi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam Bin Abdulaziz University, P.O. Box 173, Alkharj 11942, Saudi Arabia</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Abdulmalik+Saleh++Alfawaz+Altamimi">Abdulmalik Saleh Alfawaz Altamimi</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Andrea Scozzafava</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Andrea Scozzafava</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratorio di Chimica Bioinorganica, University of Florence, Polo Scientifico, Rm. 188, Via della Lastruccia 3, 50019 Sesto Fiorentino, Florence, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Andrea++Scozzafava">Andrea Scozzafava</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Claudiu T. Supuran</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Claudiu T. Supuran</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">NEUROFARBA Department, Sezione di Scienze Farmaceutiche, University of Florence, Via Ugo Schiff 6, 50019 Sesto Fiorentino, Florence, Italy</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#debdb2bfabbab7abf0adabaeabacbfb09eabb0b7b8b7f0b7aa"><span class="__cf_email__" data-cfemail="2a49464b5f4e435f04595f5a5f584b446a5f44434c4304435e">[email protected]</span></a>. Tel: +39-055-4573729. Fax: +39-055-4573385.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Claudiu+T.++Supuran">Claudiu T. Supuran</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4262-0323" title="Orcid link">http://orcid.org/0000-0003-4262-0323</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Fabrizio Carta</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Fabrizio Carta</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">NEUROFARBA Department, Sezione di Scienze Farmaceutiche, University of Florence, Via Ugo Schiff 6, 50019 Sesto Fiorentino, Florence, Italy</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#e187808393889b888ecf8280939580a1948f888788cf8895"><span class="__cf_email__" data-cfemail="395f585b4b50435056175a584b4d58794c57505f5017504d">[email protected]</span></a>. Tel: +39-055-4573666. Fax: +39-055-4573385.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Fabrizio++Carta">Fabrizio Carta</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1141-6146" title="Orcid link">http://orcid.org/0000-0002-1141-6146</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00420&amp;href=/doi/10.1021%2Facs.jmedchem.8b00420" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 11</span><span class="cit-pageRange">, 4961–4977</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 10, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>14 March 2018</li><li><span class="item_label"><b>Published</b> online</span>10 May 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 June 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b00420" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00420</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4961%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DOzlem%2BAkgul%252C%2BLorenzo%2BDi%2BCesare%2BMannelli%252C%2BDaniela%2BVullo%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D11%26contentID%3Dacs.jmedchem.8b00420%26title%3DDiscovery%2Bof%2BNovel%2BNonsteroidal%2BAnti-Inflammatory%2BDrugs%2Band%2BCarbonic%2BAnhydrase%2BInhibitors%2BHybrids%2B%2528NSAIDs%25E2%2580%2593CAIs%2529%2Bfor%2Bthe%2BManagement%2Bof%2BRheumatoid%2BArthritis%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4977%26publicationDate%3DJune%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b00420"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1563</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">25</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b00420" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of Novel Nonsteroidal Anti-Inflammatory Drugs and Carbonic Anhydrase Inhibitors Hybrids (NSAIDs–CAIs) for the Management of Rheumatoid Arthritis&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Ozlem&quot;,&quot;last_name&quot;:&quot;Akgul&quot;},{&quot;first_name&quot;:&quot;Lorenzo&quot;,&quot;last_name&quot;:&quot;Di Cesare Mannelli&quot;},{&quot;first_name&quot;:&quot;Daniela&quot;,&quot;last_name&quot;:&quot;Vullo&quot;},{&quot;first_name&quot;:&quot;Andrea&quot;,&quot;last_name&quot;:&quot;Angeli&quot;},{&quot;first_name&quot;:&quot;Carla&quot;,&quot;last_name&quot;:&quot;Ghelardini&quot;},{&quot;first_name&quot;:&quot;Gianluca&quot;,&quot;last_name&quot;:&quot;Bartolucci&quot;},{&quot;first_name&quot;:&quot;Abdulmalik&quot;,&quot;last_name&quot;:&quot;Saleh Alfawaz Altamimi&quot;},{&quot;first_name&quot;:&quot;Andrea&quot;,&quot;last_name&quot;:&quot;Scozzafava&quot;},{&quot;first_name&quot;:&quot;Claudiu&quot;,&quot;last_name&quot;:&quot;T. Supuran&quot;},{&quot;first_name&quot;:&quot;Fabrizio&quot;,&quot;last_name&quot;:&quot;Carta&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;10&quot;,&quot;issue&quot;:&quot;11&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;4961-4977&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b00420&quot;},&quot;abstract&quot;:&quot;Herein we report the design as well as the synthesis of a new series of dual hybrid compounds consisting of the therapeutically used nonsteroidal-anti-inflammatory drugs (NSAIDs; i.e., indometacin, sulindac, ketoprofen, ibuprofen, diclofenac, ketorolac, etc., cyclooxygenase inhibitors) and the carbonic anhydrase inhibitor (CAIs) fragments of the sulfonamide type. Such compounds are proposed as new tools for the management of ache symptoms associated with rheumatoid arthritis (RA) and related inflammation diseases. The majority of the hybrids reported were effective in inhibiting the ubiquitous human (h) CA I and II as well as the RA overexpressed hCAs IX and XII isoforms, with KI values comprised of the low-medium nanomolar ranges. The antihyperalgesic activity of selected compounds was assessed by means of the paw-pressure and incapacitance tests using an in vivo RA model, and among them the hybrids 6B and 8B showed potent antinociceptive effects lasting up to 60 min after administration.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00420&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00420" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00420&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00420" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00420&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00420" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00420&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00420&amp;href=/doi/10.1021/acs.jmedchem.8b00420" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b00420" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b00420" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00420&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b00420%26sid%3Dliteratum%253Aachs%26pmid%3D29746127%26genre%3Darticle%26aulast%3DAkgul%26date%3D2018%26atitle%3DDiscovery%2Bof%2BNovel%2BNonsteroidal%2BAnti-Inflammatory%2BDrugs%2Band%2BCarbonic%2BAnhydrase%2BInhibitors%2BHybrids%2B%2528NSAIDs%25E2%2580%2593CAIs%2529%2Bfor%2Bthe%2BManagement%2Bof%2BRheumatoid%2BArthritis%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D11%26spage%3D4961%26epage%3D4977%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=291594" title="Silica">Silica</a>,</li><li><a href="/action/doSearch?ConceptID=290667" title="Ions">Ions</a>,</li><li><a href="/action/doSearch?ConceptID=291152" title="Gels">Gels</a>,</li><li><a href="/action/doSearch?ConceptID=292317" title="Ethyl groups">Ethyl groups</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/11" title="Go to Volume 61, Issue 11"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/jmcmar.2018.61.issue-11/20180614/jmcmar.2018.61.issue-11.largecover.jpg" alt="Go to Volume 61, Issue 11"/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00420/20180608/images/medium/jm-2018-004205_0006.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00420/20180608/images/large/jm-2018-004205_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00420&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Herein we report the design as well as the synthesis of a new series of dual hybrid compounds consisting of the therapeutically used nonsteroidal-anti-inflammatory drugs (NSAIDs; i.e., indometacin, sulindac, ketoprofen, ibuprofen, diclofenac, ketorolac, etc., cyclooxygenase inhibitors) and the carbonic anhydrase inhibitor (CAIs) fragments of the sulfonamide type. Such compounds are proposed as new tools for the management of ache symptoms associated with rheumatoid arthritis (RA) and related inflammation diseases. The majority of the hybrids reported were effective in inhibiting the ubiquitous human (h) CA I and II as well as the RA overexpressed hCAs IX and XII isoforms, with <i>K</i><sub>I</sub> values comprised of the low-medium nanomolar ranges. The antihyperalgesic activity of selected compounds was assessed by means of the paw-pressure and incapacitance tests using an in vivo RA model, and among them the hybrids <b>6B</b> and <b>8B</b> showed potent antinociceptive effects lasting up to 60 min after administration.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16420" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16420" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We recently reported a proof-of-concept study that hybrid small molecules composed of the nonsteroidal-anti-inflammatory-drugs and carbonic-anhydrase-inhibitors (NSAIDs–CAIs) fragments were more effective, in terms of potency and time efficacy when compared to the reference drug ibuprofen, for the management of ache symptoms associated with inflammatory diseases such as rheumatoid arthritis (RA).<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> This study was mainly supported by the data obtained in an in vivo model of RA, which in turn was based on preliminary reports accounting for the contribution of several carbonic anhydrases (CAs, EC 4.2.1.1) to the inflammatory processes.<a onclick="showRef(event, 'ref2 ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4 ref5">(2−5)</a> The serum of RA-affected patients exhibited abnormal expressions of the human (h) CAs I, III, and IV isoforms.<a onclick="showRef(event, 'ref2 ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4 ref5">(2−5)</a> Our group recently demonstrated the overexpression of CA IX and XII isoforms in the synovium obtained from patients affected by juvenile idiopathic arthritis (JIA).<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a></div><div class="NLM_p">The main reaction catalyzed by CAs is the reversible hydration of carbon dioxide (CO<sub>2</sub> + H<sub>2</sub>O ⇔ H<sup>+</sup> + HCO<sub>3</sub><sup>–</sup>; eq 1).<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> The involvement of this reaction in a plethora of physiological events (both at the cellular as well as tissue level) is well-established.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> However, this transformation when uncatalyzed is not able to meet the physiological needs of the cells, which is the reason why many isoforms of the CAs have evolved.<a onclick="showRef(event, 'cit7a cit7b cit7c'); return false;" href="javascript:void(0);" class="ref cit7a cit7b cit7c">(7a−c)</a> Thus, it is not surprising that any disruption of this equilibrium is often associated with diseases, including RA.<a onclick="showRef(event, 'ref1 cit7a'); return false;" href="javascript:void(0);" class="ref ref1 cit7a">(1,7a)</a> In this context the CAs overexpression is expected to increase the ionic species concentrations (H<sup>+</sup> and HCO<sub>3</sub><sup>–</sup>) at the cellular level, and since the bicarbonate ions are essential components in cells and are immediately recovered, a local extracellular acidosis is immediately established. Pioneer studies demonstrated that intensity of inflammation processes and the ache-related symptoms in RA-affected patients were inversely correlated with tissutal pH values.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8,9)</a> In addition tissue acidosis was found to be unfavorable for the progression of both humoral and cellular immunity processes.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></div><div class="NLM_p last">Despite the enormous progress achieved in the treatment of RA, still no effective cure for the disease was obtained. To date the pharmacological approaches against RA are based on the use of (i) disease-modifying-antirheumatic-drugs (DMARDs), JAK-inhibitors, corticosteroids, and biologics which act, slowing down the course of the disease, and (ii) the NSAIDs which act to ease the symptoms of the inflammation.<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11,12)</a> As a result, many scientific reports account for the discovery of novel diagnostic tools, biological targets, as well as for a variety of lead compounds.<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13,14)</a> In this context, herein we report a large series of new small molecule hybrids of the NSAID-CAI type, which differ from the previously ones for the CAI fragment (of the sulfonamide type in this article versus the coumarin chemotype in the previous report)<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> as well as for the length of the linker connecting the two fragments. We assessed the ability of the compounds reported to inhibit the activity of the most relevant hCAs as well as to reduce the RA ache related symptoms by means of in vitro enzymatic assays and in in vivo animal models of the disease, respectively. Our aim is to further support our previous studies on hCAs as valid and robust pharmacological targets for the treatment of RA inflammatory diseases, and for this reason, no cyclooxygenase (COX) activities of the hybrids were investigated in this study, considering the fact that the COOH moiety of the NSAID is essential for their inhibition of COX (and in our reported compounds is transformed in an amide).<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46333" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46333" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Design and Synthesis of Compounds</h3><div class="NLM_p">In analogy to our earlier article,<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> we report the design and synthetic procedures of NSAID-CAI small molecule hybrids consisting of a clinically used NSAID fragment connected to a CAI of the sulfonamide type, by means of a linear alkyl spacer (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00420/20180608/images/medium/jm-2018-004205_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00420/20180608/images/large/jm-2018-004205_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Design of the NSAID-CAI hybrids.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00420/20180608/images/large/jm-2018-004205_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00420&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In our synthetic strategy, we made use of the NSAID carboxylic acid moiety in order to efficiently install an amide bond, which also represents a virtually unique single break point within the entire hybrid molecules. As for the linker, we focused on linear full carbon or ether-type fragments, which are biocompatible and of easy access from the synthetic viewpoint (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00420/20180608/images/medium/jm-2018-004205_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00420/20180608/images/large/jm-2018-004205_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthetic Procedure for the Synthesis of NSAID-CAIs</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00420/20180608/images/large/jm-2018-004205_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00420&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As above-reported, the compound series was obtained by means of well-established amide coupling reactions using the sulfanilamide <b>A</b> and 4-(2-amino-ethyl)-benzenesulfonamide <b>B</b> for the <b>1A</b>–<b>8A</b> and <b>1B</b>–<b>8B</b> series, respectively, whereas the intermediates <b>C</b>–<b>D</b> and <b>E</b> were obtained according to the synthetic procedure depicted in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00420/20180608/images/medium/jm-2018-004205_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00420/20180608/images/large/jm-2018-004205_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Procedure for the Synthesis of <b>C, D</b>, and <b>E</b> Intermediates<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00420/20180608/images/large/jm-2018-004205_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00420&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">All final compounds obtained and their intermediates were properly characterized by means of <sup>1</sup>H, <sup>13</sup>C, and <sup>19</sup>F-NMR spectroscopy, HRMS, and were ≥95% HPLC pure (see <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> for details).</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Carbonic Anhydrase Inhibition Studies</h3><div class="NLM_p">All compounds herein reported and the standard CAI acetazolamide (<b>AAZ</b>) was assessed for their inhibition properties against the relevant hCA isoforms (i.e., I, II, IV, IX, and XII) using the stopped-flow carbon dioxide hydration assay (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. hCA I, II, IV, IX, and XII in Vitro Inhibition Data with NSAID-CAI Compounds by the Stopped-Flow CO<sub>2</sub> Hydrase Assay<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="5" align="center" char="."><i>K</i><sub>I</sub> (nM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center" char=".">hCA I</th><th class="colsep0 rowsep0" align="center" char=".">hCA II</th><th class="colsep0 rowsep0" align="center" char=".">hCA IV</th><th class="colsep0 rowsep0" align="center" char=".">hCA IX<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">hCA XII</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1A</b></td><td class="colsep0 rowsep0" align="char" char=".">40.4</td><td class="colsep0 rowsep0" align="char" char=".">32.4</td><td class="colsep0 rowsep0" align="char" char=".">218.1</td><td class="colsep0 rowsep0" align="char" char=".">13.9</td><td class="colsep0 rowsep0" align="char" char=".">33.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2A</b></td><td class="colsep0 rowsep0" align="char" char=".">7.9</td><td class="colsep0 rowsep0" align="char" char=".">4.2</td><td class="colsep0 rowsep0" align="char" char=".">653.2</td><td class="colsep0 rowsep0" align="char" char=".">12.6</td><td class="colsep0 rowsep0" align="char" char=".">28.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3A</b></td><td class="colsep0 rowsep0" align="char" char=".">19.4</td><td class="colsep0 rowsep0" align="char" char=".">4.6</td><td class="colsep0 rowsep0" align="char" char=".">49.1</td><td class="colsep0 rowsep0" align="char" char=".">5.1</td><td class="colsep0 rowsep0" align="char" char=".">2.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4A</b></td><td class="colsep0 rowsep0" align="char" char=".">58.5</td><td class="colsep0 rowsep0" align="char" char=".">5.5</td><td class="colsep0 rowsep0" align="char" char=".">717.7</td><td class="colsep0 rowsep0" align="char" char=".">9.2</td><td class="colsep0 rowsep0" align="char" char=".">40.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5A</b></td><td class="colsep0 rowsep0" align="char" char=".">16.1</td><td class="colsep0 rowsep0" align="char" char=".">3.6</td><td class="colsep0 rowsep0" align="char" char=".">1495</td><td class="colsep0 rowsep0" align="char" char=".">49.1</td><td class="colsep0 rowsep0" align="char" char=".">24.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6A</b></td><td class="colsep0 rowsep0" align="char" char=".">73.3</td><td class="colsep0 rowsep0" align="char" char=".">23.3</td><td class="colsep0 rowsep0" align="char" char=".">519.1</td><td class="colsep0 rowsep0" align="char" char=".">61.3</td><td class="colsep0 rowsep0" align="char" char=".">27.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7A</b></td><td class="colsep0 rowsep0" align="char" char=".">208.6</td><td class="colsep0 rowsep0" align="char" char=".">92.5</td><td class="colsep0 rowsep0" align="char" char=".">4375</td><td class="colsep0 rowsep0" align="char" char=".">58.7</td><td class="colsep0 rowsep0" align="char" char=".">40.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8A</b></td><td class="colsep0 rowsep0" align="char" char=".">68.2</td><td class="colsep0 rowsep0" align="char" char=".">89.2</td><td class="colsep0 rowsep0" align="char" char=".">179.3</td><td class="colsep0 rowsep0" align="char" char=".">5.3</td><td class="colsep0 rowsep0" align="char" char=".">7.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1B</b></td><td class="colsep0 rowsep0" align="char" char=".">79.3</td><td class="colsep0 rowsep0" align="char" char=".">9.2</td><td class="colsep0 rowsep0" align="char" char=".">7298</td><td class="colsep0 rowsep0" align="char" char=".">72.2</td><td class="colsep0 rowsep0" align="char" char=".">93.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2B</b></td><td class="colsep0 rowsep0" align="char" char=".">19.1</td><td class="colsep0 rowsep0" align="char" char=".">5.2</td><td class="colsep0 rowsep0" align="char" char=".">6028</td><td class="colsep0 rowsep0" align="char" char=".">12.9</td><td class="colsep0 rowsep0" align="char" char=".">91.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3B</b></td><td class="colsep0 rowsep0" align="char" char=".">8.1</td><td class="colsep0 rowsep0" align="char" char=".">6.5</td><td class="colsep0 rowsep0" align="char" char=".">3005</td><td class="colsep0 rowsep0" align="char" char=".">39.3</td><td class="colsep0 rowsep0" align="char" char=".">54.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4B</b></td><td class="colsep0 rowsep0" align="char" char=".">42.5</td><td class="colsep0 rowsep0" align="char" char=".">7.8</td><td class="colsep0 rowsep0" align="char" char=".">3053</td><td class="colsep0 rowsep0" align="char" char=".">38.1</td><td class="colsep0 rowsep0" align="char" char=".">92.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5B</b></td><td class="colsep0 rowsep0" align="char" char=".">534.4</td><td class="colsep0 rowsep0" align="char" char=".">78.9</td><td class="colsep0 rowsep0" align="char" char=".">3877</td><td class="colsep0 rowsep0" align="char" char=".">94.9</td><td class="colsep0 rowsep0" align="char" char=".">90.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6B</b></td><td class="colsep0 rowsep0" align="char" char=".">64.9</td><td class="colsep0 rowsep0" align="char" char=".">27.3</td><td class="colsep0 rowsep0" align="char" char=".">6857</td><td class="colsep0 rowsep0" align="char" char=".">62.5</td><td class="colsep0 rowsep0" align="char" char=".">94.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7B</b></td><td class="colsep0 rowsep0" align="char" char=".">494.0</td><td class="colsep0 rowsep0" align="char" char=".">95.8</td><td class="colsep0 rowsep0" align="char" char=".">8365</td><td class="colsep0 rowsep0" align="char" char=".">62.5</td><td class="colsep0 rowsep0" align="char" char=".">92.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8B</b></td><td class="colsep0 rowsep0" align="char" char=".">68.4</td><td class="colsep0 rowsep0" align="char" char=".">43.7</td><td class="colsep0 rowsep0" align="char" char=".">8654</td><td class="colsep0 rowsep0" align="char" char=".">43.3</td><td class="colsep0 rowsep0" align="char" char=".">90.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1C</b></td><td class="colsep0 rowsep0" align="char" char=".">267.9</td><td class="colsep0 rowsep0" align="char" char=".">7.4</td><td class="colsep0 rowsep0" align="char" char=".">59.9</td><td class="colsep0 rowsep0" align="char" char=".">26.2</td><td class="colsep0 rowsep0" align="char" char=".">7.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2C</b></td><td class="colsep0 rowsep0" align="char" char=".">73.8</td><td class="colsep0 rowsep0" align="char" char=".">7.8</td><td class="colsep0 rowsep0" align="char" char=".">73.4</td><td class="colsep0 rowsep0" align="char" char=".">21.2</td><td class="colsep0 rowsep0" align="char" char=".">7.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3C</b></td><td class="colsep0 rowsep0" align="char" char=".">21.3</td><td class="colsep0 rowsep0" align="char" char=".">6.7</td><td class="colsep0 rowsep0" align="char" char=".">77.7</td><td class="colsep0 rowsep0" align="char" char=".">76.5</td><td class="colsep0 rowsep0" align="char" char=".">8.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4C</b></td><td class="colsep0 rowsep0" align="char" char=".">233.8</td><td class="colsep0 rowsep0" align="char" char=".">7.0</td><td class="colsep0 rowsep0" align="char" char=".">354.7</td><td class="colsep0 rowsep0" align="char" char=".">244.4</td><td class="colsep0 rowsep0" align="char" char=".">68.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6C</b></td><td class="colsep0 rowsep0" align="char" char=".">87.0</td><td class="colsep0 rowsep0" align="char" char=".">7.5</td><td class="colsep0 rowsep0" align="char" char=".">5996</td><td class="colsep0 rowsep0" align="char" char=".">103.2</td><td class="colsep0 rowsep0" align="char" char=".">65.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7C</b></td><td class="colsep0 rowsep0" align="char" char=".">375.9</td><td class="colsep0 rowsep0" align="char" char=".">4.2</td><td class="colsep0 rowsep0" align="char" char=".">1598</td><td class="colsep0 rowsep0" align="char" char=".">177.2</td><td class="colsep0 rowsep0" align="char" char=".">44.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8C</b></td><td class="colsep0 rowsep0" align="char" char=".">769.7</td><td class="colsep0 rowsep0" align="char" char=".">186.8</td><td class="colsep0 rowsep0" align="char" char=".">5483</td><td class="colsep0 rowsep0" align="char" char=".">144.4</td><td class="colsep0 rowsep0" align="char" char=".">57.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1D</b></td><td class="colsep0 rowsep0" align="char" char=".">59.4</td><td class="colsep0 rowsep0" align="char" char=".">25.2</td><td class="colsep0 rowsep0" align="char" char=".">63.7</td><td class="colsep0 rowsep0" align="char" char=".">10.4</td><td class="colsep0 rowsep0" align="char" char=".">6.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2D</b></td><td class="colsep0 rowsep0" align="char" char=".">57.6</td><td class="colsep0 rowsep0" align="char" char=".">5.8</td><td class="colsep0 rowsep0" align="char" char=".">219.8</td><td class="colsep0 rowsep0" align="char" char=".">18.3</td><td class="colsep0 rowsep0" align="char" char=".">19.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3D</b></td><td class="colsep0 rowsep0" align="char" char=".">7.1</td><td class="colsep0 rowsep0" align="char" char=".">5.0</td><td class="colsep0 rowsep0" align="char" char=".">77.2</td><td class="colsep0 rowsep0" align="char" char=".">12.5</td><td class="colsep0 rowsep0" align="char" char=".">5.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4D</b></td><td class="colsep0 rowsep0" align="char" char=".">54.2</td><td class="colsep0 rowsep0" align="char" char=".">6.3</td><td class="colsep0 rowsep0" align="char" char=".">301.3</td><td class="colsep0 rowsep0" align="char" char=".">17.5</td><td class="colsep0 rowsep0" align="char" char=".">43.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5D</b></td><td class="colsep0 rowsep0" align="char" char=".">44.4</td><td class="colsep0 rowsep0" align="char" char=".">5.0</td><td class="colsep0 rowsep0" align="char" char=".">295.9</td><td class="colsep0 rowsep0" align="char" char=".">18.3</td><td class="colsep0 rowsep0" align="char" char=".">7.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6D</b></td><td class="colsep0 rowsep0" align="char" char=".">4.9</td><td class="colsep0 rowsep0" align="char" char=".">5.4</td><td class="colsep0 rowsep0" align="char" char=".">811.0</td><td class="colsep0 rowsep0" align="char" char=".">141.0</td><td class="colsep0 rowsep0" align="char" char=".">35.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7D</b></td><td class="colsep0 rowsep0" align="char" char=".">81.7</td><td class="colsep0 rowsep0" align="char" char=".">84.3</td><td class="colsep0 rowsep0" align="char" char=".">522.6</td><td class="colsep0 rowsep0" align="char" char=".">202.4</td><td class="colsep0 rowsep0" align="char" char=".">84.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8D</b></td><td class="colsep0 rowsep0" align="char" char=".">63.4</td><td class="colsep0 rowsep0" align="char" char=".">46.2</td><td class="colsep0 rowsep0" align="char" char=".">672.8</td><td class="colsep0 rowsep0" align="char" char=".">137.1</td><td class="colsep0 rowsep0" align="char" char=".">59.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1E</b></td><td class="colsep0 rowsep0" align="char" char=".">48.4</td><td class="colsep0 rowsep0" align="char" char=".">284.7</td><td class="colsep0 rowsep0" align="char" char=".">2804</td><td class="colsep0 rowsep0" align="char" char=".">14.0</td><td class="colsep0 rowsep0" align="char" char=".">6.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2E</b></td><td class="colsep0 rowsep0" align="char" char=".">71.4</td><td class="colsep0 rowsep0" align="char" char=".">47.1</td><td class="colsep0 rowsep0" align="char" char=".">2693</td><td class="colsep0 rowsep0" align="char" char=".">16.3</td><td class="colsep0 rowsep0" align="char" char=".">4.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3E</b></td><td class="colsep0 rowsep0" align="char" char=".">20.9</td><td class="colsep0 rowsep0" align="char" char=".">6.1</td><td class="colsep0 rowsep0" align="char" char=".">92.8</td><td class="colsep0 rowsep0" align="char" char=".">8.0</td><td class="colsep0 rowsep0" align="char" char=".">4.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4E</b></td><td class="colsep0 rowsep0" align="char" char=".">242.7</td><td class="colsep0 rowsep0" align="char" char=".">86.7</td><td class="colsep0 rowsep0" align="char" char=".">7264</td><td class="colsep0 rowsep0" align="char" char=".">45.5</td><td class="colsep0 rowsep0" align="char" char=".">94.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6E</b></td><td class="colsep0 rowsep0" align="char" char=".">93.8</td><td class="colsep0 rowsep0" align="char" char=".">66.4</td><td class="colsep0 rowsep0" align="char" char=".">7737</td><td class="colsep0 rowsep0" align="char" char=".">22.0</td><td class="colsep0 rowsep0" align="char" char=".">5.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7E</b></td><td class="colsep0 rowsep0" align="char" char=".">86.5</td><td class="colsep0 rowsep0" align="char" char=".">8.1</td><td class="colsep0 rowsep0" align="char" char=".">8136</td><td class="colsep0 rowsep0" align="char" char=".">7.7</td><td class="colsep0 rowsep0" align="char" char=".">64.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8E</b></td><td class="colsep0 rowsep0" align="char" char=".">341.8</td><td class="colsep0 rowsep0" align="char" char=".">78.8</td><td class="colsep0 rowsep0" align="char" char=".">8023</td><td class="colsep0 rowsep0" align="char" char=".">51.9</td><td class="colsep0 rowsep0" align="char" char=".">93.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>AAZ</b></td><td class="colsep0 rowsep0" align="char" char=".">250.0</td><td class="colsep0 rowsep0" align="char" char=".">12.1</td><td class="colsep0 rowsep0" align="char" char=".">74.0</td><td class="colsep0 rowsep0" align="char" char=".">25.8</td><td class="colsep0 rowsep0" align="char" char=".">5.7</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Means from three diverse assays. The errors were comprised within ±5–10% of the values reported (data not shown).</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">Catalytic domain.</p></div></div></div><div class="NLM_p">On the basis of the kinetic data reported in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> on the NSAID-CAIs, the following structure–activity-relationships (SARs) can be drawn.</div><div id="sec2_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i9" class="anchor-spacer"></div><h4 class="article-section__title" id="_i9"> Compounds <b>1A</b>–<b>8A</b></h4><div class="NLM_p">(i) The in vitro kinetic data showed that the Naproxen derivative <b>2A</b> was the most potent within the series against the hCA I isoform (<i>K</i><sub>I</sub> = 7.9 nM), followed by the ketorolac <b>5A</b> and ketoprofen <b>3A</b> (<i>K</i><sub>I</sub>’s = 16.1 and 19.4 nM, respectively). Medium inhibition potencies, with <i>K</i><sub>I</sub> values spanning between 40.4 and 73.3 nM, were obtained for ibuprofen <b>1A</b>, flurbiprofen <b>4A</b>, sulindac <b>6A</b>, and diclofenac <b>8A</b>, whereas the indometacin benzenesulfonamide <b>7A</b> resulted in far less potent values (<i>K</i><sub>I</sub> = 208.6 nM) and similar to the standard CAI <b>AAZ</b> (<i>K</i><sub>I</sub> = 250 nM).</div><div class="NLM_p">(ii) As for the ubiquitous hCA II isoform, better inhibition results were obtained for the <b>1A</b>–<b>8A</b> series when compared to the hCA I. As reported in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, compounds <b>2A</b>–<b>5A</b> showed <i>K</i><sub>I</sub> values comprised between 5.5 and 3.6 nM, thus up to 3.4 fold stronger when compared to <b>AAZ</b> (<i>K</i><sub>I</sub> = 12.1 nM). The ibuprofen <b>1A</b> and sulindac <b>6A</b> derivatives were far less potent (<i>K</i><sub>I</sub>’s = 32.4 and 23.3 nM, respectively) followed by the indometacin <b>7A</b> and diclofenac <b>8A</b> derivatives (<i>K</i><sub>I</sub>’s 92.5 and 89.2 nM, respectively).</div><div class="NLM_p">(iii) The hCA IV isoform, which is of particular interest as it is widely expressed in the kidneys and heart tissues, showed that only the ketoprofen derivative <b>3A</b> was a valuable inhibitor, with a <i>K</i><sub>I</sub> value 1.51-fold lower when compared to the reference CAI <b>AAZ</b> (<i>K</i><sub>I</sub>’s = 49.1 and 74.0 nM, respectively). Conversely all other compounds of the series showed weak inhibitory properties (<i>K</i><sub>I</sub> comprised between 179.3 and 4375 nM).</div><div class="NLM_p">(iv) Compounds <b>3A</b>, <b>4A</b>, and <b>8A</b> were very potent inhibitors of the tumor associated hCA IX isoform with <i>K</i><sub>I</sub> values in the low nanomolar range (<i>K</i><sub>I</sub>’s 5.1, 9.2, and 5.3 nM, respectively), thus more potent when compared to <b>AAZ</b> (K<sub>I</sub> 25.8 nM). Weaker inhibition potencies were reported for the ibuprofen <b>1A</b> and naproxen <b>2A</b> derivatives (<i>K</i><sub>I</sub>’s = 13.9 and 12.6 nM, respectively), followed by the ketorolac <b>5A</b>, sulindac <b>6A</b>, and indometacin <b>7A</b> (<i>K</i><sub>I</sub>’s 49.1, 61.3, and 58.7 nM, respectively). The latter were also weaker in inhibiting the hCA IX isoform when compared to the standard <b>AAZ</b> (<i>K</i><sub>I</sub> = 25.8 nM).</div><div class="NLM_p last">(v) Among the <b>1A</b>–<b>8A</b> series, the ketoprofen <b>3A</b> and the diclofenac <b>8A</b> derivatives showed low nanomolar inhibition values against the second tumor associated hCA (i.e., isoform XII) and comparable to <b>AAZ</b>. As reported in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, the first resulted 1.97-fold stronger when compared to <b>AAZ</b> (<i>K</i><sub>I</sub>’s = 2.9 and 5.7 nM, respectively), whereas the latter showed a <i>K</i><sub>I</sub> inhibition value slightly higher (<i>K</i><sub>I</sub> = 7.0 nM). As for the other compounds, similar inhibition values and ranging between 27.2 and 33.0 nM were obtained for the ibuprofen <b>1A</b>, naproxen <b>2A</b>, ketorolac <b>5A</b>, and sulindac <b>6A</b>. Finally the flurbiprofen <b>4A</b> and the indometacin <b>7A</b> derivatives resulted in less potent inhibition of the hCA XII and again with close-matching <i>K</i><sub>I</sub>’s (40.0 and 40.8 nM, respectively).</div></div><div id="sec2_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i10" class="anchor-spacer"></div><h4 class="article-section__title" id="_i10"> Compounds <b>1B</b>–<b>8B</b></h4><div class="NLM_p">(i) Among the ethylaminobenzenesulfonamide series, the hCA I isoform resulted, potently inhibited from the ketoprofen <b>3B</b> derivative (<i>K</i><sub>I</sub> = 8.1 nM) followed by the naproxen <b>2B</b> compound (<i>K</i><sub>I</sub> = 19.1 nM), and thus they resulted more effective in comparison to the CAI <b>AAZ</b> (<i>K</i><sub>I</sub> = 250.0 nM). Medium inhibition values were obtained for the ibuprofen <b>1B</b>, flurbiprofen <b>4B</b>, sulindac <b>6B</b>, and diclofenac <b>8B</b> derivatives (<i>K</i><sub>I</sub>’s = 79.3, 42.5, 64.9, and 68.4 nM, respectively). The ketorolac <b>5B</b> and indometacin <b>7B</b> compounds resulted ineffective against the hCA I (<i>K</i><sub>I</sub>’s = 534.4 and 494.0 nM, respectively).</div><div class="NLM_p">(ii) Better inhibition results were obtained for the hCA II isoform. As reported in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, compounds <b>1B</b>–<b>4B</b> were all low nanomolar inhibitors of this isoform with <i>K</i><sub>I</sub>’s spanning between 5.2 and 9.2 nM, and among them, the naproxen <b>3B</b> derivative was the most potent as being 2.33-fold more potent as compared to the CAI <b>AAZ</b> (<i>K</i><sub>I</sub> = 12.1 nM). Within the <b>1B</b>–<b>8B</b> series, the sulindac <b>6B</b> and the diclofenac <b>8B</b> resulted in medium potency inhibitors (<i>K</i><sub>I</sub>’s = 27.3 and 43.7 nM, respectively), whereas the remaining ketorolac <b>5B</b> and indometacin <b>7B</b> were less potent.</div><div class="NLM_p">(iii) Compared to the <b>1A</b>–<b>8A</b> compounds previously discussed, the series <b>1B</b>–<b>8B</b> was ineffective in inhibiting the hCA IV isoform. The corresponding <i>K</i><sub>I</sub> values are reported in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and were all comprised between 3.0 and 8.7 μM.</div><div class="NLM_p">(iv) The transmembrane- and tumor-related hCA IX was efficiently inhibited only from the naproxen derivative <b>2B</b> being 2-fold more potent than the standard CAI <b>AAZ</b> (<i>K</i><sub>I</sub>’s = 12.9 and 25.8 nM, respectively). Then the ketoprofen <b>3B</b>, the flurbiprofen <b>4B</b>, and the diclofenac <b>8B</b> containing compounds showed medium nanomolar inhibition values (<i>K</i><sub>I</sub>’s = 39.3, 38.1, and 43.3 nM, respectively), whereas all remaining hybrids in the series resulted in low activity in inhibiting this isoform (<i>K</i><sub>I</sub>’s comprised between 62.5 and 94.9 nM).</div><div class="NLM_p last">(v) Among the compound series <b>1B</b>–<b>8B</b>, the ketoprofen <b>3B</b> derivative was the most potent as hCA XII inhibitor and also resulted in 9.5-fold less potency when compared to the reference <b>AAZ</b> (<i>K</i><sub>I</sub>’s = 54.0 and 5.7 nM, respectively). The remaining derivatives were all high nanomolar hCA XII inhibitors with <i>K</i><sub>I</sub>’s spanning between 90.2 and 94.4 nM.</div></div><div id="sec2_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i11" class="anchor-spacer"></div><h4 class="article-section__title" id="_i11"> Compounds <b>1C</b>–<b>4C</b> and <b>6C</b>–<b>8C</b></h4><div class="NLM_p">(i) Data in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> showed that only the ketoprofen <b>3C</b> derivative was potent against the hCA I isoform with a <i>K</i><sub>I</sub> value 10-fold higher when compared to <b>AAZ</b> (<i>K</i><sub>I</sub>’s = 21.3 and 250 nM, respectively), followed by the naproxen <b>2C</b> and the sulindac <b>6C</b>, which resulted in both high nanomolar inhibitors of this isoform (<i>K</i><sub>I</sub>’s = 73.8 and 87.0 nM). All the remaining compounds in the series were inactive in inhibiting the hCA I with <i>K</i><sub>I</sub> values comparable or higher to the reference <b>AAZ</b>.</div><div class="NLM_p">(ii) In analogy to the compound series previously discussed, also in this case the hCA II results were particularly inhibited. Data in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> showed that among this series only the diclofenac <b>8C</b> was ineffective against the hCA II (<i>K</i><sub>I</sub> = 186.8 nM), whereas all the others were nanomolar inhibitors with <i>K</i><sub>I</sub>’s ranging between 4.2 and 7.8 nM, thus slightly more potent when compared to the <b>AAZ</b> (<i>K</i><sub>I</sub> = 12.1 nM).</div><div class="NLM_p">(iii) As for hCA IV the ibuprofen <b>1C</b> resulted in the most potent inhibitor within the series with a <i>K</i><sub>I</sub> being slightly more potent (1.24 fold) when compared to the reference <b>AAZ</b> (<i>K</i><sub>I</sub>’s = 59.9 and 74.0 nM, respectively). The naproxen <b>2C</b> and the ketoprofen <b>3C</b> derivatives (73.4 and 77.7 nM, respectively) showed each other similar inhibition potencies whose values were analogous to the reference compound <b>AAZ</b> (<i>K</i><sub>I</sub> = 74.0 nM). Finally, all the other compounds in the series results were inactive against the hCA IV (<i>K</i><sub>I</sub>’s comprised between 354.7 and 5996 nM).</div><div class="NLM_p">(iv) The in vitro kinetic data reported in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> showed that the hCA IX isoform was efficiently inhibited from the ibuprofen <b>1C</b> and naproxen <b>2C</b> derivatives whose <i>K</i><sub>I</sub> values were quite similar to the reference <b>AAZ</b> (<i>K</i><sub>I</sub>’s = 26.2, 21.2, and 25.8 nM respectively). Then the ketoprofen derivative <b>3C</b> resulted in 2.97-fold less potency in inhibiting the hCA IX isoform when compared to the standard CAI (<i>K</i><sub>I</sub>’s = 76.5 and 25.8 nM, respectively), followed by all the remaining hybrids which were weak hCA IX inhibitors with <i>K</i><sub>I</sub> values ranging between 103.2 and 244.4 nM.</div><div class="NLM_p last">(v) The second tumor associated hCA isoform (XII) in analogy to the previously discussed one resulted in potent inhibitition from the ibuprofen <b>1C</b> and the naproxen <b>2C</b> derivatives with <i>K</i><sub>I</sub> values quite similar to each other (7.0 and 7.5 nM) and slightly less effective when compared to the reference <b>AAZ</b> (<i>K</i><sub>I</sub> = 5.7 nM). Again the Ketoprofen <b>3C</b> showed lower inhibition potency (<i>K</i><sub>I</sub> = 8.6 nM) followed by the remaining compounds in the series with <i>K</i><sub>I</sub> values comprised between 44.0 and 68.6 nM.</div></div><div id="sec2_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i12" class="anchor-spacer"></div><h4 class="article-section__title" id="_i12"> Compounds <b>1D</b>–<b>8D</b></h4><div class="NLM_p">(i) Within the <b>1D</b>–<b>8D</b> series tested, the ketoprofen <b>3D</b> and the sulindac <b>6D</b> were highly potent in inhibiting the hCA I isoform with <i>K</i><sub>I</sub> values comprised within the low nanomolar range (7.1 and 4.9 nM, respectively) and thus more potent when compared to the reference <b>AAZ</b> (<i>K</i><sub>I</sub> = 250 nM). All the other compounds in the series resulted in medium potency inhibitors of this isoform. Among them the ketorolac <b>5D</b> derivative was the most potent (<i>K</i><sub>I</sub> = 44.4 nM) followed by the flurbiprofen <b>4D</b>, the naproxen <b>2D</b>, and the ibuprofen <b>1D</b> (<i>K</i><sub>I</sub>’s = 54.2, 57.6, and 59.4 nM, respectively). The least potent inhibitors of the hCA I isoform were the dichlofenac <b>8D</b> and the indometacin <b>7D</b>, which showed <i>K</i><sub>I</sub>s in the high nanomolar range (<i>K</i><sub>I</sub>’s = 63.4 and 81.7 nM, respectively).</div><div class="NLM_p">(ii) The highly abundant hCA II isoform was efficiently inhibited from the naproxen <b>2D</b>, the ketoprofen <b>3D</b>, the flurbiprofen <b>4D</b>, the ketorolac <b>5D</b>, and the sulindac <b>6D</b> derivatives with low nanomolar <i>K</i><sub>I</sub>’s and spanning between 5.4 and 6.3 nM, thus being on the average of 2-fold higher potency compared to <b>AAZ</b> (<i>K</i><sub>I</sub> = 12.1 nM). Significant worsening of the hCA I inhibition was observed for the ibuprofen <b>1D</b> (<i>K</i><sub>I</sub> = 25.2 nM), the diclofenac <b>8D</b> (<i>K</i><sub>I</sub> = 46.2 nM), and the indometacin <b>7D</b> (<i>K</i><sub>I</sub> = 84.3 nM) derivatives.</div><div class="NLM_p">(iii) As reported in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, the hCA IV isoform was efficiently inhibited from the ibuprofen <b>1D</b> and the ketoprofen <b>3D</b> derivatives. In particular, the first one resulted in a 1.16-fold more potency of the reference CAI <b>AAZ</b> (<i>K</i><sub>I</sub>’s of 63.7 and 74.0 nM, respectively), whereas the latter was slightly less potent (<i>K</i><sub>I</sub> = 77.2 nM). All the remaining compounds in the series resulted in ineffectively inhibiting the hCA IV isoform with <i>K</i><sub>I</sub> values comprised within 219.8 and 811.0 nM.</div><div class="NLM_p">(iv) As for the tumor-associated hCA IX, the sulindac <b>6D</b>, the indometacin <b>7D</b>, and the diclofenac <b>8D</b> derivatives (<i>K</i><sub>I</sub>’s = 141.0, 202.4, and 137.1 nM, respectively) resulted in lower potent inhibitors in comparison to the standard CAI (<i>K</i><sub>I</sub> = 25.8 nM). More interesting results were obtained for the remaining compounds <b>1D</b>–<b>5D</b>, which showed low nanomolar inhibition values and almost flat SAR. Among them, the ibuprofen <b>1D</b> and the ketoprofen <b>3D</b> derivatives resulted in the most potent CAIs with <i>K</i><sub>I</sub>’s of 10.4 and 12.5 nM, respectively, thus being 2.5 and 2.0 fold, respectively, more potent when compared to the reference <b>AAZ</b>.</div><div class="NLM_p last">(v) Remarkable data were obtained for the second tumor-correlated hCA (the XII). The ketoprofen <b>3D</b> derivative was the most potent within the series and also being slightly more potent than the CAI <b>AAZ</b> (<i>K</i><sub>I</sub>’s of 5.2 and 5.7 nM, respectively). Similarly, the ibuprofen <b>1D</b> and the ketorolac <b>5D</b> resulted in quite effective inhibitors of the hCA XII (<i>K</i><sub>I</sub> values of 6.5 and 7.3 nM, respectively). As reported in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, a definite SAR was obtained for the remaining compounds in the series as increasing <i>K</i><sub>I</sub> values against the hCA XII were obtained for the naproxen <b>2D</b> (19.4 nM), the sulindac <b>6D</b> (35.0 nM), the flurbiprofen <b>4D</b> (43.3 nM), the diclofenac <b>8D</b> (59.2 nM), and for the indometacin <b>7D</b> (84.1 nM) derivatives.</div></div><div id="sec2_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13"> Compounds <b>1 × 10<sup>–4</sup>E</b> and <b>6 × 10<sup>–8</sup>E</b></h4><div class="NLM_p">(i) In analogy to the three compound series previously discussed, also in this case the ketoprofen <b>3E</b> derivative resulted in the most effective inhibitors of the hCA I isoform with a <i>K</i><sub>I</sub> value of 20.9 nM, thus being 12.0-fold more potent of the reference CAI <b>AAZ</b> (<i>K</i><sub>I</sub> = 250 nM). Increasing <i>K</i><sub>I</sub> values were observed for the other compounds in the series such as the ibuprofen <b>1E</b>, the naproxen <b>2E</b>, the indometacin <b>7E</b>, and the sulindac <b>6E</b>, which showed that <i>K</i><sub>I</sub> values were comprised between 48.4 and 93.8 nM. Finally the flurbiprofen <b>4E</b> and the diclofenac <b>8E</b> were the least active in the series (<i>K</i><sub>I</sub>’s = 242.7 and 341.8 nM).</div><div class="NLM_p">(ii) The hCA II isoform was efficiently inhibited from the ketoprofen <b>3E</b> and indometacin <b>7E</b> derivatives being 1.98- and 1.50-fold, respectively, more potent when compared to the standard <b>AAZ</b> (<i>K</i><sub>I</sub>’s = 6.1, 8.1, and 12.1 nM, respectively). Medium potency inhibition against the hCA II was shown from the naproxen <b>2E</b> and the sulindac <b>6E</b> (<i>K</i><sub>I</sub>’s of 47.1 and 66.6 nM) followed by the diclofenac <b>8E</b> and the flurbiprofen <b>4E</b> derivatives which were high nanomolar <i>K</i><sub>I</sub> values (<i>K</i><sub>I</sub>’s = 78.8 and 86.7 nM). Finally the ibuprofen <b>1E</b> derivative was ineffective (<i>K</i><sub>I</sub> = 284.7 nM).</div><div class="NLM_p">(iii) In analogy to the compound series previously discussed, the hCA IV was the least inhibited among those considered in the present study. As reported in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, the ketoprofen <b>3E</b> derivative was the only compound in the series which showed inhibition potency, although of modest entity, being 1.25-fold less potent when compared to the reference CAI <b>AAZ</b> (<i>K</i><sub>I</sub>’s of 92.8 and 74.0 nM, respectively). All the remaining derivatives in the series were not active with <i>K</i><sub>I</sub> values comprised within the low micromolar range.</div><div class="NLM_p">(iv) Conversely to the hCA IV, the IX isoform was potently inhibited from the majority of the compounds herein reported. In particular, the indometacin <b>7E</b> and the ketoprofen <b>3E</b> derivatives were the most potent, having <i>K</i><sub>I</sub> values 3.35- and 3.23-fold, respectively, lower when compared to the reference CAI <b>AAZ</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Slight higher inhibition values were obtained for the ibuprofen <b>1E</b> and for the naproxen <b>2E</b> derivatives (<i>K</i><sub>I</sub>’s of 14.0 and 16.3 nM, respectively), followed by the sulindac <b>6E</b> whose inhibition value was comparable to the <b>AAZ</b> (<i>K</i><sub>I</sub>’s of 22.0 and 25.8 nM, respectively). The remaining compounds in the series, the flurbiprofen <b>4E</b> and the diclofenac <b>8E</b> derivatives, were the least potent with <i>K</i><sub>I</sub>’s of 45.5. and 51.9 nM, respectively.</div><div class="NLM_p">(v) Interesting results were also obtained for the second tumor associated hCA (the XII isoform). The flurbiprofen <b>4E</b> and the diclofenac <b>8E</b> derivatives were both ineffective in inhibiting the enzyme being 16.5-fold less potent when compared to the reference CAI <b>AAZ</b> (<i>K</i><sub>I</sub>’s of 94.1, 93.8, and 5.7 nM, respectively), followed by the indometacin <b>7E</b> derivative which was a medium potency inhibitor (<i>K</i><sub>I</sub> value of 64.0 nM). Better results were obtained for the remaining compounds which showed comparable inhibition values to the standard CAI (such as the ibuprofen <b>1E</b> and the sulindac <b>6E</b> derivatives whose <i>K</i><sub>I</sub>’s were of 6.6 and 5.0 nM) or even lower as in the case of the naproxen <b>2E</b> and the ketoprofen <b>3E</b> derivatives (<i>K</i><sub>I</sub>’s = 4.2 and 4.1 nM, respectively).</div><div class="NLM_p last">In summary, the effects on the in vitro kinetic activity due to the linker lengths connecting the NSAID and the CAI fragments within the compound series here reported, afforded quite complex SARs which are not clearly defined. Among each CA isoform we observed: (i) the naproxen <b>2A</b>, the ketoprofen <b>3B</b>, and its longer derivative <b>3D</b> were the most potent inhibitors of the ubiquitous hCA I isoform (<i>K</i><sub>I</sub>’s of 7.9, 8.1, and 7.1 nM, respectively); the hCA II isoform was potently inhibited by many compounds, with <i>K</i><sub>I</sub>’s in the low nanomolar range regardless of the nature of the NSAID or the linker. Among them the ketorolac <b>5A</b>, the naproxen <b>2A</b>, the ketoprofen <b>3A</b>, and the indometacin <b>7C</b> derivatives resulted in the most effective hCA II inhibitors (<i>K</i><sub>I</sub>’s of 3.6, 4.2, 4.6, and 4.2 nM, respectively); (iii) the membrane associated hCA IV was potently inhibited by the ketoprofen <b>3A</b> (<i>K</i><sub>I</sub> = 49.1 nM) followed by the ibuprofen <b>1C</b> and <b>1D</b> derivatives (<i>K</i><sub>I</sub>’s of 59.9 and 63.7 nM), which were slightly more potent when compared to <b>AAZ</b> (K<sub>I</sub> 74.0 nM); (iv) the hCA XII isoform was potently inhibited from the ketoprofen <b>3A</b> and the diclofenac <b>8A</b> with <i>K</i><sub>I</sub>’s of 5.1 and 5.3 nM, respectively, thus being 5.1- and 4.9-fold, respectively, more potent than the reference CAI <b>AAZ</b> (<i>K</i><sub>I</sub> of 25.8 nM). Among all compounds tested, the ketoprofen <b>3A</b> derivative was also the most potent inhibitor, the last hCA here considered (XII), with a <i>K</i><sub>I</sub> value of 2.9 nM, thus being nearly 2-fold more potent than the standard CAI <b>AAZ</b> (<i>K</i><sub>I</sub> of 5.7 nM). Slightly less potent inhibition values against this isoform were obtained for the naproxen <b>2E</b>, the ketoprofen <b>3E</b>, the sulindac <b>6E</b>, and the ketoprofen <b>3D</b> derivatives (<i>K</i><sub>I</sub>’s of 4.2, 4.1, 5.0, and 5.2 nM, respectively), which behaved anyhow as very potent inhibitors.</div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Pain Relieving Tests</h3><div class="NLM_p">The acute pain relieving effect of hybrids <b>2B</b>, <b>3B</b>, <b>6B</b>, and <b>8B</b> (0.1–10.0 mg kg<sup>–1</sup> p.o.) was assessed in an in vivo model of RA, which was induced by complete Freund’s adjuvant (CFA) i.a. treatment. Efficacy was compared with NSAIDs contained in the different hybrids (naproxen, ketoprofen, sulindac, and diclofenac). For this purpose, NSAIDs were administered p.o. using a dosage equimolar to the highest dose of composite compounds (10.0 mg/kg).</div><div class="NLM_p">In <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>, the hypersensitivity to a mechanical noxious stimulus (Paw pressure test) is shown. After 14 days from i.a. CFA injection, the tolerated weight on the ipsilateral paw decreased to 43.5 ± 0.5 g (CFA + vehicle group in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>), thus considerably lower to the value of 63.3 ± 1.0 g relative to vehicle-treated animals (1% CMC), which in turn displayed a stable threshold to nociceptive stimuli over the time course of the tests. Among the compounds tested, the naproxen derivative <b>2B</b> at 0.1 mg/kg concentration was ineffective in determining any antinociceptive effect, whereas at 1.0 mg/kg concentration was able to increase the pain threshold in a dose-dependent manner. As reported in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>, a sensible effect was observed after 15 min administration, peaking at 30 min and lasting up to 60 min. The administration of <b>2B</b> at 10.0 mg/kg resulted only in a slight increase of the observed values at 30 and 45 min after administration when compared to the previous experiment at 10-fold lower concentration. Interestingly, no extension of the antinociceptive effect over time was observed. The naproxen alone (5.6 mg/kg) results were completely ineffective. As for the ketoprofen <b>3B</b>, a dosage concentration of 0.1 mg/kg determined a slight pain relieving effect at 15 min, which remained constant up to 30 min (50.0 ± 0.3 and 50.0 ± 0.2 g, respectively) and lasted for 45 min. An increase of the dosage of <b>3B</b> to 1.0 mg kg<sup>–1</sup> showed higher effects. As reported in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a> at 15 min, the antinociceptive response evoked from <b>3B</b> was significative (51.7 ± 1.7 g), picking at 30 min (53.3 ± 0.8 g) and lasting up to 60 min after administration. The higher dosage of 3B (10 mg/kg) resulted in further increase of the pain relief effects, which reached the highest value at 15 min and remained constant up to 30 (56.7 ± 0.8 g). In this case, the antinociceptive effect was also prolonged up to 75 min from the treatment. The ketoprofen alone (5.8 mg/kg) increased the pain threshold only at 15 min with value comparable to its corresponding hybrid <b>3B</b> at the lowest concentration (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).</div><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00420/20180608/images/medium/jm-2018-004205_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00420/20180608/images/large/jm-2018-004205_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Acute pain reliever effect of <b>2B</b>, <b>3B</b>, <b>6B</b>, and <b>8B</b> in a CFA i.a. injection-induced RA model in rats. The Paw pressure test was used to assess the hypersensitivity toward noxious mechanical stimuli. NSAIDs (naproxen, ketoprofen, sulindac, and diclofenac) contained in the different hybrids were used as references tested at a dosage equimolar to 10 mg/kg of the corresponding NSAID–CAI. The measurements were accomplished on day 14 after CFA injection. The hybrids were suspended in 1% carboxymethyl cellulose (CMC) and administered orally. The values reported are the mean of 8 rats performed in 2 distinct experiments. ^^<i>P</i> < 0.01 vs vehicle + vehicle treated animals. *<i>P</i> < 0.05 and **<i>P</i> < 0.01 vs time 0 min of the same group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00420/20180608/images/large/jm-2018-004205_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00420&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In analogy to <b>3B</b>, the sulindac <b>6B</b> hybrid also evoked in a dose-dependent manner the antihypersensitive effect. As reported in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>, the compound results were completely ineffective at 0.1 mg/kg<sup>–1</sup> dosage, whereas a significant efficacy at 1.0 mg/kg<sup>–1</sup> dosage was reported and lasted up to 60 min after administration. As shown in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>, the maximum effect was reached at 15 min and was constant up to 30 min (55.0 ± 2.5 and 55.0 ± 0.4 g, respectively). Finally, the treatment with <b>6B</b> at 10-fold higher concentrations (10 mg/kg<sup>–1</sup>) fully counteracted the CFA-induced hypersensitivity of the ipsilateral paw at 15 min (62.5 ± 2.0 g) and picked at 30 min (64.2 ± 0.8 g), and the effect lasted up to 75 min after administration. Again the sulindac <i>di per se</i> (6.6 mg/kg) were inactive when considered in our experiments.</div><div class="NLM_p">The last compound tested (i.e., the diclofenac derivative <b>8B</b>) at a dosage of 0.1 mg/kg<sup>–1</sup> was able to induce partial antinociceptive effect which lasted up to 45 min after administration and peaked at 15 min with a value of 52.5 ± 2.5 g. The antinociceptive response for compound <b>8B</b> resulted in further enhancement at the dose of 1.0 mg kg<sup>–1</sup>. In this case, the maximum effect was reached at 30 min (56.7 ± 0.8 g) and completely vanished at 60 min. The administration of <b>8B</b> at 10.0 mg kg<sup>–1</sup> dose resulted both in an increase of the pain threshold of the ipsilateral paw (peaking at 30 min with a value of 66.3 ± 1.0 g) as well as in the efficacy time frame (extended up to 75 min). The NSAID diclofenac alone (6.2 mg/kg<sup>–1</sup>) induced a significant pain relief only at 15 min after administration with a value perfectly matching the hybrid <b>8B</b> at 1.0 mg/kg<sup>–1</sup> dosage.</div><div class="NLM_p">Interestingly any of the tested compounds changed the pain threshold of the contralateral paw, thus suggesting that such molecules do not influence the normal pain sensitivity (data not shown).</div><div class="NLM_p">The efficacy of hybrids <b>2B</b>, <b>3B</b>, <b>6B</b>, and <b>8B</b> was also evaluated against the spontaneous pain, which was measured as the hind limb weight-bearing alterations originated by unilateral damage (incapacitance test, <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>).</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00420/20180608/images/medium/jm-2018-004205_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00420/20180608/images/large/jm-2018-004205_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Acute pain reliever effect of <b>2B</b>, <b>3B</b>, <b>6B</b>, and <b>8B</b> in a CFA i.a. injection-induced RA model in rats. The incapacitance test was performed in order to assess the hind limb weight bearing alterations, which were measured as postural imbalance related to pain stimuli. The data values are the mathematical difference between the weight applied on the contralateral and ipsilateral limb (Δweight). NSAIDs (naproxen, ketoprofen, sulindac, and diclofenac) contained in the different hybrids were used as references tested at a dosage equimolar to 10.0 mg/kg<sup>–1</sup> of the corresponding NSAID–CAI. The measurements were done 14 days after CFA injection. All hybrids were suspended in 1% CMC and administered orally. The values are the mean of 8 rats and obtained in 2 different experiments. ^^<i>P</i> < 0.01 vs vehicle + vehicle treated animals. *<i>P</i> < 0.05 and **<i>P</i> < 0.01 vs time 0 min of the same group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00420/20180608/images/large/jm-2018-004205_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00420&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The difference values between the weight burdened on the contralateral and the ipsilateral paw (Δweight) was increased in CFA-treated animals when compared to the values of the control group (54.2 ± 5.1 vs 2.5 ± 3.4 g, respectively). Compound <b>2B</b> was inactive at the lowest concentration (0.1 mg/kg<sup>–1</sup>), whereas it showed activity when administered at higher dosages of 1.0 and 10.0 mg/kg<sup>–1</sup>. In both cases, the maximum effect was reached at 30 min after administration (34.3 ± 5.6 and 29.3 ± 0.4 g, respectively) and lasted up to 60 min. As for the hybrid <b>3B</b>, its administration at the lowest concentration slightly reduced the Δweight with a peaking value at 15 min of 42.3 ± 0.7 g. Significant effects were observed when <b>3B</b> was administered at 1.0 and 10.0 mg/kg<sup>–1</sup>. In both cases, both the intensity as well as the duration of the effect were dose-dependent. As shown in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>, the compound <b>3B</b> at 1.0 mg/kg<sup>–1</sup> peaked at 30 min with a value of 36.8 ± 2.9 g and lasted up to 60 min. A 10-fold increase of the dose administered (10.0 mg/kg<sup>–1</sup>) resulted in a maximum Δweight value at 30 min of 28.6 ± 4.8 g and enhancement of the effect up to 75 min. The experiments conducted on the sulindac hybrid <b>6B</b> revealed a complete ineffectiveness on reducing the postural imbalance when administered at the lowest dosage (0.1 mg/kg<sup>–1</sup>). Conversely significant effects were observed when <b>6B</b> was administered at the concentrations of 1.0 and 10.0 mg/kg<sup>–1</sup>. As reported in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>, the acute pain reliever effect followed a dose-dependent trend after a single administration and peaked at 15 and 30 min, respectively (22.3 ± 3.5 g and 8.6 ± 1.1 g). In both cases, the effect lasted up to 60 min. The final compound considered (i.e., the diclofenac hybrid <b>8B</b>) showed a weak effect at the lowest concentration (0.1 mg/kg<sup>–1</sup>) with a peaking value of 39.0 ± 1.8 g and lasting up to 45 min after single dose administration. More intense effects were observed when the compound <b>8B</b> was administered at 1.0 and 10.0 1 mg/kg<sup>–1</sup> dosages. As reported in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>, the dosage increase resulted in both widening of the time frame efficacy as well as the magnitude with peaking values of 20.6 ± 3.9 and 14.7 ± 2.2 g, respectively, at 30 min after administration. The acute pain reliever effects of the hybrid compounds <b>2B</b>, <b>3B</b>, <b>6B</b>, and <b>8B</b> tested were compared with their relative NSAIDs counterparts (i.e., naproxen, ketoprofen, sulindac, and diclofenac). As reported in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>, only the ketoprofen and diclofenac were able to evoke significant relief effects even if their efficacy and potency were significantly lower when compared to their hybrid <b>3B</b> and <b>8B</b>, respectively (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>).</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00485" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00485" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We report new low molecular weight NSAID-CAI hybrid molecules as potential drug lead compounds for the treatment of ache-related symptoms associated with inflammatory diseases such as the RA. All compounds in the obtained series consisted of a clinically used NSAID fragment (acting as COX inhibitors) linked to a sulfonamide-based CAI moiety. Unlike our previously reported NSAID-CAI hybrids, which showed remarkable inhibition properties of the hCA IV, moderate <i>K</i><sub>I</sub>’s against the IX and XII isoforms, and no activity on the ubiquitous hCAs I and II, the ones herein reported were ineffective inhibitors of hCA IV and effective inhibitors of the remaining enzymatic isoforms considered here (hCA I, II, IX, and XII). Such a complementary in vitro kinetic activity between the two hybrid series is certainly due to the nature of the CAI fragment, which is of the coumarin type in the first series<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> and of the benzenesulfonamide in the latter one. This has been demonstrated by comparison of analogous derivatives between the two series having the same tether length. Even if it was not possible to draw a straightforward SAR from the obtained in vitro kinetic data, we were able to demonstrate that the most potent hybrid derivatives acting as efficient inhibitors against the hCAs herein considered showed remarkable in vivo efficacy. More importantly, in this study we carried out for the first time a complete kinetic profiling of a large series of NSAID-CAI hybrids potentially useful for the development of drug leads for the treatment of RA-related diseases. Such a data will be particularly useful for the selection of the compounds out of the pool having the proper selectivity index against the hCA isoforms involved in RA. The in vivo data obtained by using a CFA-induced arthritis model in rats with selected NSAID-CAI hybrids showed potent antihyperalgesic effects in a dose-dependent manner, starting already at 1 mg kg<sup>–1</sup>. In particular, compounds <b>6B</b> and <b>8B</b> resulted in the best performing ones in terms of intensity and long-lasting effects of the antihyperalgesic action, both in the in vivo tests considered.</div><div class="NLM_p last">In conclusion, we gave further evidence for our previous hypothesis that NSAID–CAI hybrid compounds are indeed valuable leads for the management of ache symptoms typical of inflammatory pathologies such as RA. Moreover, the high affinity showed by these new hybrid molecules on the ubiquitous and erythrocyte expressed hCAs I and II represents an interesting feature which can be of particular advantage both for the systemic distribution of the drugs into the organism as well as for enhancement of their half-life, since their binding to blood present CA isoforms may lead to a depot effect. In this context, it is worth mentioning that RA symptoms highly affect the life quality of patients, which are progressively unable to carry out any activities such as at work, in social relations, and leisure.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Therefore, an ideal pharmacological approach should consist of long-lasting drugs or with extended time clearances. Studies in this direction are currently being developed in our laboratories.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Experimental Protocols</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63314" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63314" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Chemistry</h3><div class="NLM_p last">All anhydrous solvents and reagents used in this study were purchased from Alfa Aesar, TCI, and Sigma-Aldrich. The synthetic reactions involving air- or moisture-sensitive chemicals were carried out under a nitrogen atmosphere using dried glassware and syringes techniques in order to transfer the solutions. Nuclear magnetic resonance (<sup>1</sup>H NMR, <sup>13</sup>C NMR, and <sup>19</sup>F-NMR) spectra were recorded using a Bruker Advance III 400 MHz spectrometer using DMSO-<i>d</i><sub>6</sub> as solvent. The chemical shifts are reported in parts per million (ppm), and the coupling constants (<i>J</i>) are expressed in Hertz (Hz). The splitting patterns are designated as s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; brs, broad singlet; and dd, doublet of doublets. The correct assignment of exchangeable protons (i.e., O<i>H</i> and N<i>H</i>) was carried out by means of the addition of D<sub>2</sub>O. Analytical thin-layer chromatography (TLC) was done on Merck silica gel F-254 plates. Flash chromatography was performed on Merck silica gel 60 (230–400 mesh ASTM) as the stationary phase, and appropriate mixtures of ethyl acetate/<i>n</i>-hexane were the eluents. Melting points (m.p.) were measured in open capillary tubes with a Gallenkamp MPD350.BM3.5 apparatus and are uncorrected. The HPLC was performed by using a Waters 2690 separation module coupled with a photodiode array detector (PDA Waters 996) using a Nova-Pak C18 4 μm 3.9 mm × 150 mm (Waters) silica-based reverse phase column. The sample was dissolved in 10% acetonitrile/H<sub>2</sub>O and an injection volume of 45 μL. The mobile phase (flow rate 1.0 mL/min) was a gradient of H<sub>2</sub>O + trifluoroacetic acid (TFA) 0.1% (A) and acetonitrile + TFA 0.1% (B), with steps as follows: (A%:B%), 0–10 min 90:10, 10–25 min gradient to 60:40, 26:28 min isocratic 20:80, and 29–35 min isocratic 90:10. TFA (0.1%) in water as well in acetonitrile was used as the counterion. All compounds reported here were ≥95% HPLC pure. The solvents used in MS measures were acetone, acetonitrile (Chromasolv grade), and mQ water 18 MΩ. The high-resolution mass spectrometry (HRMS) analysis were performed with a Thermo Finnigan LTQ Orbitrap mass spectrometer coupled with an electrospray ionization source (ESI). Analysis was carried out in positive ion mode [M + H]<sup>+</sup>, and it was used a proper dwell time acquisition to achieve 60000 units of resolution at full width at half maximum (fwhm). Elemental composition of compounds were calculated on the basis of their measured accurate masses, accepting only results with an attribution error less than 5 ppm and a not integer RDB (double bond/ring equivalents) value.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Stock solutions of analytes were prepared using acetone (1.0 mg mL<sup>–1</sup>) and stored at 4 °C. Then working solutions of each analyte were prepared by dilution of the stock solutions using mQ H<sub>2</sub>O/ACN 1/1 (<i>v/v</i>) up to a concentration of 1.0 μg mL<sup>–1</sup> The HRMS analysis was performed by introducing the analyte working solution via syringe pump at 10 μL min<sup>–1</sup>.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> General Procedure a for Synthesis of Compounds <b>1A</b>–<b>8A</b>, <b>1C</b>–<b>4C</b>, and <b>6C</b>–<b>8C</b>, <b>1D</b>–<b>8D</b>, and <b>1 × 10<sup>–8</sup>E</b>.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></h3><div class="NLM_p last">The appropriate NSAID <b>1</b>–<b>8</b> (1.0 equiv), 1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide hydrochloride salt (EDCI·HCl, 2.0 equiv), and 1-hydroxy-7-azabenzotriazole (HOAT, 2.0 equiv) were dissolved in dry DMF or DMA solvents (3.0 mL) and stirred for 10 min at r.t., followed by addition of the amine <b>A</b>, <b>C</b>, <b>D</b>, or <b>E</b> (2.0 equiv) and <i>N</i>,<i>N</i>-diisopropylethylamine (DIPEA, 4.0 equiv) in the same solvent system (1.5 mL). The reaction was stirred until the reaction stops (TLC monitoring), quenched with a 3.0 M aqueous HCl solution at 0 °C, and extracted with ethyl acetate (3 × 15 mL). The combined organic layers were washed with 3.0 M aqueous HCl solution, H<sub>2</sub>O (3 × 20 mL), satd aqueous NaHCO<sub>3</sub> (3 × 20 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and evaporated under vacuo to give a residue which was purified by silica gel column chromatography eluting with ethyl acetate/<i>n</i>-hexane or MeOH/DCM, crystallization, or trituration from the appropriate solvent to afford the titled compounds.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> General Procedure b for Synthesis of Compounds <b>1B</b>–<b>8B</b><a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></h3><div class="NLM_p">The appropriate NSAID <b>1</b>–<b>8</b> (1.0 equiv) and <i>N</i>,<i>N’</i>-dicyclohexylcarbodiimide (DCC, 1.1 equiv) were dissolved in dry dimethylformamide (DMF, 3.0 mL) and stirred at r.t. under a nitrogen atmosphere for 10 min until a white precipitate occurs, and then <i>N</i>-hydroxysuccinimide (NHS, 1.1 equiv) dissolved in dry DMF (1.5 mL) was added and the reaction mixture was stirred at r.t. until starting material was consumed (TLC monitoring) followed by addition of the 4-aminoethylbenzenesulfonamide <b>B</b> (2.0 equiv) dissolved in the same solvent. The reaction mixture was stirred until the reaction stops (TLC monitoring), quenched with a 3.0 M aqueous HCl solution at 0–5 °C, and extracted with ethyl acetate (3 × 15 mL). The precipitate formed during the extraction was filtered-off and the combined organic layers were washed with H<sub>2</sub>O (5 × 15 mL), satd aqueous NaHCO<sub>3</sub> (3 × 20 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and evaporated under vacuo to give a deposit that was purified by silica gel chromatography eluting with MeOH/DCM 5% <i>v/v</i> followed by crystallization from ethyl acetate/petroleum ether to afford the title compounds.</div><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> 2-(±)-(4-Isobutylphenyl)-<i>N</i>-(4-sulfamoylphenyl)propanamide <b>1A</b></h4><div class="NLM_p">Ibuprofen <b>1</b> (1.0 equiv), 1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide hydrochloride salt (EDCI·HCl, 2.0 equiv), and 1-hydroxy-7-azabenzotriazole (HOAT, 2.0 equiv), sulfonilamide <b>A</b> (2.0 equiv) and <i>N</i>,<i>N</i>-diisopropylethylamine (DIPEA, 4.0 equiv) in DMF (4.5 mL) were treated according to the <a class="ref internalNav" href="#sec4_2" aria-label="General Procedure a">General Procedure a</a> previously reported. The crude product was purified by silica gel column chromatography eluting with ethyl acetate/<i>n</i>-hexane 50% <i>v</i>/<i>v</i> and crystallized from ethyl acetate/petroleum ether to afford the title compound <b>1A</b> as a white solid in 19% yield, silica gel TLC <i>R</i><sub><i>f</i></sub>: 0.68 (ethyl acetate/<i>n</i>-hexane 50% <i>v/v</i>); mp: 194.8 °C; δ<sub>H</sub> (400 MHz, DMSO-<i>d</i><sub>6</sub>): 0.88 (6H, d, <i>J</i> 6.6, −CH(<u class="uu">CH</u><sub>3</sub>)<sub>2</sub>), 1.43 (3H, d, <i>J</i> 7.0, −CH<u class="uu">CH</u><sub>3</sub>), 1.83 (1H, p, <i>J</i> 6.8, <u class="uu">CH</u>(CH<sub>3</sub>)<sub>2</sub>), 2.43 (2H, d, <i>J</i> 7.1, -<u class="uu">CH</u><sub>2</sub>CH(CH<sub>3</sub>)<sub>2</sub>), 3.85 (1H, p, <i>J</i> 6.8, −<u class="uu">CH</u>CH<sub>3</sub>), 7.14 (2H, d, <i>J</i> 8.0, Ar–H), 7.26 (2H, s, SO<sub>2</sub>NH<sub>2</sub>, exchange with D<sub>2</sub>O), 7.32 (1H, d, <i>J</i> 8.0, Ar–H), 7.77 (4H, s, 4 × Ar–H), 10.39 (1H, s, −CONH, exchange with D<sub>2</sub>O); δ<sub>C</sub> (100 MHz, DMSO-<i>d</i><sub>6</sub>): 174.0 (C = O), 143.1, 140.7, 139.8, 139.3, 130.0 (2 × Ar–C), 128.0 (2 × Ar–C), 127.7 (2 × Ar–C), 119.7 (2 × Ar–C), 46.7, 45.3, 30.6, 23.2 (−CH<u class="uu">(CH</u><sub>3</sub><u class="uu">)</u><sub>2</sub>), 19.7.</div><div class="NLM_p last">Experimental in agreement with reported data.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> 2-(±)-(4-Isobutylphenyl)-<i>N</i>-(4-sulfamoylphenethyl)propanamide <b>1B</b></h4><div class="NLM_p last">Ibuprofen <b>1</b> (1.0 equiv), <i>N,N’</i>-dicyclohexylcarbodiimide (DCC, 1.1 equiv), <i>N</i>-hydroxysuccinimide (NHS, 1.1 equiv) and 4-aminoethylbenzenesulfonamide <b>B</b> (2.0 equiv), dissolved in dry DMF (1.5 mL), were treated according to the <a class="ref internalNav" href="#sec4_3" aria-label="General Procedure b">General Procedure b</a> previously reported to afford the titled compound <b>1B</b> as a white solid in 23% yield, silica gel TLC <i>R</i><sub><i>f</i></sub>: 0.19 (MeOH/DCM 5% <i>v</i>/<i>v</i>); mp: 149.3 °C; δ<sub>H</sub> (400 MHz, DMSO-<i>d</i><sub>6</sub>): 0.90 (6H, d, <i>J</i> 6.6, −CH(<u class="uu">CH</u><sub>3</sub>)<sub>2</sub>), 1.32 (3H, d, <i>J</i> 7.0, −CH<u class="uu">CH</u><sub>3</sub>), 1.85 (1H, p, <i>J</i> 6.8, −<u class="uu">CH</u>(CH<sub>3</sub>)<sub>2</sub>), 2.46 (2H, d, <i>J</i> 7.1, −<u class="uu">CH</u><sub>2</sub>CH(CH<sub>3</sub>)<sub>2</sub>), 2.77 (2H, t, <i>J</i> 7.1, −CONHCH<sub>2</sub><u class="uu">CH</u><sub>2</sub>−), 3.33–3.26 (2H, m, −CONH<u class="uu">CH</u><sub>2</sub>CH<sub>2</sub>−), 3.55 (1H, d, <i>J</i> 7.2, −<u class="uu">CH</u>CH<sub>3</sub>), 7.12 (2H, d, <i>J</i> 8.1, Ar–H), 7.22(2H, d, <i>J</i> 8.1, Ar–H), 7.30 (2H, d, <i>J</i> 8.3, Ar–H), 7.32 (2H, s, SO<sub>2</sub>NH<sub>2</sub>, exchange with D<sub>2</sub>O), 7.72 (2H, d, <i>J</i> 8.3, Ar–H), 8.03 (1H, t, <i>J</i> 5.6, CONH, exchange with D<sub>2</sub>O); δ<sub>C</sub> (100 MHz, DMSO-<i>d</i><sub>6</sub>): 174.4 (C = O), 144.7, 143.0, 140.4, 140.2, 130.2 (2 × Ar–C), 129.8 (2 × Ar–C), 128.0 (2 × Ar–C), 126.6 (2 × Ar–C), 45.7, 45.2, 40.8 (−CONH<u class="uu">CH</u><sub>2</sub><u class="uu">CH</u><sub>2</sub>−), 35.7 (−CONH<u class="uu">CH</u><sub>2</sub><u class="uu">CH</u><sub>2</sub>−), 30.7, 23.2(−CH<u class="uu">(CH</u><sub>3</sub><u class="uu">)</u><sub>2</sub>), 19.4; ESI-HRMS (<i>m</i>/<i>z</i>) calculated for [M + H]<sup>+</sup> ion species C<sub>21</sub>H<sub>29</sub>N<sub>2</sub>O<sub>3</sub>S, 389.1893; found, 389.1894.</div></div><div id="sec4_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> 2-(±)-(4-Isobutylphenyl)-<i>N</i>-(2-(4-sulfamoylphenoxy)ethyl)propanamide <b>1C</b></h4><div class="NLM_p last">Ibuprofen <b>1</b> (1.0 equiv), 1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide hydrochloride salt (EDCI·HCl, 2.0 equiv) and 1-hydroxy-7-azabenzotriazole (HOAT, 2.0 equiv), 4-((3-hydroxyethyl)amino)benzenesulfonamide <b>C</b> (2.0 equiv) and <i>N</i>,<i>N</i>-diisopropylethylamine (DIPEA, 4.0 equiv) in dry DMA (4.5 mL) were treated according to the <a class="ref internalNav" href="#sec4_3" aria-label="General Procedure b">General Procedure b</a> previously reported. The crude product was purified by silica gel column chromatography using ethyl acetate/<i>n</i>-hexane 66% <i>v/v</i> and crystallized from EtOH/H<sub>2</sub>O to afford the title compound <b>1C</b> as a white solid in 25% yield, silica gel TLC <i>R</i><sub><i>f</i></sub>: 0.36 (ethyl acetate/<i>n</i>-hexane 66% <i>v/v</i>); mp: 152 °C; δ<sub>H</sub> (400 MHz, DMSO-<i>d</i><sub>6</sub>): 0.88 (6H, d, <i>J</i> 6.4, −CH(<u class="uu">CH</u><sub>3</sub>)<sub>2</sub>), 1.34 (3H, d, <i>J</i> 7.2, −CH<u class="uu">CH</u><sub>3</sub>), 1.82 (1H, p, <i>J</i> 6.8, −<u class="uu">CH</u>(CH<sub>3</sub>)<sub>2</sub>), 2.43 (2H, d, <i>J</i> 7.2, −<u class="uu">CH</u><sub>2</sub>CH(CH<sub>3</sub>)<sub>2</sub>), 3.45 (2H, m, −CONH<u class="uu">CH</u><sub>2</sub>CH<sub>2</sub>), 3.59 (1H, q, <i>J</i> 6.8, −<u class="uu">CH</u>CH<sub>3</sub>), 4.08 (2H, t, <i>J</i> 5.6, −CONHCH<sub>2</sub><u class="uu">CH</u><sub>2</sub>), 7.08 (4H, d, <i>J</i> 8.8, Ar–H), 7.24–7.23 (4H, m, SO<sub>2</sub>NH<sub>2</sub>, exchange with D<sub>2</sub>O, 2 × Ar–H), 7.76 (2H, d, <i>J</i> 8.8, Ar–H), 8.21 (1H, t, <i>J</i> 5.6, −CONH, exchange with D<sub>2</sub>O); δ<sub>C</sub> (100 MHz, DMSO-<i>d</i><sub>6</sub>): 174.7 (C = O), 161.7, 140.3, 140.1, 137.2, 129.6 (2 × Ar–C), 128.5 (2 × Ar–C), 127.8 (2 × Ar–C), 115.4 (2 × Ar–C), 67.6 (−CONHCH<sub>2</sub><u class="uu">CH</u><sub>2</sub>), 45.5, 45.0, 39.0, 30.5, 23.1, 23.1, 19.5; ESI-HRMS (<i>m</i>/<i>z</i>) calculated for [M + H]<sup>+</sup> ion species C<sub>21</sub>H<sub>29</sub>N<sub>2</sub>O<sub>4</sub>S, 405.1842; found, 405.1841.</div></div><div id="sec4_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 2-(±)-(4-Isobutylphenyl)-<i>N</i>-(3-(4-sulfamoylphenoxy)propyl)propanamide <b>1D</b></h4><div class="NLM_p last">Ibuprofen <b>1</b> (1.0 equiv), 1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide hydrochloride salt (EDCI·HCl, 2.0 equiv) and 1-hydroxy-7-azabenzotriazole (HOAT, 2.0 equiv), 4-((3-hydroxypropyl)amino)benzenesulfonamide <b>D</b> (2.0 equiv) and <i>N</i>,<i>N</i>-diisopropylethylamine (DIPEA, 4.0 equiv) in dry DMA (4.5 mL) were treated according to the <a class="ref internalNav" href="#sec4_3" aria-label="General Procedure b">General Procedure b</a> previously reported. The crude product purified by silica gel column chromatography using ethyl acetate/<i>n</i>-hexane 50% <i>v/v</i> and crystallized from ethyl acetate/petroleum ether to yield the title compound <b>1D</b> as a white solid in 28% yield, silica gel TLC <i>R</i><sub><i>f</i></sub>: 0.10 (ethyl acetate/<i>n</i>-hexane 50% <i>v/v</i>); mp: 127.1 °C; δ<sub>H</sub> (400 MHz, DMSO-<i>d</i><sub>6</sub>): 0.87–0.85 (8H, m, −CH(<u class="uu">CH</u><sub>3</sub>)<sub>2</sub>, −CONHCH<sub>2</sub><u class="uu">CH</u><sub>2</sub>CH<sub>2</sub>), 1.32 (3H, d, <i>J</i> 7.0, −CH<u class="uu">CH</u><sub>3</sub>), 1.88–1.77 (1H, m, −<u class="uu">CH</u>(CH3)2), 2.41 (2H, d, <i>J</i> 7.1, −<u class="uu">CH</u><sub>2</sub>CH(CH3)2), 3.23–3.18 (2H, m, −CONH<u class="uu">CH</u><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>), 3.56 (1H, d, <i>J</i> 7.0, −<u class="uu">CH</u>CH3), 4.00–3.97 (2H, m, −CONHCH<sub>2</sub>CH<sub>2</sub><u class="uu">CH</u><sub>2</sub>), 7.02 (2H, d, <i>J</i> 8.9, Ar–H), 7.08 (2H, d, <i>J</i> 8.0, Ar–H), 7.23(2H, d, <i>J</i> 7.6, Ar–H), 7.23 (2H, s, SO<sub>2</sub>NH<sub>2</sub>, exchange with D<sub>2</sub>O), 7.75 (2H, d, <i>J</i> 8.9, Ar–H), 8.05 (1H, m, −CONH, exchange with D<sub>2</sub>O); δ<sub>C</sub> (100 MHz, DMSO-<i>d</i><sub>6</sub>): 173.9 (C = O), 161.3, 140.1, 139.6, 136.6, 129.2 (2 × Ar–C), 128.0 (2 × Ar–C), 127.3 (2 × Ar–C), 114.8 (2 × Ar–C), 66.0 (−CONHCH<sub>2</sub>CH<sub>2</sub><u class="uu">CH</u><sub>2</sub>), 45.2, 44.6, 35.8, 30.0, 29.0, 22.6, 19.0; ESI-HRMS (<i>m</i>/<i>z</i>) calculated for [M + H]<sup>+</sup> ion species C<sub>22</sub>H<sub>31</sub>N<sub>2</sub>O<sub>4</sub>S, 419.1999; found, 419.2006.</div></div><div id="sec4_3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 2-(±)-(4-Isobutylphenyl)-<i>N</i>-(4-(4-sulfamoylphenoxy)butyl)propanamide <b>1E</b></h4><div class="NLM_p last">Ibuprofen <b>1</b> (1.0 equiv) and 1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide hydrochloride salt (EDCI·HCl, 2.0 equiv) and 1-hydroxy-7-azabenzotriazole (HOAT, 2.0 equiv), 4-((3-hydroxybuthyl)amino)benzenesulfonamide <b>E</b> (2.0 equiv), and <i>N</i>,<i>N</i>-diisopropylethylamine (DIPEA, 4.0 equiv) in dry DMA (4.5 mL) were treated according to the <a class="ref internalNav" href="#sec4_3" aria-label="General Procedure b">General Procedure b</a> previously reported. The crude product was purified by silica gel column chromatography using ethyl acetate/<i>n</i>-hexane 50% <i>v/v</i> and crystallized from ethyl acetate/petroleum ether to afford the title compound <b>1E</b> as a white solid in 23% yield, silica gel TLC <i>R</i><sub><i>f</i></sub>: 0.5 (ethyl acetate/<i>n</i>-hexane 66% <i>v/v</i>); mp: 101.8 °C; δ<sub>H</sub> (400 MHz, DMSO-<i>d</i><sub>6</sub>): 0.88 (6H, d, <i>J</i> 6.8, −CH (<u class="uu">CH</u><sub>3</sub>)<sub>2</sub>), 1.34 (3H, d, <i>J</i> 7.2, −CH<u class="uu">CH</u><sub>3</sub>), 1.55 (2H, p, <i>J</i> 7.1, −CONHCH<sub>2</sub><u class="uu">CH</u><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>), 1.70 (2H, p, <i>J</i> 7.0, −CONHCH<sub>2</sub>CH<sub>2</sub><u class="uu">CH</u><sub>2</sub>CH<sub>2</sub>), 1.84 (1H, sep., <i>J</i> 6.8, −<u class="uu">CH</u>(CH<sub>3</sub>)<sub>2</sub>), 2.43 (2H, d, <i>J</i> 6.8, −<u class="uu">CH</u><sub>2</sub>CH(CH<sub>3</sub>)<sub>2</sub>), 3.12 (2H, q, <i>J</i> 6.4, −CONH<u class="uu">CH</u><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>), 3.58 (1H, q., <i>J</i> 6.8, −<u class="uu">CH</u>CH<sub>3</sub>), 4.03 (2H, t, <i>J</i> 6.4, −CONHCH<sub>2</sub><u class="uu">CH</u><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>), 7.11–7.06 (4H, m, 4 × Ar–H), 7.22 (2H, s, SO<sub>2</sub>NH<sub>2</sub>, exchange with D<sub>2</sub>O), 7.24 (2H, d, <i>J</i> 8.0, 2 × Ar–H), 7.77 (2H, d, <i>J</i> 8.8, 2 × Ar–H), 7.96 (1H, t, <i>J</i> 5.4, −CONH, exchange with D<sub>2</sub>O), δ<sub>C</sub> (100 MHz, DMSO-<i>d</i><sub>6</sub>) 174.2 (C = O), 161.9, 140.6, 140.0, 137.0, 129.6 (2 × Ar–C), 128.5 (2 × Ar–C), 127.8 (2 × Ar–C), 115.3 (2 × Ar–C), 68.5, 45.7, 45.1, 39.0, 30.5, 26.8, 26.5, 23.1 (−CH<u class="uu">(CH</u><sub>3</sub><u class="uu">)</u><sub>2</sub>), 19.5; ESI-HRMS (<i>m</i>/<i>z</i>) calculated for [M + H]<sup>+</sup> ion species C<sub>23</sub>H<sub>33</sub>N<sub>2</sub>O<sub>4</sub>S, 433.2155; found, 433.2163.</div></div><div id="sec4_3_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 2-(±)-(6-Methoxynaphthalen-2-yl)-<i>N</i>-(4-sulfamoylphenyl)propanamide <b>2A</b></h4><div class="NLM_p last">Naproxen <b>2</b> (1.0 equiv) and 1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide hydrochloride salt (EDCI·HCl, 2.0 equiv) and 1-hydroxy-7-azabenzotriazole (HOAT, 2.0 equiv), sulfonilamide <b>A</b> (2.0 equiv), and <i>N,N</i>-diisopropylethylamine (DIPEA, 4.0 equiv) in DMF (4.5 mL) were treated according to the <a class="ref internalNav" href="#sec4_2" aria-label="General Procedure a">General Procedure a</a> previously reported to afford the title compound <b>2A</b> as a white solid in 8% yield, silica gel TLC <i>R</i><sub><i>f</i></sub>: 0.17 (ethyl acetate/<i>n</i>-hexane 50% <i>v/v</i>); mp: 202.5 °C; δ<sub>H</sub> (400 MHz, DMSO-<i>d</i><sub>6</sub>): 1.54 (3H, d, <i>J</i> 7.0, −CH<u class="uu">CH</u><sub>3</sub>), 3.89 (3H, s, −OCH<sub>3</sub>), 4.02 (1H, d, <i>J</i> 7.0, −<u class="uu">CH</u>CH<sub>3</sub>), 7.18 (1H, dd, <i>J</i> 2.6/8.9, naphtalen-H), 7.26 (2H, s, SO<sub>2</sub>NH<sub>2</sub>, exchange with D<sub>2</sub>O), 7.32 (1H, d, <i>J</i> 2.5, naphtalen-H), 7.54 (1H, dd, <i>J</i> 1.7/8.6, naphtalen-H), 7.77–7.85 (7H, m, 3 × naphtalen-H, 4 × Ar–H), 10.46 (1H, s, −CONH, exchange with D<sub>2</sub>O); δ<sub>C</sub> (100 MHz, DMSO-<i>d</i><sub>6</sub>): 173.5 (C = O), 157.7, 142.7, 138.9, 137.2, 133.9, 129.7, 129.0, 127.5 (2 × Ar–C), 127.2, 126.8, 126.1, 119.4 (2 × Ar–C), 119.3, 106.3, 55.8 (−OCH<sub>3</sub>), 46.6 (−<u class="uu">CH</u>CH<sub>3</sub>), 19.3 (−CH<u class="uu">CH</u><sub>3</sub>); ESI-HRMS (<i>m</i>/<i>z</i>) calculated for [M + H]<sup>+</sup> ion species C<sub>20</sub>H<sub>21</sub>N<sub>2</sub>O<sub>4</sub>S, 385.1216; found, 385.1209.</div></div><div id="sec4_3_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 2-(±)-(6-Methoxynaphthalen-2-yl)-<i>N</i>-(4-sulfamoylphenethyl)propanamide <b>2B</b></h4><div class="NLM_p last">Naproxen <b>2</b> (1.0 equiv), <i>N</i>,<i>N’</i>-dicyclohexylcarbodiimide (DCC, 1.1 equiv), <i>N</i>-hydroxysuccinimide (NHS, 1.1 equiv), and 4-aminoethylbenzenesulfonamide <b>B</b> (2.0 equiv) dissolved in dry DMF (1.5 mL) were treated according to the <a class="ref internalNav" href="#sec4_3" aria-label="General Procedure b">General Procedure b</a> previously reported to afford the titled compound <b>2B</b> as a white solid in 55% yield, silica gel TLC <i>R</i><sub><i>f</i></sub>: 0.14 (MeOH/DCM 5% <i>v/v</i>); mp: 161.3 °C; δ<sub>H</sub> (400 MHz, DMSO-<i>d</i><sub>6</sub>): 1.42 (3H, d, <i>J</i> 7.0, −CH<u class="uu">CH</u><sub>3</sub>), 2.79–2.76 (2H, m, −CONHCH<sub>2</sub><u class="uu">CH</u><sub>2</sub>), 3.32–3.28 (2H, m, −CONH<u class="uu">CH</u><sub>2</sub>CH<sub>2</sub>), 3.72 (1H, q, <i>J</i> 7.0, −<u class="uu">CH</u>CH<sub>3</sub>), 3.90 (3H, s, −OCH<sub>3</sub>), 7.18 (1H, dd, <i>J</i> 2.6/8.9, naphtalen-H), 7.31–7.30 (5H, m, naphtalen-H, 2 × Ar–H, SO<sub>2</sub>NH<sub>2</sub>, exchange with D<sub>2</sub>O), 7.43 (1H, dd, <i>J</i> 1.8/8.5, naphtalen-H), 7.69 (2H, d, <i>J</i> 8.3, 2 × naphtalen-H), 7.82–7.72 (3H, m, naphtalen-H, 2 × Ar–H), 8.09 (1H, t, <i>J</i> 5.6, −CONH, exchange with D<sub>2</sub>O); δ<sub>C</sub> (100 MHz, DMSO-<i>d</i><sub>6</sub>): 174.0 (C = O), 157.6, 144.3, 142.6, 138.0, 133.8, 129.7 (2 × Ar–C), 129.0, 127.22, 127.1, 126.2 (2 × Ar–C), 125.9, 119.2, 106.3, 55.8 (−OCH<sub>3</sub>), 45.7 (−<u class="uu">CH</u>CH<sub>3</sub>), 40.8 (−CONH<u class="uu">CH</u><sub>2</sub>CH<sub>2</sub>), 35.3 (−CONHCH<sub>2</sub><u class="uu">CH</u><sub>2</sub>), 19.0 (−CH<u class="uu">CH</u><sub>3</sub>); experimental in agreement with reported data.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div></div><div id="sec4_3_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 2-(±)-(6-Methoxynaphthalen-2-yl)-<i>N</i>-(2-(4-sulfamoylphenoxy)ethyl)propanamide <b>2C</b></h4><div class="NLM_p last">Naproxen <b>2</b> (1.0 equiv) and 1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide hydrochloride salt (EDCI·HCl, 2.0 equiv) and 1-hydroxy-7-azabenzotriazole (HOAT, 2.0 equiv), 4-((3-hydroxyethyl)amino)benzenesulfonamide <b>C</b> (2.0 equiv), and <i>N,N</i>-diisopropylethylamine (DIPEA, 4.0 equiv) in dry DMA (4.5 mL) were treated according to the <a class="ref internalNav" href="#sec4_3" aria-label="General Procedure b">General Procedure b</a> previously reported. The crude product was crystallized from EtOH/H<sub>2</sub>O to afford the title compound <b>2C</b> as a white solid in 19% yield, silica gel TLC <i>R</i><sub><i>f</i></sub>: 0.23 (EtOAc/<i>n</i>-hexane 66% v/v); mp: 170.3 °C; δ<sub>H</sub> (400 MHz, DMSO-<i>d</i><sub>6</sub>): 1.44 (3H, d, <i>J</i> 6.8, −CH<u class="uu">CH</u><sub>3</sub>), 3.47 (2H, m, −CONH<u class="uu">CH</u><sub>2</sub>CH<sub>2</sub>), 3.80 (1H, d, <i>J</i> 6.8, −<u class="uu">CH</u>CH<sub>3</sub>), 3.89 (3H, s, −OCH<sub>3</sub>), 4.09 (2H, t, <i>J</i> 5.6, −CONHCH<sub>2</sub><u class="uu">CH</u><sub>2</sub>), 7.07 (2H, d, <i>J</i> 8.8, 2 × naphtalen-H), 7.16 (1H, dd, <i>J</i> 2.4/8.8, naphtalen-H), 7.24(2H, s, SO<sub>2</sub>NH<sub>2</sub>, exchange with D<sub>2</sub>O), 7.29 (1H, d, <i>J</i> 2.8, naphtalen-H), 7.46 (1H, dd, <i>J</i> 1.6/8.8, naphtalen-H), 7.77–7.73 (5H, m, naphtalen-H, 4 × Ar–H), 8.30–8.27 (1H, t, <i>J</i> 5.4, −CONH, exchange with D<sub>2</sub>O); δ<sub>C</sub> (100 MHz, DMSO-<i>d</i><sub>6</sub>): 174.7 (C = O), 161.7, 158.0, 138.2, 137.2, 134.0, 130.0, 129.3, 128.6 (2 × Ar–C), 127,5, 127.3, 126.1, 119.4, 115.4 (2 × Ar–C), 106.6, 67.6 (−CONHCH<sub>2</sub><u class="uu">CH</u><sub>2</sub>), 56.1 (−OCH<sub>3</sub>), 45.8 (−<u class="uu">CH</u>CH<sub>3</sub>), 39.1 (−CONHCH<sub>2</sub><u class="uu">CH</u><sub>2</sub>), 19.4 (−CH<u class="uu">CH</u><sub>3</sub>); ESI-HRMS (<i>m</i>/<i>z</i>) calculated for [M + H]<sup>+</sup> ion species C<sub>22</sub>H<sub>25</sub>N<sub>2</sub>O<sub>5</sub>S, 429.1479; found, 429.1484.</div></div><div id="sec4_3_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 2-(±)-(6-Methoxynaphthalen-2-yl)-<i>N</i>-(3-(4-sulfamoylphenoxy)propyl)propan amide <b>2D</b></h4><div class="NLM_p last">Naproxen <b>2</b> (1.0 equiv) and 1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide hydrochloride salt (EDCI·HCl, 2.0 equiv) and 1-hydroxy-7-azabenzotriazole (HOAT, 2.0 equiv), 4-((3-hydroxypropyl)amino)benzenesulfonamide <b>D</b> (2.0 equiv), and <i>N</i>,<i>N</i>-diisopropylethylamine (DIPEA, 4.0 equiv) in dry DMA (4.5 mL) were treated according to the <a class="ref internalNav" href="#sec4_3" aria-label="General Procedure b">General Procedure b</a> previously reported. The crude product purified by silica gel column chromatography using Ac/DCM (14.3% <i>v</i>/<i>v</i>) and crystallized from EtOH/H<sub>2</sub>O (5% <i>v</i>/<i>v</i>) to yield the title compound <b>2D</b> as a white solid in 52% yield, silica gel TLC <i>R</i><sub><i>f</i></sub>: 0.5 (Ac/DCM 14.3% <i>v/v</i>); mp: 164 °C; δH (400 MHz, DMSO-<i>d</i><sub>6</sub>): 1.44 (3H, d, <i>J</i> 7.0, −CH<u class="uu">CH</u><sub>3</sub>), 1.87 (2H, p, <i>J</i> 6.7, −CONHCH<sub>2</sub><u class="uu">CH</u><sub>2</sub>CH<sub>2</sub>), 3.26–3.23 (2H, m, −CONH<u class="uu">CH</u><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>), 3.75 (1H, d, <i>J</i> 7.0, −<u class="uu">CH</u>CH<sub>3</sub>), 3.89 (3H, s, −OCH<sub>3</sub>), 4.00 (2H, t, <i>J</i> 6.4, −CONHCH<sub>2</sub>CH<sub>2</sub><u class="uu">CH</u><sub>2</sub>), 7.00 (2H, dd, <i>J</i> 2.0/7.0, 2 × naphtalen-H), 7.17 (1H, dd, <i>J</i> 2.6/8.9, naphtalen-H), 7.23(2H, s, SO<sub>2</sub>NH<sub>2</sub>, exchange with D<sub>2</sub>O), 7.38 (1H, d, <i>J</i> 2.5, naphtalen-H), 7.47 (1H, dd, <i>J</i> 2.8/10.48, naphtalen-H), 7.80–7.73 (5H, m, naphtalen-H, 4 × Ar–H), 8.11–8.09 (1H, t, <i>J</i> 5.6, −CONH, exchange with D<sub>2</sub>O); δ<sub>C</sub> (100 MHz, DMSO-<i>d</i><sub>6</sub>): 174.1 (C = O), 161.6, 157.7, 138.2, 136.8, 133.9, 129.8, 129.1, 128.4 (2 × Ar–C), 127.3, 127.1, 125.9, 119.3, 115.1 (2 × Ar–C), 106.4, 66.3 (−CONHCH<sub>2</sub>CH<sub>2</sub><u class="uu">CH</u><sub>2</sub>), 55.9 (−OCH<sub>3</sub>), 45.9 (−<u class="uu">CH</u>CH<sub>3</sub>), 36.2, 29.3, 19.3 (−CH<u class="uu">CH</u><sub>3</sub>); ESI-HRMS (<i>m</i>/<i>z</i>) calculated for [M + H]<sup>+</sup> ion species C<sub>23</sub>H<sub>27</sub>N<sub>2</sub>O<sub>5</sub>S, 443.1635; found, 443.1637.</div></div><div id="sec4_3_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 2-(±)-(6-Methoxynaphthalen-2-yl)-<i>N</i>-(4-(4-sulfamoylphenoxy)butyl)propan amide <b>2E</b></h4><div class="NLM_p last">Naproxen <b>2</b> (1.0 equiv) and 1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide hydrochloride salt (EDCI·HCl, 2.0 equiv) and 1-hydroxy-7-azabenzotriazole (HOAT, 2.0 equiv), 4-((3-hydroxybuthyl)amino)benzenesulfonamide <b>E</b> (2.0 equiv), and <i>N</i>,<i>N</i>-diisopropylethylamine (DIPEA, 4.0 equiv) in dry DMA (4.5 mL) were treated according to the <a class="ref internalNav" href="#sec4_3" aria-label="General Procedure b">General Procedure b</a> previously reported. The crude product was triturated with DCM/petroleum (10% <i>v</i>/<i>v</i>) ether to afford the title compound <b>2E</b> as a white solid in 57% yield, silica gel TLC <i>R</i><sub><i>f</i></sub>: 0.2 (ethyl acetate/<i>n</i>-hexane 66% <i>v/v</i>); mp: 143.1 °C; δ<sub>H</sub> (400 MHz, DMSO-<i>d</i><sub>6</sub>): 1.44 (3H, d, <i>J</i> 7.2, −CH<u class="uu">CH</u><sub>3</sub>), 1.59–1.52 (2H, m, −CONHCH<sub>2</sub><u class="uu">CH</u><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>), 1.73–1.66 (2H, m, −CONHCH<sub>2</sub>CH<sub>2</sub><u class="uu">CH</u><sub>2</sub>CH<sub>2</sub>), 3.16–3.11 (2H, m, −CONH<u class="uu">CH</u><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>), 3.77–3.72 (1H, q, <i>J</i> 6.8, −<u class="uu">CH</u>CH<sub>3</sub>), 3.89 (3H, s, −OCH<sub>3</sub>), 4.02 (2H, t, <i>J</i> 6.4, −CONHCH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub><u class="uu">CH</u><sub>2</sub>), 7.06 (2H, d, <i>J</i> 8.8, 2 × naphtalen-H), 7.17 (1H, dd, <i>J</i> 2.8/8.8, naphtalen-H), 7.22 (2H, s, SO<sub>2</sub>NH<sub>2</sub>, exchange with D<sub>2</sub>O), 7.30 (1H, d, <i>J</i> 2.4, naphtalen-H), 7.48 (1H, dd, <i>J</i> 2/8.4, naphtalen-H), 7.78–7.75 (4H, m, naphtalen-H, 3 × Ar–H), 7.80 (1H, d, <i>J</i> 8.8, naphtalen-H), 8.05–8.03 (1H, t, <i>J</i> 5.6, −CONH, exchange with D<sub>2</sub>O); δ<sub>C</sub> (100 MHz, DMSO-<i>d</i><sub>6</sub>): 174.2 (C = O), 161.9, 157.9, 138.5, 136.9, 134.0, 130.0, 129.3, 128.5 (2 × Ar–C), 127,5, 127.3, 126.1, 119.4, 115.3 (2 × Ar–C), 106.60, 68.5 (−CONHCH<sub>2</sub>CH<sub>2</sub> CH<sub>2</sub><u class="uu">CH</u><sub>2</sub>), 56.1 (−OCH<sub>3</sub>), 46.0 (−<u class="uu">CH</u>CH<sub>3</sub>), 39.1, 26.8, 26.5, 19.5 (−CH<u class="uu">CH</u><sub>3</sub>); ESI-HRMS (<i>m</i>/<i>z</i>) calculated for [M + H]<sup>+</sup> ion species C<sub>24</sub>H<sub>29</sub>N<sub>2</sub>O<sub>5</sub>S, 457.1792; found, 457.1796.</div></div><div id="sec4_3_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 2-(±)-(3-Benzoylphenyl)-<i>N</i>-(4-sulfamoylphenyl)propanamide <b>3A</b></h4><div class="NLM_p last">Ketoprofen <b>3</b> (1.0 equiv) and 1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide hydrochloride salt (EDCI·HCl, 2.0 equiv) and 1-hydroxy-7-azabenzotriazole (HOAT, 2.0 equiv), sulfonilamide <b>A</b> (2.0 equiv), and <i>N</i>,<i>N</i>-diisopropylethylamine (DIPEA, 4.0 equiv) in DMF (4.5 mL) were treated according to the <a class="ref internalNav" href="#sec4_2" aria-label="General Procedure a">General Procedure a</a> previously reported to yield the title compound <b>3A</b> as a white solid in 27% yield, silica gel TLC <i>R</i><sub><i>f</i></sub>: 0.11 (ethyl acetate/<i>n</i>-hexane 50% <i>v</i>/<i>v</i>); mp: 193.0 °C; δ<sub>H</sub> (400 MHz, DMSO-<i>d</i><sub>6</sub>): 1.51 (3H, d, <i>J</i> 7.0, −CH<u class="uu">CH</u><sub>3</sub>), 4.09–4.04 (1H, m, −<u class="uu">CH</u>CH<sub>3</sub>), 7.28 (2H, s, SO<sub>2</sub>NH<sub>2</sub>, exchange with D<sub>2</sub>O), 7.60–7.57 (3H, m, 3 × Ar–H), 7.66 (1H, d, <i>J</i> 7.80, Ar–H), 7.76–7.71 (6H, m, 6 × Ar–H), 7.77 (2H, s, 2 × Ar–H), 7.84 (1H, s, Ar–H), 10.50 (1H, s, −CONH, exchange with D<sub>2</sub>O); δ<sub>C</sub> (100 MHz, DMSO-<i>d</i><sub>6</sub>): 196.6 (C = O), 173.4 (C = O), 143.0, 143.0 (2 × Ar–C), 139.5, 138.0, 138.0, 133.7, 132.6, 130.6 (2 × Ar–C), 129.8, 129.6 (3 × Ar–C), 129.5, 127.7 (2 × Ar–CH), 119.8 (2 × Ar–C), 46.9 (−<u class="uu">CH</u>CH<sub>3</sub>), 19.6 (−CH<u class="uu">CH</u><sub>3</sub>); ESI-HRMS (<i>m</i>/<i>z</i>) calculated for [M + H]<sup>+</sup> ion species C<sub>22</sub>H<sub>21</sub>N<sub>2</sub>O<sub>4</sub>S, 409.1216; found, 409.1219.</div></div><div id="sec4_3_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 2-(±)-(3-Benzoylphenyl)-<i>N</i>-(4-sulfamoylphenethyl)propanamide <b>3B</b></h4><div class="NLM_p last">Ketoprofen <b>3</b> (1.0 equiv), <i>N</i>,<i>N’</i>-dicyclohexylcarbodiimide (DCC, 1.1 equiv), <i>N</i>-hydroxysuccin imide (NHS, 1.1 equiv), and 4-aminoethylbenzenesulfonamide <b>B</b> (2.0 equiv) dissolved in dry DMF (1.5 mL) were treated according to the <a class="ref internalNav" href="#sec4_3" aria-label="General Procedure b">General Procedure b</a> previously reported to afford the titled compound <b>3B</b> as a white solid in 32% yield, silica gel TLC <i>R</i><sub><i>f</i></sub>: 0.14 (MeOH/DCM 5% <i>v</i>/<i>v</i>); mp: 116.7 °C; δ<sub>H</sub> (400 MHz, DMSO-<i>d</i><sub>6</sub>): 1.37 (3H, d, <i>J</i> 7.0, −CH<u class="uu">CH</u><sub>3</sub>), 2.77 (2H, m, −CONHCH<sub>2</sub><u class="uu">CH</u><sub>2</sub>), 3.28–3.33 (2H, m, −CONH<u class="uu">CH</u><sub>2</sub>CH<sub>2</sub>), 3.73–3.67 (1H, m, −<u class="uu">CH</u>CH<sub>3</sub>), 7.29 (2H, s, SO<sub>2</sub>NH<sub>2</sub>, exchange with D<sub>2</sub>O), 7.31–7.29 (2H, m, 2 × Ar–H), 7.53 (1H, t, <i>J</i> 7.6, Ar–H), 7.59 (2H, d, <i>J</i> 7.6, 2 × Ar–H), 7.63(2H, d, <i>J</i> 8.0, 2 × Ar–H), 7.70 (2H, t, <i>J</i> 8.0, 2 × Ar–H), 7.78–7.75 (3H, m, 3 × Ar–H), 8.16 (1H, t, <i>J</i> 5.6, CONH, exchange with D<sub>2</sub>O); δ<sub>C</sub> (100 MHz, DMSO-<i>d</i><sub>6</sub>): 196.4 (C = O), 173.5 (C = O), 144.2, 143.3, 142.6, 137.7, 137.5, 133.3 (Ar–C), 132.23, 130.2, 129.7, 129.2 (2 × Ar–C), 129.1 (2 × Ar–CH), 129.1 (2 × Ar–C), 126.2 (2 × Ar–C), 120.7, 45.5 (−<u class="uu">CH</u>CH<sub>3</sub>), 40.8 (−CONH<u class="uu">CH</u><sub>2</sub>CH<sub>2</sub>), 35.3 (−CONHCH<sub>2</sub><u class="uu">CH</u><sub>2</sub>), 19.1 (−CH<u class="uu">CH</u><sub>3</sub>); ESI-HRMS (<i>m</i>/<i>z</i>) calculated for [M + H]<sup>+</sup> ion species C<sub>24</sub>H<sub>25</sub>N<sub>2</sub>O<sub>4</sub>S, 437.1529; found, 437.1525.</div></div><div id="sec4_3_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 2-(±)-(3-Benzoylphenyl)-<i>N</i>-(2-(4-sulfamoylphenoxy)ethyl)propanamide <b>3C</b></h4><div class="NLM_p last">Ketoprofen <b>3</b> (1.0 equiv) and 1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide hydrochloride salt (EDCI·HCl, 2.0 equiv) and 1-hydroxy-7-azabenzotriazole (HOAT, 2.0 equiv), 4-((3-hydroxyethyl)amino)benzenesulfonamide <b>C</b> (2.0 equiv), and <i>N</i>,<i>N</i>-diisopropylethylamine (DIPEA, 4.0 equiv) in dry DMA (4.5 mL) were treated according to the <a class="ref internalNav" href="#sec4_3" aria-label="General Procedure b">General Procedure b</a> previously reported. The crude product was purified by silica gel column chromatography using EtOAc/<i>n</i>-hexane 66% <i>v</i>/<i>v</i> to afford the title compound <b>3C</b> as a white solid in 9% yield, silica gel TLC <i>R</i><sub><i>f</i></sub>: 0.33 (EtOAc/<i>n</i>-hexane 66% <i>v</i>/<i>v</i>); mp: 123.3 °C; δ<sub>H</sub> (400 MHz, DMSO-<i>d</i><sub>6</sub>): 2.11 (3H, d, <i>J</i> 7.2, −CH<u class="uu">CH</u><sub>3</sub>), 3.48–3.45 (2H, m., −CONH<u class="uu">CH</u><sub>2</sub>CH<sub>2</sub>), 3.82–3.77 (1H, m, −<u class="uu">CH</u>CH<sub>3</sub>), 4.08 (2H, t, <i>J</i> 5.6, −CONHCH<sub>2</sub><u class="uu">CH</u><sub>2</sub>), 7.07 (2H, d, <i>J</i> 8.8, Ar–H), 7.24 (2H, s, SO<sub>2</sub>NH<sub>2</sub>, exchange with D<sub>2</sub>O), 7.52 (1H, t, <i>J</i> 7.6, Ar–H), 7.72–7.58 (5H, m, 5 × Ar–H), 7.77–7.75 (5H, m, 5 × Ar–H), 8.37–8.34 (1H, m, −CONH, exchange with D<sub>2</sub>O); δ<sub>C</sub> (100 MHz, DMSO-<i>d</i><sub>6</sub>): 196.7 (C = O), 174.3 (C = O), 161.7, 143.6, 138.0, 137.8, 137.3, 133.6, 132.5, 130.5 (2 × Ar–C), 129.5 (2 × Ar–C), 129.5, 129.4, 129.0, 128.6 (2 × Ar–C), 115.4 (2 × Ar–C), 67.6 (−CONHCH<sub>2</sub><u class="uu">CH</u><sub>2</sub>), 45.7 (−<u class="uu">CH</u>CH<sub>3</sub>), 39.1 (−CONH<u class="uu">CH</u><sub>2</sub>CH<sub>2</sub>), 19.5 (−CH<u class="uu">CH</u><sub>3</sub>); ESI-HRMS (<i>m</i>/<i>z</i>) calculated for [M + H]<sup>+</sup> ion species C<sub>24</sub>H<sub>25</sub>N<sub>2</sub>O<sub>5</sub>S, 453.1479; found, 453.1471.</div></div><div id="sec4_3_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 2-(±)-(3-Benzoylphenyl)-<i>N</i>-(3-(4-sulfamoylphenoxy)propyl)propanamide <b>3D</b></h4><div class="NLM_p last">Ketoprofen <b>3</b> (1.0 equiv) and 1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide hydrochloride salt (EDCI·HCl, 2.0 equiv) and 1-hydroxy-7-azabenzotriazole (HOAT, 2.0 equiv), 4-((3-hydroxypropyl)amino)benzenesulfonamide <b>D</b> (2.0 equiv), and <i>N</i>,<i>N</i>-diisopropylethylamine (DIPEA, 4.0 equiv) in dry DMA (4.5 mL) were treated according to the <a class="ref internalNav" href="#sec4_3" aria-label="General Procedure b">General Procedure b</a> previously reported. The crude product purified by silica gel column chromatography using Ac/DCM 20% <i>v</i>/<i>v</i> to yield the title compound <b>3D</b> as a white solid in 11% yield, silica gel TLC <i>R</i><sub><i>f</i></sub>: 0.39 (Ac/DCM 20% <i>v/v</i>); mp: 139.5 °C; δ<sub>H</sub> (400 MHz, DMSO-<i>d</i><sub>6</sub>): 1.39 (3H, d, <i>J</i> 6.8, −CH<u class="uu">CH</u><sub>3</sub>), 1.86 (2H, pent., <i>J</i> 6.8, −CONHCH<sub>2</sub><u class="uu">CH</u><sub>2</sub>CH<sub>2</sub>), 3.22 (1H, m, −CONH<u class="uu">CH</u><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>), 3.70–3.80 (1H, m, −<u class="uu">CH</u>CH<sub>3</sub>), 4.01 (2H, t, <i>J</i> 6.4, −CONHCH<sub>2</sub>CH<sub>2</sub><u class="uu">CH</u><sub>2</sub>), 7.03 (2H, d, <i>J</i> 8.8, 2 × Ar–H), 7.24 (2H, s, SO<sub>2</sub>NH<sub>2</sub>, exchange with D<sub>2</sub>O), 7.53 (1H, t, <i>J</i> 7.6, Ar–H), 7.62–7.58 (4H, m, 4 × Ar–H), 7.73–7.70 (1H, dd, <i>J</i> 1.6/7.6, Ar–H), 7.77–7.74 (5H, m, 5 × Ar–H), 8.20 (1H, t, <i>J</i> 5.6, −CONH, exchange with D<sub>2</sub>O); δ<sub>C</sub> (100 MHz, DMSO-<i>d</i><sub>6</sub>): 196.7 (C = O), 173.9 (C = O), 161.8, 143.7, 138.0, 137.8, 137.1, 133.7, 132.5, 130.5, 129.5 (2 × Ar–C), 129.5 (2 × Ar–C), 129.4, 129.0, 128.6 (2 × Ar–C), 115.3 (2 × Ar–C), 66.5 (−CONHCH<sub>2</sub>CH<sub>2</sub><u class="uu">CH</u><sub>2</sub>), 45.9 (−<u class="uu">CH</u>CH<sub>3</sub>), 36.4, 29.5, 19.4 (−CH<u class="uu">CH</u><sub>3</sub>); ESI-HRMS (<i>m</i>/<i>z</i>) calculated for [M + H]<sup>+</sup> ion species C<sub>25</sub>H<sub>27</sub>N<sub>2</sub>O<sub>5</sub>S, 467.1635; found, 467.1643.</div></div><div id="sec4_3_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 2-(±)-(3-Benzoylphenyl)-<i>N</i>-(4-(4-sulfamoylphenoxy)butyl)propanamide <b>3E</b></h4><div class="NLM_p last">Ketoprofen <b>3</b> (1.0 equiv) and 1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide hydrochloride salt (EDCI·HCl, 2.0 equiv) and 1-hydroxy-7-azabenzotriazole (HOAT, 2.0 equiv), 4-((3-hydroxybuthyl)amino)benzenesulfonamide <b>E</b> (2.0 equiv), and <i>N</i>,<i>N</i>-diisopropylethylamine (DIPEA, 4.0 equiv) in dry DMA (4.5 mL) were treated according to the <a class="ref internalNav" href="#sec4_3" aria-label="General Procedure b">General Procedure b</a> previously reported. The crude product was triturated with DCM/petroleum ether (5% <i>v/v</i>) to afford the title compound <b>3E</b> as a white solid in 58% yield, silica gel TLC <i>R</i><sub><i>f</i></sub>: 0.22 (ethyl acetate/<i>n</i>-hexane 66% <i>v/v</i>); mp: 121.6 °C; δ<sub>H</sub> (400 MHz, DMSO-<i>d</i><sub>6</sub>): 1.39 (3H, d, <i>J</i> 6.8, −CH<u class="uu">CH</u><sub>3</sub>), 1.58–1.51 (2H, m, −CONHCH<sub>2</sub><u class="uu">CH</u><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>), 1.73–1.66 (2H, m, −CONHCH<sub>2</sub>CH<sub>2</sub><u class="uu">CH</u><sub>2</sub>CH<sub>2</sub>), 3.15–3.10 (2H, m, −CONH<u class="uu">CH</u><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>), 3.76–3.71 (1H, m, −<u class="uu">CH</u>CH<sub>3</sub>), 4.03 (2H, t, <i>J</i> 6.4, −CONHCH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub><u class="uu">CH</u><sub>2</sub>), 7.06 (2H, d, <i>J</i> 9.2, 2 × Ar–H), 7.22(2H, s, SO<sub>2</sub>NH<sub>2</sub>, exchange with D<sub>2</sub>O), 7.53 (1H, d, <i>J</i> 7.6, Ar–H), 7.75–7.57 (5H, d, <i>J</i> 7.6, 5 × Ar–H), 7.77–7.75 (5H, m, 5 × Ar–H), 8.11 (1H, t, <i>J</i> 5.6, −CONH, exchange with D<sub>2</sub>O); δ<sub>C</sub> (100 MHz, DMSO-<i>d</i><sub>6</sub>): 196.7 (C = O), 173.7 (C = O), 161.9, 143.8, 138.0, 137.8, 137.0, 133.6, 132.5, 130.5 (2 × Ar–C), 129.5 (2 × Ar–C), 129.4, 129.4, 129.0, 128.6 (2 × Ar–C), 115.3 (2 × Ar–C), 68.5 (−CONHCH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub><u class="uu">CH</u><sub>2</sub>), 45.9 (−<u class="uu">CH</u>CH<sub>3</sub>), 39.1, 26.8, 26.5, 19.4 (−CH<u class="uu">CH</u><sub>3</sub>); ESI-HRMS (<i>m</i>/<i>z</i>) calculated for [M + H]<sup>+</sup> ion species C<sub>26</sub>H<sub>29</sub>N<sub>2</sub>O<sub>5</sub>S, 481.1792; found, 481.1801.</div></div><div id="sec4_3_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 2-(±)-(2-Fluoro-[1,1′-biphenyl]-4-yl)-<i>N</i>-(4-sulfamoylphenyl)propanamide <b>4A</b></h4><div class="NLM_p">Flurbiprofen <b>4</b> (1.0 equiv) and 1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide hydrochloride salt (EDCI·HCl, 2.0 equiv) and 1-hydroxy-7-azabenzotriazole (HOAT, 2.0 equiv), sulfonilamide <b>A</b> (2.0 equiv), and <i>N</i>,<i>N</i>-diisopropylethylamine (DIPEA, 4.0 equiv) in DMF (4.5 mL) were treated according to the <a class="ref internalNav" href="#sec4_2" aria-label="General Procedure a">General Procedure a</a> previously reported to yield the title compound <b>4A</b> as a white solid in 15.1% yield, silica gel TLC <i>R</i><sub><i>f</i></sub>: 0.26 (ethyl acetate/<i>n</i>-hexane 50% <i>v/v</i>); mp: 220.1 °C; δ<sub>H</sub> (400 MHz, DMSO-<i>d</i><sub>6</sub>): 1.51 (3H, d, <i>J</i> 7.0, −CH<u class="uu">CH</u><sub>3</sub>), 4.00–3.95 (1H, q, <i>J</i> 7.0, −<u class="uu">CH</u>CH<sub>3</sub>), 7.30 (2H, s, SO<sub>2</sub>NH<sub>2</sub>, exchange with D<sub>2</sub>O), 7.34 (1H, s, biphenyl-H), 7.37 (1H, dd, <i>J</i> 1.5/5.5, biphenyl-H), 7.45–7.41 (1H, m, biphenyl-H), 7.58–7.49 (5H, m, 5 × biphenyl-H), 7.80 (4H, s, 4 × Ar–H), 10.51 (1H, s, −CONH, exchange with D<sub>2</sub>O); δ<sub>C</sub> (100 MHz, DMSO-<i>d</i><sub>6</sub>): 173.1 (C = O), 159.7 (d, <i>J</i><sub>C–F</sub> = 246.1), 144.2 (d, <i>J</i><sub>C–F</sub> = 7.7), 142.8, 139.4, 135.7, 135.7, 131.6, 131.6, 129.6, 129.6, 129.5 (2 × Ar–C), 128.7, 127.7, 127.6 (2 × Ar–C), 124.7, 124.7, 119.7, 115.8 (d, <i>J</i><sub>C–F</sub> = 23.3), 46.4 (−<u class="uu">CH</u>CH<sub>3</sub>), 19.3 (−CH<u class="uu">CH</u><sub>3</sub>); δ<sub>F</sub> (376 MHz, DMSO-<i>d</i><sub>6</sub>): −118.40 (1F, s).</div><div class="NLM_p last">Experimental in agreement with reported data.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div></div><div id="sec4_3_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 2-(±)-(2-Fluoro-[1,1′-biphenyl]-4-yl)-<i>N</i>-(4-sulfamoylphenethyl)propanamide <b>4B</b></h4><div class="NLM_p last">Flurbiprofen <b>4</b> (1.0 equiv), <i>N</i>,<i>N’</i>-dicyclohexylcarbodiimide (DCC, 1.1 equiv), <i>N</i>-hydroxysuccinimide (NHS, 1.1 equiv), and 4-aminoethylbenzenesulfonamide <b>B</b> (2.0 equiv) dissolved in dry DMF (1.5 mL) were treated according to the <a class="ref internalNav" href="#sec4_3" aria-label="General Procedure b">General Procedure b</a> previously reported to afford the titled compound <b>4B</b> as a white solid in 28% yield, silica gel TLC <i>R</i><sub><i>f</i></sub>: 0.19 (MeOH/DCM 5% <i>v/v</i>); mp: 154.1 °C; δ<sub>H</sub> (400 MHz, DMSO-<i>d</i><sub>6</sub>): 1.37 (3H, d, <i>J</i> 7.0, −CH<u class="uu">CH</u><sub>3</sub>), 2.82 (2H, t, <i>J</i> 6.8-CONHCH<sub>2</sub><u class="uu">CH</u><sub>2</sub>), 3.31–3.33 (2H, m, −CONH<u class="uu">CH</u><sub>2</sub>CH<sub>2</sub>), 3.69–3.64 (1H, m, −<u class="uu">CH</u>CH<sub>3</sub>), 7.27–7.20 (2H, m, biphenyl-H), 7.30 (2H, s, SO<sub>2</sub>NH<sub>2</sub>, exchange with D<sub>2</sub>O), 7.34 (2H, d, <i>J</i> 8.3, Ar–H), 7.42 (1H, ddd, <i>J</i> 1.2/7.2/14.4 biphenyl-H), 7.53–7.47 (3H, m, biphenyl-H), 7.59–7.57 (2H, m, biphenyl-H), 7.74 (2H, d, <i>J</i> 8.3, Ar–H), 8.17–8.14 (1H, t, <i>J</i> 5.8, −CONH, exchange with D<sub>2</sub>O); δ<sub>C</sub> (100 MHz, DMSO-<i>d</i><sub>6</sub>): 173.7 (C = O), 159.8 (d, <i>J</i><sub>C–F</sub> = 245.7), 145.2 (d, <i>J</i><sub>C–F</sub> = 7.8), 144.7, 143.1, 136.0, 136.0, 131.5, 131.5, 130.2, 129.8, 129.7 (2 × Ar–C), 128.8, 127.5, 127.3, 126.6, 124.8 (2 × Ar–C), 124.8, 115.9 (d, <i>J</i><sub>C–F</sub> = 23.1), 45.6 (−<u class="uu">CH</u>CH<sub>3</sub>), 34.3 (−CONH<u class="uu">CH</u><sub>2</sub>CH<sub>2</sub>), 31.6 (−CONHCH<sub>2</sub><u class="uu">CH</u><sub>2</sub>), 19.3 (−CH<u class="uu">CH</u><sub>3</sub>); δ<sub>F</sub> (376 MHz, DMSO-<i>d</i><sub>6</sub>): −118.76 (1F, s); ESI-HRMS (<i>m</i>/<i>z</i>) calculated for [M + H]<sup>+</sup> ion species C<sub>23</sub>H<sub>24</sub>FN<sub>2</sub>O<sub>3</sub>S, 427.1486; found, 427.1478.</div></div><div id="sec4_3_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 2-(±)-(2-Fluoro-[1,1′-biphenyl]-4-yl)-<i>N</i>-(2-(4-sulfamoylphenoxy)ethyl)propan amide <b>4C</b></h4><div class="NLM_p last">Flurbiprofen <b>4</b> (1.0 equiv), 1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide hydrochloride salt (EDCI·HCl, 2.0 equiv), 1-hydroxy-7-azabenzotriazole (HOAT, 2.0 equiv), 4-((3-hydroxyethyl)amino)benzenesulfonamide <b>C</b> (2.0 equiv), and <i>N</i>,<i>N</i>-diisopropylethylamine (DIPEA, 4.0 equiv) in dry DMA (4.5 mL) were treated according to the <a class="ref internalNav" href="#sec4_3" aria-label="General Procedure b">General Procedure b</a> previously reported. The crude product was triturated with diethyl ether to afford the title compound <b>4C</b> as a white solid in 54% yield, silica gel TLC <i>R</i><sub><i>f</i></sub>: 0.18 (EtOAc/<i>n</i>-hexane 66% <i>v/v</i>); mp: 152.6 °C; δ<sub>H</sub> (400 MHz, DMSO-<i>d</i><sub>6</sub>): 1.40 (3H, d, <i>J</i> 7.2, −CH<u class="uu">CH</u><sub>3</sub>), 3.49 (2H, dd, <i>J</i> 5.6/8.4, −CONH<u class="uu">CH</u><sub>2</sub>CH<sub>2</sub>), 3.78–3.73 (1H, d, <i>J</i> 7.2, −<u class="uu">CH</u>CH<sub>3</sub>), 4.11 (2H, t, <i>J</i> 5.6, −CONHCH<sub>2</sub><u class="uu">CH</u><sub>2</sub>), 7.11 (2H, d, <i>J</i> 8.8, AA’BB’), 7.24 (2H, s, SO<sub>2</sub>NH<sub>2</sub>, exchange with D<sub>2</sub>O), 7.29–7.26 (2H, m, biphenyl-H), 7.56–7.41 (6H, m, 6 × biphenyl-H), 7.77 (2H, d, <i>J</i> 8.8, Ar–H), 8.35 (1H, t, <i>J</i> 5.6, −CONH, exchange with D<sub>2</sub>O); δ<sub>C</sub> (100 MHz, DMSO-<i>d</i><sub>6</sub>): 174.1 (C = O), 161.7, 159.7 (d, <i>J</i><sub>C–F</sub> = 244.3), 145.0 (d, <i>J</i><sub>C–F</sub> = 7.6), 137.3, 135.9, 131.4, 131.4, 129.6, 129.6, 129.5, 128.6 (3 × Ar–C), 128.6 (2 × Ar–C), 127.4, 127.2, 124.7, 124.7, 115.8 (d, <i>J</i><sub>C–F</sub> = 23.0), 115.4 (2 × Ar–C), 67.6 (−CONHCH<sub>2</sub>CH<sub>2</sub><u class="uu">CH</u><sub>2</sub>), 45.4 (−<u class="uu">CH</u>CH<sub>3</sub>), 39.1 (−CONH<u class="uu">CH</u><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>), 19.3 (−CH<u class="uu">CH</u><sub>3</sub>); δ<sub>F</sub> (376 MHz, DMSO-<i>d</i><sub>6</sub>): −118.75 (1F, s); ESI-HRMS (<i>m</i>/<i>z</i>) calculated for [M + H]<sup>+</sup> ion species C<sub>23</sub>H<sub>24</sub>FN<sub>2</sub>O<sub>4</sub>S, 443.1435; found, 443.1443.</div></div><div id="sec4_3_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 2-(±)-(2-Fluoro-[1,1′-biphenyl]-4-yl)-<i>N</i>-(3-(4-sulfamoylphenoxy)propyl) propanamide <b>4D</b></h4><div class="NLM_p last">Flurbiprofen <b>4</b> (1.0 equiv) and 1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide hydrochloride salt (EDCI·HCl, 2.0 equiv) and 1-hydroxy-7-azabenzotriazole (HOAT, 2.0 equiv), 4-((3-hydroxypropyl)amino)benzenesulfonamide <b>D</b> (2.0 equiv), and <i>N,N</i>-diisopropylethylamine (DIPEA, 4.0 equiv) in dry DMA (4.5 mL) were treated according to the <a class="ref internalNav" href="#sec4_3" aria-label="General Procedure b">General Procedure b</a> previously reported. The crude product purified by silica gel column chromatography using Ac/DCM 20% <i>v</i>/<i>v</i> and crystallized from ethanol to yield the title compound <b>4D</b> as a white solid in 66% yield, silica gel TLC <i>R</i><sub><i>f</i></sub>: 0.37 (Ac/DCM 20% <i>v/v</i>); mp: 123.3 °C; δ<sub>H</sub> (400 MHz, DMSO-<i>d</i><sub>6</sub>): 1.39 (3H, d, <i>J</i> 7.0, −CH<u class="uu">CH</u><sub>3</sub>), 1.90–1.87 (2H, m, −CONHCH<sub>2</sub><u class="uu">CH</u><sub>2</sub>CH<sub>2</sub>), 3.29–3.21 (2H, m, −CONH<u class="uu">CH</u><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>), 3.69 (1H, q, <i>J</i> 3.6, −<u class="uu">CH</u>CH<sub>3</sub>), 4.05 (2H, t, <i>J</i> 6.6, −CONHCH<sub>2</sub>CH<sub>2</sub><u class="uu">CH</u><sub>2</sub>), 7.08–7.05 (2H, d, <i>J</i> 9.0, Ar–H), 7.24 (2H, s, SO<sub>2</sub>NH<sub>2</sub>, exchange with D<sub>2</sub>O), 7.28–7.27 (2H, m, biphenyl-H), 7.56–7.41 (6H, m, biphenyl-H), 7.76 (2H, d, <i>J</i> 8.9, Ar–H), 8.19 (1H, t, <i>J</i> 5.4, −CONH, exchange with D<sub>2</sub>O); δ<sub>C</sub> (100 MHz, DMSO-<i>d</i><sub>6</sub>): 173.7 (C = O), 161.8, 159.7 (d, <i>J</i><sub>C–F</sub> = 246.4), 145.2 (d, <i>J</i><sub>C–F</sub> = 8.1), 137.1, 135.9, 131.4, 131.4, 129.6 (2 × Ar–C), 129.6 (2 × Ar–C), 129.5, 128.7, 128.6, 127.3, 127.2, 124.7, 124.7, 115.7 (d, <i>J</i><sub>C–F</sub> = 23.2), 115.3, 66.5 (−CONHCH<sub>2</sub>CH<sub>2</sub><u class="uu">CH</u><sub>2</sub>), 45.6 (−<u class="uu">CH</u>CH<sub>3</sub>), 31.6 (−CONH<u class="uu">CH</u><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>), 29.5 (−CONHCH<sub>2</sub><u class="uu">CH</u><sub>2</sub>CH<sub>2</sub>), 19.3 (−CH<u class="uu">CH</u><sub>3</sub>); δ<sub>F</sub> (376 MHz, DMSO-<i>d</i><sub>6</sub>): −118.76 (1F, s); ESI-HRMS (<i>m</i>/<i>z</i>) calculated for [M + H]<sup>+</sup> ion species C<sub>24</sub>H<sub>26</sub>FN<sub>2</sub>O<sub>4</sub>S, 457.1592; found, 457.1593.</div></div><div id="sec4_3_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 2-(2-Fluoro-[1,1′-biphenyl]-4-yl)-<i>N</i>-(4-(4-sulfamoylphenoxy)butyl)propanamide <b>4E</b></h4><div class="NLM_p last">Flurbiprofen <b>4</b> (1.0 equiv) and 1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide hydrochloride salt (EDCI·HCl, 2.0 equiv) and 1-hydroxy-7-azabenzotriazole (HOAT, 2.0 equiv), 4-((3-hydroxybuthyl)amino)benzenesulfonamide <b>E</b> (2.0 equiv), and <i>N</i>,<i>N</i>-diisopropylethylamine (DIPEA, 4.0 equiv) in dry DMA (4.5 mL) were treated according to the <a class="ref internalNav" href="#sec4_3" aria-label="General Procedure b">General Procedure b</a> previously reported. The crude product was triturated with DCM/petroleum ether (5% <i>v/v</i>) to afford the title compound <b>4E</b> as a white solid in 59.6% yield, silica gel TLC <i>R</i><sub><i>f</i></sub>: 0.2 (ethyl acetate/<i>n</i>-hexane 66% <i>v/v</i>); mp: 126.7 °C; δ<sub>H</sub> (400 MHz, DMSO-<i>d</i><sub>6</sub>): 1.37 (3H, d, <i>J</i> 7.2, −CH<u class="uu">CH</u><sub>3</sub>), 1.55 (2H, p, <i>J</i> 6.8, −CONHCH<sub>2</sub><u class="uu">CH</u><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>), 1.70 (2H, p, <i>J</i> 6.8 −CONHCH<sub>2</sub>CH<sub>2</sub><u class="uu">CH</u><sub>2</sub>CH<sub>2</sub>), 3.11 (2H, p, <i>J</i> 6.8 −CONH<u class="uu">CH</u><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>), 3.69–3.64 (1H, m, −<u class="uu">CH</u>CH<sub>3</sub>), 4.03 (2H, t, <i>J</i> 6.4, −CONHCH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub><u class="uu">CH</u><sub>2</sub>), 7.06 (2H, d, <i>J</i> 8.8, Ar–H), 7.19 (2H, s, SO<sub>2</sub>NH<sub>2</sub>, exchange with D<sub>2</sub>O), 7.23–7.26 (2H, s, biphenyl-H), 7.54–7.37 (6H, m, biphenyl-H), 7.73 (2H, d, <i>J</i> 8.8, Ar–H), 8.07 (1H, d, <i>J</i> 5.6, −CONH, exchange with D<sub>2</sub>O); δ<sub>C</sub> (100 MHz, DMSO-<i>d</i><sub>6</sub>): 173.6 (C = O), 161.9, 159.7 (d, <i>J</i><sub>C–F</sub> = 244.2), 145.2 (d, <i>J</i><sub>C–F</sub> = 7.7), 137.0, 135.9, 135.9, 131.4, 131.3, 129.6, 129.6, 129.5 (3 × Ar–C), 128.6 (2 × Ar–C), 127.3, 127.2, 124.7, 124.7, 115.7 (d, <i>J</i><sub>C–F</sub> = 23.0), 115.3 (2 × Ar–C), 68.5 (−CONHCH<sub>2</sub>CH<sub>2</sub><u class="uu">CH</u><sub>2</sub>), 45.6 (−<u class="uu">CH</u>CH<sub>3</sub>), 39.2 (−CONH<u class="uu">CH</u><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>), 26.8, 26.5, 19.3 (−CH<u class="uu">CH</u><sub>3</sub>); δ<sub>F</sub> (376 MHz, DMSO-<i>d</i><sub>6</sub>): −118.78 (1F, s); ESI-HRMS (<i>m</i>/<i>z</i>) calculated for [M + H]<sup>+</sup> ion species C<sub>25</sub>H<sub>28</sub>FN<sub>2</sub>O<sub>4</sub>S, 471.1748; found, 471.1751.</div></div><div id="sec4_3_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 5-Benzoyl-<i>N</i>-(4-sulfamoylphenyl)-2,3-dihydro-1<i>H</i>-pyrrolizine-1-carboxamide <b>5A</b></h4><div class="NLM_p last">Ketorolac <b>5</b> (1.0 equiv) and 1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide hydrochloride salt (EDCI·HCl, 2.0 equiv) and 1-hydroxy-7-azabenzotriazole (HOAT, 2.0 equiv), sulfonilamide <b>A</b> (2.0 equiv), and <i>N</i>,<i>N</i>-diisopropylethylamine (DIPEA, 4.0 equiv) in DMF (4.5 mL) were treated according to the <a class="ref internalNav" href="#sec4_2" aria-label="General Procedure a">General Procedure a</a> previously reported to yield the title compound <b>5A</b> as a white solid in 10% yield, silica gel TLC <i>R</i><sub><i>f</i></sub>: 0.19 (ethyl acetate/<i>n</i>-hexane 50% <i>v/v</i>); mp: 201.2 °C; δ<sub>H</sub> (400 MHz, DMSO-<i>d</i><sub>6</sub>): 2.91–2.83 (5H, s, 4 × pyrrolizine-CH<sub>2</sub>, pyrrolizine-CH), 7.31 (2H, s, SO<sub>2</sub>NH<sub>2</sub>, exchange with D<sub>2</sub>O), 7.84–7.56 (11H, m, 2 × pyrrole-H, 9 × Ar–H), 10.49 (1H, m, −CONH, exchange with D<sub>2</sub>O); δ<sub>C</sub> (100 MHz, DMSO-<i>d</i><sub>6</sub>) 196.4 (C = O), 173.2 (C = O), 142.8, 142.8, 139.3, 137.8, 133.5, 132.4, 130.4 (2 × Ar–C), 129.6, 129.4 (2 × Ar–C), 129.3, 127.5 (2 × pyrrolizine = CH), 119.6 (2 × pyrrolizine = CH), 46.7 (pyrrolizine-CH), 31.5 (pyrrolizine-CH<sub>2</sub>), 19.4 (pyrrolizine-CH<sub>2</sub>); ESI-HRMS (<i>m</i>/<i>z</i>): calculated for [M + H]<sup>+</sup> ion species C<sub>21</sub>H<sub>20</sub>N<sub>3</sub>O<sub>4</sub>S, 410.1169; found, 410.1170.</div></div><div id="sec4_3_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 5-Benzoyl-<i>N</i>-(4-sulfamoylphenethyl)-2,3-dihydro-1<i>H</i>-pyrrolizine-1-carboxamide <b>5B</b></h4><div class="NLM_p last">Ketorolac <b>5</b> (1.0 equiv), <i>N</i>,<i>N’</i>-dicyclohexylcarbodiimide (DCC, 1.1 equiv), <i>N</i>-hydroxysuccinimide (NHS, 1.1 equiv), and 4-aminoethylbenzenesulfonamide <b>B</b> (2.0 equiv) dissolved in dry DMF (1.5 mL) were treated according to the <a class="ref internalNav" href="#sec4_3" aria-label="General Procedure b">General Procedure b</a> previously reported to afford the titled compound <b>5B</b> as a white solid in 4.5% yield, silica gel TLC <i>R</i><sub><i>f</i></sub>: 0.32 (MeOH/DCM 5% <i>v/v</i>); mp: 197.3 °C; δ<sub>H</sub> (400 MHz, DMSO-<i>d</i><sub>6</sub>): 2.73–2.69 (2H, q., <i>J</i> 7.2, −CONHCH<sub>2</sub><u class="uu">CH</u><sub>2</sub>), 2.89–2.85 (2H, t, <i>J</i> 7.0, −CONH<u class="uu">CH</u><sub>2</sub>CH<sub>2</sub>), 3.47–3.39 (1H, m, pyrrolizine-CH<sub>2</sub>), 3.96–3.92 (1H, m, pyrrolizine-CH<sub>2</sub>), 4.08 (1H, s, pyrrolizine-CH), 4.28–4.35 (1H, m, pyrrolizine-CH<sub>2</sub>), 4.40–4.46 (1H, m, pyrrolizine-CH<sub>2</sub>), 5.93 (1H, d, <i>J</i> 3.8, pyrrole-H), 6.79 (1H, d, <i>J</i> 4.0, pyrrole-H), 7.34 (2H, s, SO<sub>2</sub>NH<sub>2</sub>, exchange with D<sub>2</sub>O), 7.44 (2H, d, <i>J</i> 8.4, 2 × Ar–H), 7.57–7.54 (2H, m, 2 × Ar–H), 7.65–7.62 (1H, m, Ar–H), 7.80–7.77 (4H, m, 4 × Ar–H), 8.39–8.37 (1H, t, <i>J</i> 5.2, −CONH, exchange with D<sub>2</sub>O); δ<sub>C</sub> (100 MHz, DMSO-<i>d</i><sub>6</sub>): 183.9 (C = O), 170.8 (C = O), 145.8, 144.0, 142.6, 139.39, 131.8, 129.6 (2 × Ar–C), 128.9 (2 × Ar–C), 128.8 (2 × Ar–C), 126.4, 126.1 (2 × Ar–C), 124.9, 102.8, 48.2, 43.2, 35.1, 31.3, 31.1; ESI-HRMS (<i>m</i>/<i>z</i>) calculated for [M + H]<sup>+</sup> ion species C<sub>23</sub>H<sub>24</sub>N<sub>3</sub>O<sub>4</sub>S, 438.1482; found, 438.1489.</div></div><div id="sec4_3_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 5-Benzoyl-<i>N</i>-(3-(4-sulfamoylphenoxy)propyl)-2,3-dihydro-1<i>H</i>-pyrrolizine-1-carboxamide <b>5D</b></h4><div class="NLM_p last">Ketorolac <b>5</b> (1.0 equiv) and 1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide hydrochloride salt (EDCI·HCl, 2.0 equiv) and 1-hydroxy-7-azabenzotriazole (HOAT, 2.0 equiv), 4-((3-hydroxypropyl)amino)benzenesulfonamide <b>D</b> (2.0 equiv), and <i>N</i>,<i>N</i>-diisopropylethylamine (DIPEA, 4.0 equiv) in dry DMA (4.5 mL) were treated according to the <a class="ref internalNav" href="#sec4_3" aria-label="General Procedure b">General Procedure b</a> previously reported. The crude product purified by silica gel coloumn chromatography using Ac/DCM 14.3% <i>v</i>/<i>v</i> to yield the title compound <b>5D</b> as a white solid in 58% yield, silica gel TLC <i>R</i><sub><i>f</i></sub>: 0.41 (Ac/DCM 14.29% <i>v/v</i>); mp: 284.3 °C; δ<sub>H</sub> (400 MHz, DMSO-<i>d</i><sub>6</sub>): 1.27 (2H, s, −CONHCH<sub>2</sub><u class="uu">CH</u><sub>2</sub>CH<sub>2</sub>), 2.93–2.81 (2H, m, pyrrolizine-CH<sub>2</sub>), 4.27–4.24 (1H, m, pyrrolizine-CH), 4.52–4.38 (2H, m, pyrrolizine-CH<sub>2</sub>), 6.17 (1H, d, <i>J</i> 4.0, pyrrole-H), 6.81 (1H, d, <i>J</i> 4.0, pyrrole-H), 7.30 (2H, s, SO<sub>2</sub>NH<sub>2</sub>, exchange with D<sub>2</sub>O), 7.57–7.53 (2H, m, 2 × Ar–H), 7.65–7.61 (1H, m, Ar–H), 7.80 (2H, m, 2 × Ar–H), 7.82 (4H, s, 4 × Ar–H), 10.75 (1H, s, −CONH, exchange with D<sub>2</sub>O); δ<sub>C</sub> (100 MHz, DMSO-<i>d</i><sub>6</sub>): 184.6 (C = O), 170.9 (C = O), 145.5, 142.9, 139.9, 139.7, 132.5, 129.5 (2 × Ar–C), 129.4 (2 × Ar–C), 127.7 (2 × pyrrolizine = CH), 127.2 125.5, 120.0 (2 × pyrrolizine = CH), 103.7, 48.8, 44.9, 32.0; ESI-HRMS (<i>m</i>/<i>z</i>) calculated for [M + H]<sup>+</sup> ion species C<sub>24</sub>H<sub>26</sub>N<sub>3</sub>O<sub>5</sub>S, 468.1588; found, 468.1589.</div></div><div id="sec4_3_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 2-(5-Fluoro-2-methyl-1-(4-(methylsulfinyl)benzylidene)-1H-inden-3-yl)-<i>N</i>-(4-sulfamoyl phenyl) acetamide <b>6A</b></h4><div class="NLM_p last">Sulindac <b>6</b> (1.0 equiv) and 1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide hydrochloride salt (EDCI·HCl, 2.0 equiv) and 1-hydroxy-7-azabenzotriazole (HOAT, 2.0 equiv), sulfonilamide <b>A</b> (2.0 equiv), and <i>N</i>,<i>N</i>-diisopropylethylamine (DIPEA, 4.0 equiv) in DMF (4.5 mL) were treated according to the <a class="ref internalNav" href="#sec4_2" aria-label="General Procedure a">General Procedure a</a> previously reported to yield the title compound <b>6A</b> as a yellow solid in 2% yield, silica gel TLC <i>R</i><sub><i>f</i></sub>: 0.14 (MeOH/DCM 7.5% <i>v/v</i>); mp: 285.4 °C; δ<sub>H</sub> (400 MHz, DMSO-<i>d</i><sub>6</sub>): 2.27 (3H, s, indene −CH<sub>3</sub>), 2.86 (3H, s, SO<sub>2</sub>CH<sub>3</sub>), 3.78 (2H, s, −<u class="uu">CH</u><sub>2</sub>CONH), 6.77 (1H, m, indene-H), 7.24–7.19 (2H, m, 2 × indene-H), 7.30 (2H, s, exchange with D<sub>2</sub>O), 7.43 (1H, s, vinyl-H), 7.77 (2H, d, <i>J</i> 8.0, 2 × Ar–H), 7.80 (3H, s, 3 × Ar–H), 7.82 (2H, d, <i>J</i> 8.0, 2 × Ar–H), 10.61 (1H, s, −CONH, exchange with D<sub>2</sub>O); δ<sub>C</sub> (100 MHz, DMSO-<i>d</i><sub>6</sub>): 169.4 (C = O), 163.5 (d, <i>J</i><sub>C–F</sub> = 244.4), 148.2, 148.2, 148.1, 147.2, 142.9, 141.3, 139.46, 139.4, 139.3, 133.9, 130.9 (2 × Ar–C), 130.6, 130.4, 127.7 (2 × Ar–C), 124.9 (2 × Ar–C), 124.1 (d, <i>J</i><sub>C–F</sub> = 9.1), 119.7 (2 × Ar–C), 111.4 (d, <i>J</i><sub>C–F</sub> = 23.2), 107.3, 107.1 (d, <i>J</i><sub>C–F</sub> = 24.2), 44.1, 34.5, 11.4; δ<sub>F</sub> (376 MHz, DMSO-<i>d</i><sub>6</sub>): −113.49 (1F, s); ESI-HRMS (<i>m</i>/<i>z</i>) calculated for [M + H]<sup>+</sup> ion species C<sub>26</sub>H<sub>24</sub>FN<sub>2</sub>O<sub>4</sub>S<sub>2</sub>, 511.1156; found, 511.1147.</div></div><div id="sec4_3_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 2-(5-Fluoro-2-methyl-1-(4-(methylsulfinyl)benzylidene)-1H-inden-3-yl)-<i>N</i>-(4-sulfamoyl phenethyl)acetamide <b>6B</b></h4><div class="NLM_p last">Sulindac <b>6</b> (1.0 equiv), <i>N,N’</i>-dicyclohexylcarbodiimide (DCC, 1.1 equiv), <i>N</i>-hydroxysuccinimide (NHS, 1.1 equiv), and 4-aminoethylbenzenesulfonamide <b>B</b> (2.0 equiv) dissolved in dry DMF (1.5 mL) were treated according to the <a class="ref internalNav" href="#sec4_3" aria-label="General Procedure b">General Procedure b</a> previously reported to afford the titled compound <b>6B</b> as a yellow solid in 26% yield, silica gel TLC <i>R</i><sub><i>f</i></sub>: 0.12 (MeOH/DCM 5% <i>v/v</i>); mp: 152 °C; δ<sub>H</sub> (400 MHz, DMSO-<i>d</i><sub>6</sub>): 2.19 (3H, s, indene-CH<sub>3</sub>), 2.83 (2H, t, <i>J</i> 6.8, −CONHCH<sub>2</sub><u class="uu">CH</u><sub>2</sub>), 2.86 (3H, s, SO<sub>2</sub>CH<sub>3</sub>), 3.34 (2H, m, −CONH<u class="uu">CH</u><sub>2</sub>CH<sub>2</sub>), 3.45 (2H, s, -<u class="uu">CH</u><sub>2</sub>CONH), 6.78–6.73 (1H, m, indene-H), 7.15 (1H, dd, <i>J</i> 9.3/2.4 Hz, indene-H), 7.22–7.19 (1H, m, indene-H), 7.33 (2H, s, SO<sub>2</sub>NH<sub>2</sub>, exchange with D<sub>2</sub>O), 7.39 (2H, d, <i>J</i> 2.0, 2 × Ar–H), 7.41 (1H, s, vinyl-H), 7.78–7.75 (4H, m, 4 × Ar–H), 7.84–7.82 (2H, m, 2 × Ar–H), 8.23–8.21 (1H, t, <i>J</i> 5.6, −CONH, exchange with D<sub>2</sub>O); δ<sub>C</sub> (100 MHz, DMSO-<i>d</i><sub>6</sub>): 169.4 (C = O), 163.1 (d, <i>J</i><sub>C–F</sub> = 243.5), 147.9, 147.8, 146.8, 144.3, 142.7, 141.1, 139.2, 138.4, 134.2, 134.2, 130.5 (2 × Ar–C), 130.1, 130.1, 129.8, 129.7 (2 × Ar–C), 126.3 (2 × Ar–C), 124.5 (2 × Ar–C), 123.7 (d, <i>J</i><sub>C–F</sub> = 9.8), 110.9 (d, <i>J</i><sub>C–F</sub> = 22.8), 106.9 (d, <i>J</i><sub>C–F</sub> = 23.6), 56.6, 43.7, 35.4, 33.3, 11.0; δ<sub>F</sub> (376 MHz, DMSO-<i>d</i><sub>6</sub>): −113.52 (1F, s); ESI-HRMS (<i>m</i>/<i>z</i>) calculated for [M + H]<sup>+</sup> ion species C<sub>28</sub>H<sub>28</sub>FN<sub>2</sub>O<sub>4</sub>S<sub>2</sub>, 539.1469; found, 539.1464.</div></div><div id="sec4_3_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 2-(5-Fluoro-2-methyl-1-(4-(methylsulfinyl)benzylidene)-1H-inden-3-yl)-<i>N</i>-(2-(4-sulfamoylphenoxy)ethyl)acetamide <b>6C</b></h4><div class="NLM_p last">Sulindac <b>6</b> (1.0 equiv) and 1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide hydrochloride salt (EDCI·HCl, 2.0 equiv) and 1-hydroxy-7-azabenzotriazole (HOAT, 2.0 equiv), 4-((3-hydroxyethyl)amino)benzenesulfonamide <b>C</b> (2.0 equiv), and <i>N,N</i>-diisopropylethylamine (DIPEA, 4.0 equiv) in dry DMA (4.5 mL) were treated according to the <a class="ref internalNav" href="#sec4_3" aria-label="General Procedure b">General Procedure b</a> previously reported. The crude product was triturated with EtOH to afford the title compound <b>6C</b> as a yellow solid in 29% yield, silica gel TLC R<sub><i>f</i></sub>: 0.28 (ethyl acetate 100%); mp: 200.7 °C; δ<sub>H</sub> (400 MHz, DMSO-<i>d</i><sub>6</sub>): 2.21 (3H, s, indene-CH<sub>3</sub>), 2.86 (3H, s, SO<sub>2</sub>CH<sub>3</sub>), 3.51 (4H, t, <i>J</i> 8.2, −CONH<u class="uu">CH</u><sub>2</sub>CH<sub>2</sub>), 4.13 (2H, t, <i>J</i> 5.4, −CONHCH<sub>2</sub><u class="uu">CH</u><sub>2</sub>), 6.76–6.71 (1H, m, indene-H), 7.11 (2H, d, <i>J</i> 9.2, 2 × indene-H), 7.21–7.14 (2H, m, 2 × Ar–H), 7.24 (2H, s, SO<sub>2</sub>NH<sub>2</sub>, exchange with D<sub>2</sub>O), 7.38 (1H, s, vinyl-H), 7.84–7.74 (6H, m, 2 × Ar–H), 8.44 (1H, t, <i>J</i> 5.6, −CONH, exchange with D<sub>2</sub>O); δ<sub>C</sub> (100 MHz, DMSO-<i>d</i><sub>6</sub>): 170.2 (C = O), 163.5 (d, <i>J</i><sub>C–F</sub> = 244.8), 161.7, 148.2, 148.1, 147.1, 141.4, 139.5, 138.8, 137.3, 134.5, 134.5, 130.9 (2 × Ar–C), 130.4, 130.4, 130.2, 128.6 (2 × Ar–C), 124.9, 124.0 (d, <i>J</i><sub>C–F</sub> = 9.2), 115.4 (2 × Ar–C), 111.2 (d, <i>J</i><sub><i>C–F</i></sub> = 22.7), 107.1 (d, <i>J</i><sub>C–F</sub> = 24.01), 67.6, 44.0, 39.3, 33.6, 11.3; δ<sub>F</sub> (376 MHz, DMSO-<i>d</i><sub>6</sub>): −113.79 (1F, s); ESI-HRMS (<i>m</i>/<i>z</i>) calculated for [M + H]<sup>+</sup> ion species C<sub>28</sub>H<sub>28</sub>FN<sub>2</sub>O<sub>5</sub>S<sub>2</sub>, 555.1418; found, 555.1426.</div></div><div id="sec4_3_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 2-(5-Fluoro-2-methyl-1-(4-(methylsulfinyl)benzylidene)-1H-inden-3-yl)-<i>N</i>-(3-(4-sulfamoyl phenoxy)propyl)acetamide <b>6D</b></h4><div class="NLM_p last">Sulindac <b>6</b> (1.0 equiv) and 1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide hydrochloride salt (EDCI·HCl, 2.0 equiv) and 1-hydroxy-7-azabenzotriazole (HOAT, 2.0 equiv), 4-((3-hydroxypropyl)amino)benzenesulfonamide <b>D</b> (2.0 equiv), and <i>N</i>,<i>N</i>-diisopropylethylamine (DIPEA, 4.0 equiv) in dry DMA (4.5 mL) were treated according to the <a class="ref internalNav" href="#sec4_3" aria-label="General Procedure b">General Procedure b</a> previously reported. The crude product was purified by silica gel coloumn chromatography using Ac/DCM 20% <i>v/v</i> and crystallized from EtOH to afford the title compound <b>6D</b> as a yellow solid in 35% yield, silica gel TLC <i>R</i><sub><i>f</i></sub>: 0.48 (Ac/DCM 20% <i>v/v</i>); mp: 213.8 °C; δ<sub>H</sub> (400 MHz, DMSO-<i>d</i><sub>6</sub>): 1.92 (2H, t, <i>J</i> 6.4, −CONHCH<sub>2</sub><u class="uu">CH</u><sub>2</sub>CH<sub>2</sub>), 2.22 (3H, s, indene-CH<sub>3</sub>), 2.86 (3H, s, SO<sub>2</sub>CH<sub>3</sub>), 3.27 (2H, q, <i>J</i> 6.4, CONH<u class="uu">CH</u><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>), 3.46 (1H, s, −<u class="uu">CH</u><sub>2</sub>CONH), 4.10–4.07 (2H, t, <i>J</i> 6.2, −CONHCH<sub>2</sub>CH<sub>2</sub><u class="uu">CH</u><sub>2</sub>), 6.77–6.72 (1H, m, indene-H), 7.07 (2H, d, <i>J</i> 9.2, 2 × indene-H), 7.23–7.15 (4H, m, SO<sub>2</sub>NH<sub>2</sub>, exchange with D<sub>2</sub>O, 2 × Ar–H), 7.39 (1H, s, vinyl-H), 7.77–7.74 (4H, m, 4 × Ar–H), 7.84–7.82 (2H, m, 2 × Ar–H), 8.25–8.22 (1H, t, <i>J</i> 5.2, −CONH, exchange with D<sub>2</sub>O); δ<sub>C</sub> (100 MHz, DMSO-<i>d</i><sub>6</sub>): 169.8 (C = O), 163.5 (d, <i>J</i><sub>C–F</sub> = 243.2), 161.9, 148.3, 148.2, 147.2, 141.5, 139.6, 138.8, 137.2, 134.7, 134.6, 130.9 (2 x Ar–C), 130.5, 130.5, 130.3, 128.7 (2 × Ar–C), 125.0 (2 × Ar–C), 124.1 (d, <i>J</i><sub>C–F</sub> = 9.1), 115.4 (2 × Ar–C), 111.3 (d, <i>J</i><sub>C–F</sub> = 22.8), 107.2 (d, <i>J</i><sub>C–F</sub> = 23.6), 66.6, 44.1, 36.7, 33.9, 29.6, 11.4; δ<sub>F</sub> (376 MHz, DMSO-<i>d</i><sub>6</sub>): −113.56 (1F, s); ESI-HRMS (<i>m</i>/<i>z</i>) calculated for [M + H]<sup>+</sup> ion species C<sub>29</sub>H<sub>30</sub>FN<sub>2</sub>O<sub>5</sub>S<sub>2</sub>, 569.1575; found, 569.1572.</div></div><div id="sec4_3_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 2-(5-Fluoro-2-methyl-1-(4-(methylsulfinyl)benzylidene)-1H-inden-3-yl)-<i>N</i>-(4-(4-sulfamoylphenoxy)butyl)acetamide <b>6E</b></h4><div class="NLM_p last">Sulindac <b>6</b> (1.0 equiv) and 1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide hydrochloride salt (EDCI·HCl, 2.0 equiv) and 1-hydroxy-7-azabenzotriazole (HOAT, 2.0 equiv), 4-((3-hydroxybuthyl)amino)benzenesulfonamide <b>E</b> (2.0 equiv), and <i>N</i>,<i>N</i>-diisopropylethylamine (DIPEA, 4.0 equiv) in dry DMA (4.5 mL) were treated according to the <a class="ref internalNav" href="#sec4_3" aria-label="General Procedure b">General Procedure b</a> previously reported. The crude product was triturated with Ac/EtOH to afford the title compound <b>6E</b> as a yellow solid in 17% yield, silica gel TLC <i>R</i><sub><i>f</i></sub>: 0.14 (Ethyl acetate 100%); mp: 209.6 °C; δ<sub>H</sub> (400 MHz, DMSO-<i>d</i><sub>6</sub>): 1.62–1.57 (2H, m, −CONHCH<sub>2</sub><u class="uu">CH</u><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>), 1.80–1.73 (2H, m, −CONHCH<sub>2</sub>CH<sub>2</sub><u class="uu">CH</u><sub>2</sub>CH<sub>2</sub>), 2.21(3H, s, indene-CH<sub>3</sub>), 2.85 (3H, s, SO<sub>2</sub>CH<sub>3</sub>), 3.17 (2H, q, <i>J</i> 6.4, −CONH<u class="uu">CH</u><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>), 3.47 (2H, s, −<u class="uu">CH</u><sub>2</sub>CONH), 4.07 (2H, t, <i>J</i> 6.6, −CONHCH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub><u class="uu">CH</u><sub>2</sub>), 6.76–6.72 (1H, m, indene-H), 7.09 (2H, d, <i>J</i> 8.8, 2 × indene-H), 7.22–7.14 (2H, m, 2 × Ar–H), 7.23 (2H, s, SO<sub>2</sub>NH<sub>2</sub>, exchange with D<sub>2</sub>O), 7.38 (1H, s, vinyl-H), 7.78–7.74 (4H, m, 4 x Ar–H), 7.82 (2H, d, <i>J</i> 8.4, Ar–H), 8.19 (1H, t, <i>J</i> 5.6, −CONH, exchange with D<sub>2</sub>O); δ<sub>C</sub> (100 MHz, DMSO-<i>d</i><sub>6</sub>): 169.6 (C = O), 163.4 (d, <i>J</i><sub>C–F</sub> = 241.9), 161.9 (2 × Ar–C), 148.3, 148.2, 147.1, 141.4, 139.5, 138.6, 137.0, 134.7, 134.7, 130.8 (2 × Ar–C), 130.4, 130.4, 130.1, 128.6 (2 × Ar–C), 124.9 (2 × Ar–C), 124.0 (d, <i>J</i><sub>C–F</sub> = 9.2), 115.3, 111.2 (d, <i>J</i><sub>C–F</sub> = 22.5), 107.1 (d, <i>J</i><sub>C–F</sub> = 24.0), 68.5, 44.0, 39.3, 33.8, 26.9, 26.6, 11.3; δ<sub>F</sub> (376 MHz, DMSO-<i>d</i><sub>6</sub>): −113.78 (1F, s); ESI-HRMS (<i>m</i>/<i>z</i>) calculated for [M + H]<sup>+</sup> ion species C<sub>30</sub>H<sub>32</sub>FN<sub>2</sub>O<sub>5</sub>S<sub>2</sub>, 583.1731; found, 583.1731.</div></div><div id="sec4_3_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 2-(1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl)-<i>N</i>-(4-sulfamoyl phenyl)acetamide <b>7A</b></h4><div class="NLM_p last">Indometacin <b>7</b> (1.0 equiv) and 1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide hydrochloride salt (EDCI·HCl, 2.0 equiv) and 1-hydroxy-7-azabenzotriazole (HOAT, 2.0 equiv), sulfonilamide <b>A</b> (2.0 equiv), and <i>N</i>,<i>N</i>-diisopropylethylamine (DIPEA, 4.0 equiv) in DMF (4.5 mL) were treated according to the <a class="ref internalNav" href="#sec4_2" aria-label="General Procedure a">General Procedure a</a> previously reported to yield the title compound <b>7A</b> as a white solid in 17% yield, silica gel TLC <i>R</i><sub><i>f</i></sub>: 0.23 (ethyl acetate/<i>n</i>-hexane 50% <i>v/v</i>); mp: 244.4 °C; δ<sub>H</sub> (400 MHz, DMSO-<i>d</i><sub>6</sub>): 2.32 (3H, s, indol-CH<sub>3</sub>), 3.78 (3H, s, −OCH<sub>3</sub>), 3.83 (2H, s, −<u class="uu">CH</u><sub>2</sub>CONH), 6.77–6.74 (1H, dd, <i>J</i> 2.4/4.8, indol-H), 6.96 (1H, d, <i>J</i> 9.0, indol-H), 7.21 (1H, d, <i>J</i> 2.5, indol-H), 7.27 (2H, s, SO<sub>2</sub>NH<sub>2</sub>, exchange with D<sub>2</sub>O), 7.71 (4H, dd, <i>J</i> 8.4, 4 × Ar–H), 7.79 (4H, s, 4 × Ar–H), 10.58 (1H, s, −CONH, exchange with D<sub>2</sub>O); δ<sub>C</sub> (100 MHz, DMSO-<i>d</i><sub>6</sub>) 170.2 (C = O), 169.0 (C = O), 156.7, 143.0, 139.5, 138.7, 136.6, 135.3, 132.3 (2 × Ar–C), 131.9, 131.4, 130.2 (2 × Ar–C), 127.8 (2 × Ar–C), 119.9 (2 × Ar–C), 115.7, 114.8, 112.3, 103.0, 56.6 (−OCH<sub>3</sub>), 33.1, 14.5; ESI-HRMS (<i>m</i>/<i>z</i>) calculated for [M + H]<sup>+</sup> ion species C<sub>25</sub>H<sub>23</sub>ClN<sub>3</sub>O<sub>5</sub>S, 512.1041; found, 512.1049.</div></div><div id="sec4_3_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 2-(1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl)-<i>N</i>-(4-sulfamoyl phenethyl)acetamide <b>7B</b></h4><div class="NLM_p last">Indometacin <b>7</b> (1.0 equiv), <i>N</i>,<i>N’</i>-dicyclohexylcarbodiimide (DCC, 1.1 equiv), <i>N</i>-hydroxy succin imide (NHS, 1.1 equiv), and 4-aminoethylbenzenesulfonamide <b>B</b> (2.0 equiv) dissolved in dry DMF (1.5 mL) were treated according to the <a class="ref internalNav" href="#sec4_3" aria-label="General Procedure b">General Procedure b</a> previously reported to afford the titled compound <b>7B</b> as a white solid in 1% yield, silica gel TLC <i>R</i><sub><i>f</i></sub>: 0.21 (MeOH/DCM 5% <i>v/v</i>); mp: 210.3 °C; δ<sub>H</sub> (400 MHz, DMSO-<i>d</i><sub>6</sub>): 2.26 (3H, s, indol-CH<sub>3</sub>), 2.82 (2H, s, −CONHCH<sub>2</sub><u class="uu">CH</u><sub>2</sub>), 3.37–3.53 (4H, m, −CONH<u class="uu">CH</u><sub>2</sub>CH<sub>2</sub>, −<u class="uu">CH</u><sub>2</sub>CONH), 3.80 (3H, s, −OCH<sub>3</sub>), 6.77 (1H, m, indol-H), 6.98 (1H, d, <i>J</i> 8.8, indol-H), 7.16 (1H, s, indol-H), 7.31 (2H, s, SO<sub>2</sub>NH<sub>2</sub>, exchange with D<sub>2</sub>O), 7.39 (2H, d, <i>J</i> 7.8, 2 × Ar–H), 7.74–7.70 (6H, m, 6 × Ar–H), 8.16 (1H, s, −CONH, exchange with D<sub>2</sub>O); δ<sub>C</sub> (100 MHz, DMSO-<i>d</i><sub>6</sub>): 170.4 (C = O), 168.8 (C = O), 156.5, 144.7, 143.0, 138.5, 136.2, 135.2, 132.1 (2 × Ar–C), 131.9, 131.3, 130.1 (2 × Ar–C), 130.0 (2 × Ar–C), 126.6 (2 x Ar–C), 115.5, 115.2, 112.1, 103.0, 56.4 (−OCH<sub>3</sub>), 35.9, 32.1, 31.7, 14.3; ESI-HRMS (<i>m</i>/<i>z</i>) calculated for [M + H]<sup>+</sup> ion species C<sub>27</sub>H<sub>27</sub>ClN<sub>3</sub>O<sub>5</sub>S, 540.1354; found, 540.1363.</div></div><div id="sec4_3_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 2-(1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl)-<i>N</i>-(2-(4-sulfamoylphenoxy)ethyl)acetamide <b>7C</b></h4><div class="NLM_p last">Indometacin <b>7</b> (1.0 equiv) and 1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide hydrochloride salt (EDCI·HCl, 2.0 equiv) and 1-hydroxy-7-azabenzotriazole (HOAT, 2.0 equiv), 4-((3-hydroxyethyl)amino)benzenesulfonamide <b>C</b> (2.0 equiv), and <i>N,N</i>-diisopropylethylamine (DIPEA, 4.0 equiv) in dry DMA (4.5 mL) were treated according to the <a class="ref internalNav" href="#sec4_3" aria-label="General Procedure b">General Procedure b</a> previously reported. The crude product was triturated with DCM/petroleum ether (10% <i>v/v</i>) to afford the title compound <b>7C</b> as a white solid in 13% yield, silica gel TLC R<sub><i>f</i></sub>: 0.22 (EtOAc/<i>n</i>-hexane 66% <i>v/v</i>), mp: 197.5 °C; δ<sub>H</sub> (400 MHz, DMSO-<i>d</i><sub>6</sub>): 2.26 (3H, s, indol-CH<sub>3</sub>), 3.47 (2H, q, <i>J</i> 5.6, −CONH<u class="uu">CH</u><sub>2</sub>CH<sub>2</sub>), 3.58 (2H, s, −CH<sub>2</sub>CONH), 3.74 (3H, s, −OCH<sub>3</sub>), 4.13–4.10 (2H, q, <i>J</i> 5.6, −CONHCH<sub>2</sub><u class="uu">CH</u><sub>2</sub>), 6.74 (1H, dd, <i>J</i> 2.6/9.4, indol-H), 6.98 (1H, d, <i>J</i> 9.2, indol-H), 7.09 (2H, d, <i>J</i> 7.2, 2 × Ar–H), 7.15–7.14 (1H, m, indol-H), 7.24 (2H, brs, SO<sub>2</sub>NH<sub>2</sub>, exchange with D<sub>2</sub>O), 7.68 (2H, d, <i>J</i> 8.8, Ar–H), 7.73 (2H, d, <i>J</i> 8.8, 2 × Ar–H), 7.77 (2H, d, <i>J</i> 9.2, 2 × Ar–H), 8.35 (1H, t, <i>J</i> 5.6, −CONH, exchange with D<sub>2</sub>O); δ<sub>C</sub> (101 MHz, DMSO-<i>d</i><sub>6</sub>): 170.8 (C = O), 168.8 (C = O), 161.7, 156.5, 138.5, 137.3, 136.1, 135.2, 132.1 (2 × Ar–C), 131.8, 131.2, 130.0 (2 × Ar–C), 128.6 (2 × Ar–C), 115.5, 115.4 (2 × Ar–C), 115.2, 112.1, 102.9, 67.7, 56.3, 39.2, 32.0, 14.3; ESI-HRMS (<i>m</i>/<i>z</i>) calculated for [M + H]<sup>+</sup> ion species C<sub>27</sub>H<sub>27</sub>ClN<sub>3</sub>O<sub>6</sub>S, 556.1304; found, 556.1303.</div></div><div id="sec4_3_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 2-(1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl)-<i>N</i>-(3-(4-sulfamoylphenoxy)propyl)acetamide <b>7D</b></h4><div class="NLM_p last">Indometacin <b>7</b> (1.0 equiv) and 1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide hydrochloride salt (EDCI·HCl, 2.0 equiv) and 1-hydroxy-7-azabenzotriazole (HOAT, 2.0 equiv), 4-((3-hydroxypropyl)amino)benzenesulfonamide <b>C</b> (2.0 equiv), and <i>N</i>,<i>N</i>-diisopropylethylamine (DIPEA, 4.0 equiv) in dry DMA (4.5 mL) were treated according to the <a class="ref internalNav" href="#sec4_3" aria-label="General Procedure b">General Procedure b</a> previously reported. The crude product was purified by silica gel column chromatography using Ac/DCM 14.3% <i>v/v</i> to afford the title compound <b>7D</b> as a white solid in 3% yield, silica gel TLC <i>R</i><sub><i>f</i></sub>: 0.24 (Ac/DCM 14.3% <i>v/v</i>); mp: 116.7 °C; δ<sub>H</sub> (400 MHz, DMSO-<i>d</i><sub>6</sub>): 1.87–1.94 (2H, m, −CONHCH<sub>2</sub><u class="uu">CH</u><sub>2</sub>CH<sub>2</sub>), 2.27 (3H, s, indol-CH<sub>3</sub>), 3.24–3.29 (2H, m, −CONH<u class="uu">CH</u><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>), 3.54 (2H, s, −<u class="uu">CH</u><sub>2</sub>CONH), 3.77 (3H, s, −OCH<sub>3</sub>), 4.06 (2H, t, <i>J</i> 6.4, −CONHCH<sub>2</sub>CH<sub>2</sub><u class="uu">CH</u><sub>2</sub>), 6.76–6.73 (1H, dd, <i>J</i> 2.4/9.2, indol-H), 6.98 (1H, d, <i>J</i> 9.2, indol-H), 7.03 (2H, d, <i>J</i> 8.8, 2 × Ar–H), 7.15 (1H, d, <i>J</i> 2.4, indol-H), 7.24 (2H, s, SO<sub>2</sub>NH<sub>2</sub>, exchange with D<sub>2</sub>O),7.67 (2H, d, <i>J</i> 8.8, 2 × Ar–H), 7.72 (2H, d, <i>J</i> 8.8, 2 × Ar–H), 7.75 (2H, d, <i>J</i> 9.2, 2 × Ar–H), 8.17 (1H, t, <i>J</i> 5.6, CONH, exchange with D<sub>2</sub>O); δ<sub>C</sub> (100 MHz, DMSO-<i>d</i><sub>6</sub>): 170.4 (C = O), 168.8 (C = O), 161.8, 156.5, 138.5, 137.1, 136.1, 135.2, 132.1 (2 × Ar–C), 131.8, 131.2, 130.0 (2 × Ar–C), 128.6 (2 × Ar–C), 115.5, 115.3 (2 × Ar–C), 115.3, 112.1, 102.8, 66.6, 56.4 (−OCH<sub>3</sub>), 36.5, 32.2, 29.6, 14.3; ESI-HRMS (<i>m</i>/<i>z</i>) calculated for [M + H]<sup>+</sup> ion species C<sub>28</sub>H<sub>29</sub>ClN<sub>3</sub>O<sub>6</sub>S, 570.1460; found, 570.1449.</div></div><div id="sec4_3_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 2-(1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl)-<i>N</i>-(4-(4-sulfamoyl phenoxy)butyl)acetamide <b>7E</b></h4><div class="NLM_p last">Indometacin <b>7</b> (1.0 equiv) and 1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide hydrochloride salt (EDCI·HCl, 2.0 equiv) and 1-hydroxy-7-azabenzotriazole (HOAT, 2.0 equiv), 4-((3-hydroxybuthyl)amino)benzenesulfonamide <b>E</b> (2.0 equiv), and <i>N,N</i>-diisopropylethylamine (DIPEA, 4.0 equiv) in dry DMA (4.5 mL) were treated according to the <a class="ref internalNav" href="#sec4_3" aria-label="General Procedure b">General Procedure b</a> previously reported. The crude product was triturated with DCM/petroleum ether (10% <i>v/v</i>) to afford the title compound <b>7E</b> as a white solid in 30% yield, silica gel TLC <i>R</i><sub><i>f</i></sub>: 0.31 (ethyl acetate/<i>n</i>-hexane 66% <i>v/v</i>); mp: 135.1 °C; δ<sub>H</sub> (400 MHz, DMSO-<i>d</i><sub>6</sub>): 1.56–1.63 (2H, m, −CONHCH<sub>2</sub><u class="uu">CH</u><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>), 1.79–1.72 (2H, m, −CONHCH<sub>2</sub>CH<sub>2</sub><u class="uu">CH</u><sub>2</sub>CH<sub>2</sub>), 2.27 (3H, s, indol-CH<sub>3</sub>), 3.16 (2H, q, <i>J</i> 6.4, −CONH<u class="uu">CH</u><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>), 3.54 (2H, s, −<u class="uu">CH</u><sub>2</sub>CONH), 3.79 (3H, s, −OCH<sub>3</sub>), 4.06 (2H, t, <i>J</i> 6.4, −CONHCH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub><u class="uu">CH</u><sub>2</sub>), 6.74 (1H, dd, <i>J</i> 2.5/9.0, indol-H), 6.99 (1H, d, <i>J</i> 9.0, indol-H), 7.08 (2H, d, <i>J</i> 9.0, 2 × Ar–H), 7.16 (1H, d, <i>J</i> 2.5, indol-H), 7.21 (2H, brs, SO<sub>2</sub>NH<sub>2</sub>, exchange with D<sub>2</sub>O), 7.68 (2H, d, <i>J</i> 8.8, 2 × Ar–H), 7.73 (2H, d, <i>J</i> 8.8, 2 × Ar–H), 7.76 (2H, d, <i>J</i> 9.0, 2 × Ar–H), 8.09 (1H, t, <i>J</i> 5.6, −CONH, exchange with D<sub>2</sub>O); δ<sub>C</sub> (100 MHz, DMSO-<i>d</i><sub>6</sub>): 170.2 (C = O), 168.8 (C = O), 162.0, 156.5, 138.5, 137.0, 136.0, 135.2, 132.0 (2 × Ar–C), 131.8, 131.2, 129.9 (2 × Ar–C), 128.6 (2 × Ar–C), 115.5, 115.3, 115.3 (2 × Ar–C), 112.2, 102.8, 68.5, 56.3, 39.2, 32.1, 26.9, 26.7, 14.3; ESI-HRMS (<i>m</i>/<i>z</i>) calculated for [M + H]<sup>+</sup> ion species C<sub>29</sub>H<sub>31</sub>ClN<sub>3</sub>O<sub>6</sub>S, 584.1617; found, 584.1621.</div></div><div id="sec4_3_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 2-(2-((2,6-Dichlorophenyl)amino)phenyl)-N-(4-sulfamoylphenyl)acetamide <b>8A</b></h4><div class="NLM_p">Diclofenac <b>8</b> (1.0 equiv) and 1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide hydrochloride salt (EDCI·HCl, 2.0 equiv) and 1-hydroxy-7-azabenzotriazole (HOAT, 2.0 equiv), sulfonilamide <b>A</b> (2.0 equiv), and <i>N-</i>methylmorpholine (NMM, 2.0 equiv) in DMF (4.5 mL) were treated according to the <a class="ref internalNav" href="#sec4_2" aria-label="General Procedure a">General Procedure a</a> previously reported to yield the title compound <b>8A</b> as a white solid in 2% yield, silica gel TLC <i>R</i><sub><i>f</i></sub>: 0.29 (ethyl acetate/<i>n</i>-hexane 50% <i>v/v</i>); mp: 251.9 °C; δ<sub>H</sub> (400 MHz, DMSO-<i>d</i><sub>6</sub>): 3.88 (2H, s, −<u class="uu">CH</u><sub>2</sub>CONH), 6.34 (1H, d, <i>J</i> 8.4, Ar–H), 6.92 (1H, td, <i>J</i> 1.2/6.4, Ar–H), 7.13–7.09 (1H, m, Ar–H), 7.24 (1H, t, <i>J</i> 8.2, Ar–H), 7.30 (2H, s, SO<sub>2</sub>NH<sub>2</sub>, exchange with D<sub>2</sub>O), 7.33 (1H, dd, <i>J</i> 1.2/7.3, Ar–H), 7.58 (2H, d, <i>J</i> 8.0, Ar–H), 7.81 (4H, s, 4 × Ar–H), 7.79 (1H, s, NH), 10.71 (1H, s, −CONH, exchange with D<sub>2</sub>O).</div><div class="NLM_p last">Experimental in agreement with reported data.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div></div><div id="sec4_3_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 2-(2-((2,6-Dichlorophenyl)amino)phenyl)-<i>N</i>-(4-sulfamoylphenethyl)acetamide <b>8B</b></h4><div class="NLM_p last">Dichlofenac <b>8</b> (1.0 equiv), <i>N</i>,<i>N’</i>-dicyclohexylcarbodiimide (DCC, 1.1 equiv), <i>N</i>-hydroxysuccinimide (NHS, 1.1 equiv), and 4-aminoethylbenzenesulfonamide <b>B</b> (2.0 equiv) dissolved in dry DMF (1.5 mL) were treated according to the <a class="ref internalNav" href="#sec4_3" aria-label="General Procedure b">General Procedure b</a> previously reported to afford the titled compound <b>8B</b> as a white solid in 37% yield, silica gel TLC <i>R</i><sub><i>f</i></sub>: 0.24 (MeOH/DCM 5% <i>v/v</i>); mp: 186.3 °C; δ<sub>H</sub> (400 MHz, DMSO-<i>d</i><sub>6</sub>): 2.85 (2H, t, <i>J</i> 7.0, −CONHCH<sub>2</sub><u class="uu">CH</u><sub>2</sub>), 3.40–3.37 (2H, m, −CONH<u class="uu">CH</u><sub>2</sub>CH<sub>2</sub>), 3.60 (2H, s, −<u class="uu">CH</u><sub>2</sub>CONH), 6.33 (1H, d, <i>J</i> 7.8, Ar–H), 6.89 (1H, td, <i>J</i> 1.0/7.4, Ar–H), 7.11–7.06 (1H, m, Ar–H), 7.22–7.18 (1H, m, Ar–H), 7.20 (1H, dd, <i>J</i> 1.4/7.5, Ar–H), 7.32 (2H, s, SO<sub>2</sub>NH<sub>2</sub>,, exchange with D<sub>2</sub>O), 7.39 (2H, d, <i>J</i> 8.3, Ar–H), 7.55 (2H, d, <i>J</i> 8.1, 2 x Ar–H), 7.75 (2H, d, <i>J</i> 8.4, Ar–H), 8.37 (1H, s, NH), 8.50–8.47 (1H, t, <i>J</i> 6.0, −CONH, exchange with D<sub>2</sub>O); δ<sub>C</sub> (100 MHz, DMSO-<i>d</i><sub>6</sub>): 172.5 (C = O), 144.4, 143.9, 143.0, 138.1, 131.3, 130.4 (2 × Ar–C), 130.1 (2 × Ar–C), 130.0 (2 × Ar–C), 128.1, 126.6 (2 × Ar–C), 126.3, 126.0, 121.5, 116.8, 35.4, 34.2, 31.6; ESI-HRMS (<i>m</i>/<i>z</i>) calculated for [M + H]<sup>+</sup> ion species C<sub>22</sub>H<sub>22</sub>Cl<sub>2</sub>N<sub>3</sub>O<sub>3</sub>S, 478.0753; found, 478.0750.</div></div><div id="sec4_3_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 2-(2-((2,6-Dichlorophenyl)amino)phenyl)-<i>N</i>-(2-(4-sulfamoylphenoxy)ethyl) acetamide <b>8C</b></h4><div class="NLM_p last">Dichlofenac <b>8</b> (1.0 equiv) and 1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide hydrochloride salt (EDCI·HCl, 2.0 equiv) and 1-hydroxy-7-azabenzotriazole (HOAT, 2.0 equiv), 4-((3-hydroxyethyl)amino)benzenesulfonamide <b>C</b> (2.0 equiv), and <i>N</i>,<i>N</i>-diisopropylethylamine (DIPEA, 4.0 equiv) in dry DMA (4.5 mL) were treated according to the <a class="ref internalNav" href="#sec4_3" aria-label="General Procedure b">General Procedure b</a> previously reported. The crude product was triturated with EtOH to afford the title compound <b>8C</b> as a white solid in 27% yield, silica gel TLC <i>R</i><sub><i>f</i></sub>: 0.64 (ethyl acetate/<i>n</i>-hexane 50% <i>v/v</i>); mp: 210.2 °C; 3.53 (2H, q, <i>J</i> 5.6, −CONH<u class="uu">CH</u><sub>2</sub>CH<sub>2</sub>), 3.66 (2H, s, −<u class="uu">CH</u><sub>2</sub>CONH), 4.14 (2H, t, <i>J</i> 5.4, −CONHCH<sub>2</sub><u class="uu">CH</u><sub>2</sub>), 6.33 (1H, d, <i>J</i> 8.0, Ar–H), 6.87 (1H, td, <i>J</i> 7.2/0.8, Ar–H), 7.07 (1H, td, <i>J</i> 8.0/1.6, Ar–H), 7.12 (2H, d, <i>J</i> 8.8, Ar–H), 7.22–7.18 (2H, m, 2 × Ar–H), 7.24 (2H, s, SO<sub>2</sub>NH<sub>2</sub>, exchange with D<sub>2</sub>O), 7.55 (2H, d, <i>J</i> 8.0, 2 × Ar–H), 7.77 (2H, d, <i>J</i> 8.8, Ar–H), 8.33 (1H, s, NH), 8.70–8.68 (1H, t, <i>J</i> 5.4, −CONH, exchange with D<sub>2</sub>O); δ<sub>C</sub> (100 MHz, DMSO-<i>d</i><sub>6</sub>): 172.9 (C = O), 161.7, 143.9, 138.1, 137.3, 131.4, 130.5, 130.1 (2 × Ar–C), 128.6 (2 × Ar–C), 128.2, 126.2 (2 × Ar–C), 126.0, 121.6, 116.9, 115.5 (2 × Ar–C), 67.6, 39.3, 31.6; ESI-HRMS (<i>m</i>/<i>z</i>) calculated for [M + H]<sup>+</sup> ion species C<sub>22</sub>H<sub>22</sub>Cl<sub>2</sub>N<sub>3</sub>O<sub>4</sub>S, 494.0703; found, 494.0702.</div></div><div id="sec4_3_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 2-(2-((2,6-Dichlorophenyl)amino)phenyl)-<i>N</i>-(3-(4-sulfamoylphenoxy)propyl) acetamide <b>8D</b></h4><div class="NLM_p last">Dichlofenac <b>8</b> (1.0 equiv) and 1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide hydrochloride salt (EDCI·HCl, 2.0 equiv) and 1-hydroxy-7-azabenzotriazole (HOAT, 2.0 equiv), 4-((3-hydroxypropyl)amino)benzenesulfonamide <b>D</b> (2.0 equiv), and <i>N</i>,<i>N</i>-diisopropylethylamine (DIPEA, 4.0 equiv) in dry DMA (4.5 mL) were treated according to the <a class="ref internalNav" href="#sec4_3" aria-label="General Procedure b">General Procedure b</a> previously reported. The crude product was purified by silica gel column chromatography using ethyl acetate/<i>n</i>-hexane 50% <i>v/v</i> to afford the title compound <b>8D</b> as a white solid in 55% yield, silica gel TLC <i>R</i><sub><i>f</i></sub>: 0.20 (ethyl acetate/<i>n</i>-hexane 50% <i>v/v</i>); mp: 190.2 °C; 1.93 (2H, q, <i>J</i> 6.4, −CONHCH<sub>2</sub><u class="uu">CH</u><sub>2</sub>CH<sub>2</sub>) 3.31–3.26 (2H, q, <i>J</i> 6.4, −CONH<u class="uu">CH</u><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>), 3.62 (2H, s, −<u class="uu">CH</u><sub>2</sub>CONH), 4.03 (2H, t, <i>J</i> 6.2, −CONHCH<sub>2</sub>CH<sub>2</sub><u class="uu">CH</u><sub>2</sub>), 6.33 (1H, d, <i>J</i> 7.8, Ar–H), 6.88 (1H, dt, <i>J</i> 7.2/1.2, Ar–H), 7.09–7.06 (3H, m, 3 × Ar–H), 7.23–7.18 (4H, m, 2 × Ar–H, SO<sub>2</sub>NH<sub>2</sub>, exchange with D<sub>2</sub>O), 7.55 (2H, d, <i>J</i> 8.0, 2 × Ar–H), 7.77–7.75(2H, m, 2 × Ar–H), 8.38 (1H, s, NH), 8.50 (1H, t, <i>J</i> 5.4, −CONH, exchange with D<sub>2</sub>O); δ<sub>C</sub> (100 MHz, DMSO-<i>d</i><sub>6</sub>): 172.5 (C = O), 161.8, 143.9, 138.1, 137.1, 131.3, 130.4 (2 × Ar–C), 130.1 (2 × Ar–C), 128.5 (2 × Ar–C), 128.1, 126.3, 126.0, 121.6, 116.8, 115.3 (2 × Ar–C), 66.5, 40.5, 36.6, 29.4; ESI-HRMS (<i>m</i>/<i>z</i>) calculated for [M + H]<sup>+</sup> ion species C<sub>23</sub>H<sub>24</sub>Cl<sub>2</sub>N<sub>3</sub>O<sub>4</sub>S, 508.0859; found, 508.0850.</div></div><div id="sec4_3_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> 2-(2-((2,6-Dichlorophenyl)amino)phenyl)-<i>N</i>-(4-(4-sulfamoylphenoxy)butyl) acetamide <b>8E</b></h4><div class="NLM_p last">Dichlofenac <b>8</b> (1.0 equiv) and 1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide hydrochloride salt (EDCI·HCl, 2.0 equiv) and 1-hydroxy-7-azabenzotriazole (HOAT, 2.0 equiv), 4-((3-hydroxybuthyl)amino)benzenesulfonamide <b>E</b> (2.0 equiv), and <i>N,N</i>-diisopropylethylamine (DIPEA, 4.0 equiv) in dry DMA (4.5 mL) were treated according to the <a class="ref internalNav" href="#sec4_3" aria-label="General Procedure b">General Procedure b</a> previously reported. The crude product was triturated with diethyl ether to afford the title compound <b>8E</b> as a white solid in 46% yield, silica gel TLC <i>R</i><sub><i>f</i></sub>: 0.35 (ethyl acetate/<i>n</i>-hexane 66% <i>v/v</i>); mp: 170.5 °C; δ<sub>H</sub> (400 MHz, DMSO-<i>d</i><sub>6</sub>): 1.65–1.61 (2H, m, −CONHCH<sub>2</sub><u class="uu">CH</u><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>), 1.81–1.74 (2H, m, −CONHCH<sub>2</sub>CH<sub>2</sub><u class="uu">CH</u><sub>2</sub>CH<sub>2</sub>), 3.21–3.16 (2H, m, −CONH<u class="uu">CH</u><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>), 3.62 (2H, s, −<u class="uu">CH</u><sub>2</sub>CONH), 4.08 (2H, t, <i>J</i> 6.4, −CONHCH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub><u class="uu">CH</u><sub>2</sub>), 6.33 (1H, d, <i>J</i> 8.0, Ar–H), 6.90–6.86 (1H, m, Ar–H), 7.07–7.05 (1H, m, Ar–H), 7.09 (2H, d, <i>J</i> 8.8, Ar–H), 7.19 (1H, t, <i>J</i> 8.2, Ar–H), 7.23–7.21 (3H, m, Ar–H, SO<sub>2</sub>NH<sub>2</sub>, exchange with D<sub>2</sub>O), 7.55(2H, d, <i>J</i> 8.0, 2 × Ar–H), 7.77 (2H, d, <i>J</i> 8.8, Ar–H), 8.44–8.41 (2H, m, NH, −CONH, exchange with D<sub>2</sub>O); δ<sub>C</sub> (100 MHz, DMSO-<i>d</i><sub>6</sub>) 172.4 (C = O), 161.9, 143.9, 138.1, 137.0, 131.3, 130.3, 130.1 (2 × Ar–C), 128.6 (2 × Ar–C), 128.1, 126.5 (2 × Ar–C), 125.9, 121.6, 116.9, 115.3 (2 × Ar–C), 68.5, 40.5, 39.3, 26.9, 26.4; ESI-HRMS (<i>m</i>/<i>z</i>) calculated for [M + H]<sup>+</sup> ion species C<sub>24</sub>H<sub>26</sub>Cl<sub>2</sub>N3O<sub>4</sub>S, 522.1016; found, 522.1014.</div></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> Carbonic Anhydrase Inhibition</h3><div class="NLM_p last">The CA-catalyzed CO<sub>2</sub> hydration activity was performed on an Applied Photophysics stopped-flow instrument using phenol red (at a concentration of 0.2 mM) as a pH indicator with 20 mM Hepes (pH 7.5) as the buffer, 20 mM Na<sub>2</sub>SO<sub>4</sub>, and following the initial rates of the CA-catalyzed CO<sub>2</sub> hydration reaction for a period of 10–100 s and working at the maximum absorbance of 557 nm.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> The CO<sub>2</sub> concentrations ranged from 1.7 to 17 mM. For each inhibitor six traces of the initial 5–10% of the reaction have been used in order to determine the initial velocity. The uncatalyzed reaction rates were determined in the same manner and subtracted from the total observed rates. Stock solutions of inhibitor (0.1 mM) were prepared in distilled water, and dilutions up to 0.01 nM were prepared. Solutions containing inhibitor and enzyme were preincubated for 15 min at room temperature prior to assay in order to allow the formation of the E–I complex. The inhibition constants were obtained as nonlinear least-squares protocols using PRISM 3<a onclick="showRef(event, 'ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref21 ref22 ref23">(21−23)</a> and are the mean from at three different measurements. All hCAs were recombinant ones and were obtained in house.<a onclick="showRef(event, 'ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref21 ref22 ref23">(21−23)</a></div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> Animals</h3><div class="NLM_p last">Sprague-Dawley rats (Harlan, Italy,Varese) of weight 200–250 g were used. Animals were housed in the Centro Stabulazione Animali da Laboratorio (University of 65 Florence) and used 1 week after arrival. Four rats were housed per cage (size 26 × 41 cm); animals were fed a standard laboratory diet and tap water ad libitum and kept at 23 ± 1 °C with a 12 h light/dark cycle (light at 7 a.m.). All animal manipulations were done according to the European Community guidelines for animal care [DL 116/92, application of the European Communities Council Directive of 24 November 1986 (86/609/EEC)]. The ethical policy of the University of Florence complies with the Guide for the Care and Use of Laboratory Animals of the U.S. National Institutes of Health (NIH Publication no. 85-23, revised 1996; University of Florence assurance number A5278–01). Formal approval to conduct the experiments described was obtained from the Animal Subjects Review Board of the University of Florence. Experiments involving animals have been reported according to ARRIVE, Animal Research: Reporting of In Vivo Experiments, guidelines.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Efforts were made in order to minimize suffering and to reduce the number of animals used.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> Complete Freund’s Adjuvant-Induced Arthritis</h3><div class="NLM_p last">Articular damage was induced by injection into the tibiotarsal joint of the Complete Freund’s adjuvant (CFA; Sigma-Aldrich St Louis, MO), which contained 1 mg/mL heat-killed and dried <i>Mycobacterium tuberculosis</i> in paraffin oil and mannide monooleate.<a onclick="showRef(event, 'ref25 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref25 ref26 ref27">(25−27)</a> The rats were anesthetized with 2% isoflurane, the left leg skin was sterilized with 75% alcohol, and the lateral malleolus located by palpation. A 28-gauge needle was inserted to penetrate the skin and turned distally into the articular cavity at the gap between the tibiofibular and tarsal bone. A volume of 50 μL of CFA was injected (day 0). Control rats received 50 μL of saline solution within the tibiotarsal joint.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> Administration of Compounds</h3><div class="NLM_p last">Compounds <b>2B</b>, <b>3B</b>, <b>6B</b>, and <b>8B</b> were tested at the doses of 0.1, 1.0, and 10 mg kg<sup>–1</sup>. The relative NSAIDs, naproxen, ketoprofen, sulindac, and diclofenac were administered equimolarly to 10 mg/kg of the corresponding hydrid. All compounds were suspended in a 1% CMC solution and administered per os (p.o.) on day 14 after CFA i.a. injection.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> Paw Pressure Test</h3><div class="NLM_p last">The nociceptive threshold of rats was assessed with an analgesimeter (Ugo Basile, Varese, Italy).<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> A constantly increasing pressure was applied to a small area of the dorsal surface of the hind paw using a blunt conical probe as a mechanical device. Mechanical pressure was increased until vocalization or a withdrawal reflex occurred while the animals were restrained. Vocalization or withdrawal reflex thresholds were expressed in grams. Rats scoring below 40 g or over 75 g during the test before drug administration were rejected (25%). For analgesia measures, the mechanical pressure application limit was set at 120 g.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> Incapacitance Test</h3><div class="NLM_p last">Weight-bearing changes were measured using an incapacitance apparatus (Linton Instrumentation, Norfolk, U.K.) to detect modifications in postural equilibrium after a hind limb injury occurred.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Rats were trained to stand on their hind paws in a box with an 65° inclined plane. This box was placed above the incapacitance apparatus. The value reported for each animal is the mean of five and consecutive measurements. In the absence of hind limb injury, the animals applied an equal weight distribution on both hind limbs (postural equilibrium), whereas an unequal distribution indicated a monolateral decreased pain threshold. Data are obtained as the difference between the weight applied to the limb contralateral to the injury and the weight applied to the ipsilateral limb (Δweight).</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> Statistical Analysis</h3><div class="NLM_p last">Behavioral measurements were performed on 8 rats used for each treatment carried out in two different experiments. The results were expressed as mean (S.E.M.) with one-way analysis of variance. The Bonferroni’s significant difference procedure was used as a post hoc comparison. <i>P</i>-values < 0.05 or < 0.01 were considered significant. Data were analyzed on the Origin 9 software (OriginLab, Northampton, MA).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i65"><a href="/doi/suppl/10.1021/acs.jmedchem.8b00420" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31626" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31626" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b00420" class="ext-link">10.1021/acs.jmedchem.8b00420</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Enzymatic activity curves of compounds <b>5A, 2B, 3C, 3D, 3E</b> and <b>AAZ</b> on hCAs I, II, IV, IX and XII (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00420/suppl_file/jm8b00420_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">SMILES representation for compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00420/suppl_file/jm8b00420_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00420/suppl_file/jm8b00420_si_001.pdf">jm8b00420_si_001.pdf (753.96 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00420/suppl_file/jm8b00420_si_002.csv">jm8b00420_si_002.csv (2.66 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.8b00420" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73418" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73418" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Claudiu T. Supuran</span> - <span class="hlFld-Affiliation affiliation">NEUROFARBA
Department, Sezione di Scienze Farmaceutiche, University of Florence, Via Ugo Schiff 6, 50019 Sesto Fiorentino, Florence, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4262-0323" title="Orcid link">http://orcid.org/0000-0003-4262-0323</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#51323d30243538247f2224212423303f11243f3837387f3825"><span class="__cf_email__" data-cfemail="72111e1307161b075c0107020700131c32071c1b141b5c1b06">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fabrizio Carta</span> - <span class="hlFld-Affiliation affiliation">NEUROFARBA
Department, Sezione di Scienze Farmaceutiche, University of Florence, Via Ugo Schiff 6, 50019 Sesto Fiorentino, Florence, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1141-6146" title="Orcid link">http://orcid.org/0000-0002-1141-6146</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#15737477677c6f7c7a3b767467617455607b7c737c3b7c61"><span class="__cf_email__" data-cfemail="37515655455e4d5e581954564543567742595e515e195e43">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ozlem Akgul</span> - <span class="hlFld-Affiliation affiliation">Faculty
of Pharmacy, Department of Pharmaceutical Chemistry, Ege University Bornova, İzmir, Turkey 35100</span>; 
    <span class="hlFld-Affiliation affiliation">NEUROFARBA
Department, Sezione di Scienze Farmaceutiche, University of Florence, Via Ugo Schiff 6, 50019 Sesto Fiorentino, Florence, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lorenzo Di Cesare Mannelli</span> - <span class="hlFld-Affiliation affiliation">Department
of Neuroscience, Psychology, Drug Research
and Child Health-NEUROFARBA-Pharmacology and Toxicology Section, University
of Florence, 50139 Florence, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniela Vullo</span> - <span class="hlFld-Affiliation affiliation">Laboratorio
di Chimica Bioinorganica, University of
Florence, Polo Scientifico, Rm. 188, Via della Lastruccia 3, 50019 Sesto Fiorentino, Florence, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrea Angeli</span> - <span class="hlFld-Affiliation affiliation">NEUROFARBA
Department, Sezione di Scienze Farmaceutiche, University of Florence, Via Ugo Schiff 6, 50019 Sesto Fiorentino, Florence, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carla Ghelardini</span> - <span class="hlFld-Affiliation affiliation">Department
of Neuroscience, Psychology, Drug Research
and Child Health-NEUROFARBA-Pharmacology and Toxicology Section, University
of Florence, 50139 Florence, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gianluca Bartolucci</span> - <span class="hlFld-Affiliation affiliation">NEUROFARBA
Department, Sezione di Scienze Farmaceutiche, University of Florence, Via Ugo Schiff 6, 50019 Sesto Fiorentino, Florence, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5631-8769" title="Orcid link">http://orcid.org/0000-0002-5631-8769</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Abdulmalik Saleh Alfawaz Altamimi</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam Bin Abdulaziz University, P.O. Box 173, Alkharj 11942, Saudi Arabia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrea Scozzafava</span> - <span class="hlFld-Affiliation affiliation">Laboratorio
di Chimica Bioinorganica, University of
Florence, Polo Scientifico, Rm. 188, Via della Lastruccia 3, 50019 Sesto Fiorentino, Florence, Italy</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><p>The authors declare no competing financial interest.<br /></br></p></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i66">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47018" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47018" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This project was supported in part by the Deanship of Scientific Research at Prince Sattam bin Abdulaziz University under the research project no. 2016/03/6824.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">NSAIDs</td><td class="NLM_def"><p class="first last">nonsteroidal-anti-inflammatory-drugs</p></td></tr><tr><td class="NLM_term">CAIs</td><td class="NLM_def"><p class="first last">carbonic-anhydrase-inhibitors</p></td></tr><tr><td class="NLM_term">RA</td><td class="NLM_def"><p class="first last">rheumatoid arthritis</p></td></tr><tr><td class="NLM_term">CFA</td><td class="NLM_def"><p class="first last">complete Freund’s adjuvant</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i68">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71045" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71045" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 31 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bua, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Cesare Mannelli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vullo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghelardini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartolucci, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scozzafava, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supuran, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carta, F.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of novel Nonsteroidal Anti-Inflammatory Drugs and Carbonic Anhydrase Inhibitors hybrids (NSAIDs-CAIs) for the treatment of rheumatoid arthritis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1159</span>– <span class="NLM_lpage">1170</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01607</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01607" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A528%3ADC%252BC2sXptlWnsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1159-1170&author=S.+Buaauthor=L.+Di+Cesare+Mannelliauthor=D.+Vulloauthor=C.+Ghelardiniauthor=G.+Bartolucciauthor=A.+Scozzafavaauthor=C.+T.+Supuranauthor=F.+Carta&title=Design+and+synthesis+of+novel+Nonsteroidal+Anti-Inflammatory+Drugs+and+Carbonic+Anhydrase+Inhibitors+hybrids+%28NSAIDs-CAIs%29+for+the+treatment+of+rheumatoid+arthritis&doi=10.1021%2Facs.jmedchem.6b01607"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Novel Nonsteroidal Anti-Inflammatory Drugs and Carbonic Anhydrase Inhibitors Hybrids (NSAIDs-CAIs) for the Treatment of Rheumatoid Arthritis</span></div><div class="casAuthors">Bua, Silvia; Di Cesare Mannelli, Lorenzo; Vullo, Daniela; Ghelardini, Carla; Bartolucci, Gianluca; Scozzafava, Andrea; Supuran, Claudiu T.; Carta, Fabrizio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1159-1170</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors report the synthesis of a series of hybrid compds. incorporating 6- and 7-substituted coumarins (carbonic anhydrase, CA inhibitors) derivatized with clin. used NSAIDs (indomethacin, sulindac, ketoprofen, ibuprofen, diclofenac, ketorolac, etc., cyclooxygenase inhibitors) as agents for the management of rheumatoid arthritis (RA).  Most compds. were effective in inhibiting the RA overexpressed hCA IX and XII, with KI values in the low nanomolar-subnanomolar ranges.  The antihyperalgesic activity of such compds. was assessed by means of the paw-pressure and incapacitance tests using an in vivo RA model.  Among all tested compds., the 7-coumarin hybrid with ibuprofen showed potent and persistent antihyperalgesic effect up to 60 min after administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-g5uSZwfOBrVg90H21EOLACvtfcHk0lgG7zjTBm1klw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXptlWnsQ%253D%253D&md5=ee11328363ef5ae81ed20a8a751b172d</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01607%26sid%3Dliteratum%253Aachs%26aulast%3DBua%26aufirst%3DS.%26aulast%3DDi%2BCesare%2BMannelli%26aufirst%3DL.%26aulast%3DVullo%26aufirst%3DD.%26aulast%3DGhelardini%26aufirst%3DC.%26aulast%3DBartolucci%26aufirst%3DG.%26aulast%3DScozzafava%26aufirst%3DA.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26aulast%3DCarta%26aufirst%3DF.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520novel%2520Nonsteroidal%2520Anti-Inflammatory%2520Drugs%2520and%2520Carbonic%2520Anhydrase%2520Inhibitors%2520hybrids%2520%2528NSAIDs-CAIs%2529%2520for%2520the%2520treatment%2520of%2520rheumatoid%2520arthritis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D1159%26epage%3D1170%26doi%3D10.1021%2Facs.jmedchem.6b01607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, Y.</span></span> <span> </span><span class="NLM_article-title">Increased expression of carbonic anhydrase I in the synovium of patients with ankylosing spondylitis</span>. <i>BMC Musculoskeletal Disord.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">279</span>– <span class="NLM_lpage">290</span>, <span class="refDoi"> DOI: 10.1186/1471-2474-11-279</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.1186%2F1471-2474-11-279" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=21143847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFylsrjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=279-290&author=X.+Changauthor=J.+Hanauthor=Y.+Zhaoauthor=X.+Yanauthor=S.+Sunauthor=Y.+Cui&title=Increased+expression+of+carbonic+anhydrase+I+in+the+synovium+of+patients+with+ankylosing+spondylitis&doi=10.1186%2F1471-2474-11-279"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Increased expression of carbonic anhydrase I in the synovium of patients with ankylosing spondylitis</span></div><div class="casAuthors">Chang, Xiaotian; Han, Jinxiang; Zhao, Yan; Yan, Xinfeng; Shun, Shui; Cui, Yazhou</div><div class="citationInfo"><span class="NLM_cas:title">BMC Musculoskeletal Disorders</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">279</span>CODEN:
                <span class="NLM_cas:coden">BMDMCE</span>;
        ISSN:<span class="NLM_cas:issn">1471-2474</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: One of the most distinctive features of ankylosing spondylitis (AS) is new bone formation and bone resorption at sites of chronic inflammation.  Previous studies have indicated that the hyperplasia and inflammation of synovial tissues are significantly related to the pathogenic process of AS.  The present study used a proteomic approach to identify novel AS-specific proteins by simultaneously comparing the expression profiles of synovial membranes from patients with AS, rheumatoid arthritis (RA) and osteoarthritis (OA).  Methods: Synovial tissues were collected from the hip joints of patients with AS and knee joints of patients with RA or OA (n = 10 for each disease) during joint replacement surgery.  Proteins extd. from the synovial tissues were sepd. by 2-D electrophoresis (2-DE), and the proteins with significantly increased expression in the AS samples were subjected to MALDI-TOF/TOF-MS anal.  The results were verified using western blotting and immunohistochem.  Levels of the candidate proteins in synovial fluids from knee joints (n = 40 for each disease) were measured using ELISA.  Results: The proteomic approach revealed significantly increased expression of carbonic anhydrase I (CA1) in the synovial membrane of patients with AS as compared with the RA and OA tissue samples.  Immunohistochem. and western blotting anal. confirmed the findings described above.  The ELISA detected a higher level of CA1 in synovial fluids from patients with AS than those with OA.  The mean value of the CA1 level was also higher in AS patients as compared with RA patients.  This study also detected increased expression of alpha-1-antitrypsin in the synovial tissues from AS patients, which is in agreement with other reports.  Conclusion: In vitro expts. by other groups indicated that CA1 catalyzes the generation of HCO3- through the hydration of CO2, which then combines with Ca2+ to form a CaCO3 ppt.  Calcification is an essential step of bone formation.  Substantial evidence indicates that carbonic anhydrase also stimulates bone resorption.  Hence, overexpression of CA1 in the synovial tissues of AS patients may promote improper calcification and bone resorption in AS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCHbyoabCvlrVg90H21EOLACvtfcHk0lgG7zjTBm1klw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFylsrjK&md5=3fe0aded3642803229d61d98ea2471d0</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1186%2F1471-2474-11-279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2474-11-279%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DX.%26aulast%3DHan%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DYan%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DS.%26aulast%3DCui%26aufirst%3DY.%26atitle%3DIncreased%2520expression%2520of%2520carbonic%2520anhydrase%2520I%2520in%2520the%2520synovium%2520of%2520patients%2520with%2520ankylosing%2520spondylitis%26jtitle%3DBMC%2520Musculoskeletal%2520Disord.%26date%3D2010%26volume%3D11%26spage%3D279%26epage%3D290%26doi%3D10.1186%2F1471-2474-11-279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, X.</span></span> <span> </span><span class="NLM_article-title">Transgenic mice over-expressing carbonic anhydrase I showed aggravated joint inflammation and tissue destruction</span>. <i>BMC Musculoskeletal Disord.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">256</span>– <span class="NLM_lpage">265</span>, <span class="refDoi"> DOI: 10.1186/1471-2474-13-256</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.1186%2F1471-2474-13-256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=23256642" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A528%3ADC%252BC3sXns1Oqtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=256-265&author=Y.+Zhengauthor=L.+Wangauthor=W.+Zhangauthor=H.+Xuauthor=X.+Chang&title=Transgenic+mice+over-expressing+carbonic+anhydrase+I+showed+aggravated+joint+inflammation+and+tissue+destruction&doi=10.1186%2F1471-2474-13-256"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Transgenic mice over-expressing carbonic anhydrase I showed aggravated joint inflammation and tissue destruction</span></div><div class="casAuthors">Zheng, Yabing; Wang, Lin; Zhang, Wei; Xu, Hengwei; Chang, Xiaotian</div><div class="citationInfo"><span class="NLM_cas:title">BMC Musculoskeletal Disorders</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">256</span>CODEN:
                <span class="NLM_cas:coden">BMDMCE</span>;
        ISSN:<span class="NLM_cas:issn">1471-2474</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Studies have demonstrated that carbonic anhydrase I (CA1) stimulates calcium salt pptn. and cell calcification, which is an essential step in new bone formation.  Our study had reported that CA1 encoding gene has a strong assocn. with rheumatoid arthritis (RA) and ankylosing spondylitis (AS), two rheumatic diseases with abnormal new bone formation and bone resorption in joints.  This study investigated the effect of CA1 on joint inflammation and tissue destruction in transgenic mice that over-express CA1 (CA1-Tg).  Methods: CA1-Tg was generated with C57BL/6J mice by conventional methods.  CA1-Tg was treated with collagen-II to induce arthritis (CIA).  Wild-type mice, CA1-Tg treated with bovine serum albumin (BSA) and transgenic mice over-expressing PADI4 (PADI4-Tg), a gene known to be involved in rheumatoid arthritis, were used as controls.  Histochem. and X-ray radiog. assay were used to examine joint destruction.  Western blotting and real time-PCR were used to examine CA1 expression.  Results: CIA was obsd. in 60% of CA1-Tg, 20% of PADI4-Tg and 20% of wild-type mice after collagen injections.  No CIA was found in CA1-Tg mice that received injections of BSA.  The arthritic score was 5.5 ± 0.84 in the CA1-Tgs but the score was less than 2 in the injected wild-type mice and the PADI4-Tgs.  The thickness of the hind paws in the CA1-Tgs was 3.46 ± 0.11 mm, which was thicker than that of PADI4-Tgs (2.23 ± 0.08 mm), wild-type mice (2.08 ± 0.06 mm) and BSA-treated CA1-Tgs (2.04 ± 0.07 mm).  Histochem. showed obvious inflammation, synovial hyperplasia and bone destruction in the joints of CA1-Tg that was not detected in PADI4-Tgs or wild-type mice.  X-ray assays showed bone fusion in the paws and spines of CA1-Tg mice.  Conclusion: Over-expression of CA1 may aggravate joint inflammation and tissue destruction in the transgenic mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBgR7O5Re0G7Vg90H21EOLACvtfcHk0lgG7zjTBm1klw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXns1Oqtrw%253D&md5=ccd41a8452b65cf7e8d510302ca8f44d</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1186%2F1471-2474-13-256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2474-13-256%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DChang%26aufirst%3DX.%26atitle%3DTransgenic%2520mice%2520over-expressing%2520carbonic%2520anhydrase%2520I%2520showed%2520aggravated%2520joint%2520inflammation%2520and%2520tissue%2520destruction%26jtitle%3DBMC%2520Musculoskeletal%2520Disord.%26date%3D2012%26volume%3D13%26spage%3D256%26epage%3D265%26doi%3D10.1186%2F1471-2474-13-256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deutsch, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krief, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konttinen, Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaks, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aframian, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmon, A.</span></span> <span> </span><span class="NLM_article-title">Identification of Sjögren’s syndrome oral fluid biomarker candidates following high-abundance protein depletion</span>. <i>Rheumatology</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">884</span>– <span class="NLM_lpage">890</span>, <span class="refDoi"> DOI: 10.1093/rheumatology/keu405</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.1093%2Frheumatology%2Fkeu405" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2015&pages=884-890&author=O.+Deutschauthor=G.+Kriefauthor=Y.+T.+Konttinenauthor=B.+Zaksauthor=D.+T.+Wongauthor=D.+J.+Aframianauthor=A.+Palmon&title=Identification+of+Sj%C3%B6gren%E2%80%99s+syndrome+oral+fluid+biomarker+candidates+following+high-abundance+protein+depletion&doi=10.1093%2Frheumatology%2Fkeu405"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1093%2Frheumatology%2Fkeu405&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Frheumatology%252Fkeu405%26sid%3Dliteratum%253Aachs%26aulast%3DDeutsch%26aufirst%3DO.%26aulast%3DKrief%26aufirst%3DG.%26aulast%3DKonttinen%26aufirst%3DY.%2BT.%26aulast%3DZaks%26aufirst%3DB.%26aulast%3DWong%26aufirst%3DD.%2BT.%26aulast%3DAframian%26aufirst%3DD.%2BJ.%26aulast%3DPalmon%26aufirst%3DA.%26atitle%3DIdentification%2520of%2520Sj%25C3%25B6gren%25E2%2580%2599s%2520syndrome%2520oral%2520fluid%2520biomarker%2520candidates%2520following%2520high-abundance%2520protein%2520depletion%26jtitle%3DRheumatology%26date%3D2015%26volume%3D54%26spage%3D884%26epage%3D890%26doi%3D10.1093%2Frheumatology%2Fkeu405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span> <span> </span><span class="NLM_article-title">Carbonic anhydrases III and IV autoantibodies in rheumatoid arthritis, systemic lupus erythematosus, diabetes, hypertensive renal disease, and heart failure</span>. <i>Clin. Dev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>2012</i></span>,  <span class="NLM_fpage">354594</span>, <span class="refDoi"> DOI: 10.1155/2012/354594</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.1155%2F2012%2F354594" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=23049597" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A280%3ADC%252BC3s%252FjslSksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2012&publication_year=2012&pages=354594&author=C.+Liuauthor=Y.+Weiauthor=J.+Wangauthor=L.+Piauthor=J.+Huangauthor=P.+Wang&title=Carbonic+anhydrases+III+and+IV+autoantibodies+in+rheumatoid+arthritis%2C+systemic+lupus+erythematosus%2C+diabetes%2C+hypertensive+renal+disease%2C+and+heart+failure&doi=10.1155%2F2012%2F354594"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Carbonic anhydrases III and IV autoantibodies in rheumatoid arthritis, systemic lupus erythematosus, diabetes, hypertensive renal disease, and heart failure</span></div><div class="casAuthors">Liu Chengeng; Wei Yue; Wang Jianmin; Pi Langan; Huang Jianjun; Wang Peichang</div><div class="citationInfo"><span class="NLM_cas:title">Clinical & developmental immunology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2012</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">354594</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">In the present study, the CA III and IV autoantibodies, CA activity, antioxidant enzymes and cytokines in rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), diabetes, hypertensive renal disease, and heart failure were investigated.  The anti-CA III antibody titers in patients with RA, SLE, and type 1 diabetes (T1D) were significantly higher than that in control groups (P < 0.05).  The anti-CA IV antibody titers in patients with RA, SLE, type 1 diabetic nephropathy (T1DN), and heart failure were significantly higher than that in control groups (P < 0.05) while anti-CA IV antibody could suppress the total CA activity.  The SOD and GPx levels in patients with RA, SLE, and T1DN were significantly lower than that in control groups (P < 0.05).  IL-6, IL-17, IFN-γ, and TNF-α levels were significantly higher in SLE group compared with the control group (P < 0.05).  Weak but significant correlations were found between anti-CA III antibodies and ESR in RA (r = 0.403, P = 0.013) and SLE patients (r = 0.397, P = 0.007).  These results suggested that the generation of CA III and IV autoantibodies, antioxidant enzymes, and cytokines might influence each other and CA autoantibodies might affect the normal physiology function of CA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTMwJt9ij_06p6KlWarZTAzfW6udTcc2eYL-cDPnePj07ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s%252FjslSksQ%253D%253D&md5=7b1a21e831746b620169ecc4b4b16211</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1155%2F2012%2F354594&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2012%252F354594%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DWei%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DPi%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DP.%26atitle%3DCarbonic%2520anhydrases%2520III%2520and%2520IV%2520autoantibodies%2520in%2520rheumatoid%2520arthritis%252C%2520systemic%2520lupus%2520erythematosus%252C%2520diabetes%252C%2520hypertensive%2520renal%2520disease%252C%2520and%2520heart%2520failure%26jtitle%3DClin.%2520Dev.%2520Immunol.%26date%3D2012%26volume%3D2012%26spage%3D354594%26doi%3D10.1155%2F2012%2F354594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Margheri, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ceruso, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carta, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laurenzana, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maggi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazzeri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simonini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Annunziato, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Rosso, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supuran, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cimaz, R.</span></span> <span> </span><span class="NLM_article-title">Overexpression of the transmembrane carbonic anhydrase isoforms IX and XII in the inflamed synovium</span>. <i>J. Enzyme Inhib. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">60</span>– <span class="NLM_lpage">63</span>, <span class="refDoi"> DOI: 10.1080/14756366.2016.1217857</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.1080%2F14756366.2016.1217857" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=27539792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlOmt7%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2016&pages=60-63&author=F.+Margheriauthor=M.+Cerusoauthor=F.+Cartaauthor=A.+Laurenzanaauthor=L.+Maggiauthor=S.+Lazzeriauthor=G.+Simoniniauthor=F.+Annunziatoauthor=M.+Del+Rossoauthor=C.+T.+Supuranauthor=R.+Cimaz&title=Overexpression+of+the+transmembrane+carbonic+anhydrase+isoforms+IX+and+XII+in+the+inflamed+synovium&doi=10.1080%2F14756366.2016.1217857"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of the transmembrane carbonic anhydrase isoforms IX and XII in the inflamed synovium</span></div><div class="casAuthors">Margheri, Francesca; Ceruso, Mariangela; Carta, Fabrizio; Laurenzana, Anna; Maggi, Laura; Lazzeri, Simone; Simonini, Gabriele; Annunziato, Francesco; Del Rosso, Mario; Supuran, Claudiu T.; Cimaz, Rolando</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">sup4</span>),
    <span class="NLM_cas:pages">60-63</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Juvenile idiopathic arthritis (JIA) is the most common form of chronic rheumatic disease affecting children worldwide, with some features similar to adult rheumatoid arthritis (RA).  In the present study, we aim at investigating novel markers that will allow in the future for tailored, more personalized treatment strategies.  Hence, taking notice of several reports proving the role of local acidosis as a causal link between inflammatory diseases and related pain, and the involvement of several carbonic anhydrases (CA, EC 4.2.1.1) isoforms in articular diseases, we evaluated in JIA patients the expression of these metalloenzymes.  We identified that JIA patients show high levels of active CA IX and XII isoforms.  Our results represent the first evidence of the identification of these enzymes as potential therapeutic targets and development of novel innovative therapies for arthritis, also considering that the two isoforms are validated antitumor targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4HZAqJSLZZLVg90H21EOLACvtfcHk0lhgpYmMZzNiwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlOmt7%252FI&md5=780b2ae6f9d02050c0c167e8cec91c8c</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1080%2F14756366.2016.1217857&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14756366.2016.1217857%26sid%3Dliteratum%253Aachs%26aulast%3DMargheri%26aufirst%3DF.%26aulast%3DCeruso%26aufirst%3DM.%26aulast%3DCarta%26aufirst%3DF.%26aulast%3DLaurenzana%26aufirst%3DA.%26aulast%3DMaggi%26aufirst%3DL.%26aulast%3DLazzeri%26aufirst%3DS.%26aulast%3DSimonini%26aufirst%3DG.%26aulast%3DAnnunziato%26aufirst%3DF.%26aulast%3DDel%2BRosso%26aufirst%3DM.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26aulast%3DCimaz%26aufirst%3DR.%26atitle%3DOverexpression%2520of%2520the%2520transmembrane%2520carbonic%2520anhydrase%2520isoforms%2520IX%2520and%2520XII%2520in%2520the%2520inflamed%2520synovium%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2016%26volume%3D31%26spage%3D60%26epage%3D63%26doi%3D10.1080%2F14756366.2016.1217857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Supuran, C. T.</span></span> <span> </span><span class="NLM_article-title">Carbonic anhydrases: novel therapeutic applications for inhibitors and activators</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">168</span>– <span class="NLM_lpage">181</span>, <span class="refDoi"> DOI: 10.1038/nrd2467</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.1038%2Fnrd2467" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=18167490" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhs1Khsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=168-181&author=C.+T.+Supuran&title=Carbonic+anhydrases%3A+novel+therapeutic+applications+for+inhibitors+and+activators&doi=10.1038%2Fnrd2467"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">Carbonic anhydrases: novel therapeutic applications for inhibitors and activators</span></div><div class="casAuthors">Supuran, Claudiu T.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">168-181</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Carbonic anhydrases (CAs), a group of ubiquitously expressed metalloenzymes, are involved in numerous physiol. and pathol. processes, including gluconeogenesis, lipogenesis, ureagenesis, tumorigenicity and the growth and virulence of various pathogens.  In addn. to the established role of CA inhibitors (CAIs) as diuretics and antiglaucoma drugs, it has recently emerged that CAIs could have potential as novel antiobesity, anticancer and anti-infective drugs.  Furthermore, recent studies suggest that CA activation may provide a novel therapy for Alzheimer's disease.  This article discusses the biol. rationale for the novel uses of inhibitors or activators of CA activity in multiple diseases, and highlights progress in the development of specific modulators of the relevant CA isoforms, some of which are now being evaluated in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8lavoPtcpPrVg90H21EOLACvtfcHk0lhgpYmMZzNiwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhs1Khsr0%253D&md5=f00fe348bbcf38048727c1283496cdfa</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1038%2Fnrd2467&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2467%26sid%3Dliteratum%253Aachs%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DCarbonic%2520anhydrases%253A%2520novel%2520therapeutic%2520applications%2520for%2520inhibitors%2520and%2520activators%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2008%26volume%3D7%26spage%3D168%26epage%3D181%26doi%3D10.1038%2Fnrd2467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Tanc, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carta, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scozzafava, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supuran, C. T.</span></span> <span> </span><span class="NLM_article-title">α-Carbonic anhydrases possess thioesterase activity</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">292</span>– <span class="NLM_lpage">295</span>, <span class="refDoi"> DOI: 10.1021/ml500470b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500470b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=292-295&author=M.+Tancauthor=F.+Cartaauthor=A.+Scozzafavaauthor=C.+T.+Supuran&title=%CE%B1-Carbonic+anhydrases+possess+thioesterase+activity&doi=10.1021%2Fml500470b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1021%2Fml500470b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500470b%26sid%3Dliteratum%253Aachs%26aulast%3DTanc%26aufirst%3DM.%26aulast%3DCarta%26aufirst%3DF.%26aulast%3DScozzafava%26aufirst%3DA.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3D%25CE%25B1-Carbonic%2520anhydrases%2520possess%2520thioesterase%2520activity%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D292%26epage%3D295%26doi%3D10.1021%2Fml500470b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit7c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Supuran, C. T.</span></span> <span> </span><span class="NLM_article-title">How many carbonic anhydrase inhibition mechanisms exist?</span>. <i>J. Enzyme Inhib. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">345</span>– <span class="NLM_lpage">360</span>, <span class="refDoi"> DOI: 10.3109/14756366.2015.1122001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.3109%2F14756366.2015.1122001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=26619898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFGms7bE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2016&pages=345-360&author=C.+T.+Supuran&title=How+many+carbonic+anhydrase+inhibition+mechanisms+exist%3F&doi=10.3109%2F14756366.2015.1122001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7cR"><div class="casContent"><span class="casTitleNuber">7c</span><div class="casTitle"><span class="NLM_cas:atitle">How many carbonic anhydrase inhibition mechanisms exist?</span></div><div class="casAuthors">Supuran, Claudiu T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">345-360</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  Six genetic families of the enzyme carbonic anhydrase (CA, EC 4.2.1.1) were described to date.  Inhibition of CAs has pharmacol. applications in the field of antiglaucoma, anticonvulsant, anticancer, and anti-infective agents.  New classes of CA inhibitors (CAIs) were described in the last decade with enzyme inhibition mechanisms differing considerably from the classical inhibitors of the sulfonamide or anion type.  Five different CA inhibition mechanisms are known: (i) the zinc binders coordinate to the catalytically crucial Zn(II) ion from the enzyme active site, with the metal in tetrahedral or trigonal bipyramidal geometries.  Sulfonamides and their isosters, most anions, dithiocarbamates and their isosters, carboxylates, and hydroxamates bind in this way; (ii) inhibitors that anchor to the zinc-coordinated water mol./hydroxide ion (phenols, carboxylates, polyamines, 2-thioxocoumarins, sulfocoumarins); (iii) inhibitors which occlude the entrance to the active site cavity (coumarins and their isosters), this binding site coinciding with that where CA activators bind; (iv) compds. which bind out of the active site cavity (a carboxylic acid deriv. was seen to inhibit CA in this manner), and (v) compds. for which the inhibition mechanism is not known, among which the secondary/tertiary sulfonamides as well as imatinib/nilotinib are the most investigated examples.  As CAIs are used clin. in many pathologies, with a sulfonamide inhibitor (SLC-0111) in Phase I clin. trials for the management of metastatic solid tumors, this review updates the recent findings in the field which may be useful for a structure-based drug design approach of more selective/potent modulators of the activity of these enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrh8n13uOvB17Vg90H21EOLACvtfcHk0li0J9daxZ3DLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFGms7bE&md5=3f7f8071c39c4fbf59a8b71205ae973d</span></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=10.3109%2F14756366.2015.1122001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F14756366.2015.1122001%26sid%3Dliteratum%253Aachs%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DHow%2520many%2520carbonic%2520anhydrase%2520inhibition%2520mechanisms%2520exist%253F%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2016%26volume%3D31%26spage%3D345%26epage%3D360%26doi%3D10.3109%2F14756366.2015.1122001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit7d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Carta, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vullo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maresca, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scozzafava, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supuran, C. T.</span></span> <span> </span><span class="NLM_article-title">New chemotypes acting as isozyme-selective carbonic anhydrase inhibitors with low affinity for the offtarget cytosolic isoform II</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">2182</span>– <span class="NLM_lpage">2185</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.01.129</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.1016%2Fj.bmcl.2012.01.129" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2182-2185&author=F.+Cartaauthor=D.+Vulloauthor=A.+Marescaauthor=A.+Scozzafavaauthor=C.+T.+Supuran&title=New+chemotypes+acting+as+isozyme-selective+carbonic+anhydrase+inhibitors+with+low+affinity+for+the+offtarget+cytosolic+isoform+II&doi=10.1016%2Fj.bmcl.2012.01.129"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7d&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.01.129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.01.129%26sid%3Dliteratum%253Aachs%26aulast%3DCarta%26aufirst%3DF.%26aulast%3DVullo%26aufirst%3DD.%26aulast%3DMaresca%26aufirst%3DA.%26aulast%3DScozzafava%26aufirst%3DA.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DNew%2520chemotypes%2520acting%2520as%2520isozyme-selective%2520carbonic%2520anhydrase%2520inhibitors%2520with%2520low%2520affinity%2520for%2520the%2520offtarget%2520cytosolic%2520isoform%2520II%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2182%26epage%3D2185%26doi%3D10.1016%2Fj.bmcl.2012.01.129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit7e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Scozzafava, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supuran, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carta, F.</span></span> <span> </span><span class="NLM_article-title">Antiobesity carbonic anhydrase inhibitors: a literature and patent review</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">725</span>– <span class="NLM_lpage">735</span>, <span class="refDoi"> DOI: 10.1517/13543776.2013.790957</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.1517%2F13543776.2013.790957" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=23607332" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnsl2qtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=725-735&author=A.+Scozzafavaauthor=C.+T.+Supuranauthor=F.+Carta&title=Antiobesity+carbonic+anhydrase+inhibitors%3A+a+literature+and+patent+review&doi=10.1517%2F13543776.2013.790957"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7eR"><div class="casContent"><span class="casTitleNuber">7e</span><div class="casTitle"><span class="NLM_cas:atitle">Antiobesity carbonic anhydrase inhibitors: a literature and patent review</span></div><div class="casAuthors">Scozzafava, Andrea; Supuran, Claudiu T.; Carta, Fabrizio</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">725-735</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Obesity is ranked as one of the top 10 global health problems and the major concern deriving from it is the exposure of the population to a vast array of chronic pathologies such as cardiovascular and musculoskeletal disorders, type 2 diabetes, cancer, such as colon, breast and endometrial cancer, together with psychol. disorders derived from this condition.  The discovery that the clin. used anticonvulsants topiramate (TPM) and zonisamide (ZNS) induced wt. loss in obese, epileptic patients, afforded the validation of the mitochondrial carbonic anhydrases (CAs, EC 4.2.1.1) VA and VB as targets for the development of antiobesity drugs.Areas covered: This review deals with the scientific and patent literature regarding obesity or obesity-related pathologies, being particularly focused on the use of carbonic anhydrase inhibitors (CAI) such as TPM and ZNS which inhibit the de novo lipogenesis. Expert opinion: There is an urgent need of new drugs for the treatment of obesity.  The identification that the mitochondrial CAs are implicated in the de novo lipogenesis allowed to consider selective inhibitors of such enzymes as useful for the development of new antiobesity drugs.  Actually TPM was approved 1 yr ago for this therapy, whereas ZNS is also an effective such agent.  These compds. are the lead mols. in this field and an intense research is on the way in order to develop new compds. based on the selective inhibition of mitochondrial CA isoforms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpV5LUSX76OrVg90H21EOLACvtfcHk0li0J9daxZ3DLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnsl2qtL4%253D&md5=52482234cea242b5564460a01575053f</span></div><a href="/servlet/linkout?suffix=cit7e&amp;dbid=16384&amp;doi=10.1517%2F13543776.2013.790957&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2013.790957%26sid%3Dliteratum%253Aachs%26aulast%3DScozzafava%26aufirst%3DA.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26aulast%3DCarta%26aufirst%3DF.%26atitle%3DAntiobesity%2520carbonic%2520anhydrase%2520inhibitors%253A%2520a%2520literature%2520and%2520patent%2520review%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2013%26volume%3D23%26spage%3D725%26epage%3D735%26doi%3D10.1517%2F13543776.2013.790957" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit7f"><span><span class="NLM_label">(f) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Alterio, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Fiore, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Ambrosio, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supuran, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Simone, G.</span></span> <span> </span><span class="NLM_article-title">Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">4421</span>– <span class="NLM_lpage">4468</span>, <span class="refDoi"> DOI: 10.1021/cr200176r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr200176r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A528%3ADC%252BC38Xnt1Wrsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2012&pages=4421-4468&author=V.+Alterioauthor=A.+Di+Fioreauthor=K.+D%E2%80%99Ambrosioauthor=C.+T.+Supuranauthor=G.+De+Simone&title=Multiple+binding+modes+of+inhibitors+to+carbonic+anhydrases%3A+how+to+design+specific+drugs+targeting+15+different+isoforms%3F&doi=10.1021%2Fcr200176r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7fR"><div class="casContent"><span class="casTitleNuber">7f</span><div class="casTitle"><span class="NLM_cas:atitle">Multiple Binding Modes of Inhibitors to Carbonic Anhydrases: How to Design Specific Drugs Targeting 15 Different Isoforms?</span></div><div class="casAuthors">Alterio, Vincenzo; Di Fiore, Anna; D'Ambrosio, Katia; Supuran, Claudiu T.; De Simone, Giuseppina</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4421-4468</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The aim of this review is to provide an exhaustive description of the structural studies on α-CAs (carbonic anhydrases) so far reported.  In particular, the main structural features of the catalytically active α-CA isoenzymes characterized to date will be described and the current state of the art on complexes of hCA II with the principal classes of inhibitors will be summarized.  A comparison with the corresponding adducts of other isoforms, when available, will be also performed, in order to find for each isoform the key residues responsible for enzyme/inhibitor interaction.  Finally, recent advances in the field of drug design of selective CAIs will be illustrated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA0GdtMHwlZ7Vg90H21EOLACvtfcHk0ljGHMpdGqAU9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xnt1Wrsbg%253D&md5=eb45ffb5efe07980f1388d99bf51406a</span></div><a href="/servlet/linkout?suffix=cit7f&amp;dbid=16384&amp;doi=10.1021%2Fcr200176r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr200176r%26sid%3Dliteratum%253Aachs%26aulast%3DAlterio%26aufirst%3DV.%26aulast%3DDi%2BFiore%26aufirst%3DA.%26aulast%3DD%25E2%2580%2599Ambrosio%26aufirst%3DK.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26aulast%3DDe%2BSimone%26aufirst%3DG.%26atitle%3DMultiple%2520binding%2520modes%2520of%2520inhibitors%2520to%2520carbonic%2520anhydrases%253A%2520how%2520to%2520design%2520specific%2520drugs%2520targeting%252015%2520different%2520isoforms%253F%26jtitle%3DChem.%2520Rev.%26date%3D2012%26volume%3D112%26spage%3D4421%26epage%3D4468%26doi%3D10.1021%2Fcr200176r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit7g"><span><span class="NLM_label">(g) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Supuran, C.
T.</span></span> <span> </span><span class="NLM_article-title">Structure-based drug discovery of carbonic anhydrase inhibitors</span>. <i>J. Enzyme Inhib. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">759</span>– <span class="NLM_lpage">772</span>, <span class="refDoi"> DOI: 10.3109/14756366.2012.672983</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7g&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.3109%2F14756366.2012.672983" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7g&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=22468747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7g&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslCgtL7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2012&pages=759-772&author=C.%0AT.+Supuran&title=Structure-based+drug+discovery+of+carbonic+anhydrase+inhibitors&doi=10.3109%2F14756366.2012.672983"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7gR"><div class="casContent"><span class="casTitleNuber">7g</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based drug discovery of carbonic anhydrase inhibitors</span></div><div class="casAuthors">Supuran, Claudiu T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">759-772</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Inhibition of the metalloenzyme carbonic anhydrase (CA; EC 4.2.1.1) has pharmacol. applications in the field of anti-glaucoma, anti-convulsant and anti-cancer agents.  But recently, it has also emerged that these enzymes have the potential for designing anti-infective drugs (anti-fungal and anti-bacterial agents) with a novel mechanism of action.  Sulfonamides and their isosteres (sulfamates/sulfamides) constitute the main class of CA inhibitors (CAIs), which bind to the metal ion from the enzyme active site.  Recently, the dithiocarbamates (DTCs), possessing a similar mechanism of action, were reported as a new class of inhibitors.  These types of CAIs will be discussed in detail in this review.  Novel drug design strategies have been reported ultimately based on the tail approach for obtaining sulfonamides/DTCs, which exploit more external binding regions within the enzyme active site (in addn. to coordination to the metal ion), leading thus to isoform-selective compds.  Most of the promising data have been obtained by combining x-ray crystallog. of enzyme-inhibitor adducts with novel synthetic approaches for generating chem. diversity.  Whereas sulfonamide - NO donating hybrid drugs were reported as effective anti-glaucoma agents, most of the interesting new inhibitors were designed for inhibiting specifically the tumor-assocd. isoforms CA IX and XII, validated targets for imaging and treatment of hypoxic tumors.  Promising compds. that inhibit CAs from bacterial and fungal pathogens, of the DTC and carboxylate types, will be also reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsmAtcxdWfHbVg90H21EOLACvtfcHk0ljGHMpdGqAU9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslCgtL7N&md5=55a993be904b13c63eb52b9d0229e187</span></div><a href="/servlet/linkout?suffix=cit7g&amp;dbid=16384&amp;doi=10.3109%2F14756366.2012.672983&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F14756366.2012.672983%26sid%3Dliteratum%253Aachs%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DStructure-based%2520drug%2520discovery%2520of%2520carbonic%2520anhydrase%2520inhibitors%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2012%26volume%3D27%26spage%3D759%26epage%3D772%26doi%3D10.3109%2F14756366.2012.672983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Farr, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garvey, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bold, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kendall, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bacon, P. A.</span></span> <span> </span><span class="NLM_article-title">Significance of the hydrogen ion concentration in synovial fluid in rheumatoid arthritis</span>. <i>Clin. Exp. Rheumatol.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">99</span>– <span class="NLM_lpage">104</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=4017318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A280%3ADyaL2M3lsFOgsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1985&pages=99-104&author=M.+Farrauthor=K.+Garveyauthor=A.+M.+Boldauthor=M.+J.+Kendallauthor=P.+A.+Bacon&title=Significance+of+the+hydrogen+ion+concentration+in+synovial+fluid+in+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Significance of the hydrogen ion concentration in synovial fluid in rheumatoid arthritis</span></div><div class="casAuthors">Farr M; Garvey K; Bold A M; Kendall M J; Bacon P A</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and experimental rheumatology</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">99-104</span>
        ISSN:<span class="NLM_cas:issn">0392-856X</span>.
    </div><div class="casAbstract">The hydrogen ion (H+) concentration and pCO2 were measured in the synovial fluid (SF) from the knee joints of 130 patients with arthritis by an acid-base analyser (ABL2 Acid-Base Laboratory), using a simple technique which prevented contact with air.  H+ concentration was significantly higher in SF from 60 RA patients (mean 64.4 n mol/l; range 38-142 n mol/l) compared with patients with OA (mean 44 n mol/l; range 29-56 n mol/l), and 40 with other arthritides (mean 52 n mol/l).  The H+ concentration in the SF showed a significant association with other variables of local inflammation-platelet, total leucocyte and polymorph counts, 5-nucleotidase, acid phosphatase and IgA levels in the SF and the clinical knee score, but not with the volume of the effusion.  A similar relationship between these variables of inflammatory activity and SF pCO2 was also established.  A higher SF H+ concentration was also found in systemically active disease, but no difference in SF pH between seropositive and seronegative patients.  Whilst the pH of SF approximated to that of the blood in OA, it was significantly lower in the SF in RA.  SF pH is a useful marker of local inflammatory activity, and its measurement is simple, reliable and rapid.  It is relevant because changes in pH influence many of the processes involved in inflammation and the pH difference between SF and blood influences the transfer of drugs into the joint.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQWQDsjjJW6DkQ0lWbKiCflfW6udTcc2eaLVxKmRlVUDLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2M3lsFOgsQ%253D%253D&md5=85e9c6f8a2d7772871e0368759fcadb5</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFarr%26aufirst%3DM.%26aulast%3DGarvey%26aufirst%3DK.%26aulast%3DBold%26aufirst%3DA.%2BM.%26aulast%3DKendall%26aufirst%3DM.%2BJ.%26aulast%3DBacon%26aufirst%3DP.%2BA.%26atitle%3DSignificance%2520of%2520the%2520hydrogen%2520ion%2520concentration%2520in%2520synovial%2520fluid%2520in%2520rheumatoid%2520arthritis%26jtitle%3DClin.%2520Exp.%2520Rheumatol.%26date%3D1985%26volume%3D3%26spage%3D99%26epage%3D104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Steen, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steen, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reeh, P. W.</span></span> <span> </span><span class="NLM_article-title">A dominant role of acid pH in inflammatory excitation and sensitization of nociceptors in rat skin, in vitro</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">3982</span>– <span class="NLM_lpage">3989</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.15-05-03982.1995</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.1523%2FJNEUROSCI.15-05-03982.1995" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=7751959" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A528%3ADyaK2MXls1aisbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1995&pages=3982-3989&author=K.+H.+Steenauthor=A.+E.+Steenauthor=P.+W.+Reeh&title=A+dominant+role+of+acid+pH+in+inflammatory+excitation+and+sensitization+of+nociceptors+in+rat+skin%2C+in+vitro&doi=10.1523%2FJNEUROSCI.15-05-03982.1995"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">A dominant role of acid pH in inflammatory excitation and sensitization of nociceptors in rat skin, in vitro</span></div><div class="casAuthors">Steen, Kay H.; Steen, Astrid E.; Reeh, Peter W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">5, Pt. 2</span>),
    <span class="NLM_cas:pages">3982-9</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">A major role of local acidosis in long lasting excitation and sensitization of cutaneous nociceptors has recently been demonstrated.  In inflamed tissue, acid pH meets with a mixt. of inflammatory mediators which, by themselves, stimulate nociceptors though being subject to profound tachyphylaxis.  We have mimicked this condition in a rat skin-saphenous nerve prepn. in vitro which allows direct application of chems. to the isolated receptive fields at the corium side.  Stimulant solns. used were CO2-satd. "synthetic interstitial fluid" (CO2-SIF, pH 6.1), an "inflammatory soup" (IS) in submaximal concn. contg. bradykinin, 5-HT, histamine, prostaglandin E2 (all 10-6M in SIF at 38.5° and pH 7.0), and a combination made of CO2-satd. IS (CO2-IS, pH 6.1).  Identified mechano-heat sensitive ("polymodal") C-fiber terminals (n = 36) were treated with these solns. for 5 min at 10 min intervals or for 30 min of sustained stimulation: 20 units responded to CO2-SIF, 12 to IS, whereas 27 units (75%) were excited by CO2-IS.  Thus, 6 out of 15 units insensitive to either of the two basic solns. were stimulated by their combination.  This enhanced effect of CO2-IS was also expressed in shorter latencies (than with CO2-SIF) and in a significantly larger mean response magnitude of the fiber population: 152 spikes with the combination vs. 45 spikes evoked by IS and 93 spikes by CO2-SIF (n = 25; p < 0.002 and < 0.02, resp., Wilcoxon test).  The synergistic interaction between CO2 and IS also showed up during sustained nociceptor stimulation (30 min) by either CO2SIF (n = 7) or IS (n = 1) when, during the middle 10 min, CO2-IS was applied which significantly increased the discharge.  There is a strong, potentially algogenic, interaction between acid pH and inflammatory mediators in terms of prevalence and magnitude of nociceptor excitation.  At equal and pathophysiol. relevant concn., however, hydrogen ions play a dominant role.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8eLXfegRJPLVg90H21EOLACvtfcHk0ljGHMpdGqAU9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXls1aisbs%253D&md5=35d850f5272831214c9af2aa43859320</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.15-05-03982.1995&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.15-05-03982.1995%26sid%3Dliteratum%253Aachs%26aulast%3DSteen%26aufirst%3DK.%2BH.%26aulast%3DSteen%26aufirst%3DA.%2BE.%26aulast%3DReeh%26aufirst%3DP.%2BW.%26atitle%3DA%2520dominant%2520role%2520of%2520acid%2520pH%2520in%2520inflammatory%2520excitation%2520and%2520sensitization%2520of%2520nociceptors%2520in%2520rat%2520skin%252C%2520in%2520vitro%26jtitle%3DJ.%2520Neurosci.%26date%3D1995%26volume%3D15%26spage%3D3982%26epage%3D3989%26doi%3D10.1523%2FJNEUROSCI.15-05-03982.1995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lardner, A.</span></span> <span> </span><span class="NLM_article-title">The effects of extracellular pH on immune function</span>. <i>J. Leukoc. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">522</span>– <span class="NLM_lpage">530</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=11310837" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A528%3ADC%252BD3MXivVagurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2001&pages=522-530&author=A.+Lardner&title=The+effects+of+extracellular+pH+on+immune+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The effects of extracellular pH on immune function</span></div><div class="casAuthors">Lardner, Anne</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Leukocyte Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">522-530</span>CODEN:
                <span class="NLM_cas:coden">JLBIE7</span>;
        ISSN:<span class="NLM_cas:issn">0741-5400</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">A review with 80 refs.  The effect of alterations in extracellular pH on cellular and humoral immune function is reviewed.  Because acidic pH predominates at inflammatory loci and other sites of immune activity, most studies to date focus on the effect of acidic rather than alk. pH.  Investigations on polymorphonuclear leukocytes demonstrate mainly inhibition of chemotaxis, respiratory activity, and bactericidal capacity at reduced pH.  Evidence of impaired lymphocyte cytotoxicity and proliferation at acidic pH is also beginning to emerge.  Many of the clin. acidosis are accompanied similarly by immunodeficiency.  Studies on macrophages and eosinophils are few and inconclusive.  A small no. of studies demonstrate acid-induced activation of complement proteins and the alternative complement pathway, plus increased antibody-binding to leukocytes at lowered pH.  A differential effect of acidic pH on humoral and cellular immunity may, therefore, exist.  Increasing recognition of the significance of extracellular pH in relation to immune function warrants further studies in this presently incomplete but rewarding field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqi8Hr7d3nZXbVg90H21EOLACvtfcHk0lj6lOwiqbl3tA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXivVagurs%253D&md5=86f05548986270622e403e359f0f2422</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLardner%26aufirst%3DA.%26atitle%3DThe%2520effects%2520of%2520extracellular%2520pH%2520on%2520immune%2520function%26jtitle%3DJ.%2520Leukoc.%2520Biol.%26date%3D2001%26volume%3D69%26spage%3D522%26epage%3D530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Singh, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saag, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bridges, S. L.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akl, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bannuru, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaysbrot, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNaughton, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shmerling, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtis, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furst, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parks, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kavanaugh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Dell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leong, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matteson, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schousboe, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drevlow, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ginsberg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grober, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">St. Clair, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tindall, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McAlindon, T.</span></span> <span> </span><span class="NLM_article-title">2015 American college of rheumatology guideline for the treatment of rheumatoid arthritis</span>. <i>Arthritis Rheumatol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">26</span>, <span class="refDoi"> DOI: 10.1002/art.39480</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.1002%2Fart.39480" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=26545940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A280%3ADC%252BC28zpvVGnsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2016&pages=1-26&author=J.+A.+Singhauthor=K.+G.+Saagauthor=S.+L.+Bridgesauthor=E.+A.+Aklauthor=R.+R.+Bannuruauthor=M.+C.+Sullivanauthor=E.+Vaysbrotauthor=C.+McNaughtonauthor=M.+Osaniauthor=R.+H.+Shmerlingauthor=J.+R.+Curtisauthor=D.+E.+Furstauthor=D.+Parksauthor=A.+Kavanaughauthor=J.+O%E2%80%99Dellauthor=C.+Kingauthor=A.+Leongauthor=E.+L.+Mattesonauthor=J.+T.+Schousboeauthor=B.+Drevlowauthor=S.+Ginsbergauthor=J.+Groberauthor=E.+W.+St.+Clairauthor=E.+Tindallauthor=A.+S.+Millerauthor=T.+McAlindon&title=2015+American+college+of+rheumatology+guideline+for+the+treatment+of+rheumatoid+arthritis&doi=10.1002%2Fart.39480"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis</span></div><div class="casAuthors">Singh Jasvinder A; Saag Kenneth G; Bridges S Louis Jr; Curtis Jeffrey R; Akl Elie A; Bannuru Raveendhara R; Sullivan Matthew C; Vaysbrot Elizaveta; McNaughton Christine; Osani Mikala; McAlindon Timothy; Shmerling Robert H; Furst Daniel E; Parks Deborah; Kavanaugh Arthur; O'Dell James; King Charles; Leong Amye; Matteson Eric L; Schousboe John T; Drevlow Barbara; Grober James; Ginsberg Seth; St Clair E William; Tindall Elizabeth; Miller Amy S</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & rheumatology (Hoboken, N.J.)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-26</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  To develop a new evidence-based, pharmacologic treatment guideline for rheumatoid arthritis (RA).  METHODS:  We conducted systematic reviews to synthesize the evidence for the benefits and harms of various treatment options.  We used the Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology to rate the quality of evidence.  We employed a group consensus process to grade the strength of recommendations (either strong or conditional).  A strong recommendation indicates that clinicians are certain that the benefits of an intervention far outweigh the harms (or vice versa).  A conditional recommendation denotes uncertainty over the balance of benefits and harms and/or more significant variability in patient values and preferences.  RESULTS:  The guideline covers the use of traditional disease-modifying antirheumatic drugs (DMARDs), biologic agents, tofacitinib, and glucocorticoids in early (<6 months) and established (≥6 months) RA.  In addition, it provides recommendations on using a treat-to-target approach, tapering and discontinuing medications, and the use of biologic agents and DMARDs in patients with hepatitis, congestive heart failure, malignancy, and serious infections.  The guideline addresses the use of vaccines in patients starting/receiving DMARDs or biologic agents, screening for tuberculosis in patients starting/receiving biologic agents or tofacitinib, and laboratory monitoring for traditional DMARDs.  The guideline includes 74 recommendations: 23% are strong and 77% are conditional.  CONCLUSION:  This RA guideline should serve as a tool for clinicians and patients (our two target audiences) for pharmacologic treatment decisions in commonly encountered clinical situations.  These recommendations are not prescriptive, and the treatment decisions should be made by physicians and patients through a shared decision-making process taking into account patients' values, preferences, and comorbidities.  These recommendations should not be used to limit or deny access to therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTI9Xng6yKjfjEC-75aqa5AfW6udTcc2eaHNBQm67XjN7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28zpvVGnsA%253D%253D&md5=b00a30744da179f257667fdb7f40ed2f</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1002%2Fart.39480&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.39480%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DJ.%2BA.%26aulast%3DSaag%26aufirst%3DK.%2BG.%26aulast%3DBridges%26aufirst%3DS.%2BL.%26aulast%3DAkl%26aufirst%3DE.%2BA.%26aulast%3DBannuru%26aufirst%3DR.%2BR.%26aulast%3DSullivan%26aufirst%3DM.%2BC.%26aulast%3DVaysbrot%26aufirst%3DE.%26aulast%3DMcNaughton%26aufirst%3DC.%26aulast%3DOsani%26aufirst%3DM.%26aulast%3DShmerling%26aufirst%3DR.%2BH.%26aulast%3DCurtis%26aufirst%3DJ.%2BR.%26aulast%3DFurst%26aufirst%3DD.%2BE.%26aulast%3DParks%26aufirst%3DD.%26aulast%3DKavanaugh%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Dell%26aufirst%3DJ.%26aulast%3DKing%26aufirst%3DC.%26aulast%3DLeong%26aufirst%3DA.%26aulast%3DMatteson%26aufirst%3DE.%2BL.%26aulast%3DSchousboe%26aufirst%3DJ.%2BT.%26aulast%3DDrevlow%26aufirst%3DB.%26aulast%3DGinsberg%26aufirst%3DS.%26aulast%3DGrober%26aufirst%3DJ.%26aulast%3DSt.%2BClair%26aufirst%3DE.%2BW.%26aulast%3DTindall%26aufirst%3DE.%26aulast%3DMiller%26aufirst%3DA.%2BS.%26aulast%3DMcAlindon%26aufirst%3DT.%26atitle%3D2015%2520American%2520college%2520of%2520rheumatology%2520guideline%2520for%2520the%2520treatment%2520of%2520rheumatoid%2520arthritis%26jtitle%3DArthritis%2520Rheumatol.%26date%3D2016%26volume%3D68%26spage%3D1%26epage%3D26%26doi%3D10.1002%2Fart.39480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Agca, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heslinga, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rollefstad, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heslinga, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McInnes, I. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kvien, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dougados, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atzeni, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Primdahl, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Södergren, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallberg Jonsson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Rompay, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zabalan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedersen, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobsson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Vlam, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez-Gay, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Semb, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitas, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smulders, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szekanecz, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sattar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Symmons, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nurmohamed, M. T.</span></span> <span> </span><span class="NLM_article-title">EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update</span>. <i>Ann. Rheum. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">17</span>– <span class="NLM_lpage">28</span>, <span class="refDoi"> DOI: 10.1136/annrheumdis-2016-209775</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.1136%2Fannrheumdis-2016-209775" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=27697765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A280%3ADC%252BC2svlslWjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2017&pages=17-28&author=R.+Agcaauthor=S.+C.+Heslingaauthor=S.+Rollefstadauthor=M.+Heslingaauthor=I.+B.+McInnesauthor=M.+J.+Petersauthor=T.+K.+Kvienauthor=M.+Dougadosauthor=H.+Radnerauthor=F.+Atzeniauthor=J.+Primdahlauthor=A.+S%C3%B6dergrenauthor=S.+Wallberg+Jonssonauthor=J.+van+Rompayauthor=C.+Zabalanauthor=T.+R.+Pedersenauthor=L.+Jacobssonauthor=K.+de+Vlamauthor=M.+A.+Gonzalez-Gayauthor=A.+G.+Sembauthor=G.+D.+Kitasauthor=Y.+M.+Smuldersauthor=Z.+Szekaneczauthor=N.+Sattarauthor=D.+P.+Symmonsauthor=M.+T.+Nurmohamed&title=EULAR+recommendations+for+cardiovascular+disease+risk+management+in+patients+with+rheumatoid+arthritis+and+other+forms+of+inflammatory+joint+disorders%3A+2015%2F2016+update&doi=10.1136%2Fannrheumdis-2016-209775"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update</span></div><div class="casAuthors">Agca R; Heslinga S C; Heslinga M; Rollefstad S; Semb A G; McInnes I B; Peters M J L; Smulders Y M; Kvien T K; Dougados M; Radner H; Atzeni F; Primdahl J; Primdahl J; Primdahl J; Sodergren A; Wallberg Jonsson S; van Rompay J; Zabalan C; Pedersen T R; Jacobsson L; Jacobsson L; de Vlam K; Gonzalez-Gay M A; Kitas G D; Szekanecz Z; Sattar N; Symmons D P M; Nurmohamed M T</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the rheumatic diseases</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17-28</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Patients with rheumatoid arthritis (RA) and other inflammatory joint disorders (IJD) have increased cardiovascular disease (CVD) risk compared with the general population.  In 2009, the European League Against Rheumatism (EULAR) taskforce recommended screening, identification of CVD risk factors and CVD risk management largely based on expert opinion.  In view of substantial new evidence, an update was conducted with the aim of producing CVD risk management recommendations for patients with IJD that now incorporates an increasing evidence base.  A multidisciplinary steering committee (representing 13 European countries) comprised 26 members including patient representatives, rheumatologists, cardiologists, internists, epidemiologists, a health professional and fellows.  Systematic literature searches were performed and evidence was categorised according to standard guidelines.  The evidence was discussed and summarised by the experts in the course of a consensus finding and voting process.  Three overarching principles were defined.  First, there is a higher risk for CVD in patients with RA, and this may also apply to ankylosing spondylitis and psoriatic arthritis.  Second, the rheumatologist is responsible for CVD risk management in patients with IJD.  Third, the use of non-steroidal anti-inflammatory drugs and corticosteroids should be in accordance with treatment-specific recommendations from EULAR and Assessment of Spondyloarthritis International Society.  Ten recommendations were defined, of which one is new and six were changed compared with the 2009 recommendations.  Each designated an appropriate evidence support level.  The present update extends on the evidence that CVD risk in the whole spectrum of IJD is increased.  This underscores the need for CVD risk management in these patients.  These recommendations are defined to provide assistance in CVD risk management in IJD, based on expert opinion and scientific evidence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQzCYVs9aAtomHOrQ6qeX-mfW6udTcc2eY7ooBqWr4PMbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2svlslWjtQ%253D%253D&md5=a0755bf22a92e5469f33f04a835d4474</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1136%2Fannrheumdis-2016-209775&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fannrheumdis-2016-209775%26sid%3Dliteratum%253Aachs%26aulast%3DAgca%26aufirst%3DR.%26aulast%3DHeslinga%26aufirst%3DS.%2BC.%26aulast%3DRollefstad%26aufirst%3DS.%26aulast%3DHeslinga%26aufirst%3DM.%26aulast%3DMcInnes%26aufirst%3DI.%2BB.%26aulast%3DPeters%26aufirst%3DM.%2BJ.%26aulast%3DKvien%26aufirst%3DT.%2BK.%26aulast%3DDougados%26aufirst%3DM.%26aulast%3DRadner%26aufirst%3DH.%26aulast%3DAtzeni%26aufirst%3DF.%26aulast%3DPrimdahl%26aufirst%3DJ.%26aulast%3DS%25C3%25B6dergren%26aufirst%3DA.%26aulast%3DWallberg%2BJonsson%26aufirst%3DS.%26aulast%3Dvan%2BRompay%26aufirst%3DJ.%26aulast%3DZabalan%26aufirst%3DC.%26aulast%3DPedersen%26aufirst%3DT.%2BR.%26aulast%3DJacobsson%26aufirst%3DL.%26aulast%3Dde%2BVlam%26aufirst%3DK.%26aulast%3DGonzalez-Gay%26aufirst%3DM.%2BA.%26aulast%3DSemb%26aufirst%3DA.%2BG.%26aulast%3DKitas%26aufirst%3DG.%2BD.%26aulast%3DSmulders%26aufirst%3DY.%2BM.%26aulast%3DSzekanecz%26aufirst%3DZ.%26aulast%3DSattar%26aufirst%3DN.%26aulast%3DSymmons%26aufirst%3DD.%2BP.%26aulast%3DNurmohamed%26aufirst%3DM.%2BT.%26atitle%3DEULAR%2520recommendations%2520for%2520cardiovascular%2520disease%2520risk%2520management%2520in%2520patients%2520with%2520rheumatoid%2520arthritis%2520and%2520other%2520forms%2520of%2520inflammatory%2520joint%2520disorders%253A%25202015%252F2016%2520update%26jtitle%3DAnn.%2520Rheum.%2520Dis.%26date%3D2017%26volume%3D76%26spage%3D17%26epage%3D28%26doi%3D10.1136%2Fannrheumdis-2016-209775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Agarwal, S.
K.</span></span> <span> </span><span class="NLM_article-title">Core management principles in rheumatoid arthritis to help guide managed care professionals</span>. <i>J. Manag. Care. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">S03</span>– <span class="NLM_lpage">S08</span>, <span class="refDoi"> DOI: 10.18553/jmcp.2011.17.s9-b.S03</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.18553%2Fjmcp.2011.17.s9-b.S03" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=22073933" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=S03-S08&author=S.%0AK.+Agarwal&title=Core+management+principles+in+rheumatoid+arthritis+to+help+guide+managed+care+professionals&doi=10.18553%2Fjmcp.2011.17.s9-b.S03"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.18553%2Fjmcp.2011.17.s9-b.S03&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18553%252Fjmcp.2011.17.s9-b.S03%26sid%3Dliteratum%253Aachs%26aulast%3DAgarwal%26aufirst%3DS.%2BK.%26atitle%3DCore%2520management%2520principles%2520in%2520rheumatoid%2520arthritis%2520to%2520help%2520guide%2520managed%2520care%2520professionals%26jtitle%3DJ.%2520Manag.%2520Care.%2520Pharm.%26date%3D2011%26volume%3D17%26spage%3DS03%26epage%3DS08%26doi%3D10.18553%2Fjmcp.2011.17.s9-b.S03" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit13b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kharlamova, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherina, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potempa, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Israelsson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quirke, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eriksson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yucel-Lindberg, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venables, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potempa, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alfredsson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lundberg, K.</span></span> <span> </span><span class="NLM_article-title">Antibodies to porphyromonas gingivalis indicate interaction between oral infection, smoking, and risk genes in rheumatoid arthritis etiology</span>. <i>Arthritis Rheumatol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">604</span>– <span class="NLM_lpage">613</span>, <span class="refDoi"> DOI: 10.1002/art.39491</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.1002%2Fart.39491" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=26554752" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A528%3ADC%252BC28XjsFejs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2016&pages=604-613&author=N.+Kharlamovaauthor=X.+Jiangauthor=N.+Sherinaauthor=B.+Potempaauthor=L.+Israelssonauthor=A.+M.+Quirkeauthor=K.+Erikssonauthor=T.+Yucel-Lindbergauthor=P.+J.+Venablesauthor=J.+Potempaauthor=L.+Alfredssonauthor=K.+Lundberg&title=Antibodies+to+porphyromonas+gingivalis+indicate+interaction+between+oral+infection%2C+smoking%2C+and+risk+genes+in+rheumatoid+arthritis+etiology&doi=10.1002%2Fart.39491"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13bR"><div class="casContent"><span class="casTitleNuber">13b</span><div class="casTitle"><span class="NLM_cas:atitle">Antibodies to Porphyromonas gingivalis Indicate Interaction Between Oral Infection, Smoking, and Risk Genes in Rheumatoid Arthritis Etiology</span></div><div class="casAuthors">Kharlamova, Nastya; Jiang, Xia; Sherina, Natalia; Potempa, Barbara; Israelsson, Lena; Quirke, Anne-Marie; Eriksson, Kaja; Yucel-Lindberg, Tuelay; Venables, Patrick J.; Potempa, Jan; Alfredsson, Lars; Lundberg, Karin</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">604-613</span>CODEN:
                <span class="NLM_cas:coden">ARRHBO</span>;
        ISSN:<span class="NLM_cas:issn">2326-5191</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective: To investigate the role of the periodontal pathogen Porphyromonas gingivalis in the etiol. of rheumatoid arthritis (RA) by analyzing the antibody response to the P gingivalis virulence factor arginine gingipain type B (RgpB) in relation to anti-citrullinated protein antibodies (ACPAs), smoking, and HLA-DRB1 shared epitope (SE) alleles in patients with periodontitis, patients with RA, and controls.  Methods: Anti-RgpB IgG was measured by ELISA in 65 periodontitis patients and 59 controls without periodontitis, and in 1,974 RA patients and 377 controls without RA from the Swedish population-based case-control Epidemiol. Investigation of Rheumatoid Arthritis (EIRA) study.  Autoantibody status, smoking habits, and genetic data were retrieved from the EIRA database.  Differences in antibody levels were examd. using the Mann-Whitney U test.  Unconditional logistic regression was used to calc. odds ratios (ORs) with 95% confidence intervals (95% CIs) for the assocn. of anti-RgpB IgG with different subsets of RA patients.  Results: Anti-RgpB antibody levels were significantly elevated in periodontitis patients compared to controls without periodontitis, in RA patients compared to controls without RA, and in ACPA-pos. RA patients compared to ACPA-neg. RA patients.  There was a significant assocn. between anti-RgpB IgG and RA (OR 2.96 [95% CI 2.00, 4.37]), which was even stronger than the assocn. between smoking and RA (OR 1.37 [95% CI 1.07, 1.74]), and in ACPA-pos. RA there were interactions between anti-RgpB antibodies and both smoking and the HLA-DRB1 SE.  Conclusion: Our study suggests that the previously reported link between periodontitis and RA could be accounted for by P gingivalis infection, and we conclude that P gingivalis is a credible candidate for triggering and/or driving autoimmunity and autoimmune disease in a subset of RA patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGZVz8WqP0kLVg90H21EOLACvtfcHk0lgCNDx5hN_H3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjsFejs7g%253D&md5=eb120132bcdd1e4feff9d2f70178d92c</span></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1002%2Fart.39491&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.39491%26sid%3Dliteratum%253Aachs%26aulast%3DKharlamova%26aufirst%3DN.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DSherina%26aufirst%3DN.%26aulast%3DPotempa%26aufirst%3DB.%26aulast%3DIsraelsson%26aufirst%3DL.%26aulast%3DQuirke%26aufirst%3DA.%2BM.%26aulast%3DEriksson%26aufirst%3DK.%26aulast%3DYucel-Lindberg%26aufirst%3DT.%26aulast%3DVenables%26aufirst%3DP.%2BJ.%26aulast%3DPotempa%26aufirst%3DJ.%26aulast%3DAlfredsson%26aufirst%3DL.%26aulast%3DLundberg%26aufirst%3DK.%26atitle%3DAntibodies%2520to%2520porphyromonas%2520gingivalis%2520indicate%2520interaction%2520between%2520oral%2520infection%252C%2520smoking%252C%2520and%2520risk%2520genes%2520in%2520rheumatoid%2520arthritis%2520etiology%26jtitle%3DArthritis%2520Rheumatol.%26date%3D2016%26volume%3D68%26spage%3D604%26epage%3D613%26doi%3D10.1002%2Fart.39491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit13c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lundberg, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wegner, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yucel-Lindberg, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venables, P. J.</span></span> <span> </span><span class="NLM_article-title">Periodontitis in RA-the citrullinated enolase connection</span>. <i>Nat. Rev. Rheumatol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">727</span>– <span class="NLM_lpage">730</span>, <span class="refDoi"> DOI: 10.1038/nrrheum.2010.139</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.1038%2Fnrrheum.2010.139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=20820197" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsV2gtLzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=727-730&author=K.+Lundbergauthor=N.+Wegnerauthor=T.+Yucel-Lindbergauthor=P.+J.+Venables&title=Periodontitis+in+RA-the+citrullinated+enolase+connection&doi=10.1038%2Fnrrheum.2010.139"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13cR"><div class="casContent"><span class="casTitleNuber">13c</span><div class="casTitle"><span class="NLM_cas:atitle">Periodontitis in RA-the citrullinated enolase connection</span></div><div class="casAuthors">Lundberg, Karin; Wegner, Natalia; Yucel-Lindberg, Tulay; Venables, Patrick J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Rheumatology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">727-730</span>CODEN:
                <span class="NLM_cas:coden">NRRACB</span>;
        ISSN:<span class="NLM_cas:issn">1759-4790</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Antibodies to citrullinated enolase define a subset of rheumatoid arthritis (RA) assocd. with smoking and DR4 alleles.  In this Perspectives article, the authors review epidemiol. and genetic links between periodontitis (a disease in which Porphyromonas gingivalis is a major pathogen) and RA and propose that that the assocn. might be causal, due to mol. mimicry between epitopes on host and P. gingivalis citrullinated enolases driving the autoimmune response.  Autoimmunity in rheumatoid arthritis (RA) is characterized by an antibody response to citrullinated proteins.  Two of the risk factors for RA-HLA-DRB1 shared epitope alleles and smoking-are also assocd. with periodontitis, which is largely, but not exclusively, caused by Porphyromonas gingivalis infection.  Furthermore, RA and periodontitis have a similar pathophysiol., characterized by destructive inflammation.  The citrullination of proteins by P. gingivalis and the subsequent generation of autoantigens that drive autoimmunity in RA represents a possible causative link between these two diseases.  Antibodies directed towards the immunodominant epitope of human citrullinated α-enolase cross-react with a conserved sequence on citrullinated P. gingivalis enolase.  On the basis of this cross-reactivity, in this Perspectives article we explore the hypothesis of mol. mimicry in the etiol. of RA, with citrullinated enolase as the specific antigen involved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAuxMkj0Tgk7Vg90H21EOLACvtfcHk0lgUc_FykaV8Ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsV2gtLzI&md5=adae31402135be903bbc4d710422188d</span></div><a href="/servlet/linkout?suffix=cit13c&amp;dbid=16384&amp;doi=10.1038%2Fnrrheum.2010.139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrrheum.2010.139%26sid%3Dliteratum%253Aachs%26aulast%3DLundberg%26aufirst%3DK.%26aulast%3DWegner%26aufirst%3DN.%26aulast%3DYucel-Lindberg%26aufirst%3DT.%26aulast%3DVenables%26aufirst%3DP.%2BJ.%26atitle%3DPeriodontitis%2520in%2520RA-the%2520citrullinated%2520enolase%2520connection%26jtitle%3DNat.%2520Rev.%2520Rheumatol.%26date%3D2010%26volume%3D6%26spage%3D727%26epage%3D730%26doi%3D10.1038%2Fnrrheum.2010.139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit13d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Koziel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mydel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potempa, J.</span></span> <span> </span><span class="NLM_article-title">The link between periodontal disease and rheumatoid arthritis: an updated review</span>. <i>Curr. Rheumatol. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">408</span>, <span class="refDoi"> DOI: 10.1007/s11926-014-0408-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.1007%2Fs11926-014-0408-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=24458478" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A280%3ADC%252BC2czovFGmsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=408&author=J.+Kozielauthor=P.+Mydelauthor=J.+Potempa&title=The+link+between+periodontal+disease+and+rheumatoid+arthritis%3A+an+updated+review&doi=10.1007%2Fs11926-014-0408-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13dR"><div class="casContent"><span class="casTitleNuber">13d</span><div class="casTitle"><span class="NLM_cas:atitle">The link between periodontal disease and rheumatoid arthritis: an updated review</span></div><div class="casAuthors">Koziel Joanna; Mydel Piotr; Potempa Jan</div><div class="citationInfo"><span class="NLM_cas:title">Current rheumatology reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">408</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Porphyromonas gingivalis is a leading pathogen in chronic periodontitis, a disease process involving progressive destruction of the tissues that support the teeth.  Recently, the organism has been reported to produce a unique bacterial enzyme, P. gingivalis peptidyl-arginine deiminase (PPAD), which has the ability to convert arginine residues in proteins to citrulline.  Protein citrullination alters protein structure and function; hence, PPAD may be involved in deregulation of the host's signalling network and immune evasion.  Further, accumulating evidence suggests a role for autoimmunity against citrullinated proteins in the development of rheumatoid arthritis (RA).  As inflammatory conditions in the lungs of cigarette smokers contribute to the breakdown of immune tolerance to citrullinated epitopes, chronic exposure to citrullinated proteins at periodontitis sites may also predispose susceptible individuals to the development of autoantibodies and the initiation of RA.  In this review, we discuss evidence that PPAD may represent a mechanistic link between periodontitis and RA, diseases that are known to be significantly associated at the epidemiological level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRec_aWYOizrNj_Vg2vObihfW6udTcc2eYXqlw3VR3rLLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2czovFGmsQ%253D%253D&md5=9fe703574164ad0b5dd9b69e0e8f204f</span></div><a href="/servlet/linkout?suffix=cit13d&amp;dbid=16384&amp;doi=10.1007%2Fs11926-014-0408-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11926-014-0408-9%26sid%3Dliteratum%253Aachs%26aulast%3DKoziel%26aufirst%3DJ.%26aulast%3DMydel%26aufirst%3DP.%26aulast%3DPotempa%26aufirst%3DJ.%26atitle%3DThe%2520link%2520between%2520periodontal%2520disease%2520and%2520rheumatoid%2520arthritis%253A%2520an%2520updated%2520review%26jtitle%3DCurr.%2520Rheumatol.%2520Rep.%26date%3D2014%26volume%3D16%26spage%3D408%26doi%3D10.1007%2Fs11926-014-0408-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit13e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Trabocchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pala, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krimmelbein, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menchi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guarna, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sechi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dreker, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scozzafava, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supuran, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carta, F.</span></span> <span> </span><span class="NLM_article-title">Peptidomimetics as protein arginine deiminase 4 (PAD4) inhibitors</span>. <i>J. Enzyme Inhib. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">466</span>– <span class="NLM_lpage">471</span>, <span class="refDoi"> DOI: 10.3109/14756366.2014.947976</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.3109%2F14756366.2014.947976" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=25198885" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFGlsbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2015&pages=466-471&author=A.+Trabocchiauthor=N.+Palaauthor=I.+Krimmelbeinauthor=G.+Menchiauthor=A.+Guarnaauthor=M.+Sechiauthor=T.+Drekerauthor=A.+Scozzafavaauthor=C.+T.+Supuranauthor=F.+Carta&title=Peptidomimetics+as+protein+arginine+deiminase+4+%28PAD4%29+inhibitors&doi=10.3109%2F14756366.2014.947976"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13eR"><div class="casContent"><span class="casTitleNuber">13e</span><div class="casTitle"><span class="NLM_cas:atitle">Peptidomimetics as protein arginine deiminase 4 (PAD4) inhibitors</span></div><div class="casAuthors">Trabocchi, Andrea; Pala, Nicolino; Krimmelbein, Ilga; Menchi, Gloria; Guarna, Antonio; Sechi, Mario; Dreker, Tobias; Scozzafava, Andrea; Supuran, Claudiu T.; Carta, Fabrizio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">466-471</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">The protein arginine deiminase 4 (PAD4) is a calcium-dependent enzyme, which catalyzes the irreversible conversion of peptidyl-arginines into peptidyl-citrullines and plays an important role in several diseases such as in the rheumatoid arthritis, multiple sclerosis, Alzheimer's disease, Creutzfeldt-Jacob's disease and cancer.  In this study, the authors report the inhibition profiles and computational docking toward the PAD4 enzyme of a series of 1,2,3-triazole peptidomimetic-based derivs. incorporating the β-phenylalanine and guanidine scaffolds.  Several effective, low micromolar PAD4 inhibitors are reported in this study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgnjqFPrxaT7Vg90H21EOLACvtfcHk0lgUc_FykaV8Ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFGlsbvE&md5=3524acfe15eeb79049a7bceb6dd1b6e7</span></div><a href="/servlet/linkout?suffix=cit13e&amp;dbid=16384&amp;doi=10.3109%2F14756366.2014.947976&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F14756366.2014.947976%26sid%3Dliteratum%253Aachs%26aulast%3DTrabocchi%26aufirst%3DA.%26aulast%3DPala%26aufirst%3DN.%26aulast%3DKrimmelbein%26aufirst%3DI.%26aulast%3DMenchi%26aufirst%3DG.%26aulast%3DGuarna%26aufirst%3DA.%26aulast%3DSechi%26aufirst%3DM.%26aulast%3DDreker%26aufirst%3DT.%26aulast%3DScozzafava%26aufirst%3DA.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26aulast%3DCarta%26aufirst%3DF.%26atitle%3DPeptidomimetics%2520as%2520protein%2520arginine%2520deiminase%25204%2520%2528PAD4%2529%2520inhibitors%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2015%26volume%3D30%26spage%3D466%26epage%3D471%26doi%3D10.3109%2F14756366.2014.947976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit13f"><span><span class="NLM_label">(f) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Witalison, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofseth, L. J.</span></span> <span> </span><span class="NLM_article-title">Protein arginine deiminases and associated citrullination: physiological functions and diseases associated with dysregulation</span>. <i>Curr. Drug Targets</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">700</span>– <span class="NLM_lpage">710</span>, <span class="refDoi"> DOI: 10.2174/1389450116666150202160954</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.2174%2F1389450116666150202160954" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13f&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=25642720" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFSht7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2015&pages=700-710&author=E.+E.+Witalisonauthor=P.+R.+Thompsonauthor=L.+J.+Hofseth&title=Protein+arginine+deiminases+and+associated+citrullination%3A+physiological+functions+and+diseases+associated+with+dysregulation&doi=10.2174%2F1389450116666150202160954"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13fR"><div class="casContent"><span class="casTitleNuber">13f</span><div class="casTitle"><span class="NLM_cas:atitle">Protein Arginine Deiminases and Associated Citrullination: Physiological Functions and Diseases Associated with Dysregulation</span></div><div class="casAuthors">Witalison, Erin E.; Thompson, Paul R.; Hofseth, Lorne J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">700-710</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Human proteins are subjected to more than 200 known post-translational modifications (PTMs) (e.g., phosphorylation, glycosylation, ubiquitination, S-nitrosylation, methylation, Nacetylation, and citrullination) and these PTMs can alter protein structure and function with consequent effects on the multitude of pathways necessary for maintaining the physiol. homeostasis.  When dysregulated, however, the enzymes that catalyze these PTMs can impact the genesis of countless diseases.  In this review, we will focus on protein citrullination, a PTM catalyzed by the Protein Arginine Deiminase (PAD) family of enzymes.  Specifically, we will describe the roles of the PADs in both normal human physiol. and disease.  The development of PAD inhibitors and their efficacy in a variety of autoimmune disorders and cancer will also be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdv_o7-kOsurVg90H21EOLACvtfcHk0lgUc_FykaV8Ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFSht7vJ&md5=9d0072b3b5e23308858bb4cd4ed0cab7</span></div><a href="/servlet/linkout?suffix=cit13f&amp;dbid=16384&amp;doi=10.2174%2F1389450116666150202160954&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389450116666150202160954%26sid%3Dliteratum%253Aachs%26aulast%3DWitalison%26aufirst%3DE.%2BE.%26aulast%3DThompson%26aufirst%3DP.%2BR.%26aulast%3DHofseth%26aufirst%3DL.%2BJ.%26atitle%3DProtein%2520arginine%2520deiminases%2520and%2520associated%2520citrullination%253A%2520physiological%2520functions%2520and%2520diseases%2520associated%2520with%2520dysregulation%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2015%26volume%3D16%26spage%3D700%26epage%3D710%26doi%3D10.2174%2F1389450116666150202160954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Maddur, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miossec, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaveri, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayry, J.</span></span> <span> </span><span class="NLM_article-title">Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies</span>. <i>Am. J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>181</i></span>,  <span class="NLM_fpage">8</span>– <span class="NLM_lpage">18</span>, <span class="refDoi"> DOI: 10.1016/j.ajpath.2012.03.044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.1016%2Fj.ajpath.2012.03.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=22640807" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFOitbbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=181&publication_year=2012&pages=8-18&author=M.+S.+Maddurauthor=P.+Miossecauthor=S.+V.+Kaveriauthor=J.+Bayry&title=Th17+cells%3A+biology%2C+pathogenesis+of+autoimmune+and+inflammatory+diseases%2C+and+therapeutic+strategies&doi=10.1016%2Fj.ajpath.2012.03.044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14aR"><div class="casContent"><span class="casTitleNuber">14a</span><div class="casTitle"><span class="NLM_cas:atitle">Th 17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies</span></div><div class="casAuthors">Maddur, Mohan S.; Miossec, Pierre; Kaveri, Srini V.; Bayry, Jagadeesh</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">181</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">8-18</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Th17 cells that secrete the cytokines IL-17A and IL-17F and express lineage-specific transcription factor RORC (RORγt in mice) represent a distinct lineage of CD4+ T cells.  Transforming growth factor-β and inflammatory cytokines, such as IL-6, IL-21, IL-1β, and IL-23, play central roles in the generation of Th17 cells.  Th17 cells are crit. for the clearance of extracellular pathogens, including Candida and Klebsiella.  However, under certain conditions, these cells and their effector mols., such as IL-17, IL-21, IL-22, GM-CSF, and CCL20, are assocd. with the pathogenesis of several autoimmune and inflammatory diseases, such as rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis, psoriasis, inflammatory bowel disease, and allergy and asthma.  This review discusses these disease states and the various therapeutic strategies under investigation to target Th17 cells, which include blocking the differentiation and amplification of Th17 cells, inhibiting or neutralizing the cytokines of Th17 cells, and suppressing the transcription factors specific for Th17 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8EspukaEizbVg90H21EOLACvtfcHk0lhrHIhTh0nYoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFOitbbF&md5=15b79f41578ef7eaef6798a93e175c16</span></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.1016%2Fj.ajpath.2012.03.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ajpath.2012.03.044%26sid%3Dliteratum%253Aachs%26aulast%3DMaddur%26aufirst%3DM.%2BS.%26aulast%3DMiossec%26aufirst%3DP.%26aulast%3DKaveri%26aufirst%3DS.%2BV.%26aulast%3DBayry%26aufirst%3DJ.%26atitle%3DTh17%2520cells%253A%2520biology%252C%2520pathogenesis%2520of%2520autoimmune%2520and%2520inflammatory%2520diseases%252C%2520and%2520therapeutic%2520strategies%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2012%26volume%3D181%26spage%3D8%26epage%3D18%26doi%3D10.1016%2Fj.ajpath.2012.03.044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit14b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Skapenko, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leipe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lipsky, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulze-Koops, H.</span></span> <span> </span><span class="NLM_article-title">The role of the T cell in autoimmune inflammation</span>. <i>Arthritis Res. Ther</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">S4</span>– <span class="NLM_lpage">S14</span>, <span class="refDoi"> DOI: 10.1186/ar1703</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.1186%2Far1703" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=15833146" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=S4-S14&author=A.+Skapenkoauthor=J.+Leipeauthor=P.+E.+Lipskyauthor=H.+Schulze-Koops&title=The+role+of+the+T+cell+in+autoimmune+inflammation&doi=10.1186%2Far1703"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.1186%2Far1703&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Far1703%26sid%3Dliteratum%253Aachs%26aulast%3DSkapenko%26aufirst%3DA.%26aulast%3DLeipe%26aufirst%3DJ.%26aulast%3DLipsky%26aufirst%3DP.%2BE.%26aulast%3DSchulze-Koops%26aufirst%3DH.%26atitle%3DThe%2520role%2520of%2520the%2520T%2520cell%2520in%2520autoimmune%2520inflammation%26jtitle%3DArthritis%2520Res.%2520Ther%26date%3D2005%26volume%3D7%26spage%3DS4%26epage%3DS14%26doi%3D10.1186%2Far1703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit14c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kanda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokota, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohno, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komagata, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimada, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mimura, T.</span></span> <span> </span><span class="NLM_article-title">Effects of low-dosage simvastatin on rheumatoid arthritis through reduction of Th1/Th2 and CD4/CD8 ratios</span>. <i>Mod. Rheumatol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">364</span>– <span class="NLM_lpage">368</span>, <span class="refDoi"> DOI: 10.3109/s10165-007-0589-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.3109%2Fs10165-007-0589-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=17929126" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFGgs7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=364-368&author=H.+Kandaauthor=K.+Yokotaauthor=C.+Kohnoauthor=T.+Sawadaauthor=K.+Satoauthor=M.+Yamaguchiauthor=Y.+Komagataauthor=K.+Shimadaauthor=K.+Yamamotoauthor=T.+Mimura&title=Effects+of+low-dosage+simvastatin+on+rheumatoid+arthritis+through+reduction+of+Th1%2FTh2+and+CD4%2FCD8+ratios&doi=10.3109%2Fs10165-007-0589-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14cR"><div class="casContent"><span class="casTitleNuber">14c</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of low-dosage simvastatin on rheumatoid arthritis through reduction of Th1/Th2 and CD4/CD8 ratios</span></div><div class="casAuthors">Kanda, Hiroko; Yokota, Kazuhiro; Kohno, Chieko; Sawada, Tetsuji; Sato, Kojiro; Yamaguchi, Masao; Komagata, Yoshinori; Shimada, Kota; Yamamoto, Kazuhiko; Mimura, Toshihide</div><div class="citationInfo"><span class="NLM_cas:title">Modern Rheumatology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">364-368</span>CODEN:
                <span class="NLM_cas:coden">MROHA4</span>;
        ISSN:<span class="NLM_cas:issn">1439-7595</span>.
    
            (<span class="NLM_cas:orgname">Springer Japan</span>)
        </div><div class="casAbstract">The objective of this study was to assess both the anti-inflammatory and immunomodulatory effects of low-dosage simvastatin on rheumatoid arthritis (RA).  In each patient, simvastatin at 10 mg/day was administered for 12 wk.  The other treatments were unchanged at least 3 mo before simvastatin administration to the end of the study.  Patients were assessed for the improvement in clin., lab., and immunol. parameters of RA and for adverse events.  Twenty-four patients with RA were enrolled.  Clin. symptoms, including patient's assessment of pain and disease activity on visual analog scale (VAS), the swollen joint and tender joint counts, and handgrip strength significantly improved.  Physician's assessment of disease activity on VAS, a period of morning stiffness and modified health assessment questionnaire showed a tendency of improving after administration of low-dosage of simvastatin.  Of special interest was that the median levels of erythrocytes sedimentation rate, C-reactive protein, and rheumatoid factor were significantly decreased from 54.0 mm/h to 45.5 mm/h, from 1.50 mg/dL to 0.85 mg/dL, and from 57.0 IU/mL to 28.0 IU/mL, resp., after administration of simvastatin.  ACR20 and ACR50 responses were achieved in 62% and 38%, resp., of simvastatin-treated patients for 12 wk.  Immunol. assessment in peripheral blood revealed that the Th1/Th2 and CD4/CD8 ratios were significantly reduced by simvastatin.  No adverse events were reported during simvastatin treatment.  Immunomodulation through the alteration of Th1/Th2 and CD4/CD8 ratios may be a pharmacol. mechanism in the anti-rheumatic effect of low-dosage simvastatin.  Although it is necessary to evaluate the long-term effects of statins, low-dosage statins appear to be good as addnl. therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo71tTjmt1TOLVg90H21EOLACvtfcHk0lhrHIhTh0nYoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFGgs7rL&md5=d2d8b418160109620bb7ec906003c2b9</span></div><a href="/servlet/linkout?suffix=cit14c&amp;dbid=16384&amp;doi=10.3109%2Fs10165-007-0589-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252Fs10165-007-0589-4%26sid%3Dliteratum%253Aachs%26aulast%3DKanda%26aufirst%3DH.%26aulast%3DYokota%26aufirst%3DK.%26aulast%3DKohno%26aufirst%3DC.%26aulast%3DSawada%26aufirst%3DT.%26aulast%3DSato%26aufirst%3DK.%26aulast%3DYamaguchi%26aufirst%3DM.%26aulast%3DKomagata%26aufirst%3DY.%26aulast%3DShimada%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DK.%26aulast%3DMimura%26aufirst%3DT.%26atitle%3DEffects%2520of%2520low-dosage%2520simvastatin%2520on%2520rheumatoid%2520arthritis%2520through%2520reduction%2520of%2520Th1%252FTh2%2520and%2520CD4%252FCD8%2520ratios%26jtitle%3DMod.%2520Rheumatol.%26date%3D2007%26volume%3D17%26spage%3D364%26epage%3D368%26doi%3D10.3109%2Fs10165-007-0589-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit14d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Leipe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grunke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dechant, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reindl, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerzendorf, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulze-Koops, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skapenko, A.</span></span> <span> </span><span class="NLM_article-title">Role of Th17 cells in human autoimmune arthritis</span>. <i>Arthritis Rheum.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">2876</span>– <span class="NLM_lpage">2885</span>, <span class="refDoi"> DOI: 10.1002/art.27622</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.1002%2Fart.27622" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=20583102" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVSqtrrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2010&pages=2876-2885&author=J.+Leipeauthor=M.+Grunkeauthor=C.+Dechantauthor=C.+Reindlauthor=U.+Kerzendorfauthor=H.+Schulze-Koopsauthor=A.+Skapenko&title=Role+of+Th17+cells+in+human+autoimmune+arthritis&doi=10.1002%2Fart.27622"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14dR"><div class="casContent"><span class="casTitleNuber">14d</span><div class="casTitle"><span class="NLM_cas:atitle">Role of Th17 cells in human autoimmune arthritis</span></div><div class="casAuthors">Leipe, Jan; Grunke, Mathias; Dechant, Claudia; Reindl, Christiane; Kerzendorf, Ulrike; Schulze-Koops, Hendrik; Skapenko, Alla</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2876-2885</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">To delineate the role of Th17 cells in the pathogenesis of autoimmune arthritides.  Th17 cells were analyzed in well-defined homogeneous cohorts of patients with the prototypical autoimmune arthritides rheumatoid arthritis (RA) and psoriatic arthritis (PsA), grouped according to patients who had very early active RA (n = 36; mean disease duration 2.8 mo, Disease Activity Score in 28 joints 5.0) and those who had very early active PsA (n = 20; mean disease duration 2.3 mo), none of whom had received treatment with glucocorticoids or disease-modifying antirheumatic drugs, as well as patients with established RA (n = 21; mean disease duration 68 mo) who were considered either responders or nonresponders to therapy.  Groups of healthy individuals and patients with osteoarthritis (a noninflammatory arthritis) were used as control cohorts.  Expression of T lineage-specific transcription factors (RORC, T-bet, GATA-3, and FoxP3) and the response of CD4 T cells to Th17 cell-inducing conditions were analyzed in vitro.  The frequencies of Th17 cells and levels of interleukin-17 strongly correlated with systemic disease activity at both the onset and the progression of RA or PsA.  The values were reduced to control levels in patients with treatment-controlled disease activity.  Th17 cells were enriched in the joints, and increased frequencies of synovial Th17 cells expressed CCR4 and CCR6, indicative of selective migration of Th17 cells to the joints.  The intrinsically elevated expression of RORC, accompanied by biased Th17 cell development, and the resistance of Th17 cells to a natural cytokine antagonist in patients with RA and patients with PsA were suggestive of the underlying mol. mechanisms of uncontrolled Th17 activity in these patients.  Th17 cells play an important role in inflammation in human autoimmune arthritides, both at the onset and in established disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp62F0RUDGaUrVg90H21EOLACvtfcHk0ljqab512MHb3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVSqtrrK&md5=922bf3cabf3d6ad57ebeb90c07def4c2</span></div><a href="/servlet/linkout?suffix=cit14d&amp;dbid=16384&amp;doi=10.1002%2Fart.27622&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.27622%26sid%3Dliteratum%253Aachs%26aulast%3DLeipe%26aufirst%3DJ.%26aulast%3DGrunke%26aufirst%3DM.%26aulast%3DDechant%26aufirst%3DC.%26aulast%3DReindl%26aufirst%3DC.%26aulast%3DKerzendorf%26aufirst%3DU.%26aulast%3DSchulze-Koops%26aufirst%3DH.%26aulast%3DSkapenko%26aufirst%3DA.%26atitle%3DRole%2520of%2520Th17%2520cells%2520in%2520human%2520autoimmune%2520arthritis%26jtitle%3DArthritis%2520Rheum.%26date%3D2010%26volume%3D62%26spage%3D2876%26epage%3D2885%26doi%3D10.1002%2Fart.27622" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit14e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Souza-Moreira, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campos-Salinas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez-Rey, E.</span></span> <span> </span><span class="NLM_article-title">Neuropeptides as pleiotropic modulators of the immune response</span>. <i>Neuroendocrinology</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">89</span>– <span class="NLM_lpage">100</span>, <span class="refDoi"> DOI: 10.1159/000328636</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.1159%2F000328636" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=21734355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1yltbzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2011&pages=89-100&author=L.+Souza-Moreiraauthor=J.+Campos-Salinasauthor=M.+Caroauthor=E.+Gonzalez-Rey&title=Neuropeptides+as+pleiotropic+modulators+of+the+immune+response&doi=10.1159%2F000328636"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14eR"><div class="casContent"><span class="casTitleNuber">14e</span><div class="casTitle"><span class="NLM_cas:atitle">Neuropeptides as pleiotropic modulators of the immune response</span></div><div class="casAuthors">Souza-Moreira, Luciana; Campos-Salinas, Jenny; Caro, Marta; Gonzalez-Rey, Elena</div><div class="citationInfo"><span class="NLM_cas:title">Neuroendocrinology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">89-100</span>CODEN:
                <span class="NLM_cas:coden">NUNDAJ</span>;
        ISSN:<span class="NLM_cas:issn">0028-3835</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">A review.  Although necessary to eliminate pathogens, inflammation can lead to serious deleterious effects in the host if left unchecked.  During the inflammatory response, further damage may arise from potential autoimmune responses occurring when the immune cells and mols. that respond to pathogen-derived antigens also react to self-antigens.  In this sense, the identification of endogenous factors that control exacerbated immune responses is a key goal for the development of new therapeutic approaches for inflammatory and autoimmune diseases.  Some neuropeptides that are produced during the ongoing inflammatory response have emerged as endogenous anti-inflammatory agents that could collaborate in tuning the balanced steady state of the immune system.  These neuropeptides participate in maintaining immune tolerance through two distinct mechanisms: by regulating the balance between pro-inflammatory and anti-inflammatory factors, and by inducing the emergence of regulatory T cells with suppressive activity against autoreactive T cell effectors.  Indeed, a functioning neuropeptide system contributes to general health, and alterations in the levels of these neuropeptides and/or their receptors lead to changes in susceptibility to inflammatory and autoimmune diseases.  Recently, we found that some neuropeptides also have antimicrobial and antiparasitic actions, suggesting that they could act as primary mediators of innate defense, even in the most primitive organisms.  In this review, we use the vasoactive intestinal peptide as example of an immunomodulatory neuropeptide to summarize the most relevant data found for other neuropeptides with similar characteristics, including adrenomedullin, urocortin, cortistatin and ghrelin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroOMkNxl3ofbVg90H21EOLACvtfcHk0ljqab512MHb3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1yltbzJ&md5=948602015c5ab1cda2af2c4b6f7c2ea8</span></div><a href="/servlet/linkout?suffix=cit14e&amp;dbid=16384&amp;doi=10.1159%2F000328636&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000328636%26sid%3Dliteratum%253Aachs%26aulast%3DSouza-Moreira%26aufirst%3DL.%26aulast%3DCampos-Salinas%26aufirst%3DJ.%26aulast%3DCaro%26aufirst%3DM.%26aulast%3DGonzalez-Rey%26aufirst%3DE.%26atitle%3DNeuropeptides%2520as%2520pleiotropic%2520modulators%2520of%2520the%2520immune%2520response%26jtitle%3DNeuroendocrinology%26date%3D2011%26volume%3D94%26spage%3D89%26epage%3D100%26doi%3D10.1159%2F000328636" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit14f"><span><span class="NLM_label">(f) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Delgado, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganea, D.</span></span> <span> </span><span class="NLM_article-title">Anti-inflammatory neuropeptides: a new class of endogenous immunoregulatory agents</span>. <i>Brain, Behav., Immun.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1146</span>– <span class="NLM_lpage">1151</span>, <span class="refDoi"> DOI: 10.1016/j.bbi.2008.06.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.1016%2Fj.bbi.2008.06.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=1146-1151&author=M.+Delgadoauthor=D.+Ganea&title=Anti-inflammatory+neuropeptides%3A+a+new+class+of+endogenous+immunoregulatory+agents&doi=10.1016%2Fj.bbi.2008.06.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14f&amp;dbid=16384&amp;doi=10.1016%2Fj.bbi.2008.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbi.2008.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DDelgado%26aufirst%3DM.%26aulast%3DGanea%26aufirst%3DD.%26atitle%3DAnti-inflammatory%2520neuropeptides%253A%2520a%2520new%2520class%2520of%2520endogenous%2520immunoregulatory%2520agents%26jtitle%3DBrain%252C%2520Behav.%252C%2520Immun.%26date%3D2008%26volume%3D22%26spage%3D1146%26epage%3D1151%26doi%3D10.1016%2Fj.bbi.2008.06.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gassani, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rezende, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paiva-Lima, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferreira-Alves, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">dos Reis, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakhle, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Francischi, J. N.</span></span> <span> </span><span class="NLM_article-title">Is the sulphonamide radical in the celecoxib molecule essential for its analgesic activity?</span>. <i>Pharmacol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">439</span>– <span class="NLM_lpage">443</span>, <span class="refDoi"> DOI: 10.1016/j.phrs.2010.06.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.1016%2Fj.phrs.2010.06.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=20600917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1Wmt7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2010&pages=439-443&author=B.+C.+Gassaniauthor=R.+M.+Rezendeauthor=P.+Paiva-Limaauthor=D.+L.+Ferreira-Alvesauthor=W.+G.+dos+Reisauthor=Y.+S.+Bakhleauthor=J.+N.+de+Francischi&title=Is+the+sulphonamide+radical+in+the+celecoxib+molecule+essential+for+its+analgesic+activity%3F&doi=10.1016%2Fj.phrs.2010.06.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Is the sulphonamide radical in the celecoxib molecule essential for its analgesic activity?</span></div><div class="casAuthors">Gassani, Beatriz Carvalho Andraus; Rezende, Rafael Machado; Paiva-Lima, Patricia; Ferreira-Alves, Dalton L.; Pimenta dos Reis, Webster Glayser; Bakhle, Y. S.; Nogueira de Francischi, Janetti</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">439-443</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">In a model of peripherally induced inflammatory pain in rats, selective inhibitors of cyclooxygenase (COX)-2 raised nociceptive thresholds above basal values, an effect referred to as "hypoalgesia".  However other, non-selective, inhibitors of COX (indomethacin, piroxicam) or a selective inhibitor of COX-1 did not induce hypoalgesia in this model, implying that COX inhibition was not causally related to the hypoalgesic effect.  Here, we have assessed whether other COX-2 inhibitors or other sulfonamides, apart from celecoxib could exhibit hypoalgesia in our model of inflammatory pain.  Inflammation was induced in one hind paw of rats by intraplantar injection of carrageenan (250 μg).  Nociceptive thresholds to mech. stimulation were measured in the inflamed and contralateral paws for 6 h after carrageenan.  Three sulfonamides, celecoxib itself, furosemide (a loop diuretic), acetazolamide (a carbonic anhydrase inhibitor), or a selective COX-2 inhibitor lacking the sulfonamide group, lumiracoxib, were injected s.c., 30 min before the pro-inflammatory stimulus.  Naltrexone, a non-selective opioid antagonist was also administered s.c., 30 min before test drugs.  Furosemide and acetazolamide dose-dependently induced hypoalgesia in the inflamed paw, as did celecoxib.  However, lumiracoxib only produced anti-hyperalgesia.  Pre-treatment with naltrexone completely prevented the hypoalgesia induced by the sulfonamides, but only partially prevented the anti-hyperalgesic effect of lumiracoxib.  Taken together, our results suggest that the sulfonamide group in the structure of celecoxib is more crit. for the development of hypoalgesia in our model than its ability to inhibit COX-2.  Further, other sulfonamides lacking significant COX inhibition were also able to exhibit hypoalgesic effects, mediated by the endogenous opioid system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAIBl7KrzaJrVg90H21EOLACvtfcHk0ljqab512MHb3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1Wmt7nJ&md5=a98b9b5b264740d23c2fa74b711cf244</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2010.06.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2010.06.007%26sid%3Dliteratum%253Aachs%26aulast%3DGassani%26aufirst%3DB.%2BC.%26aulast%3DRezende%26aufirst%3DR.%2BM.%26aulast%3DPaiva-Lima%26aufirst%3DP.%26aulast%3DFerreira-Alves%26aufirst%3DD.%2BL.%26aulast%3Ddos%2BReis%26aufirst%3DW.%2BG.%26aulast%3DBakhle%26aufirst%3DY.%2BS.%26aulast%3Dde%2BFrancischi%26aufirst%3DJ.%2BN.%26atitle%3DIs%2520the%2520sulphonamide%2520radical%2520in%2520the%2520celecoxib%2520molecule%2520essential%2520for%2520its%2520analgesic%2520activity%253F%26jtitle%3DPharmacol.%2520Res.%26date%3D2010%26volume%3D62%26spage%3D439%26epage%3D443%26doi%3D10.1016%2Fj.phrs.2010.06.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bozdag, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carta, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scozzafava, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenna, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supuran, C. T.</span></span> <span> </span><span class="NLM_article-title">A class of 4-sulfamoylphenyl-ω-aminoalkyl ethers with effective carbonic anhydrase inhibitory action and antiglaucoma effects</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">9673</span>– <span class="NLM_lpage">9686</span>, <span class="refDoi"> DOI: 10.1021/jm501497m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501497m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVensLrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9673-9686&author=M.+Bozdagauthor=M.+Pinardauthor=F.+Cartaauthor=E.+Masiniauthor=A.+Scozzafavaauthor=R.+McKennaauthor=C.+T.+Supuran&title=A+class+of+4-sulfamoylphenyl-%CF%89-aminoalkyl+ethers+with+effective+carbonic+anhydrase+inhibitory+action+and+antiglaucoma+effects&doi=10.1021%2Fjm501497m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">A Class of 4-Sulfamoylphenyl-ω-aminoalkyl Ethers with Effective Carbonic Anhydrase Inhibitory Action and Antiglaucoma Effects</span></div><div class="casAuthors">Bozdag, Murat; Pinard, Melissa; Carta, Fabrizio; Masini, Emanuela; Scozzafava, Andrea; McKenna, Robert; Supuran, Claudiu T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9673-9686</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report a series of 4-sulfamoylphenyl-ω-aminoalkyl ethers as carbonic anhydrase (CA, EC 4.2.1.1) inhibitors.  The structure-activity relationship was drawn for the inhibition of four physiol. relevant isoforms: hCA I, II, IX, and XII.  Many of these compds. were highly effective, low nanomolar inhibitors of all CA isoforms, whereas several isoform-selective were also identified.  X-ray crystal structures of two new sulfonamides bound to the physiol. dominant CA II isoform showed the tails of these derivs. bound within the hydrophobic half of the enzyme active site through van der Waals contacts with Val135, Leu198, Leu204, Trp209, Pro201, and Pro202 amino acids.  One of the highly water-sol. compd. (as trifluoroacetate salt) showed effective IOP lowering properties in an animal model of glaucoma.  Several fluorescent sulfonamides incorporating either the fluorescein-thiourea (7a-c) or tetramethylrhodamine-thiourea (9a,b) moieties were also obtained and showed interesting CA inhibitory properties for the tumor-assocd. isoforms CA IX and XII.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHHbJ45OcmhLVg90H21EOLACvtfcHk0licjdo8F354CQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVensLrP&md5=d8ccf7da4a68a95cbd2c060afea9f515</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm501497m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501497m%26sid%3Dliteratum%253Aachs%26aulast%3DBozdag%26aufirst%3DM.%26aulast%3DPinard%26aufirst%3DM.%26aulast%3DCarta%26aufirst%3DF.%26aulast%3DMasini%26aufirst%3DE.%26aulast%3DScozzafava%26aufirst%3DA.%26aulast%3DMcKenna%26aufirst%3DR.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DA%2520class%2520of%25204-sulfamoylphenyl-%25CF%2589-aminoalkyl%2520ethers%2520with%2520effective%2520carbonic%2520anhydrase%2520inhibitory%2520action%2520and%2520antiglaucoma%2520effects%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D9673%26epage%3D9686%26doi%3D10.1021%2Fjm501497m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khalifah, R. G.</span></span> <span> </span><span class="NLM_article-title">The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1971</span>,  <span class="NLM_volume"><i>246</i></span>,  <span class="NLM_fpage">2561</span>– <span class="NLM_lpage">2573</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.1016%2FS0021-9258%2818%2962326-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=4994926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A528%3ADyaE3MXhtlGmu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=246&publication_year=1971&pages=2561-2573&author=R.+G.+Khalifah&title=The+carbon+dioxide+hydration+activity+of+carbonic+anhydrase.+I.+Stop-flow+kinetic+studies+on+the+native+human+isoenzymes+B+and+C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Carbon dioxide hydration activity of carbonic anhydrase.  I.  Stop-flow kinetic studies on the native human isoenzymes B and C</span></div><div class="casAuthors">Khalifah, Raja G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1971</span>),
    <span class="NLM_cas:volume">246</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2561-73</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">The kinetics of catalysis of carbon dioxide hydration by human carbonic anhydrases B and C (EC 4.2.1.1) has been reinvestigated with the use of an improved pH indicator stop-flow approach that was checked by studying the uncatalyzed rate of hydration, with Michaelis-Menten parameters being detd. between pH 5.8 and 8.8 in noninhibitory buffers.  For both isoenzymes, Km was independent of pH, whereas Vmax increased with increasing pH with results being similar to the finding of others on bovine carbonic anhydrase, but differing from earlier reports of Gibbons and Edsall (1964) in the finding that Km was pH-independent.  Despite the differences between the low and high activity forms of the enzyme, there were close kinetic similarities between them that indicated underlying similarities in active site structure.  Imidazole (I) (0.22-1.32M) inhibited the B enzyme, apparently competitively, and had no effect on the C enzyme.  N-Methyl substitution of I abolished its inhibitory effect.  Nitrous oxide (11-45mM) did not inhibit catalysis of carbon dioxide hydration by either of the 2 human isoenzymes, or by bovine carbonic anhydrase.  The enzyme-catalyzed hydration of carbon dioxide probably requires not only water activation by a basic group, but also charge neutralization in the transition state by an electron acceptor function.  The zinc-bound water in carbonic anhydrase could be involved in both donor and acceptor roles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGri57EkpgPMx7Vg90H21EOLACvtfcHk0licjdo8F354CQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3MXhtlGmu7k%253D&md5=2764970fcd4f08250b28b9e8e9474681</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2FS0021-9258%2818%2962326-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0021-9258%252818%252962326-9%26sid%3Dliteratum%253Aachs%26aulast%3DKhalifah%26aufirst%3DR.%2BG.%26atitle%3DThe%2520carbon%2520dioxide%2520hydration%2520activity%2520of%2520carbonic%2520anhydrase.%2520I.%2520Stop-flow%2520kinetic%2520studies%2520on%2520the%2520native%2520human%2520isoenzymes%2520B%2520and%2520C%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1971%26volume%3D246%26spage%3D2561%26epage%3D2573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Joullié, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lassen, K. M.</span></span> <span> </span><span class="NLM_article-title">Evolution of amide bond formation</span>. <i>ARKIVOC</i> <span class="NLM_year" style="font-weight: bold;">2010</span>, (<span class="NLM_issue">viii</span>),  <span class="NLM_fpage">189</span>– <span class="NLM_lpage">250</span>, <span class="refDoi"> DOI: 10.3998/ark.5550190.0011.816</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.3998%2Fark.5550190.0011.816" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&pages=189-250&issue=viii&author=M.+M.+Joulli%C3%A9author=K.+M.+Lassen&title=Evolution+of+amide+bond+formation&doi=10.3998%2Fark.5550190.0011.816"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.3998%2Fark.5550190.0011.816&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3998%252Fark.5550190.0011.816%26sid%3Dliteratum%253Aachs%26aulast%3DJoulli%25C3%25A9%26aufirst%3DM.%2BM.%26aulast%3DLassen%26aufirst%3DK.%2BM.%26atitle%3DEvolution%2520of%2520amide%2520bond%2520formation%26jtitle%3DARKIVOC%26date%3D2010%26issue%3Dviii%26spage%3D189%26epage%3D250%26doi%3D10.3998%2Fark.5550190.0011.816" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Makhija, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somani, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chavan, A. V.</span></span> <span> </span><span class="NLM_article-title">Synthesis and pharmacological evaluation of antiinflammatory mutual amide prodrugs</span>. <i>Indian J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">353</span>– <span class="NLM_lpage">357</span>, <span class="refDoi"> DOI: 10.4103/0250-474X.117399</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.4103%2F0250-474X.117399" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=24082352" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1agsb3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2013&pages=353-357&author=D.+T.+Makhijaauthor=R.+R.+Somaniauthor=A.+V.+Chavan&title=Synthesis+and+pharmacological+evaluation+of+antiinflammatory+mutual+amide+prodrugs&doi=10.4103%2F0250-474X.117399"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and pharmacological evaluation of antiinflammatory mutual amide prodrugs</span></div><div class="casAuthors">Makhija, D. T.; Somani, R. R.; Chavan, A. V.</div><div class="citationInfo"><span class="NLM_cas:title">Indian Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">353-357</span>CODEN:
                <span class="NLM_cas:coden">IJSIDW</span>;
        ISSN:<span class="NLM_cas:issn">0250-474X</span>.
    
            (<span class="NLM_cas:orgname">Medknow Publications and Media Pvt. Ltd.</span>)
        </div><div class="casAbstract">The amide prodrugs of nonsteroidal antiinflammatory drugs viz. ibuprofen, diclofenac and flurbiprofen were synthesized by coupling reaction with sulfonamides like sulfamethoxazole and sulfanilamide.  The synthesized prodrugs were screened for their analgesic and antiinflammatory activity using Eddy's hot plate, acetic acid-induced writhing and carrageenan-induced rat paw edema method, resp.  These prodrugs were also evaluated for their ulcerogenic potential.  All synthesized prodrugs were found to be less ulcerogenic than their parent nonsteroidal antiinflammatory drugs and showed better activity profile in terms of analgesic and antiinflammatory activity as compared to their resp. parent drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp18mvHHk7VW7Vg90H21EOLACvtfcHk0licjdo8F354CQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1agsb3P&md5=8d55792e72d97a5254630a2da8a6cc27</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.4103%2F0250-474X.117399&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4103%252F0250-474X.117399%26sid%3Dliteratum%253Aachs%26aulast%3DMakhija%26aufirst%3DD.%2BT.%26aulast%3DSomani%26aufirst%3DR.%2BR.%26aulast%3DChavan%26aufirst%3DA.%2BV.%26atitle%3DSynthesis%2520and%2520pharmacological%2520evaluation%2520of%2520antiinflammatory%2520mutual%2520amide%2520prodrugs%26jtitle%3DIndian%2520J.%2520Pharm.%2520Sci.%26date%3D2013%26volume%3D75%26spage%3D353%26epage%3D357%26doi%3D10.4103%2F0250-474X.117399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lai, C.</span>; <span class="NLM_string-name">Wang, T.</span></span> <span> </span><span class="NLM_article-title">Modified Forms of Nonsteroidal Antiinflammatory Drugs (NSAIDs) Having Reduced Side Effects</span>. U.S. Pat. Appl. Publ. <span class="NLM_year">2003</span>, <span class="NLM_patent">U.S. 20030220468 A1</span>, 20031127.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=C.+Lai&author=T.+Wang&title=Modified+Forms+of+Nonsteroidal+Antiinflammatory+Drugs+%28NSAIDs%29+Having+Reduced+Side+Effects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLai%26aufirst%3DC.%26atitle%3DModified%2520Forms%2520of%2520Nonsteroidal%2520Antiinflammatory%2520Drugs%2520%2528NSAIDs%2529%2520Having%2520Reduced%2520Side%2520Effects%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Winum, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carta, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langdon, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cecchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scozzafava, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunkler, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supuran, C. T.</span></span> <span> </span><span class="NLM_article-title">Ureido-substituted sulfamates show potent carbonic anhydrase IX inhibitory and antiproliferative activities against breast cancer cell lines</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">4681</span>– <span class="NLM_lpage">4685</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.05.083</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.1016%2Fj.bmcl.2012.05.083" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=4681-4685&author=J.+Y.+Winumauthor=F.+Cartaauthor=C.+Wardauthor=P.+Mullenauthor=D.+Harrisonauthor=S.+P.+Langdonauthor=A.+Cecchiauthor=A.+Scozzafavaauthor=I.+Kunklerauthor=C.+T.+Supuran&title=Ureido-substituted+sulfamates+show+potent+carbonic+anhydrase+IX+inhibitory+and+antiproliferative+activities+against+breast+cancer+cell+lines&doi=10.1016%2Fj.bmcl.2012.05.083"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.05.083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.05.083%26sid%3Dliteratum%253Aachs%26aulast%3DWinum%26aufirst%3DJ.%2BY.%26aulast%3DCarta%26aufirst%3DF.%26aulast%3DWard%26aufirst%3DC.%26aulast%3DMullen%26aufirst%3DP.%26aulast%3DHarrison%26aufirst%3DD.%26aulast%3DLangdon%26aufirst%3DS.%2BP.%26aulast%3DCecchi%26aufirst%3DA.%26aulast%3DScozzafava%26aufirst%3DA.%26aulast%3DKunkler%26aufirst%3DI.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DUreido-substituted%2520sulfamates%2520show%2520potent%2520carbonic%2520anhydrase%2520IX%2520inhibitory%2520and%2520antiproliferative%2520activities%2520against%2520breast%2520cancer%2520cell%2520lines%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D4681%26epage%3D4685%26doi%3D10.1016%2Fj.bmcl.2012.05.083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">D’Ambrosio, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smaine, F. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carta, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Simone, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winum, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supuran, C. T.</span></span> <span> </span><span class="NLM_article-title">Development of potent carbonic anhydrase inhibitors incorporating both sulfonamide and sulfamide groups</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">6776</span>– <span class="NLM_lpage">6783</span>, <span class="refDoi"> DOI: 10.1021/jm300818k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300818k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6776-6783&author=K.+D%E2%80%99Ambrosioauthor=F.+Z.+Smaineauthor=F.+Cartaauthor=G.+De+Simoneauthor=J.+Y.+Winumauthor=C.+T.+Supuran&title=Development+of+potent+carbonic+anhydrase+inhibitors+incorporating+both+sulfonamide+and+sulfamide+groups&doi=10.1021%2Fjm300818k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm300818k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300818k%26sid%3Dliteratum%253Aachs%26aulast%3DD%25E2%2580%2599Ambrosio%26aufirst%3DK.%26aulast%3DSmaine%26aufirst%3DF.%2BZ.%26aulast%3DCarta%26aufirst%3DF.%26aulast%3DDe%2BSimone%26aufirst%3DG.%26aulast%3DWinum%26aufirst%3DJ.%2BY.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DDevelopment%2520of%2520potent%2520carbonic%2520anhydrase%2520inhibitors%2520incorporating%2520both%2520sulfonamide%2520and%2520sulfamide%2520groups%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6776%26epage%3D6783%26doi%3D10.1021%2Fjm300818k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pala, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Micheletto, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sechi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aggarwal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carta, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenna, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supuran, C. T.</span></span> <span> </span><span class="NLM_article-title">Carbonic Anhydrase inhibition with benzenesulfonamides and tetrafluorobenzenesulfonamides obtained via click chemistry</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">927</span>– <span class="NLM_lpage">930</span>, <span class="refDoi"> DOI: 10.1021/ml500196t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500196t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=927-930&author=N.+Palaauthor=L.+Michelettoauthor=M.+Sechiauthor=M.+Aggarwalauthor=F.+Cartaauthor=R.+McKennaauthor=C.+T.+Supuran&title=Carbonic+Anhydrase+inhibition+with+benzenesulfonamides+and+tetrafluorobenzenesulfonamides+obtained+via+click+chemistry&doi=10.1021%2Fml500196t"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fml500196t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500196t%26sid%3Dliteratum%253Aachs%26aulast%3DPala%26aufirst%3DN.%26aulast%3DMicheletto%26aufirst%3DL.%26aulast%3DSechi%26aufirst%3DM.%26aulast%3DAggarwal%26aufirst%3DM.%26aulast%3DCarta%26aufirst%3DF.%26aulast%3DMcKenna%26aufirst%3DR.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DCarbonic%2520Anhydrase%2520inhibition%2520with%2520benzenesulfonamides%2520and%2520tetrafluorobenzenesulfonamides%2520obtained%2520via%2520click%2520chemistry%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D927%26epage%3D930%26doi%3D10.1021%2Fml500196t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kilkenny, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Browne, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuthill, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emerson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altman, D. G.</span></span> <span> </span><span class="NLM_article-title">Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research</span>. <i>J. Pharmacol. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">94</span>– <span class="NLM_lpage">99</span>, <span class="refDoi"> DOI: 10.4103/0976-500X.72351</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.4103%2F0976-500X.72351" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=21350617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A280%3ADC%252BC3M3hvVyksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=94-99&author=C.+Kilkennyauthor=W.+J.+Browneauthor=I.+C.+Cuthillauthor=M.+Emersonauthor=D.+G.+Altman&title=Improving+bioscience+research+reporting%3A+the+ARRIVE+guidelines+for+reporting+animal+research&doi=10.4103%2F0976-500X.72351"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research</span></div><div class="casAuthors">Kilkenny Carol; Browne William J; Cuthill Innes C; Emerson Michael; Altman Douglas G</div><div class="citationInfo"><span class="NLM_cas:title">Journal of pharmacology & pharmacotherapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">94-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTFwcJ9W7T-OWyYR5VtavbzfW6udTcc2eadMc7CIQtW1bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M3hvVyksg%253D%253D&md5=adb67f1d88a6f9cf879d5b5bab56dd40</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.4103%2F0976-500X.72351&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4103%252F0976-500X.72351%26sid%3Dliteratum%253Aachs%26aulast%3DKilkenny%26aufirst%3DC.%26aulast%3DBrowne%26aufirst%3DW.%2BJ.%26aulast%3DCuthill%26aufirst%3DI.%2BC.%26aulast%3DEmerson%26aufirst%3DM.%26aulast%3DAltman%26aufirst%3DD.%2BG.%26atitle%3DImproving%2520bioscience%2520research%2520reporting%253A%2520the%2520ARRIVE%2520guidelines%2520for%2520reporting%2520animal%2520research%26jtitle%3DJ.%2520Pharmacol.%2520Pharmacother.%26date%3D2010%26volume%3D1%26spage%3D94%26epage%3D99%26doi%3D10.4103%2F0976-500X.72351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Butler, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godefroy, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besson, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weil-Fugazza, J.</span></span> <span> </span><span class="NLM_article-title">A limited arthritic model for chronic pain studies in the rat</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">73</span>– <span class="NLM_lpage">81</span>, <span class="refDoi"> DOI: 10.1016/0304-3959(92)90133-V</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.1016%2F0304-3959%2892%2990133-V" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1738577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A280%3ADyaK387ltVSqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=1992&pages=73-81&author=S.+H.+Butlerauthor=F.+Godefroyauthor=J.+M.+Bessonauthor=J.+Weil-Fugazza&title=A+limited+arthritic+model+for+chronic+pain+studies+in+the+rat&doi=10.1016%2F0304-3959%2892%2990133-V"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">A limited arthritic model for chronic pain studies in the rat</span></div><div class="casAuthors">Butler S H; Godefroy F; Besson J M; Weil-Fugazza J</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">73-81</span>
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    </div><div class="casAbstract">Freund's adjuvant induced polyarthritis in rats has been used extensively to study pain processes of long duration.  There are limitations of this model for chronic studies of pain/arthritis since the severe systemic changes provoke ethical concerns and also affect behaviour, physiology and biochemistry.  Attempts to limit adjuvant-induced arthritis by plantar injection of the inoculum have been made.  In this model, however, the process evolved to produce widespread polyarthritis if followed for the 6-plus-weeks necessary for chronic studies.  Therefore, although it offers the researcher a reliable limited model of inflammation and nociception at the outset, for longer studies it may have all the disadvantages of the polyarthritic rat.  The purpose of the present study was to produce a limited arthritic process in rats, stable over 6 weeks and suitable for behavioural and neurochemical studies of various chronic pain treatment methods.  Injection (0.05 ml) of complete adjuvant containing 300 micrograms Mycobacterium butyricum in the tibio-tarsal joint produces a predictable monoarthritis, stable clinically and behaviourly from weeks 2 through 6 post injection.  As revealed by clinical observations and X-ray examinations, the arthritis produced was limited anatomically, pronounced, prolonged and stable.  A marked increase in sensitivity to paw pressure was seen in the affected limb.  Animals gained weight and remained active, indicating little systemic disturbance as opposed to polyarthritic rats.  We propose this limited model of arthritis as a suitable alternative to the polyarthritic rat for prolonged studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT8JqpNUe2Bd9XdcedVHT5tfW6udTcc2eadMc7CIQtW1bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK387ltVSqug%253D%253D&md5=3e5b40828514fb38a83a8ca180f889b3</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2F0304-3959%2892%2990133-V&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0304-3959%252892%252990133-V%26sid%3Dliteratum%253Aachs%26aulast%3DButler%26aufirst%3DS.%2BH.%26aulast%3DGodefroy%26aufirst%3DF.%26aulast%3DBesson%26aufirst%3DJ.%2BM.%26aulast%3DWeil-Fugazza%26aufirst%3DJ.%26atitle%3DA%2520limited%2520arthritic%2520model%2520for%2520chronic%2520pain%2520studies%2520in%2520the%2520rat%26jtitle%3DPain%26date%3D1992%26volume%3D48%26spage%3D73%26epage%3D81%26doi%3D10.1016%2F0304-3959%2892%2990133-V" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di
Cesare Mannelli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bani, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bencini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandi, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calosi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantore, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carossino, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghelardini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valtancoli, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Failli, P.</span></span> <span> </span><span class="NLM_article-title">Therapeutic effects of the superoxide dismutase mimetic compound MnIIMe2DO2A on experimental articular pain in rats</span>. <i>Mediators Inflammation</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>2013</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">11</span>, <span class="refDoi"> DOI: 10.1155/2013/905360</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.1155%2F2013%2F905360" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2013&publication_year=2013&pages=1-11&author=L.+Di%0ACesare+Mannelliauthor=D.+Baniauthor=A.+Benciniauthor=M.+L.+Brandiauthor=L.+Calosiauthor=M.+Cantoreauthor=A.+M.+Carossinoauthor=C.+Ghelardiniauthor=B.+Valtancoliauthor=P.+Failli&title=Therapeutic+effects+of+the+superoxide+dismutase+mimetic+compound+MnIIMe2DO2A+on+experimental+articular+pain+in+rats&doi=10.1155%2F2013%2F905360"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1155%2F2013%2F905360&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2013%252F905360%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BCesare%2BMannelli%26aufirst%3DL.%26aulast%3DBani%26aufirst%3DD.%26aulast%3DBencini%26aufirst%3DA.%26aulast%3DBrandi%26aufirst%3DM.%2BL.%26aulast%3DCalosi%26aufirst%3DL.%26aulast%3DCantore%26aufirst%3DM.%26aulast%3DCarossino%26aufirst%3DA.%2BM.%26aulast%3DGhelardini%26aufirst%3DC.%26aulast%3DValtancoli%26aufirst%3DB.%26aulast%3DFailli%26aufirst%3DP.%26atitle%3DTherapeutic%2520effects%2520of%2520the%2520superoxide%2520dismutase%2520mimetic%2520compound%2520MnIIMe2DO2A%2520on%2520experimental%2520articular%2520pain%2520in%2520rats%26jtitle%3DMediators%2520Inflammation%26date%3D2013%26volume%3D2013%26spage%3D1%26epage%3D11%26doi%3D10.1155%2F2013%2F905360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di Cesare Mannelli, L.</span>; <span class="NLM_string-name">Micheli, L.</span>; <span class="NLM_string-name">Cinci, L.</span>; <span class="NLM_string-name">Maresca, M.</span>; <span class="NLM_string-name">Vergelli, C.</span>; <span class="NLM_string-name">Pacini, A.</span>; <span class="NLM_string-name">Quinn, M.
T.</span>; <span class="NLM_string-name">Giovannoni, M. P.</span>; <span class="NLM_string-name">Ghelardini, C.</span></span> <i>Effects of the Neutrophil Elastase Inhibitor EL-17 in Rat Adjuvant-Induced Arthritis</i>; <span class="NLM_publisher-name">Rheumatology</span>: <span class="NLM_publisher-loc">Oxford</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.1093%2Frheumatology%2Fkew055" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=L.+Di+Cesare+Mannelli&author=L.+Micheli&author=L.+Cinci&author=M.+Maresca&author=C.+Vergelli&author=A.+Pacini&author=M.%0AT.+Quinn&author=M.+P.+Giovannoni&author=C.+Ghelardini&title=Effects+of+the+Neutrophil+Elastase+Inhibitor+EL-17+in+Rat+Adjuvant-Induced+Arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1093%2Frheumatology%2Fkew055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1093%252Frheumatology%252Fkew055%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BCesare%2BMannelli%26aufirst%3DL.%26btitle%3DEffects%2520of%2520the%2520Neutrophil%2520Elastase%2520Inhibitor%2520EL-17%2520in%2520Rat%2520Adjuvant-Induced%2520Arthritis%26pub%3DRheumatology%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leighton, G.
E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, J.</span></span> <span> </span><span class="NLM_article-title">κ-Opioid agonist produce antinociception after i.v. and i.c.v. but not intrathecal administration in the rat</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>93</i></span>,  <span class="NLM_fpage">553</span>– <span class="NLM_lpage">560</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.1988.tb10310.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.1111%2Fj.1476-5381.1988.tb10310.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=2836010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A528%3ADyaL1cXhvVSjtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1988&pages=553-560&author=G.%0AE.+Leightonauthor=R.+E.+Rodriguezauthor=R.+G.+Hillauthor=J.+Hughes&title=%CE%BA-Opioid+agonist+produce+antinociception+after+i.v.+and+i.c.v.+but+not+intrathecal+administration+in+the+rat&doi=10.1111%2Fj.1476-5381.1988.tb10310.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">κ-Opioid agonists produce antinociception after i.v. and i.c.v. but not intrathecal administration in the rat</span></div><div class="casAuthors">Leighton, G. E.; Rodriguez, R. E.; Hill, R. G.; Hughes, J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">553-60</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    </div><div class="casAbstract">Following i.v. administration to rats, PD117302, U50488, U69593, and morphine produced steep parallel dose-response curves indicating antinociceptive activity when evaluated in the paw-pressure test.  When U50488 and U69593 were tested at a single dose of 3.3 mg/kg no effect was seen in the tail-flick test.  When given by the intrathecal route, only morphine was effective at increasing the nociceptive threshold.  PD117302, U50488 and U69593 were without effect in either the paw-pressure or tail-flick tests at ≤100 μg per rat.  PD117302 caused flaccid paralysis of the hindlimbs following intrathecal administration at the top dose tested.  This effect was not reversible by naloxone.  All 3 κ-opioid receptor agonists produced naloxone-reversible antinociception in the paw-pressure test, and to a lesser extent in the tail-flick test, when injected directly into the 3rd cerebral ventricle with the max. effect occurring between 5 and 10 min after administration and declining back to control levels by 60 min.  Morphine had a much slower onset of action with the peak effect being obsd. 30 min after dosing.  The antinociceptive effects of κ-agonists are likely to operate via an action at a supraspinal rather than a spinal site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRnCwR2n4YdLVg90H21EOLACvtfcHk0litIAE5__Bk4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXhvVSjtLo%253D&md5=a07f811b47c181c8d06a9abf42fbf83e</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1988.tb10310.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1988.tb10310.x%26sid%3Dliteratum%253Aachs%26aulast%3DLeighton%26aufirst%3DG.%2BE.%26aulast%3DRodriguez%26aufirst%3DR.%2BE.%26aulast%3DHill%26aufirst%3DR.%2BG.%26aulast%3DHughes%26aufirst%3DJ.%26atitle%3D%25CE%25BA-Opioid%2520agonist%2520produce%2520antinociception%2520after%2520i.v.%2520and%2520i.c.v.%2520but%2520not%2520intrathecal%2520administration%2520in%2520the%2520rat%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1988%26volume%3D93%26spage%3D553%26epage%3D560%26doi%3D10.1111%2Fj.1476-5381.1988.tb10310.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bove, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calcaterra, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brooker, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman, R. E.</span></span> <span> </span><span class="NLM_article-title">Weight bearing as a measure of disease progression and efficacy of anti-inflammatory compounds in a model of monosodium iodoacetate-induced osteoarthritis</span>. <i>Osteoarthritis and Cartilage</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">821</span>– <span class="NLM_lpage">830</span>, <span class="refDoi"> DOI: 10.1016/S1063-4584(03)00163-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.1016%2FS1063-4584%2803%2900163-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=14609535" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A280%3ADC%252BD3srjt1KitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=821-830&author=S.+E.+Boveauthor=S.+L.+Calcaterraauthor=R.+M.+Brookerauthor=C.+M.+Huberauthor=R.+E.+Guzman&title=Weight+bearing+as+a+measure+of+disease+progression+and+efficacy+of+anti-inflammatory+compounds+in+a+model+of+monosodium+iodoacetate-induced+osteoarthritis&doi=10.1016%2FS1063-4584%2803%2900163-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Weight bearing as a measure of disease progression and efficacy of anti-inflammatory compounds in a model of monosodium iodoacetate-induced osteoarthritis</span></div><div class="casAuthors">Bove S E; Calcaterra S L; Brooker R M; Huber C M; Guzman R E; Juneau P L; Schrier D J; Kilgore K S</div><div class="citationInfo"><span class="NLM_cas:title">Osteoarthritis and cartilage</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">821-30</span>
        ISSN:<span class="NLM_cas:issn">1063-4584</span>.
    </div><div class="casAbstract">OBJECTIVE:  To describe an in vivo model in the rat in which change in weight distribution is used as a measure of disease progression and efficacy of acetaminophen and two nonsteroidal anti-inflammatory drugs (NSAIDs) in a model of monosodium iodoacetate (MIA)-induced osteoarthritis (OA).  METHODS:  Intra-articular injections of MIA and saline were administered to male Wistar rats (175-200 g) into the right and left knee joints, respectively.  Changes in hind paw weight distribution between the right (osteoarthritic) and left (contralateral control) limbs were utilized as an index of joint discomfort.  Acetaminophen and two archetypal, orally administered NSAIDs, naproxen and rofecoxib, were examined for their ability to decrease MIA-induced change in weight distribution.  RESULTS:  A concentration-dependent increase in change in hind paw weight distribution was noted after intra-articular injection of MIA.  Both naproxen and rofecoxib demonstrated the capacity to significantly (P<0.05) decrease hind paw weight distribution in a dose-dependent fashion, indicating that the change in weight distribution associated with MIA injection is susceptible to pharmacological intervention.  CONCLUSION:  The determination of differences in hind paw weight distribution in the rat MIA model of OA is a technically straightforward, reproducible method that is predictive of the effects of anti-inflammatory and analgesic agents.  This system may be useful for the discovery of novel pharmacologic agents in human OA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSXM-0hOfBxH_6xYuD7tu2XfW6udTcc2eYVtDMfIGvF57ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3srjt1KitA%253D%253D&md5=12ee3d4de4609d794d4e4f4b176f25a3</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2FS1063-4584%2803%2900163-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1063-4584%252803%252900163-8%26sid%3Dliteratum%253Aachs%26aulast%3DBove%26aufirst%3DS.%2BE.%26aulast%3DCalcaterra%26aufirst%3DS.%2BL.%26aulast%3DBrooker%26aufirst%3DR.%2BM.%26aulast%3DHuber%26aufirst%3DC.%2BM.%26aulast%3DGuzman%26aufirst%3DR.%2BE.%26atitle%3DWeight%2520bearing%2520as%2520a%2520measure%2520of%2520disease%2520progression%2520and%2520efficacy%2520of%2520anti-inflammatory%2520compounds%2520in%2520a%2520model%2520of%2520monosodium%2520iodoacetate-induced%2520osteoarthritis%26jtitle%3DOsteoarthritis%2520and%2520Cartilage%26date%3D2003%26volume%3D11%26spage%3D821%26epage%3D830%26doi%3D10.1016%2FS1063-4584%2803%2900163-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Yelin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lubeck, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epstein, W.</span></span> <span> </span><span class="NLM_article-title">The impact of rheumatoid arthritis and osteoarthritis: the activities of patients with rheumatoid arthritis and osteoarthritis compared to controls</span>. <i>J. Rheumatol.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">710</span>– <span class="NLM_lpage">717</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=3668977" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A280%3ADyaL1c%252FjsFyksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1987&pages=710-717&author=E.+Yelinauthor=D.+Lubeckauthor=H.+Holmanauthor=W.+Epstein&title=The+impact+of+rheumatoid+arthritis+and+osteoarthritis%3A+the+activities+of+patients+with+rheumatoid+arthritis+and+osteoarthritis+compared+to+controls"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30aR"><div class="casContent"><span class="casTitleNuber">30a</span><div class="casTitle"><span class="NLM_cas:atitle">The impact of rheumatoid arthritis and osteoarthritis: the activities of patients with rheumatoid arthritis and osteoarthritis compared to controls</span></div><div class="casAuthors">Yelin E; Lubeck D; Holman H; Epstein W</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of rheumatology</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">710-7</span>
        ISSN:<span class="NLM_cas:issn">0315-162X</span>.
    </div><div class="casAbstract">We measured the impact of rheumatoid arthritis (RA) and osteoarthritis (OA) by comparing the activities of patients with these illnesses to controls matched for age, sex, and community of residence.  Our results indicate that patients with RA experience more losses than controls in every domain of human activity and that patients with OA experience more losses in the performance of household chores, shopping and errands, and leisure activities.  The methods described here provide a simple, reliable way to assess the impacts of illness in the same terms for all dimensions of human activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQI2S3ZhUeOWw5nADWVYHg1fW6udTcc2eaO-RLOrphLLrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1c%252FjsFyksw%253D%253D&md5=6f0e79449f64d6cca2b7d928a130941e</span></div><a href="/servlet/linkout?suffix=cit30a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYelin%26aufirst%3DE.%26aulast%3DLubeck%26aufirst%3DD.%26aulast%3DHolman%26aufirst%3DH.%26aulast%3DEpstein%26aufirst%3DW.%26atitle%3DThe%2520impact%2520of%2520rheumatoid%2520arthritis%2520and%2520osteoarthritis%253A%2520the%2520activities%2520of%2520patients%2520with%2520rheumatoid%2520arthritis%2520and%2520osteoarthritis%2520compared%2520to%2520controls%26jtitle%3DJ.%2520Rheumatol.%26date%3D1987%26volume%3D14%26spage%3D710%26epage%3D717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit30b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Yelin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henke, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epstein, W.</span></span> <span> </span><span class="NLM_article-title">The work dynamics of the person with rheumatoid arthritis</span>. <i>Arthritis Rheum.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">507</span>– <span class="NLM_lpage">512</span>, <span class="refDoi"> DOI: 10.1002/art.1780300504</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.1002%2Fart.1780300504" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=3593434" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A280%3ADyaL2s3ktFOmsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1987&pages=507-512&author=E.+Yelinauthor=C.+Henkeauthor=W.+Epstein&title=The+work+dynamics+of+the+person+with+rheumatoid+arthritis&doi=10.1002%2Fart.1780300504"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30bR"><div class="casContent"><span class="casTitleNuber">30b</span><div class="casTitle"><span class="NLM_cas:atitle">The work dynamics of the person with rheumatoid arthritis</span></div><div class="casAuthors">Yelin E; Henke C; Epstein W</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis and rheumatism</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">507-12</span>
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    </div><div class="casAbstract">This paper traces the work history of patients with rheumatoid arthritis (RA) from the year of diagnosis to 1985.  The paper also describes the risk factors for work loss among patients with RA.  It uses data from a panel of 698 RA patients, observed for 4 years, from the practices of a random sample of northern California rheumatologists.  Of these 698, 353 had worked for pay at some point in their lives.  Three hundred six of the 353 had worked when diagnosed as having RA.  Of these 306, 157 (51%) were no longer working in 1985.  Forty-seven individuals started working after the onset of illness, but of these, approximately one-third had stopped working by 1985.  In all, 50% of RA patients with some work experience stopped working within a decade of diagnosis, 60% within 15 years, and 90% within 30 years.  We found that the probability of work loss is lessened among persons in jobs that have few physical requirements, among those with high levels of discretion over the pace and activities of work, and among those who were able to stay on the job held when the diagnosis was made.  The probability of work loss is increased among service workers.  The findings of this longitudinal study, showing that work characteristics profoundly alter the probability of work loss among persons with RA, are consistent with the findings of our earlier cross-sectional studies of work outcome and RA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQOCSTunNuI7A20zIbnCCI3fW6udTcc2eaO-RLOrphLLrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2s3ktFOmsg%253D%253D&md5=139f479967b8d4b6435044c279ca6814</span></div><a href="/servlet/linkout?suffix=cit30b&amp;dbid=16384&amp;doi=10.1002%2Fart.1780300504&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.1780300504%26sid%3Dliteratum%253Aachs%26aulast%3DYelin%26aufirst%3DE.%26aulast%3DHenke%26aufirst%3DC.%26aulast%3DEpstein%26aufirst%3DW.%26atitle%3DThe%2520work%2520dynamics%2520of%2520the%2520person%2520with%2520rheumatoid%2520arthritis%26jtitle%3DArthritis%2520Rheum.%26date%3D1987%26volume%3D30%26spage%3D507%26epage%3D512%26doi%3D10.1002%2Fart.1780300504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendrickson, C. L.</span></span> <span> </span><span class="NLM_article-title">High-resolution mass spectrometers</span>. <i>Annu. Rev. Anal. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">579</span>– <span class="NLM_lpage">599</span>, <span class="refDoi"> DOI: 10.1146/annurev.anchem.1.031207.112945</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.1146%2Fannurev.anchem.1.031207.112945" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=20636090" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFygsLzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2008&pages=579-599&author=A.+G.+Marshallauthor=C.+L.+Hendrickson&title=High-resolution+mass+spectrometers&doi=10.1146%2Fannurev.anchem.1.031207.112945"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">High-resolution mass spectrometers</span></div><div class="casAuthors">Marshall, Alan G.; Hendrickson, Christopher L.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Analytical Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">579-599</span>CODEN:
                <span class="NLM_cas:coden">ARACFU</span>;
        ISSN:<span class="NLM_cas:issn">1936-1327</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Over the past decade, mass spectrometry has been revolutionized by access to instruments of increasingly high mass-resolving power.  For small mols. up to ∼400 Da (e.g., drugs, metabolites, and various natural org. mixts. ranging from foods to petroleum), it is possible to det. elemental compns. (CcHhNnOoSsPp...) of thousands of chem. components simultaneously from accurate mass measurements (the same can be done up to 1000 Da if addnl. information is included).  At higher mass, it becomes possible to identify proteins (including posttranslational modifications) from proteolytic peptides, as well as lipids, glycoconjugates, and other biol. components.  At even higher mass (∼100,000 Da or higher), it is possible to characterize posttranslational modifications of intact proteins and to map the binding surfaces of large biomol. complexes.  Here we review the principles and techniques of the highest-resoln. anal. mass spectrometers (time-of-flight and Fourier transform ion cyclotron resonance and orbitrap mass analyzers) and describe some representative high-resoln. applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEujA9fN7IGLVg90H21EOLACvtfcHk0lg8NHVQFEleJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFygsLzI&md5=f4da150f5e6a8448f8313466ef8f9e08</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1146%2Fannurev.anchem.1.031207.112945&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.anchem.1.031207.112945%26sid%3Dliteratum%253Aachs%26aulast%3DMarshall%26aufirst%3DA.%2BG.%26aulast%3DHendrickson%26aufirst%3DC.%2BL.%26atitle%3DHigh-resolution%2520mass%2520spectrometers%26jtitle%3DAnnu.%2520Rev.%2520Anal.%2520Chem.%26date%3D2008%26volume%3D1%26spage%3D579%26epage%3D599%26doi%3D10.1146%2Fannurev.anchem.1.031207.112945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7a','cit7b','cit7c','cit7d','cit7e','cit7f','cit7g'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13a','cit13b','cit13c','cit13d','cit13e','cit13f'],'ref14':['cit14a','cit14b','cit14c','cit14d','cit14e','cit14f'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30a','cit30b'],'ref31':['cit31']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 25 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Samuel Obeng, Takato Hiranita, Francisco León, Lance R. McMahon, <span class="NLM_string-name hlFld-ContribAuthor">Christopher R. McCurdy</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Approaches, Drug Candidates, and Targets in Pain Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (10)
                                     , 6523-6548. <a href="https://doi.org/10.1021/acs.jmedchem.1c00028" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00028%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BApproaches%25252C%252BDrug%252BCandidates%25252C%252Band%252BTargets%252Bin%252BPain%252BDrug%252BDiscovery%26aulast%3DObeng%26aufirst%3DSamuel%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D07012021%26date%3D06052021%26volume%3D64%26issue%3D10%26spage%3D6523%26epage%3D6548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Silvia Bua, Laura Lucarini, Laura Micheli, Marta Menicatti, Gianluca Bartolucci, Silvia Selleri, Lorenzo Di Cesare Mannelli, Carla Ghelardini, Emanuela Masini, Fabrizio Carta, Paola Gratteri, Alessio Nocentini, <span class="NLM_string-name hlFld-ContribAuthor">Claudiu T. Supuran</span>. </span><span class="cited-content_cbyCitation_article-title">Bioisosteric Development of Multitarget Nonsteroidal Anti-Inflammatory Drug–Carbonic Anhydrases Inhibitor Hybrids for the Management of Rheumatoid Arthritis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (5)
                                     , 2325-2342. <a href="https://doi.org/10.1021/acs.jmedchem.9b01130" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01130</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01130&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01130%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBioisosteric%252BDevelopment%252Bof%252BMultitarget%252BNonsteroidal%252BAnti-Inflammatory%252BDrug%2525E2%252580%252593Carbonic%252BAnhydrases%252BInhibitor%252BHybrids%252Bfor%252Bthe%252BManagement%252Bof%252BRheumatoid%252BArthritis%26aulast%3DBua%26aufirst%3DSilvia%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D12072019%26date%3D15112019%26date%3D05112019%26volume%3D63%26issue%3D5%26spage%3D2325%26epage%3D2342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Emanuela Berrino, Lisa Milazzo, Laura Micheli, Daniela Vullo, Andrea Angeli, Murat Bozdag, Alessio Nocentini, Marta Menicatti, Gianluca Bartolucci, Lorenzo di Cesare Mannelli, Carla Ghelardini, Claudiu T. Supuran, <span class="NLM_string-name hlFld-ContribAuthor">Fabrizio Carta</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Evaluation of Carbonic Anhydrase Inhibitors with Carbon Monoxide Releasing Properties for the Management of Rheumatoid Arthritis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (15)
                                     , 7233-7249. <a href="https://doi.org/10.1021/acs.jmedchem.9b00845" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00845</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00845&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00845%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BEvaluation%252Bof%252BCarbonic%252BAnhydrase%252BInhibitors%252Bwith%252BCarbon%252BMonoxide%252BReleasing%252BProperties%252Bfor%252Bthe%252BManagement%252Bof%252BRheumatoid%252BArthritis%26aulast%3DBerrino%26aufirst%3DEmanuela%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D24052019%26date%3D23072019%26date%3D09072019%26volume%3D62%26issue%3D15%26spage%3D7233%26epage%3D7249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Silvia  Salerno</span>, <span class="hlFld-ContribAuthor ">Giorgio  Amendola</span>, <span class="hlFld-ContribAuthor ">Andrea  Angeli</span>, <span class="hlFld-ContribAuthor ">Emma  Baglini</span>, <span class="hlFld-ContribAuthor ">Elisabetta  Barresi</span>, <span class="hlFld-ContribAuthor ">Anna Maria  Marini</span>, <span class="hlFld-ContribAuthor ">Rahul  Ravichandran</span>, <span class="hlFld-ContribAuthor ">Monica  Viviano</span>, <span class="hlFld-ContribAuthor ">Sabrina  Castellano</span>, <span class="hlFld-ContribAuthor ">Ettore  Novellino</span>, <span class="hlFld-ContribAuthor ">Federico  Da Settimo</span>, <span class="hlFld-ContribAuthor ">Claudiu T.  Supuran</span>, <span class="hlFld-ContribAuthor ">Sandro  Cosconati</span>, <span class="hlFld-ContribAuthor ">Sabrina  Taliani</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition studies on carbonic anhydrase isoforms I, II, IV and IX with N-arylsubstituted secondary sulfonamides featuring a bicyclic tetrahydroindazole scaffold. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>220 </em>, 113490. <a href="https://doi.org/10.1016/j.ejmech.2021.113490" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113490</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113490&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113490%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DInhibition%252Bstudies%252Bon%252Bcarbonic%252Banhydrase%252Bisoforms%252BI%25252C%252BII%25252C%252BIV%252Band%252BIX%252Bwith%252BN-arylsubstituted%252Bsecondary%252Bsulfonamides%252Bfeaturing%252Ba%252Bbicyclic%252Btetrahydroindazole%252Bscaffold%26aulast%3DSalerno%26aufirst%3DSilvia%26date%3D2021%26volume%3D220%26spage%3D113490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zuo-Peng  Zhang</span>, <span class="hlFld-ContribAuthor ">Ye  Zhong</span>, <span class="hlFld-ContribAuthor ">Zhen-Bin  Han</span>, <span class="hlFld-ContribAuthor ">Lin  Zhou</span>, <span class="hlFld-ContribAuthor ">Hua-Sheng  Su</span>, <span class="hlFld-ContribAuthor ">Jian  Wang</span>, <span class="hlFld-ContribAuthor ">Yang  Liu</span>, <span class="hlFld-ContribAuthor ">Mao-Sheng  Cheng</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, Molecular Docking Analysis and Biological Evaluations of Saccharide-Modified Thiadiazole Sulfonamide Derivatives. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (11)
                                     , 5482. <a href="https://doi.org/10.3390/ijms22115482" title="DOI URL">https://doi.org/10.3390/ijms22115482</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22115482&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22115482%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DSynthesis%25252C%252BMolecular%252BDocking%252BAnalysis%252Band%252BBiological%252BEvaluations%252Bof%252BSaccharide-Modified%252BThiadiazole%252BSulfonamide%252BDerivatives%26aulast%3DZhang%26aufirst%3DZuo-Peng%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D11%26spage%3D5482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Claudiu T.  Supuran</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging role of carbonic anhydrase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Clinical Science</span><span> <strong>2021,</strong> <em>135 </em>
                                    (10)
                                     , 1233-1249. <a href="https://doi.org/10.1042/CS20210040" title="DOI URL">https://doi.org/10.1042/CS20210040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1042/CS20210040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1042%2FCS20210040%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Science%26atitle%3DEmerging%252Brole%252Bof%252Bcarbonic%252Banhydrase%252Binhibitors%26aulast%3DSupuran%26aufirst%3DClaudiu%25C2%25A0T.%26date%3D2021%26date%3D2021%26volume%3D135%26issue%3D10%26spage%3D1233%26epage%3D1249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alberto  Galisteo</span>, <span class="hlFld-ContribAuthor ">Fatin  Jannus</span>, <span class="hlFld-ContribAuthor ">Amalia  García-García</span>, <span class="hlFld-ContribAuthor ">Houssam  Aheget</span>, <span class="hlFld-ContribAuthor ">Sara  Rojas</span>, <span class="hlFld-ContribAuthor ">José A.  Lupiañez</span>, <span class="hlFld-ContribAuthor ">Antonio  Rodríguez-Diéguez</span>, <span class="hlFld-ContribAuthor ">Fernando J.  Reyes-Zurita</span>, <span class="hlFld-ContribAuthor ">José F.  Quílez del Moral</span>. </span><span class="cited-content_cbyCitation_article-title">Diclofenac N-Derivatives as Therapeutic Agents with Anti-Inflammatory and Anti-Cancer Effect. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (10)
                                     , 5067. <a href="https://doi.org/10.3390/ijms22105067" title="DOI URL">https://doi.org/10.3390/ijms22105067</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22105067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22105067%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DDiclofenac%252BN-Derivatives%252Bas%252BTherapeutic%252BAgents%252Bwith%252BAnti-Inflammatory%252Band%252BAnti-Cancer%252BEffect%26aulast%3DGalisteo%26aufirst%3DAlberto%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D10%26spage%3D5067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Claudiu T.  Supuran</span>. </span><span class="cited-content_cbyCitation_article-title">A Story on Carbon Dioxide and Its Hydration. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 115-131. <a href="https://doi.org/10.1007/978-3-030-57456-7_6" title="DOI URL">https://doi.org/10.1007/978-3-030-57456-7_6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-57456-7_6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-57456-7_6%26sid%3Dliteratum%253Aachs%26atitle%3DA%252BStory%252Bon%252BCarbon%252BDioxide%252Band%252BIts%252BHydration%26aulast%3DSupuran%26aufirst%3DClaudiu%2BT.%26date%3D2021%26date%3D2021%26spage%3D115%26epage%3D131%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DNew%252BTrends%252Bin%252BMacromolecular%252Band%252BSupramolecular%252BChemistry%252Bfor%252BBiological%252BApplications%26aulast%3DJ.M.%2BAbadie%26aufirst%3DMarc%26date%3D2021%26volume%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chandra B.  Mishra</span>, <span class="hlFld-ContribAuthor ">Manisha  Tiwari</span>, <span class="hlFld-ContribAuthor ">Claudiu T.  Supuran</span>. </span><span class="cited-content_cbyCitation_article-title">Progress in the development of human carbonic anhydrase inhibitors and their pharmacological applications: Where are we today?. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2020,</strong> <em>40 </em>
                                    (6)
                                     , 2485-2565. <a href="https://doi.org/10.1002/med.21713" title="DOI URL">https://doi.org/10.1002/med.21713</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21713&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21713%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DProgress%252Bin%252Bthe%252Bdevelopment%252Bof%252Bhuman%252Bcarbonic%252Banhydrase%2525C2%2525A0inhibitors%252Band%252Btheir%252Bpharmacological%252Bapplications%25253A%252BWhere%252Bare%252Bwe%252Btoday%25253F%26aulast%3DMishra%26aufirst%3DChandra%2BB.%26date%3D2020%26date%3D2020%26volume%3D40%26issue%3D6%26spage%3D2485%26epage%3D2565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laura  Lucarini</span>, <span class="hlFld-ContribAuthor ">Mariaconcetta  Durante</span>, <span class="hlFld-ContribAuthor ">Silvia  Sgambellone</span>, <span class="hlFld-ContribAuthor ">Cecilia  Lanzi</span>, <span class="hlFld-ContribAuthor ">Elisabetta  Bigagli</span>, <span class="hlFld-ContribAuthor ">Ozlem  Akgul</span>, <span class="hlFld-ContribAuthor ">Emanuela  Masini</span>, <span class="hlFld-ContribAuthor ">Claudiu T.  Supuran</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Carta</span>. </span><span class="cited-content_cbyCitation_article-title">Effects of New NSAID-CAI Hybrid Compounds in Inflammation and Lung Fibrosis. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2020,</strong> <em>10 </em>
                                    (9)
                                     , 1307. <a href="https://doi.org/10.3390/biom10091307" title="DOI URL">https://doi.org/10.3390/biom10091307</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom10091307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom10091307%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DEffects%252Bof%252BNew%252BNSAID-CAI%252BHybrid%252BCompounds%252Bin%252BInflammation%252Band%252BLung%252BFibrosis%26aulast%3DLucarini%26aufirst%3DLaura%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D9%26spage%3D1307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cosmin I.  Ciotu</span>, <span class="hlFld-ContribAuthor ">Michael J. M.  Fischer</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Analgesics with Peripheral Targets. </span><span class="cited-content_cbyCitation_journal-name">Neurotherapeutics</span><span> <strong>2020,</strong> <em>17 </em>
                                    (3)
                                     , 784-825. <a href="https://doi.org/10.1007/s13311-020-00937-z" title="DOI URL">https://doi.org/10.1007/s13311-020-00937-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s13311-020-00937-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs13311-020-00937-z%26sid%3Dliteratum%253Aachs%26jtitle%3DNeurotherapeutics%26atitle%3DNovel%252BAnalgesics%252Bwith%252BPeripheral%252BTargets%26aulast%3DCiotu%26aufirst%3DCosmin%2BI.%26date%3D2020%26date%3D2020%26volume%3D17%26issue%3D3%26spage%3D784%26epage%3D825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Claudiu T.  Supuran</span>. </span><span class="cited-content_cbyCitation_article-title">Exploring the multiple binding modes of inhibitors to carbonic anhydrases for novel drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2020,</strong> <em>15 </em>
                                    (6)
                                     , 671-686. <a href="https://doi.org/10.1080/17460441.2020.1743676" title="DOI URL">https://doi.org/10.1080/17460441.2020.1743676</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2020.1743676&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2020.1743676%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DExploring%252Bthe%252Bmultiple%252Bbinding%252Bmodes%252Bof%252Binhibitors%252Bto%252Bcarbonic%252Banhydrases%252Bfor%252Bnovel%252Bdrug%252Bdiscovery%26aulast%3DSupuran%26aufirst%3DClaudiu%2BT.%26date%3D2020%26date%3D2020%26volume%3D15%26issue%3D6%26spage%3D671%26epage%3D686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Claudiu T.  Supuran</span>. </span><span class="cited-content_cbyCitation_article-title">An update on drug interaction considerations in the therapeutic use of carbonic anhydrase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Metabolism & Toxicology</span><span> <strong>2020,</strong> <em>16 </em>
                                    (4)
                                     , 297-307. <a href="https://doi.org/10.1080/17425255.2020.1743679" title="DOI URL">https://doi.org/10.1080/17425255.2020.1743679</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17425255.2020.1743679&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17425255.2020.1743679%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Metabolism%2520%2526%2520Toxicology%26atitle%3DAn%252Bupdate%252Bon%252Bdrug%252Binteraction%252Bconsiderations%252Bin%252Bthe%252Btherapeutic%252Buse%252Bof%252Bcarbonic%252Banhydrase%252Binhibitors%26aulast%3DSupuran%26aufirst%3DClaudiu%2BT.%26date%3D2020%26date%3D2020%26volume%3D16%26issue%3D4%26spage%3D297%26epage%3D307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Majid  Ali</span>, <span class="hlFld-ContribAuthor ">Murat  Bozdag</span>, <span class="hlFld-ContribAuthor ">Umar  Farooq</span>, <span class="hlFld-ContribAuthor ">Andrea  Angeli</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Carta</span>, <span class="hlFld-ContribAuthor ">Paola  Berto</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Zanotti</span>, <span class="hlFld-ContribAuthor ">Claudiu T.  Supuran</span>. </span><span class="cited-content_cbyCitation_article-title">Benzylaminoethyureido-Tailed Benzenesulfonamides: Design, Synthesis, Kinetic and X-ray Investigations on Human Carbonic Anhydrases. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (7)
                                     , 2560. <a href="https://doi.org/10.3390/ijms21072560" title="DOI URL">https://doi.org/10.3390/ijms21072560</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21072560&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21072560%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DBenzylaminoethyureido-Tailed%252BBenzenesulfonamides%25253A%252BDesign%25252C%252BSynthesis%25252C%252BKinetic%252Band%252BX-ray%252BInvestigations%252Bon%252BHuman%252BCarbonic%252BAnhydrases%26aulast%3DAli%26aufirst%3DMajid%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D7%26spage%3D2560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dildar  Khan</span>, <span class="hlFld-ContribAuthor ">Maimoona  Qindeel</span>, <span class="hlFld-ContribAuthor ">Naveed  Ahmed</span>, <span class="hlFld-ContribAuthor ">Ashraf U  Khan</span>, <span class="hlFld-ContribAuthor ">Salman  Khan</span>, <span class="hlFld-ContribAuthor ">Asim ur  Rehman</span>. </span><span class="cited-content_cbyCitation_article-title">Development of novel pH-sensitive nanoparticle-based transdermal patch for management of rheumatoid arthritis. </span><span class="cited-content_cbyCitation_journal-name">Nanomedicine</span><span> <strong>2020,</strong> <em>15 </em>
                                    (6)
                                     , 603-624. <a href="https://doi.org/10.2217/nnm-2019-0385" title="DOI URL">https://doi.org/10.2217/nnm-2019-0385</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2217/nnm-2019-0385&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2217%2Fnnm-2019-0385%26sid%3Dliteratum%253Aachs%26jtitle%3DNanomedicine%26atitle%3DDevelopment%252Bof%252Bnovel%252BpH-sensitive%252Bnanoparticle-based%252Btransdermal%252Bpatch%252Bfor%252Bmanagement%252Bof%252Brheumatoid%252Barthritis%26aulast%3DKhan%26aufirst%3DDildar%26date%3D2020%26volume%3D15%26issue%3D6%26spage%3D603%26epage%3D624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ashok  Aspatwar</span>, <span class="hlFld-ContribAuthor ">Emanuela  Berrino</span>, <span class="hlFld-ContribAuthor ">Silvia  Bua</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Carta</span>, <span class="hlFld-ContribAuthor ">Clemente  Capasso</span>, <span class="hlFld-ContribAuthor ">Seppo  Parkkila</span>, <span class="hlFld-ContribAuthor ">Claudiu T.  Supuran</span>. </span><span class="cited-content_cbyCitation_article-title">Toxicity evaluation of sulfamides and coumarins that efficiently inhibit human carbonic anhydrases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2020,</strong> <em>35 </em>
                                    (1)
                                     , 1765-1772. <a href="https://doi.org/10.1080/14756366.2020.1822829" title="DOI URL">https://doi.org/10.1080/14756366.2020.1822829</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2020.1822829&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2020.1822829%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DToxicity%252Bevaluation%252Bof%252Bsulfamides%252Band%252Bcoumarins%252Bthat%252Befficiently%252Binhibit%252Bhuman%252Bcarbonic%252Banhydrases%26aulast%3DAspatwar%26aufirst%3DAshok%26date%3D2020%26date%3D2020%26volume%3D35%26issue%3D1%26spage%3D1765%26epage%3D1772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alessio  Nocentini</span>, <span class="hlFld-ContribAuthor ">Claudiu T.  Supuran</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in the structural annotation of human carbonic anhydrases and impact on future drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2019,</strong> <em>14 </em>
                                    (11)
                                     , 1175-1197. <a href="https://doi.org/10.1080/17460441.2019.1651289" title="DOI URL">https://doi.org/10.1080/17460441.2019.1651289</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2019.1651289&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2019.1651289%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DAdvances%252Bin%252Bthe%252Bstructural%252Bannotation%252Bof%252Bhuman%252Bcarbonic%252Banhydrases%252Band%252Bimpact%252Bon%252Bfuture%252Bdrug%252Bdiscovery%26aulast%3DNocentini%26aufirst%3DAlessio%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D11%26spage%3D1175%26epage%3D1197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shiyang  Zhou</span>, <span class="hlFld-ContribAuthor ">Huiying  Zou</span>, <span class="hlFld-ContribAuthor ">Guangying  Chen</span>, <span class="hlFld-ContribAuthor ">Gangliang  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Activities of Chemical Drugs for the Treatment of Rheumatoid Arthritis. </span><span class="cited-content_cbyCitation_journal-name">Topics in Current Chemistry</span><span> <strong>2019,</strong> <em>377 </em>
                                    (5)
                                     <a href="https://doi.org/10.1007/s41061-019-0252-5" title="DOI URL">https://doi.org/10.1007/s41061-019-0252-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s41061-019-0252-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs41061-019-0252-5%26sid%3Dliteratum%253Aachs%26jtitle%3DTopics%2520in%2520Current%2520Chemistry%26atitle%3DSynthesis%252Band%252BBiological%252BActivities%252Bof%252BChemical%252BDrugs%252Bfor%252Bthe%252BTreatment%252Bof%252BRheumatoid%252BArthritis%26aulast%3DZhou%26aufirst%3DShiyang%26date%3D2019%26date%3D2019%26volume%3D377%26issue%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ghulam  Mustafa</span>, <span class="hlFld-ContribAuthor ">Andrea  Angeli</span>, <span class="hlFld-ContribAuthor ">Muhammad  Zia-ur-Rehman</span>, <span class="hlFld-ContribAuthor ">Nosheen  Akbar</span>, <span class="hlFld-ContribAuthor ">Saiqa  Ishtiaq</span>, <span class="hlFld-ContribAuthor ">Claudiu T.  Supuran</span>. </span><span class="cited-content_cbyCitation_article-title">An efficient method for the synthesis of novel derivatives 4-{5-[4-(4-amino-5-mercapto-4H-[1,2,4]triazol-3-yl)-phenyl]-3-trifluoromethyl-pyrazol-1-yl}-benzenesulfonamide and their anti-inflammatory potential. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>91 </em>, 103110. <a href="https://doi.org/10.1016/j.bioorg.2019.103110" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.103110</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.103110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.103110%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DAn%252Befficient%252Bmethod%252Bfor%252Bthe%252Bsynthesis%252Bof%252Bnovel%252Bderivatives%252B4-%25257B5-%25255B4-%2525284-amino-5-mercapto-4H-%25255B1%25252C2%25252C4%25255Dtriazol-3-yl%252529-phenyl%25255D-3-trifluoromethyl-pyrazol-1-yl%25257D-benzenesulfonamide%252Band%252Btheir%252Banti-inflammatory%252Bpotential%26aulast%3DMustafa%26aufirst%3DGhulam%26date%3D2019%26volume%3D91%26spage%3D103110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Richa  Mishra</span>, <span class="hlFld-ContribAuthor ">Soumendra  Rana</span>. </span><span class="cited-content_cbyCitation_article-title">A rational search for discovering potential neutraligands of human complement fragment 5a (hC5a). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (19)
                                     , 115052. <a href="https://doi.org/10.1016/j.bmc.2019.115052" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.115052</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.115052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.115052%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DA%252Brational%252Bsearch%252Bfor%252Bdiscovering%252Bpotential%252Bneutraligands%252Bof%252Bhuman%252Bcomplement%252Bfragment%252B5a%252B%252528hC5a%252529%26aulast%3DMishra%26aufirst%3DRicha%26date%3D2019%26volume%3D27%26issue%3D19%26spage%3D115052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Micheli</span>, <span class="hlFld-ContribAuthor ">Bozdag</span>, <span class="hlFld-ContribAuthor ">Akgul</span>, <span class="hlFld-ContribAuthor ">Carta</span>, <span class="hlFld-ContribAuthor ">Guccione</span>, <span class="hlFld-ContribAuthor ">Bergonzi</span>, <span class="hlFld-ContribAuthor ">Bilia</span>, <span class="hlFld-ContribAuthor ">Cinci</span>, <span class="hlFld-ContribAuthor ">Lucarini</span>, <span class="hlFld-ContribAuthor ">Parisio</span>, <span class="hlFld-ContribAuthor ">Supuran</span>, <span class="hlFld-ContribAuthor ">Ghelardini</span>, <span class="hlFld-ContribAuthor ">Di Cesare Mannelli</span>. </span><span class="cited-content_cbyCitation_article-title">Pain Relieving Effect of-NSAIDs-CAIs Hybrid Molecules: Systemic and Intra-Articular Treatments against Rheumatoid Arthritis. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2019,</strong> <em>20 </em>
                                    (8)
                                     , 1923. <a href="https://doi.org/10.3390/ijms20081923" title="DOI URL">https://doi.org/10.3390/ijms20081923</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms20081923&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms20081923%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DPain%252BRelieving%252BEffect%252Bof-NSAIDs-CAIs%252BHybrid%252BMolecules%25253A%252BSystemic%252Band%252BIntra-Articular%252BTreatments%252Bagainst%252BRheumatoid%252BArthritis%26aulast%3DMicheli%26date%3D2019%26date%3D2019%26volume%3D20%26issue%3D8%26spage%3D1923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Asmaa  Sakr</span>, <span class="hlFld-ContribAuthor ">Hend  Kothayer</span>, <span class="hlFld-ContribAuthor ">Samy M.  Ibrahim</span>, <span class="hlFld-ContribAuthor ">Mohamed M.  Baraka</span>, <span class="hlFld-ContribAuthor ">Samar  Rezq</span>. </span><span class="cited-content_cbyCitation_article-title">1,4-Dihydroquinazolin-3(2H)-yl benzamide derivatives as anti-inflammatory and analgesic agents with an improved gastric profile: Design, synthesis, COX-1/2 inhibitory activity and molecular docking study. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>84 </em>, 76-86. <a href="https://doi.org/10.1016/j.bioorg.2018.11.030" title="DOI URL">https://doi.org/10.1016/j.bioorg.2018.11.030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2018.11.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2018.11.030%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3D1%25252C4-Dihydroquinazolin-3%2525282H%252529-yl%252Bbenzamide%252Bderivatives%252Bas%252Banti-inflammatory%252Band%252Banalgesic%252Bagents%252Bwith%252Ban%252Bimproved%252Bgastric%252Bprofile%25253A%252BDesign%25252C%252Bsynthesis%25252C%252BCOX-1%25252F2%252Binhibitory%252Bactivity%252Band%252Bmolecular%252Bdocking%252Bstudy%26aulast%3DSakr%26aufirst%3DAsmaa%26date%3D2019%26volume%3D84%26spage%3D76%26epage%3D86" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peteris  Trapencieris</span>, <span class="hlFld-ContribAuthor ">Anete  Parkova</span>, <span class="hlFld-ContribAuthor ">Ineta  Vendina-Birzniece</span>. </span><span class="cited-content_cbyCitation_article-title">Carbonic Anhydrase Inhibitors with Dual Targeting. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 163-178. <a href="https://doi.org/10.1007/978-3-030-12780-0_12" title="DOI URL">https://doi.org/10.1007/978-3-030-12780-0_12</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-12780-0_12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-12780-0_12%26sid%3Dliteratum%253Aachs%26atitle%3DCarbonic%252BAnhydrase%252BInhibitors%252Bwith%252BDual%252BTargeting%26aulast%3DTrapencieris%26aufirst%3DPeteris%26date%3D2019%26date%3D2019%26spage%3D163%26epage%3D178%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DCarbonic%252BAnhydrase%252Bas%252BDrug%252BTarget%26aulast%3DMatulis%26aufirst%3DDaumantas%26date%3D2019%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alessio  Nocentini</span>, <span class="hlFld-ContribAuthor ">Claudiu T.  Supuran</span>. </span><span class="cited-content_cbyCitation_article-title">Carbonic anhydrase inhibitors for the treatment of neuropathic pain and arthritis. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 367-386. <a href="https://doi.org/10.1016/B978-0-12-816476-1.00017-4" title="DOI URL">https://doi.org/10.1016/B978-0-12-816476-1.00017-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-816476-1.00017-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-816476-1.00017-4%26sid%3Dliteratum%253Aachs%26atitle%3DCarbonic%252Banhydrase%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252Bneuropathic%252Bpain%252Band%252Barthritis%26aulast%3DNocentini%26aufirst%3DAlessio%26date%3D2019%26spage%3D367%26epage%3D386%26pub%3DElsevier%26atitle%3DCarbonic%252BAnhydrases%26date%3D2019%26volume%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alessio  Nocentini</span>, <span class="hlFld-ContribAuthor ">Claudiu T.  Supuran</span>. </span><span class="cited-content_cbyCitation_article-title">Carbonic anhydrase inhibitors as antitumor/antimetastatic agents: a patent review (2008–2018). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2018,</strong> <em>28 </em>
                                    (10)
                                     , 729-740. <a href="https://doi.org/10.1080/13543776.2018.1508453" title="DOI URL">https://doi.org/10.1080/13543776.2018.1508453</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2018.1508453&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2018.1508453%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DCarbonic%252Banhydrase%252Binhibitors%252Bas%252Bantitumor%25252Fantimetastatic%252Bagents%25253A%252Ba%252Bpatent%252Breview%252B%2525282008%2525E2%252580%2525932018%252529%26aulast%3DNocentini%26aufirst%3DAlessio%26date%3D2018%26date%3D2018%26volume%3D28%26issue%3D10%26spage%3D729%26epage%3D740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00420/20180608/images/medium/jm-2018-004205_0006.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00420/20180608/images/large/jm-2018-004205_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00420&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00420/20180608/images/medium/jm-2018-004205_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00420/20180608/images/large/jm-2018-004205_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Design of the NSAID-CAI hybrids.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00420/20180608/images/large/jm-2018-004205_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00420&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00420/20180608/images/medium/jm-2018-004205_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00420/20180608/images/large/jm-2018-004205_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthetic Procedure for the Synthesis of NSAID-CAIs</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00420/20180608/images/large/jm-2018-004205_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00420&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00420/20180608/images/medium/jm-2018-004205_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00420/20180608/images/large/jm-2018-004205_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Procedure for the Synthesis of <b>C, D</b>, and <b>E</b> Intermediates<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00420/20180608/images/large/jm-2018-004205_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00420&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00420/20180608/images/medium/jm-2018-004205_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00420/20180608/images/large/jm-2018-004205_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Acute pain reliever effect of <b>2B</b>, <b>3B</b>, <b>6B</b>, and <b>8B</b> in a CFA i.a. injection-induced RA model in rats. The Paw pressure test was used to assess the hypersensitivity toward noxious mechanical stimuli. NSAIDs (naproxen, ketoprofen, sulindac, and diclofenac) contained in the different hybrids were used as references tested at a dosage equimolar to 10 mg/kg of the corresponding NSAID–CAI. The measurements were accomplished on day 14 after CFA injection. The hybrids were suspended in 1% carboxymethyl cellulose (CMC) and administered orally. The values reported are the mean of 8 rats performed in 2 distinct experiments. ^^<i>P</i> < 0.01 vs vehicle + vehicle treated animals. *<i>P</i> < 0.05 and **<i>P</i> < 0.01 vs time 0 min of the same group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00420/20180608/images/large/jm-2018-004205_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00420&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00420/20180608/images/medium/jm-2018-004205_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00420/20180608/images/large/jm-2018-004205_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Acute pain reliever effect of <b>2B</b>, <b>3B</b>, <b>6B</b>, and <b>8B</b> in a CFA i.a. injection-induced RA model in rats. The incapacitance test was performed in order to assess the hind limb weight bearing alterations, which were measured as postural imbalance related to pain stimuli. The data values are the mathematical difference between the weight applied on the contralateral and ipsilateral limb (Δweight). NSAIDs (naproxen, ketoprofen, sulindac, and diclofenac) contained in the different hybrids were used as references tested at a dosage equimolar to 10.0 mg/kg<sup>–1</sup> of the corresponding NSAID–CAI. The measurements were done 14 days after CFA injection. All hybrids were suspended in 1% CMC and administered orally. The values are the mean of 8 rats and obtained in 2 different experiments. ^^<i>P</i> < 0.01 vs vehicle + vehicle treated animals. *<i>P</i> < 0.05 and **<i>P</i> < 0.01 vs time 0 min of the same group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00420/20180608/images/large/jm-2018-004205_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00420&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i68">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42248" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42248" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 31 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bua, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Cesare Mannelli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vullo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghelardini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartolucci, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scozzafava, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supuran, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carta, F.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of novel Nonsteroidal Anti-Inflammatory Drugs and Carbonic Anhydrase Inhibitors hybrids (NSAIDs-CAIs) for the treatment of rheumatoid arthritis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1159</span>– <span class="NLM_lpage">1170</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01607</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01607" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A528%3ADC%252BC2sXptlWnsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1159-1170&author=S.+Buaauthor=L.+Di+Cesare+Mannelliauthor=D.+Vulloauthor=C.+Ghelardiniauthor=G.+Bartolucciauthor=A.+Scozzafavaauthor=C.+T.+Supuranauthor=F.+Carta&title=Design+and+synthesis+of+novel+Nonsteroidal+Anti-Inflammatory+Drugs+and+Carbonic+Anhydrase+Inhibitors+hybrids+%28NSAIDs-CAIs%29+for+the+treatment+of+rheumatoid+arthritis&doi=10.1021%2Facs.jmedchem.6b01607"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Novel Nonsteroidal Anti-Inflammatory Drugs and Carbonic Anhydrase Inhibitors Hybrids (NSAIDs-CAIs) for the Treatment of Rheumatoid Arthritis</span></div><div class="casAuthors">Bua, Silvia; Di Cesare Mannelli, Lorenzo; Vullo, Daniela; Ghelardini, Carla; Bartolucci, Gianluca; Scozzafava, Andrea; Supuran, Claudiu T.; Carta, Fabrizio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1159-1170</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors report the synthesis of a series of hybrid compds. incorporating 6- and 7-substituted coumarins (carbonic anhydrase, CA inhibitors) derivatized with clin. used NSAIDs (indomethacin, sulindac, ketoprofen, ibuprofen, diclofenac, ketorolac, etc., cyclooxygenase inhibitors) as agents for the management of rheumatoid arthritis (RA).  Most compds. were effective in inhibiting the RA overexpressed hCA IX and XII, with KI values in the low nanomolar-subnanomolar ranges.  The antihyperalgesic activity of such compds. was assessed by means of the paw-pressure and incapacitance tests using an in vivo RA model.  Among all tested compds., the 7-coumarin hybrid with ibuprofen showed potent and persistent antihyperalgesic effect up to 60 min after administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-g5uSZwfOBrVg90H21EOLACvtfcHk0ljDy39ci9L2fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXptlWnsQ%253D%253D&md5=ee11328363ef5ae81ed20a8a751b172d</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01607%26sid%3Dliteratum%253Aachs%26aulast%3DBua%26aufirst%3DS.%26aulast%3DDi%2BCesare%2BMannelli%26aufirst%3DL.%26aulast%3DVullo%26aufirst%3DD.%26aulast%3DGhelardini%26aufirst%3DC.%26aulast%3DBartolucci%26aufirst%3DG.%26aulast%3DScozzafava%26aufirst%3DA.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26aulast%3DCarta%26aufirst%3DF.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520novel%2520Nonsteroidal%2520Anti-Inflammatory%2520Drugs%2520and%2520Carbonic%2520Anhydrase%2520Inhibitors%2520hybrids%2520%2528NSAIDs-CAIs%2529%2520for%2520the%2520treatment%2520of%2520rheumatoid%2520arthritis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D1159%26epage%3D1170%26doi%3D10.1021%2Facs.jmedchem.6b01607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, Y.</span></span> <span> </span><span class="NLM_article-title">Increased expression of carbonic anhydrase I in the synovium of patients with ankylosing spondylitis</span>. <i>BMC Musculoskeletal Disord.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">279</span>– <span class="NLM_lpage">290</span>, <span class="refDoi"> DOI: 10.1186/1471-2474-11-279</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.1186%2F1471-2474-11-279" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=21143847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFylsrjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=279-290&author=X.+Changauthor=J.+Hanauthor=Y.+Zhaoauthor=X.+Yanauthor=S.+Sunauthor=Y.+Cui&title=Increased+expression+of+carbonic+anhydrase+I+in+the+synovium+of+patients+with+ankylosing+spondylitis&doi=10.1186%2F1471-2474-11-279"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Increased expression of carbonic anhydrase I in the synovium of patients with ankylosing spondylitis</span></div><div class="casAuthors">Chang, Xiaotian; Han, Jinxiang; Zhao, Yan; Yan, Xinfeng; Shun, Shui; Cui, Yazhou</div><div class="citationInfo"><span class="NLM_cas:title">BMC Musculoskeletal Disorders</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">279</span>CODEN:
                <span class="NLM_cas:coden">BMDMCE</span>;
        ISSN:<span class="NLM_cas:issn">1471-2474</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: One of the most distinctive features of ankylosing spondylitis (AS) is new bone formation and bone resorption at sites of chronic inflammation.  Previous studies have indicated that the hyperplasia and inflammation of synovial tissues are significantly related to the pathogenic process of AS.  The present study used a proteomic approach to identify novel AS-specific proteins by simultaneously comparing the expression profiles of synovial membranes from patients with AS, rheumatoid arthritis (RA) and osteoarthritis (OA).  Methods: Synovial tissues were collected from the hip joints of patients with AS and knee joints of patients with RA or OA (n = 10 for each disease) during joint replacement surgery.  Proteins extd. from the synovial tissues were sepd. by 2-D electrophoresis (2-DE), and the proteins with significantly increased expression in the AS samples were subjected to MALDI-TOF/TOF-MS anal.  The results were verified using western blotting and immunohistochem.  Levels of the candidate proteins in synovial fluids from knee joints (n = 40 for each disease) were measured using ELISA.  Results: The proteomic approach revealed significantly increased expression of carbonic anhydrase I (CA1) in the synovial membrane of patients with AS as compared with the RA and OA tissue samples.  Immunohistochem. and western blotting anal. confirmed the findings described above.  The ELISA detected a higher level of CA1 in synovial fluids from patients with AS than those with OA.  The mean value of the CA1 level was also higher in AS patients as compared with RA patients.  This study also detected increased expression of alpha-1-antitrypsin in the synovial tissues from AS patients, which is in agreement with other reports.  Conclusion: In vitro expts. by other groups indicated that CA1 catalyzes the generation of HCO3- through the hydration of CO2, which then combines with Ca2+ to form a CaCO3 ppt.  Calcification is an essential step of bone formation.  Substantial evidence indicates that carbonic anhydrase also stimulates bone resorption.  Hence, overexpression of CA1 in the synovial tissues of AS patients may promote improper calcification and bone resorption in AS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCHbyoabCvlrVg90H21EOLACvtfcHk0ljDy39ci9L2fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFylsrjK&md5=3fe0aded3642803229d61d98ea2471d0</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1186%2F1471-2474-11-279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2474-11-279%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DX.%26aulast%3DHan%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DYan%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DS.%26aulast%3DCui%26aufirst%3DY.%26atitle%3DIncreased%2520expression%2520of%2520carbonic%2520anhydrase%2520I%2520in%2520the%2520synovium%2520of%2520patients%2520with%2520ankylosing%2520spondylitis%26jtitle%3DBMC%2520Musculoskeletal%2520Disord.%26date%3D2010%26volume%3D11%26spage%3D279%26epage%3D290%26doi%3D10.1186%2F1471-2474-11-279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, X.</span></span> <span> </span><span class="NLM_article-title">Transgenic mice over-expressing carbonic anhydrase I showed aggravated joint inflammation and tissue destruction</span>. <i>BMC Musculoskeletal Disord.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">256</span>– <span class="NLM_lpage">265</span>, <span class="refDoi"> DOI: 10.1186/1471-2474-13-256</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.1186%2F1471-2474-13-256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=23256642" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A528%3ADC%252BC3sXns1Oqtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=256-265&author=Y.+Zhengauthor=L.+Wangauthor=W.+Zhangauthor=H.+Xuauthor=X.+Chang&title=Transgenic+mice+over-expressing+carbonic+anhydrase+I+showed+aggravated+joint+inflammation+and+tissue+destruction&doi=10.1186%2F1471-2474-13-256"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Transgenic mice over-expressing carbonic anhydrase I showed aggravated joint inflammation and tissue destruction</span></div><div class="casAuthors">Zheng, Yabing; Wang, Lin; Zhang, Wei; Xu, Hengwei; Chang, Xiaotian</div><div class="citationInfo"><span class="NLM_cas:title">BMC Musculoskeletal Disorders</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">256</span>CODEN:
                <span class="NLM_cas:coden">BMDMCE</span>;
        ISSN:<span class="NLM_cas:issn">1471-2474</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Studies have demonstrated that carbonic anhydrase I (CA1) stimulates calcium salt pptn. and cell calcification, which is an essential step in new bone formation.  Our study had reported that CA1 encoding gene has a strong assocn. with rheumatoid arthritis (RA) and ankylosing spondylitis (AS), two rheumatic diseases with abnormal new bone formation and bone resorption in joints.  This study investigated the effect of CA1 on joint inflammation and tissue destruction in transgenic mice that over-express CA1 (CA1-Tg).  Methods: CA1-Tg was generated with C57BL/6J mice by conventional methods.  CA1-Tg was treated with collagen-II to induce arthritis (CIA).  Wild-type mice, CA1-Tg treated with bovine serum albumin (BSA) and transgenic mice over-expressing PADI4 (PADI4-Tg), a gene known to be involved in rheumatoid arthritis, were used as controls.  Histochem. and X-ray radiog. assay were used to examine joint destruction.  Western blotting and real time-PCR were used to examine CA1 expression.  Results: CIA was obsd. in 60% of CA1-Tg, 20% of PADI4-Tg and 20% of wild-type mice after collagen injections.  No CIA was found in CA1-Tg mice that received injections of BSA.  The arthritic score was 5.5 ± 0.84 in the CA1-Tgs but the score was less than 2 in the injected wild-type mice and the PADI4-Tgs.  The thickness of the hind paws in the CA1-Tgs was 3.46 ± 0.11 mm, which was thicker than that of PADI4-Tgs (2.23 ± 0.08 mm), wild-type mice (2.08 ± 0.06 mm) and BSA-treated CA1-Tgs (2.04 ± 0.07 mm).  Histochem. showed obvious inflammation, synovial hyperplasia and bone destruction in the joints of CA1-Tg that was not detected in PADI4-Tgs or wild-type mice.  X-ray assays showed bone fusion in the paws and spines of CA1-Tg mice.  Conclusion: Over-expression of CA1 may aggravate joint inflammation and tissue destruction in the transgenic mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBgR7O5Re0G7Vg90H21EOLACvtfcHk0ljUbsyT4xHoRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXns1Oqtrw%253D&md5=ccd41a8452b65cf7e8d510302ca8f44d</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1186%2F1471-2474-13-256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2474-13-256%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DChang%26aufirst%3DX.%26atitle%3DTransgenic%2520mice%2520over-expressing%2520carbonic%2520anhydrase%2520I%2520showed%2520aggravated%2520joint%2520inflammation%2520and%2520tissue%2520destruction%26jtitle%3DBMC%2520Musculoskeletal%2520Disord.%26date%3D2012%26volume%3D13%26spage%3D256%26epage%3D265%26doi%3D10.1186%2F1471-2474-13-256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deutsch, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krief, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konttinen, Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaks, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aframian, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmon, A.</span></span> <span> </span><span class="NLM_article-title">Identification of Sjögren’s syndrome oral fluid biomarker candidates following high-abundance protein depletion</span>. <i>Rheumatology</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">884</span>– <span class="NLM_lpage">890</span>, <span class="refDoi"> DOI: 10.1093/rheumatology/keu405</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.1093%2Frheumatology%2Fkeu405" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2015&pages=884-890&author=O.+Deutschauthor=G.+Kriefauthor=Y.+T.+Konttinenauthor=B.+Zaksauthor=D.+T.+Wongauthor=D.+J.+Aframianauthor=A.+Palmon&title=Identification+of+Sj%C3%B6gren%E2%80%99s+syndrome+oral+fluid+biomarker+candidates+following+high-abundance+protein+depletion&doi=10.1093%2Frheumatology%2Fkeu405"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1093%2Frheumatology%2Fkeu405&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Frheumatology%252Fkeu405%26sid%3Dliteratum%253Aachs%26aulast%3DDeutsch%26aufirst%3DO.%26aulast%3DKrief%26aufirst%3DG.%26aulast%3DKonttinen%26aufirst%3DY.%2BT.%26aulast%3DZaks%26aufirst%3DB.%26aulast%3DWong%26aufirst%3DD.%2BT.%26aulast%3DAframian%26aufirst%3DD.%2BJ.%26aulast%3DPalmon%26aufirst%3DA.%26atitle%3DIdentification%2520of%2520Sj%25C3%25B6gren%25E2%2580%2599s%2520syndrome%2520oral%2520fluid%2520biomarker%2520candidates%2520following%2520high-abundance%2520protein%2520depletion%26jtitle%3DRheumatology%26date%3D2015%26volume%3D54%26spage%3D884%26epage%3D890%26doi%3D10.1093%2Frheumatology%2Fkeu405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span> <span> </span><span class="NLM_article-title">Carbonic anhydrases III and IV autoantibodies in rheumatoid arthritis, systemic lupus erythematosus, diabetes, hypertensive renal disease, and heart failure</span>. <i>Clin. Dev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>2012</i></span>,  <span class="NLM_fpage">354594</span>, <span class="refDoi"> DOI: 10.1155/2012/354594</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.1155%2F2012%2F354594" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=23049597" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A280%3ADC%252BC3s%252FjslSksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2012&publication_year=2012&pages=354594&author=C.+Liuauthor=Y.+Weiauthor=J.+Wangauthor=L.+Piauthor=J.+Huangauthor=P.+Wang&title=Carbonic+anhydrases+III+and+IV+autoantibodies+in+rheumatoid+arthritis%2C+systemic+lupus+erythematosus%2C+diabetes%2C+hypertensive+renal+disease%2C+and+heart+failure&doi=10.1155%2F2012%2F354594"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Carbonic anhydrases III and IV autoantibodies in rheumatoid arthritis, systemic lupus erythematosus, diabetes, hypertensive renal disease, and heart failure</span></div><div class="casAuthors">Liu Chengeng; Wei Yue; Wang Jianmin; Pi Langan; Huang Jianjun; Wang Peichang</div><div class="citationInfo"><span class="NLM_cas:title">Clinical & developmental immunology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2012</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">354594</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">In the present study, the CA III and IV autoantibodies, CA activity, antioxidant enzymes and cytokines in rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), diabetes, hypertensive renal disease, and heart failure were investigated.  The anti-CA III antibody titers in patients with RA, SLE, and type 1 diabetes (T1D) were significantly higher than that in control groups (P < 0.05).  The anti-CA IV antibody titers in patients with RA, SLE, type 1 diabetic nephropathy (T1DN), and heart failure were significantly higher than that in control groups (P < 0.05) while anti-CA IV antibody could suppress the total CA activity.  The SOD and GPx levels in patients with RA, SLE, and T1DN were significantly lower than that in control groups (P < 0.05).  IL-6, IL-17, IFN-γ, and TNF-α levels were significantly higher in SLE group compared with the control group (P < 0.05).  Weak but significant correlations were found between anti-CA III antibodies and ESR in RA (r = 0.403, P = 0.013) and SLE patients (r = 0.397, P = 0.007).  These results suggested that the generation of CA III and IV autoantibodies, antioxidant enzymes, and cytokines might influence each other and CA autoantibodies might affect the normal physiology function of CA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTMwJt9ij_06p6KlWarZTAzfW6udTcc2eaalt33vkpgo7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s%252FjslSksQ%253D%253D&md5=7b1a21e831746b620169ecc4b4b16211</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1155%2F2012%2F354594&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2012%252F354594%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DWei%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DPi%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DP.%26atitle%3DCarbonic%2520anhydrases%2520III%2520and%2520IV%2520autoantibodies%2520in%2520rheumatoid%2520arthritis%252C%2520systemic%2520lupus%2520erythematosus%252C%2520diabetes%252C%2520hypertensive%2520renal%2520disease%252C%2520and%2520heart%2520failure%26jtitle%3DClin.%2520Dev.%2520Immunol.%26date%3D2012%26volume%3D2012%26spage%3D354594%26doi%3D10.1155%2F2012%2F354594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Margheri, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ceruso, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carta, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laurenzana, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maggi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazzeri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simonini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Annunziato, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Rosso, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supuran, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cimaz, R.</span></span> <span> </span><span class="NLM_article-title">Overexpression of the transmembrane carbonic anhydrase isoforms IX and XII in the inflamed synovium</span>. <i>J. Enzyme Inhib. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">60</span>– <span class="NLM_lpage">63</span>, <span class="refDoi"> DOI: 10.1080/14756366.2016.1217857</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.1080%2F14756366.2016.1217857" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=27539792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlOmt7%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2016&pages=60-63&author=F.+Margheriauthor=M.+Cerusoauthor=F.+Cartaauthor=A.+Laurenzanaauthor=L.+Maggiauthor=S.+Lazzeriauthor=G.+Simoniniauthor=F.+Annunziatoauthor=M.+Del+Rossoauthor=C.+T.+Supuranauthor=R.+Cimaz&title=Overexpression+of+the+transmembrane+carbonic+anhydrase+isoforms+IX+and+XII+in+the+inflamed+synovium&doi=10.1080%2F14756366.2016.1217857"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of the transmembrane carbonic anhydrase isoforms IX and XII in the inflamed synovium</span></div><div class="casAuthors">Margheri, Francesca; Ceruso, Mariangela; Carta, Fabrizio; Laurenzana, Anna; Maggi, Laura; Lazzeri, Simone; Simonini, Gabriele; Annunziato, Francesco; Del Rosso, Mario; Supuran, Claudiu T.; Cimaz, Rolando</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">sup4</span>),
    <span class="NLM_cas:pages">60-63</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Juvenile idiopathic arthritis (JIA) is the most common form of chronic rheumatic disease affecting children worldwide, with some features similar to adult rheumatoid arthritis (RA).  In the present study, we aim at investigating novel markers that will allow in the future for tailored, more personalized treatment strategies.  Hence, taking notice of several reports proving the role of local acidosis as a causal link between inflammatory diseases and related pain, and the involvement of several carbonic anhydrases (CA, EC 4.2.1.1) isoforms in articular diseases, we evaluated in JIA patients the expression of these metalloenzymes.  We identified that JIA patients show high levels of active CA IX and XII isoforms.  Our results represent the first evidence of the identification of these enzymes as potential therapeutic targets and development of novel innovative therapies for arthritis, also considering that the two isoforms are validated antitumor targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4HZAqJSLZZLVg90H21EOLACvtfcHk0liqLbMpdGb8pA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlOmt7%252FI&md5=780b2ae6f9d02050c0c167e8cec91c8c</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1080%2F14756366.2016.1217857&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14756366.2016.1217857%26sid%3Dliteratum%253Aachs%26aulast%3DMargheri%26aufirst%3DF.%26aulast%3DCeruso%26aufirst%3DM.%26aulast%3DCarta%26aufirst%3DF.%26aulast%3DLaurenzana%26aufirst%3DA.%26aulast%3DMaggi%26aufirst%3DL.%26aulast%3DLazzeri%26aufirst%3DS.%26aulast%3DSimonini%26aufirst%3DG.%26aulast%3DAnnunziato%26aufirst%3DF.%26aulast%3DDel%2BRosso%26aufirst%3DM.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26aulast%3DCimaz%26aufirst%3DR.%26atitle%3DOverexpression%2520of%2520the%2520transmembrane%2520carbonic%2520anhydrase%2520isoforms%2520IX%2520and%2520XII%2520in%2520the%2520inflamed%2520synovium%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2016%26volume%3D31%26spage%3D60%26epage%3D63%26doi%3D10.1080%2F14756366.2016.1217857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Supuran, C. T.</span></span> <span> </span><span class="NLM_article-title">Carbonic anhydrases: novel therapeutic applications for inhibitors and activators</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">168</span>– <span class="NLM_lpage">181</span>, <span class="refDoi"> DOI: 10.1038/nrd2467</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.1038%2Fnrd2467" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=18167490" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhs1Khsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=168-181&author=C.+T.+Supuran&title=Carbonic+anhydrases%3A+novel+therapeutic+applications+for+inhibitors+and+activators&doi=10.1038%2Fnrd2467"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">Carbonic anhydrases: novel therapeutic applications for inhibitors and activators</span></div><div class="casAuthors">Supuran, Claudiu T.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">168-181</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Carbonic anhydrases (CAs), a group of ubiquitously expressed metalloenzymes, are involved in numerous physiol. and pathol. processes, including gluconeogenesis, lipogenesis, ureagenesis, tumorigenicity and the growth and virulence of various pathogens.  In addn. to the established role of CA inhibitors (CAIs) as diuretics and antiglaucoma drugs, it has recently emerged that CAIs could have potential as novel antiobesity, anticancer and anti-infective drugs.  Furthermore, recent studies suggest that CA activation may provide a novel therapy for Alzheimer's disease.  This article discusses the biol. rationale for the novel uses of inhibitors or activators of CA activity in multiple diseases, and highlights progress in the development of specific modulators of the relevant CA isoforms, some of which are now being evaluated in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8lavoPtcpPrVg90H21EOLACvtfcHk0liqLbMpdGb8pA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhs1Khsr0%253D&md5=f00fe348bbcf38048727c1283496cdfa</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1038%2Fnrd2467&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2467%26sid%3Dliteratum%253Aachs%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DCarbonic%2520anhydrases%253A%2520novel%2520therapeutic%2520applications%2520for%2520inhibitors%2520and%2520activators%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2008%26volume%3D7%26spage%3D168%26epage%3D181%26doi%3D10.1038%2Fnrd2467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Tanc, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carta, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scozzafava, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supuran, C. T.</span></span> <span> </span><span class="NLM_article-title">α-Carbonic anhydrases possess thioesterase activity</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">292</span>– <span class="NLM_lpage">295</span>, <span class="refDoi"> DOI: 10.1021/ml500470b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500470b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=292-295&author=M.+Tancauthor=F.+Cartaauthor=A.+Scozzafavaauthor=C.+T.+Supuran&title=%CE%B1-Carbonic+anhydrases+possess+thioesterase+activity&doi=10.1021%2Fml500470b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1021%2Fml500470b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500470b%26sid%3Dliteratum%253Aachs%26aulast%3DTanc%26aufirst%3DM.%26aulast%3DCarta%26aufirst%3DF.%26aulast%3DScozzafava%26aufirst%3DA.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3D%25CE%25B1-Carbonic%2520anhydrases%2520possess%2520thioesterase%2520activity%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D292%26epage%3D295%26doi%3D10.1021%2Fml500470b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit7c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Supuran, C. T.</span></span> <span> </span><span class="NLM_article-title">How many carbonic anhydrase inhibition mechanisms exist?</span>. <i>J. Enzyme Inhib. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">345</span>– <span class="NLM_lpage">360</span>, <span class="refDoi"> DOI: 10.3109/14756366.2015.1122001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.3109%2F14756366.2015.1122001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=26619898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFGms7bE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2016&pages=345-360&author=C.+T.+Supuran&title=How+many+carbonic+anhydrase+inhibition+mechanisms+exist%3F&doi=10.3109%2F14756366.2015.1122001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7cR"><div class="casContent"><span class="casTitleNuber">7c</span><div class="casTitle"><span class="NLM_cas:atitle">How many carbonic anhydrase inhibition mechanisms exist?</span></div><div class="casAuthors">Supuran, Claudiu T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">345-360</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  Six genetic families of the enzyme carbonic anhydrase (CA, EC 4.2.1.1) were described to date.  Inhibition of CAs has pharmacol. applications in the field of antiglaucoma, anticonvulsant, anticancer, and anti-infective agents.  New classes of CA inhibitors (CAIs) were described in the last decade with enzyme inhibition mechanisms differing considerably from the classical inhibitors of the sulfonamide or anion type.  Five different CA inhibition mechanisms are known: (i) the zinc binders coordinate to the catalytically crucial Zn(II) ion from the enzyme active site, with the metal in tetrahedral or trigonal bipyramidal geometries.  Sulfonamides and their isosters, most anions, dithiocarbamates and their isosters, carboxylates, and hydroxamates bind in this way; (ii) inhibitors that anchor to the zinc-coordinated water mol./hydroxide ion (phenols, carboxylates, polyamines, 2-thioxocoumarins, sulfocoumarins); (iii) inhibitors which occlude the entrance to the active site cavity (coumarins and their isosters), this binding site coinciding with that where CA activators bind; (iv) compds. which bind out of the active site cavity (a carboxylic acid deriv. was seen to inhibit CA in this manner), and (v) compds. for which the inhibition mechanism is not known, among which the secondary/tertiary sulfonamides as well as imatinib/nilotinib are the most investigated examples.  As CAIs are used clin. in many pathologies, with a sulfonamide inhibitor (SLC-0111) in Phase I clin. trials for the management of metastatic solid tumors, this review updates the recent findings in the field which may be useful for a structure-based drug design approach of more selective/potent modulators of the activity of these enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrh8n13uOvB17Vg90H21EOLACvtfcHk0liqLbMpdGb8pA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFGms7bE&md5=3f7f8071c39c4fbf59a8b71205ae973d</span></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=10.3109%2F14756366.2015.1122001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F14756366.2015.1122001%26sid%3Dliteratum%253Aachs%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DHow%2520many%2520carbonic%2520anhydrase%2520inhibition%2520mechanisms%2520exist%253F%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2016%26volume%3D31%26spage%3D345%26epage%3D360%26doi%3D10.3109%2F14756366.2015.1122001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit7d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Carta, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vullo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maresca, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scozzafava, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supuran, C. T.</span></span> <span> </span><span class="NLM_article-title">New chemotypes acting as isozyme-selective carbonic anhydrase inhibitors with low affinity for the offtarget cytosolic isoform II</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">2182</span>– <span class="NLM_lpage">2185</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.01.129</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.1016%2Fj.bmcl.2012.01.129" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2182-2185&author=F.+Cartaauthor=D.+Vulloauthor=A.+Marescaauthor=A.+Scozzafavaauthor=C.+T.+Supuran&title=New+chemotypes+acting+as+isozyme-selective+carbonic+anhydrase+inhibitors+with+low+affinity+for+the+offtarget+cytosolic+isoform+II&doi=10.1016%2Fj.bmcl.2012.01.129"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7d&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.01.129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.01.129%26sid%3Dliteratum%253Aachs%26aulast%3DCarta%26aufirst%3DF.%26aulast%3DVullo%26aufirst%3DD.%26aulast%3DMaresca%26aufirst%3DA.%26aulast%3DScozzafava%26aufirst%3DA.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DNew%2520chemotypes%2520acting%2520as%2520isozyme-selective%2520carbonic%2520anhydrase%2520inhibitors%2520with%2520low%2520affinity%2520for%2520the%2520offtarget%2520cytosolic%2520isoform%2520II%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2182%26epage%3D2185%26doi%3D10.1016%2Fj.bmcl.2012.01.129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit7e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Scozzafava, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supuran, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carta, F.</span></span> <span> </span><span class="NLM_article-title">Antiobesity carbonic anhydrase inhibitors: a literature and patent review</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">725</span>– <span class="NLM_lpage">735</span>, <span class="refDoi"> DOI: 10.1517/13543776.2013.790957</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.1517%2F13543776.2013.790957" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=23607332" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnsl2qtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=725-735&author=A.+Scozzafavaauthor=C.+T.+Supuranauthor=F.+Carta&title=Antiobesity+carbonic+anhydrase+inhibitors%3A+a+literature+and+patent+review&doi=10.1517%2F13543776.2013.790957"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7eR"><div class="casContent"><span class="casTitleNuber">7e</span><div class="casTitle"><span class="NLM_cas:atitle">Antiobesity carbonic anhydrase inhibitors: a literature and patent review</span></div><div class="casAuthors">Scozzafava, Andrea; Supuran, Claudiu T.; Carta, Fabrizio</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">725-735</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Obesity is ranked as one of the top 10 global health problems and the major concern deriving from it is the exposure of the population to a vast array of chronic pathologies such as cardiovascular and musculoskeletal disorders, type 2 diabetes, cancer, such as colon, breast and endometrial cancer, together with psychol. disorders derived from this condition.  The discovery that the clin. used anticonvulsants topiramate (TPM) and zonisamide (ZNS) induced wt. loss in obese, epileptic patients, afforded the validation of the mitochondrial carbonic anhydrases (CAs, EC 4.2.1.1) VA and VB as targets for the development of antiobesity drugs.Areas covered: This review deals with the scientific and patent literature regarding obesity or obesity-related pathologies, being particularly focused on the use of carbonic anhydrase inhibitors (CAI) such as TPM and ZNS which inhibit the de novo lipogenesis. Expert opinion: There is an urgent need of new drugs for the treatment of obesity.  The identification that the mitochondrial CAs are implicated in the de novo lipogenesis allowed to consider selective inhibitors of such enzymes as useful for the development of new antiobesity drugs.  Actually TPM was approved 1 yr ago for this therapy, whereas ZNS is also an effective such agent.  These compds. are the lead mols. in this field and an intense research is on the way in order to develop new compds. based on the selective inhibition of mitochondrial CA isoforms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpV5LUSX76OrVg90H21EOLACvtfcHk0lh1oIgboo0mww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnsl2qtL4%253D&md5=52482234cea242b5564460a01575053f</span></div><a href="/servlet/linkout?suffix=cit7e&amp;dbid=16384&amp;doi=10.1517%2F13543776.2013.790957&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2013.790957%26sid%3Dliteratum%253Aachs%26aulast%3DScozzafava%26aufirst%3DA.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26aulast%3DCarta%26aufirst%3DF.%26atitle%3DAntiobesity%2520carbonic%2520anhydrase%2520inhibitors%253A%2520a%2520literature%2520and%2520patent%2520review%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2013%26volume%3D23%26spage%3D725%26epage%3D735%26doi%3D10.1517%2F13543776.2013.790957" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit7f"><span><span class="NLM_label">(f) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Alterio, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Fiore, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Ambrosio, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supuran, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Simone, G.</span></span> <span> </span><span class="NLM_article-title">Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">4421</span>– <span class="NLM_lpage">4468</span>, <span class="refDoi"> DOI: 10.1021/cr200176r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr200176r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A528%3ADC%252BC38Xnt1Wrsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2012&pages=4421-4468&author=V.+Alterioauthor=A.+Di+Fioreauthor=K.+D%E2%80%99Ambrosioauthor=C.+T.+Supuranauthor=G.+De+Simone&title=Multiple+binding+modes+of+inhibitors+to+carbonic+anhydrases%3A+how+to+design+specific+drugs+targeting+15+different+isoforms%3F&doi=10.1021%2Fcr200176r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7fR"><div class="casContent"><span class="casTitleNuber">7f</span><div class="casTitle"><span class="NLM_cas:atitle">Multiple Binding Modes of Inhibitors to Carbonic Anhydrases: How to Design Specific Drugs Targeting 15 Different Isoforms?</span></div><div class="casAuthors">Alterio, Vincenzo; Di Fiore, Anna; D'Ambrosio, Katia; Supuran, Claudiu T.; De Simone, Giuseppina</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4421-4468</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The aim of this review is to provide an exhaustive description of the structural studies on α-CAs (carbonic anhydrases) so far reported.  In particular, the main structural features of the catalytically active α-CA isoenzymes characterized to date will be described and the current state of the art on complexes of hCA II with the principal classes of inhibitors will be summarized.  A comparison with the corresponding adducts of other isoforms, when available, will be also performed, in order to find for each isoform the key residues responsible for enzyme/inhibitor interaction.  Finally, recent advances in the field of drug design of selective CAIs will be illustrated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA0GdtMHwlZ7Vg90H21EOLACvtfcHk0lh1oIgboo0mww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xnt1Wrsbg%253D&md5=eb45ffb5efe07980f1388d99bf51406a</span></div><a href="/servlet/linkout?suffix=cit7f&amp;dbid=16384&amp;doi=10.1021%2Fcr200176r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr200176r%26sid%3Dliteratum%253Aachs%26aulast%3DAlterio%26aufirst%3DV.%26aulast%3DDi%2BFiore%26aufirst%3DA.%26aulast%3DD%25E2%2580%2599Ambrosio%26aufirst%3DK.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26aulast%3DDe%2BSimone%26aufirst%3DG.%26atitle%3DMultiple%2520binding%2520modes%2520of%2520inhibitors%2520to%2520carbonic%2520anhydrases%253A%2520how%2520to%2520design%2520specific%2520drugs%2520targeting%252015%2520different%2520isoforms%253F%26jtitle%3DChem.%2520Rev.%26date%3D2012%26volume%3D112%26spage%3D4421%26epage%3D4468%26doi%3D10.1021%2Fcr200176r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit7g"><span><span class="NLM_label">(g) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Supuran, C.
T.</span></span> <span> </span><span class="NLM_article-title">Structure-based drug discovery of carbonic anhydrase inhibitors</span>. <i>J. Enzyme Inhib. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">759</span>– <span class="NLM_lpage">772</span>, <span class="refDoi"> DOI: 10.3109/14756366.2012.672983</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7g&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.3109%2F14756366.2012.672983" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7g&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=22468747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7g&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslCgtL7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2012&pages=759-772&author=C.%0AT.+Supuran&title=Structure-based+drug+discovery+of+carbonic+anhydrase+inhibitors&doi=10.3109%2F14756366.2012.672983"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7gR"><div class="casContent"><span class="casTitleNuber">7g</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based drug discovery of carbonic anhydrase inhibitors</span></div><div class="casAuthors">Supuran, Claudiu T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">759-772</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Inhibition of the metalloenzyme carbonic anhydrase (CA; EC 4.2.1.1) has pharmacol. applications in the field of anti-glaucoma, anti-convulsant and anti-cancer agents.  But recently, it has also emerged that these enzymes have the potential for designing anti-infective drugs (anti-fungal and anti-bacterial agents) with a novel mechanism of action.  Sulfonamides and their isosteres (sulfamates/sulfamides) constitute the main class of CA inhibitors (CAIs), which bind to the metal ion from the enzyme active site.  Recently, the dithiocarbamates (DTCs), possessing a similar mechanism of action, were reported as a new class of inhibitors.  These types of CAIs will be discussed in detail in this review.  Novel drug design strategies have been reported ultimately based on the tail approach for obtaining sulfonamides/DTCs, which exploit more external binding regions within the enzyme active site (in addn. to coordination to the metal ion), leading thus to isoform-selective compds.  Most of the promising data have been obtained by combining x-ray crystallog. of enzyme-inhibitor adducts with novel synthetic approaches for generating chem. diversity.  Whereas sulfonamide - NO donating hybrid drugs were reported as effective anti-glaucoma agents, most of the interesting new inhibitors were designed for inhibiting specifically the tumor-assocd. isoforms CA IX and XII, validated targets for imaging and treatment of hypoxic tumors.  Promising compds. that inhibit CAs from bacterial and fungal pathogens, of the DTC and carboxylate types, will be also reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsmAtcxdWfHbVg90H21EOLACvtfcHk0lguttBMxQ2PYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslCgtL7N&md5=55a993be904b13c63eb52b9d0229e187</span></div><a href="/servlet/linkout?suffix=cit7g&amp;dbid=16384&amp;doi=10.3109%2F14756366.2012.672983&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F14756366.2012.672983%26sid%3Dliteratum%253Aachs%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DStructure-based%2520drug%2520discovery%2520of%2520carbonic%2520anhydrase%2520inhibitors%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2012%26volume%3D27%26spage%3D759%26epage%3D772%26doi%3D10.3109%2F14756366.2012.672983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Farr, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garvey, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bold, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kendall, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bacon, P. A.</span></span> <span> </span><span class="NLM_article-title">Significance of the hydrogen ion concentration in synovial fluid in rheumatoid arthritis</span>. <i>Clin. Exp. Rheumatol.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">99</span>– <span class="NLM_lpage">104</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=4017318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A280%3ADyaL2M3lsFOgsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1985&pages=99-104&author=M.+Farrauthor=K.+Garveyauthor=A.+M.+Boldauthor=M.+J.+Kendallauthor=P.+A.+Bacon&title=Significance+of+the+hydrogen+ion+concentration+in+synovial+fluid+in+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Significance of the hydrogen ion concentration in synovial fluid in rheumatoid arthritis</span></div><div class="casAuthors">Farr M; Garvey K; Bold A M; Kendall M J; Bacon P A</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and experimental rheumatology</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">99-104</span>
        ISSN:<span class="NLM_cas:issn">0392-856X</span>.
    </div><div class="casAbstract">The hydrogen ion (H+) concentration and pCO2 were measured in the synovial fluid (SF) from the knee joints of 130 patients with arthritis by an acid-base analyser (ABL2 Acid-Base Laboratory), using a simple technique which prevented contact with air.  H+ concentration was significantly higher in SF from 60 RA patients (mean 64.4 n mol/l; range 38-142 n mol/l) compared with patients with OA (mean 44 n mol/l; range 29-56 n mol/l), and 40 with other arthritides (mean 52 n mol/l).  The H+ concentration in the SF showed a significant association with other variables of local inflammation-platelet, total leucocyte and polymorph counts, 5-nucleotidase, acid phosphatase and IgA levels in the SF and the clinical knee score, but not with the volume of the effusion.  A similar relationship between these variables of inflammatory activity and SF pCO2 was also established.  A higher SF H+ concentration was also found in systemically active disease, but no difference in SF pH between seropositive and seronegative patients.  Whilst the pH of SF approximated to that of the blood in OA, it was significantly lower in the SF in RA.  SF pH is a useful marker of local inflammatory activity, and its measurement is simple, reliable and rapid.  It is relevant because changes in pH influence many of the processes involved in inflammation and the pH difference between SF and blood influences the transfer of drugs into the joint.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQWQDsjjJW6DkQ0lWbKiCflfW6udTcc2ea2T-pmbypz3Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2M3lsFOgsQ%253D%253D&md5=85e9c6f8a2d7772871e0368759fcadb5</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFarr%26aufirst%3DM.%26aulast%3DGarvey%26aufirst%3DK.%26aulast%3DBold%26aufirst%3DA.%2BM.%26aulast%3DKendall%26aufirst%3DM.%2BJ.%26aulast%3DBacon%26aufirst%3DP.%2BA.%26atitle%3DSignificance%2520of%2520the%2520hydrogen%2520ion%2520concentration%2520in%2520synovial%2520fluid%2520in%2520rheumatoid%2520arthritis%26jtitle%3DClin.%2520Exp.%2520Rheumatol.%26date%3D1985%26volume%3D3%26spage%3D99%26epage%3D104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Steen, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steen, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reeh, P. W.</span></span> <span> </span><span class="NLM_article-title">A dominant role of acid pH in inflammatory excitation and sensitization of nociceptors in rat skin, in vitro</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">3982</span>– <span class="NLM_lpage">3989</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.15-05-03982.1995</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.1523%2FJNEUROSCI.15-05-03982.1995" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=7751959" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A528%3ADyaK2MXls1aisbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1995&pages=3982-3989&author=K.+H.+Steenauthor=A.+E.+Steenauthor=P.+W.+Reeh&title=A+dominant+role+of+acid+pH+in+inflammatory+excitation+and+sensitization+of+nociceptors+in+rat+skin%2C+in+vitro&doi=10.1523%2FJNEUROSCI.15-05-03982.1995"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">A dominant role of acid pH in inflammatory excitation and sensitization of nociceptors in rat skin, in vitro</span></div><div class="casAuthors">Steen, Kay H.; Steen, Astrid E.; Reeh, Peter W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">5, Pt. 2</span>),
    <span class="NLM_cas:pages">3982-9</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">A major role of local acidosis in long lasting excitation and sensitization of cutaneous nociceptors has recently been demonstrated.  In inflamed tissue, acid pH meets with a mixt. of inflammatory mediators which, by themselves, stimulate nociceptors though being subject to profound tachyphylaxis.  We have mimicked this condition in a rat skin-saphenous nerve prepn. in vitro which allows direct application of chems. to the isolated receptive fields at the corium side.  Stimulant solns. used were CO2-satd. "synthetic interstitial fluid" (CO2-SIF, pH 6.1), an "inflammatory soup" (IS) in submaximal concn. contg. bradykinin, 5-HT, histamine, prostaglandin E2 (all 10-6M in SIF at 38.5° and pH 7.0), and a combination made of CO2-satd. IS (CO2-IS, pH 6.1).  Identified mechano-heat sensitive ("polymodal") C-fiber terminals (n = 36) were treated with these solns. for 5 min at 10 min intervals or for 30 min of sustained stimulation: 20 units responded to CO2-SIF, 12 to IS, whereas 27 units (75%) were excited by CO2-IS.  Thus, 6 out of 15 units insensitive to either of the two basic solns. were stimulated by their combination.  This enhanced effect of CO2-IS was also expressed in shorter latencies (than with CO2-SIF) and in a significantly larger mean response magnitude of the fiber population: 152 spikes with the combination vs. 45 spikes evoked by IS and 93 spikes by CO2-SIF (n = 25; p < 0.002 and < 0.02, resp., Wilcoxon test).  The synergistic interaction between CO2 and IS also showed up during sustained nociceptor stimulation (30 min) by either CO2SIF (n = 7) or IS (n = 1) when, during the middle 10 min, CO2-IS was applied which significantly increased the discharge.  There is a strong, potentially algogenic, interaction between acid pH and inflammatory mediators in terms of prevalence and magnitude of nociceptor excitation.  At equal and pathophysiol. relevant concn., however, hydrogen ions play a dominant role.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8eLXfegRJPLVg90H21EOLACvtfcHk0liuzoAQW8Zw7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXls1aisbs%253D&md5=35d850f5272831214c9af2aa43859320</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.15-05-03982.1995&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.15-05-03982.1995%26sid%3Dliteratum%253Aachs%26aulast%3DSteen%26aufirst%3DK.%2BH.%26aulast%3DSteen%26aufirst%3DA.%2BE.%26aulast%3DReeh%26aufirst%3DP.%2BW.%26atitle%3DA%2520dominant%2520role%2520of%2520acid%2520pH%2520in%2520inflammatory%2520excitation%2520and%2520sensitization%2520of%2520nociceptors%2520in%2520rat%2520skin%252C%2520in%2520vitro%26jtitle%3DJ.%2520Neurosci.%26date%3D1995%26volume%3D15%26spage%3D3982%26epage%3D3989%26doi%3D10.1523%2FJNEUROSCI.15-05-03982.1995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lardner, A.</span></span> <span> </span><span class="NLM_article-title">The effects of extracellular pH on immune function</span>. <i>J. Leukoc. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">522</span>– <span class="NLM_lpage">530</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=11310837" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A528%3ADC%252BD3MXivVagurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2001&pages=522-530&author=A.+Lardner&title=The+effects+of+extracellular+pH+on+immune+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The effects of extracellular pH on immune function</span></div><div class="casAuthors">Lardner, Anne</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Leukocyte Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">522-530</span>CODEN:
                <span class="NLM_cas:coden">JLBIE7</span>;
        ISSN:<span class="NLM_cas:issn">0741-5400</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">A review with 80 refs.  The effect of alterations in extracellular pH on cellular and humoral immune function is reviewed.  Because acidic pH predominates at inflammatory loci and other sites of immune activity, most studies to date focus on the effect of acidic rather than alk. pH.  Investigations on polymorphonuclear leukocytes demonstrate mainly inhibition of chemotaxis, respiratory activity, and bactericidal capacity at reduced pH.  Evidence of impaired lymphocyte cytotoxicity and proliferation at acidic pH is also beginning to emerge.  Many of the clin. acidosis are accompanied similarly by immunodeficiency.  Studies on macrophages and eosinophils are few and inconclusive.  A small no. of studies demonstrate acid-induced activation of complement proteins and the alternative complement pathway, plus increased antibody-binding to leukocytes at lowered pH.  A differential effect of acidic pH on humoral and cellular immunity may, therefore, exist.  Increasing recognition of the significance of extracellular pH in relation to immune function warrants further studies in this presently incomplete but rewarding field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqi8Hr7d3nZXbVg90H21EOLACvtfcHk0liuzoAQW8Zw7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXivVagurs%253D&md5=86f05548986270622e403e359f0f2422</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLardner%26aufirst%3DA.%26atitle%3DThe%2520effects%2520of%2520extracellular%2520pH%2520on%2520immune%2520function%26jtitle%3DJ.%2520Leukoc.%2520Biol.%26date%3D2001%26volume%3D69%26spage%3D522%26epage%3D530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Singh, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saag, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bridges, S. L.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akl, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bannuru, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaysbrot, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNaughton, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shmerling, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtis, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furst, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parks, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kavanaugh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Dell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leong, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matteson, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schousboe, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drevlow, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ginsberg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grober, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">St. Clair, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tindall, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McAlindon, T.</span></span> <span> </span><span class="NLM_article-title">2015 American college of rheumatology guideline for the treatment of rheumatoid arthritis</span>. <i>Arthritis Rheumatol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">26</span>, <span class="refDoi"> DOI: 10.1002/art.39480</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.1002%2Fart.39480" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=26545940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A280%3ADC%252BC28zpvVGnsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2016&pages=1-26&author=J.+A.+Singhauthor=K.+G.+Saagauthor=S.+L.+Bridgesauthor=E.+A.+Aklauthor=R.+R.+Bannuruauthor=M.+C.+Sullivanauthor=E.+Vaysbrotauthor=C.+McNaughtonauthor=M.+Osaniauthor=R.+H.+Shmerlingauthor=J.+R.+Curtisauthor=D.+E.+Furstauthor=D.+Parksauthor=A.+Kavanaughauthor=J.+O%E2%80%99Dellauthor=C.+Kingauthor=A.+Leongauthor=E.+L.+Mattesonauthor=J.+T.+Schousboeauthor=B.+Drevlowauthor=S.+Ginsbergauthor=J.+Groberauthor=E.+W.+St.+Clairauthor=E.+Tindallauthor=A.+S.+Millerauthor=T.+McAlindon&title=2015+American+college+of+rheumatology+guideline+for+the+treatment+of+rheumatoid+arthritis&doi=10.1002%2Fart.39480"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis</span></div><div class="casAuthors">Singh Jasvinder A; Saag Kenneth G; Bridges S Louis Jr; Curtis Jeffrey R; Akl Elie A; Bannuru Raveendhara R; Sullivan Matthew C; Vaysbrot Elizaveta; McNaughton Christine; Osani Mikala; McAlindon Timothy; Shmerling Robert H; Furst Daniel E; Parks Deborah; Kavanaugh Arthur; O'Dell James; King Charles; Leong Amye; Matteson Eric L; Schousboe John T; Drevlow Barbara; Grober James; Ginsberg Seth; St Clair E William; Tindall Elizabeth; Miller Amy S</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & rheumatology (Hoboken, N.J.)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-26</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  To develop a new evidence-based, pharmacologic treatment guideline for rheumatoid arthritis (RA).  METHODS:  We conducted systematic reviews to synthesize the evidence for the benefits and harms of various treatment options.  We used the Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology to rate the quality of evidence.  We employed a group consensus process to grade the strength of recommendations (either strong or conditional).  A strong recommendation indicates that clinicians are certain that the benefits of an intervention far outweigh the harms (or vice versa).  A conditional recommendation denotes uncertainty over the balance of benefits and harms and/or more significant variability in patient values and preferences.  RESULTS:  The guideline covers the use of traditional disease-modifying antirheumatic drugs (DMARDs), biologic agents, tofacitinib, and glucocorticoids in early (<6 months) and established (≥6 months) RA.  In addition, it provides recommendations on using a treat-to-target approach, tapering and discontinuing medications, and the use of biologic agents and DMARDs in patients with hepatitis, congestive heart failure, malignancy, and serious infections.  The guideline addresses the use of vaccines in patients starting/receiving DMARDs or biologic agents, screening for tuberculosis in patients starting/receiving biologic agents or tofacitinib, and laboratory monitoring for traditional DMARDs.  The guideline includes 74 recommendations: 23% are strong and 77% are conditional.  CONCLUSION:  This RA guideline should serve as a tool for clinicians and patients (our two target audiences) for pharmacologic treatment decisions in commonly encountered clinical situations.  These recommendations are not prescriptive, and the treatment decisions should be made by physicians and patients through a shared decision-making process taking into account patients' values, preferences, and comorbidities.  These recommendations should not be used to limit or deny access to therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTI9Xng6yKjfjEC-75aqa5AfW6udTcc2eauRYVwSa29j7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28zpvVGnsA%253D%253D&md5=b00a30744da179f257667fdb7f40ed2f</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1002%2Fart.39480&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.39480%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DJ.%2BA.%26aulast%3DSaag%26aufirst%3DK.%2BG.%26aulast%3DBridges%26aufirst%3DS.%2BL.%26aulast%3DAkl%26aufirst%3DE.%2BA.%26aulast%3DBannuru%26aufirst%3DR.%2BR.%26aulast%3DSullivan%26aufirst%3DM.%2BC.%26aulast%3DVaysbrot%26aufirst%3DE.%26aulast%3DMcNaughton%26aufirst%3DC.%26aulast%3DOsani%26aufirst%3DM.%26aulast%3DShmerling%26aufirst%3DR.%2BH.%26aulast%3DCurtis%26aufirst%3DJ.%2BR.%26aulast%3DFurst%26aufirst%3DD.%2BE.%26aulast%3DParks%26aufirst%3DD.%26aulast%3DKavanaugh%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Dell%26aufirst%3DJ.%26aulast%3DKing%26aufirst%3DC.%26aulast%3DLeong%26aufirst%3DA.%26aulast%3DMatteson%26aufirst%3DE.%2BL.%26aulast%3DSchousboe%26aufirst%3DJ.%2BT.%26aulast%3DDrevlow%26aufirst%3DB.%26aulast%3DGinsberg%26aufirst%3DS.%26aulast%3DGrober%26aufirst%3DJ.%26aulast%3DSt.%2BClair%26aufirst%3DE.%2BW.%26aulast%3DTindall%26aufirst%3DE.%26aulast%3DMiller%26aufirst%3DA.%2BS.%26aulast%3DMcAlindon%26aufirst%3DT.%26atitle%3D2015%2520American%2520college%2520of%2520rheumatology%2520guideline%2520for%2520the%2520treatment%2520of%2520rheumatoid%2520arthritis%26jtitle%3DArthritis%2520Rheumatol.%26date%3D2016%26volume%3D68%26spage%3D1%26epage%3D26%26doi%3D10.1002%2Fart.39480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Agca, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heslinga, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rollefstad, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heslinga, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McInnes, I. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kvien, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dougados, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atzeni, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Primdahl, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Södergren, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallberg Jonsson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Rompay, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zabalan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedersen, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobsson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Vlam, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez-Gay, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Semb, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitas, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smulders, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szekanecz, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sattar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Symmons, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nurmohamed, M. T.</span></span> <span> </span><span class="NLM_article-title">EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update</span>. <i>Ann. Rheum. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">17</span>– <span class="NLM_lpage">28</span>, <span class="refDoi"> DOI: 10.1136/annrheumdis-2016-209775</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.1136%2Fannrheumdis-2016-209775" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=27697765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A280%3ADC%252BC2svlslWjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2017&pages=17-28&author=R.+Agcaauthor=S.+C.+Heslingaauthor=S.+Rollefstadauthor=M.+Heslingaauthor=I.+B.+McInnesauthor=M.+J.+Petersauthor=T.+K.+Kvienauthor=M.+Dougadosauthor=H.+Radnerauthor=F.+Atzeniauthor=J.+Primdahlauthor=A.+S%C3%B6dergrenauthor=S.+Wallberg+Jonssonauthor=J.+van+Rompayauthor=C.+Zabalanauthor=T.+R.+Pedersenauthor=L.+Jacobssonauthor=K.+de+Vlamauthor=M.+A.+Gonzalez-Gayauthor=A.+G.+Sembauthor=G.+D.+Kitasauthor=Y.+M.+Smuldersauthor=Z.+Szekaneczauthor=N.+Sattarauthor=D.+P.+Symmonsauthor=M.+T.+Nurmohamed&title=EULAR+recommendations+for+cardiovascular+disease+risk+management+in+patients+with+rheumatoid+arthritis+and+other+forms+of+inflammatory+joint+disorders%3A+2015%2F2016+update&doi=10.1136%2Fannrheumdis-2016-209775"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update</span></div><div class="casAuthors">Agca R; Heslinga S C; Heslinga M; Rollefstad S; Semb A G; McInnes I B; Peters M J L; Smulders Y M; Kvien T K; Dougados M; Radner H; Atzeni F; Primdahl J; Primdahl J; Primdahl J; Sodergren A; Wallberg Jonsson S; van Rompay J; Zabalan C; Pedersen T R; Jacobsson L; Jacobsson L; de Vlam K; Gonzalez-Gay M A; Kitas G D; Szekanecz Z; Sattar N; Symmons D P M; Nurmohamed M T</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the rheumatic diseases</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17-28</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Patients with rheumatoid arthritis (RA) and other inflammatory joint disorders (IJD) have increased cardiovascular disease (CVD) risk compared with the general population.  In 2009, the European League Against Rheumatism (EULAR) taskforce recommended screening, identification of CVD risk factors and CVD risk management largely based on expert opinion.  In view of substantial new evidence, an update was conducted with the aim of producing CVD risk management recommendations for patients with IJD that now incorporates an increasing evidence base.  A multidisciplinary steering committee (representing 13 European countries) comprised 26 members including patient representatives, rheumatologists, cardiologists, internists, epidemiologists, a health professional and fellows.  Systematic literature searches were performed and evidence was categorised according to standard guidelines.  The evidence was discussed and summarised by the experts in the course of a consensus finding and voting process.  Three overarching principles were defined.  First, there is a higher risk for CVD in patients with RA, and this may also apply to ankylosing spondylitis and psoriatic arthritis.  Second, the rheumatologist is responsible for CVD risk management in patients with IJD.  Third, the use of non-steroidal anti-inflammatory drugs and corticosteroids should be in accordance with treatment-specific recommendations from EULAR and Assessment of Spondyloarthritis International Society.  Ten recommendations were defined, of which one is new and six were changed compared with the 2009 recommendations.  Each designated an appropriate evidence support level.  The present update extends on the evidence that CVD risk in the whole spectrum of IJD is increased.  This underscores the need for CVD risk management in these patients.  These recommendations are defined to provide assistance in CVD risk management in IJD, based on expert opinion and scientific evidence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQzCYVs9aAtomHOrQ6qeX-mfW6udTcc2eZujHr46KBnvLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2svlslWjtQ%253D%253D&md5=a0755bf22a92e5469f33f04a835d4474</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1136%2Fannrheumdis-2016-209775&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fannrheumdis-2016-209775%26sid%3Dliteratum%253Aachs%26aulast%3DAgca%26aufirst%3DR.%26aulast%3DHeslinga%26aufirst%3DS.%2BC.%26aulast%3DRollefstad%26aufirst%3DS.%26aulast%3DHeslinga%26aufirst%3DM.%26aulast%3DMcInnes%26aufirst%3DI.%2BB.%26aulast%3DPeters%26aufirst%3DM.%2BJ.%26aulast%3DKvien%26aufirst%3DT.%2BK.%26aulast%3DDougados%26aufirst%3DM.%26aulast%3DRadner%26aufirst%3DH.%26aulast%3DAtzeni%26aufirst%3DF.%26aulast%3DPrimdahl%26aufirst%3DJ.%26aulast%3DS%25C3%25B6dergren%26aufirst%3DA.%26aulast%3DWallberg%2BJonsson%26aufirst%3DS.%26aulast%3Dvan%2BRompay%26aufirst%3DJ.%26aulast%3DZabalan%26aufirst%3DC.%26aulast%3DPedersen%26aufirst%3DT.%2BR.%26aulast%3DJacobsson%26aufirst%3DL.%26aulast%3Dde%2BVlam%26aufirst%3DK.%26aulast%3DGonzalez-Gay%26aufirst%3DM.%2BA.%26aulast%3DSemb%26aufirst%3DA.%2BG.%26aulast%3DKitas%26aufirst%3DG.%2BD.%26aulast%3DSmulders%26aufirst%3DY.%2BM.%26aulast%3DSzekanecz%26aufirst%3DZ.%26aulast%3DSattar%26aufirst%3DN.%26aulast%3DSymmons%26aufirst%3DD.%2BP.%26aulast%3DNurmohamed%26aufirst%3DM.%2BT.%26atitle%3DEULAR%2520recommendations%2520for%2520cardiovascular%2520disease%2520risk%2520management%2520in%2520patients%2520with%2520rheumatoid%2520arthritis%2520and%2520other%2520forms%2520of%2520inflammatory%2520joint%2520disorders%253A%25202015%252F2016%2520update%26jtitle%3DAnn.%2520Rheum.%2520Dis.%26date%3D2017%26volume%3D76%26spage%3D17%26epage%3D28%26doi%3D10.1136%2Fannrheumdis-2016-209775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Agarwal, S.
K.</span></span> <span> </span><span class="NLM_article-title">Core management principles in rheumatoid arthritis to help guide managed care professionals</span>. <i>J. Manag. Care. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">S03</span>– <span class="NLM_lpage">S08</span>, <span class="refDoi"> DOI: 10.18553/jmcp.2011.17.s9-b.S03</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.18553%2Fjmcp.2011.17.s9-b.S03" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=22073933" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=S03-S08&author=S.%0AK.+Agarwal&title=Core+management+principles+in+rheumatoid+arthritis+to+help+guide+managed+care+professionals&doi=10.18553%2Fjmcp.2011.17.s9-b.S03"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.18553%2Fjmcp.2011.17.s9-b.S03&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18553%252Fjmcp.2011.17.s9-b.S03%26sid%3Dliteratum%253Aachs%26aulast%3DAgarwal%26aufirst%3DS.%2BK.%26atitle%3DCore%2520management%2520principles%2520in%2520rheumatoid%2520arthritis%2520to%2520help%2520guide%2520managed%2520care%2520professionals%26jtitle%3DJ.%2520Manag.%2520Care.%2520Pharm.%26date%3D2011%26volume%3D17%26spage%3DS03%26epage%3DS08%26doi%3D10.18553%2Fjmcp.2011.17.s9-b.S03" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit13b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kharlamova, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherina, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potempa, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Israelsson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quirke, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eriksson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yucel-Lindberg, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venables, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potempa, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alfredsson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lundberg, K.</span></span> <span> </span><span class="NLM_article-title">Antibodies to porphyromonas gingivalis indicate interaction between oral infection, smoking, and risk genes in rheumatoid arthritis etiology</span>. <i>Arthritis Rheumatol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">604</span>– <span class="NLM_lpage">613</span>, <span class="refDoi"> DOI: 10.1002/art.39491</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.1002%2Fart.39491" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=26554752" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A528%3ADC%252BC28XjsFejs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2016&pages=604-613&author=N.+Kharlamovaauthor=X.+Jiangauthor=N.+Sherinaauthor=B.+Potempaauthor=L.+Israelssonauthor=A.+M.+Quirkeauthor=K.+Erikssonauthor=T.+Yucel-Lindbergauthor=P.+J.+Venablesauthor=J.+Potempaauthor=L.+Alfredssonauthor=K.+Lundberg&title=Antibodies+to+porphyromonas+gingivalis+indicate+interaction+between+oral+infection%2C+smoking%2C+and+risk+genes+in+rheumatoid+arthritis+etiology&doi=10.1002%2Fart.39491"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13bR"><div class="casContent"><span class="casTitleNuber">13b</span><div class="casTitle"><span class="NLM_cas:atitle">Antibodies to Porphyromonas gingivalis Indicate Interaction Between Oral Infection, Smoking, and Risk Genes in Rheumatoid Arthritis Etiology</span></div><div class="casAuthors">Kharlamova, Nastya; Jiang, Xia; Sherina, Natalia; Potempa, Barbara; Israelsson, Lena; Quirke, Anne-Marie; Eriksson, Kaja; Yucel-Lindberg, Tuelay; Venables, Patrick J.; Potempa, Jan; Alfredsson, Lars; Lundberg, Karin</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">604-613</span>CODEN:
                <span class="NLM_cas:coden">ARRHBO</span>;
        ISSN:<span class="NLM_cas:issn">2326-5191</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective: To investigate the role of the periodontal pathogen Porphyromonas gingivalis in the etiol. of rheumatoid arthritis (RA) by analyzing the antibody response to the P gingivalis virulence factor arginine gingipain type B (RgpB) in relation to anti-citrullinated protein antibodies (ACPAs), smoking, and HLA-DRB1 shared epitope (SE) alleles in patients with periodontitis, patients with RA, and controls.  Methods: Anti-RgpB IgG was measured by ELISA in 65 periodontitis patients and 59 controls without periodontitis, and in 1,974 RA patients and 377 controls without RA from the Swedish population-based case-control Epidemiol. Investigation of Rheumatoid Arthritis (EIRA) study.  Autoantibody status, smoking habits, and genetic data were retrieved from the EIRA database.  Differences in antibody levels were examd. using the Mann-Whitney U test.  Unconditional logistic regression was used to calc. odds ratios (ORs) with 95% confidence intervals (95% CIs) for the assocn. of anti-RgpB IgG with different subsets of RA patients.  Results: Anti-RgpB antibody levels were significantly elevated in periodontitis patients compared to controls without periodontitis, in RA patients compared to controls without RA, and in ACPA-pos. RA patients compared to ACPA-neg. RA patients.  There was a significant assocn. between anti-RgpB IgG and RA (OR 2.96 [95% CI 2.00, 4.37]), which was even stronger than the assocn. between smoking and RA (OR 1.37 [95% CI 1.07, 1.74]), and in ACPA-pos. RA there were interactions between anti-RgpB antibodies and both smoking and the HLA-DRB1 SE.  Conclusion: Our study suggests that the previously reported link between periodontitis and RA could be accounted for by P gingivalis infection, and we conclude that P gingivalis is a credible candidate for triggering and/or driving autoimmunity and autoimmune disease in a subset of RA patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGZVz8WqP0kLVg90H21EOLACvtfcHk0liXb1k4FEff6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjsFejs7g%253D&md5=eb120132bcdd1e4feff9d2f70178d92c</span></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1002%2Fart.39491&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.39491%26sid%3Dliteratum%253Aachs%26aulast%3DKharlamova%26aufirst%3DN.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DSherina%26aufirst%3DN.%26aulast%3DPotempa%26aufirst%3DB.%26aulast%3DIsraelsson%26aufirst%3DL.%26aulast%3DQuirke%26aufirst%3DA.%2BM.%26aulast%3DEriksson%26aufirst%3DK.%26aulast%3DYucel-Lindberg%26aufirst%3DT.%26aulast%3DVenables%26aufirst%3DP.%2BJ.%26aulast%3DPotempa%26aufirst%3DJ.%26aulast%3DAlfredsson%26aufirst%3DL.%26aulast%3DLundberg%26aufirst%3DK.%26atitle%3DAntibodies%2520to%2520porphyromonas%2520gingivalis%2520indicate%2520interaction%2520between%2520oral%2520infection%252C%2520smoking%252C%2520and%2520risk%2520genes%2520in%2520rheumatoid%2520arthritis%2520etiology%26jtitle%3DArthritis%2520Rheumatol.%26date%3D2016%26volume%3D68%26spage%3D604%26epage%3D613%26doi%3D10.1002%2Fart.39491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit13c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lundberg, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wegner, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yucel-Lindberg, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venables, P. J.</span></span> <span> </span><span class="NLM_article-title">Periodontitis in RA-the citrullinated enolase connection</span>. <i>Nat. Rev. Rheumatol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">727</span>– <span class="NLM_lpage">730</span>, <span class="refDoi"> DOI: 10.1038/nrrheum.2010.139</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.1038%2Fnrrheum.2010.139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=20820197" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsV2gtLzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=727-730&author=K.+Lundbergauthor=N.+Wegnerauthor=T.+Yucel-Lindbergauthor=P.+J.+Venables&title=Periodontitis+in+RA-the+citrullinated+enolase+connection&doi=10.1038%2Fnrrheum.2010.139"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13cR"><div class="casContent"><span class="casTitleNuber">13c</span><div class="casTitle"><span class="NLM_cas:atitle">Periodontitis in RA-the citrullinated enolase connection</span></div><div class="casAuthors">Lundberg, Karin; Wegner, Natalia; Yucel-Lindberg, Tulay; Venables, Patrick J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Rheumatology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">727-730</span>CODEN:
                <span class="NLM_cas:coden">NRRACB</span>;
        ISSN:<span class="NLM_cas:issn">1759-4790</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Antibodies to citrullinated enolase define a subset of rheumatoid arthritis (RA) assocd. with smoking and DR4 alleles.  In this Perspectives article, the authors review epidemiol. and genetic links between periodontitis (a disease in which Porphyromonas gingivalis is a major pathogen) and RA and propose that that the assocn. might be causal, due to mol. mimicry between epitopes on host and P. gingivalis citrullinated enolases driving the autoimmune response.  Autoimmunity in rheumatoid arthritis (RA) is characterized by an antibody response to citrullinated proteins.  Two of the risk factors for RA-HLA-DRB1 shared epitope alleles and smoking-are also assocd. with periodontitis, which is largely, but not exclusively, caused by Porphyromonas gingivalis infection.  Furthermore, RA and periodontitis have a similar pathophysiol., characterized by destructive inflammation.  The citrullination of proteins by P. gingivalis and the subsequent generation of autoantigens that drive autoimmunity in RA represents a possible causative link between these two diseases.  Antibodies directed towards the immunodominant epitope of human citrullinated α-enolase cross-react with a conserved sequence on citrullinated P. gingivalis enolase.  On the basis of this cross-reactivity, in this Perspectives article we explore the hypothesis of mol. mimicry in the etiol. of RA, with citrullinated enolase as the specific antigen involved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAuxMkj0Tgk7Vg90H21EOLACvtfcHk0liXb1k4FEff6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsV2gtLzI&md5=adae31402135be903bbc4d710422188d</span></div><a href="/servlet/linkout?suffix=cit13c&amp;dbid=16384&amp;doi=10.1038%2Fnrrheum.2010.139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrrheum.2010.139%26sid%3Dliteratum%253Aachs%26aulast%3DLundberg%26aufirst%3DK.%26aulast%3DWegner%26aufirst%3DN.%26aulast%3DYucel-Lindberg%26aufirst%3DT.%26aulast%3DVenables%26aufirst%3DP.%2BJ.%26atitle%3DPeriodontitis%2520in%2520RA-the%2520citrullinated%2520enolase%2520connection%26jtitle%3DNat.%2520Rev.%2520Rheumatol.%26date%3D2010%26volume%3D6%26spage%3D727%26epage%3D730%26doi%3D10.1038%2Fnrrheum.2010.139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit13d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Koziel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mydel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potempa, J.</span></span> <span> </span><span class="NLM_article-title">The link between periodontal disease and rheumatoid arthritis: an updated review</span>. <i>Curr. Rheumatol. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">408</span>, <span class="refDoi"> DOI: 10.1007/s11926-014-0408-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.1007%2Fs11926-014-0408-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=24458478" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A280%3ADC%252BC2czovFGmsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=408&author=J.+Kozielauthor=P.+Mydelauthor=J.+Potempa&title=The+link+between+periodontal+disease+and+rheumatoid+arthritis%3A+an+updated+review&doi=10.1007%2Fs11926-014-0408-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13dR"><div class="casContent"><span class="casTitleNuber">13d</span><div class="casTitle"><span class="NLM_cas:atitle">The link between periodontal disease and rheumatoid arthritis: an updated review</span></div><div class="casAuthors">Koziel Joanna; Mydel Piotr; Potempa Jan</div><div class="citationInfo"><span class="NLM_cas:title">Current rheumatology reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">408</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Porphyromonas gingivalis is a leading pathogen in chronic periodontitis, a disease process involving progressive destruction of the tissues that support the teeth.  Recently, the organism has been reported to produce a unique bacterial enzyme, P. gingivalis peptidyl-arginine deiminase (PPAD), which has the ability to convert arginine residues in proteins to citrulline.  Protein citrullination alters protein structure and function; hence, PPAD may be involved in deregulation of the host's signalling network and immune evasion.  Further, accumulating evidence suggests a role for autoimmunity against citrullinated proteins in the development of rheumatoid arthritis (RA).  As inflammatory conditions in the lungs of cigarette smokers contribute to the breakdown of immune tolerance to citrullinated epitopes, chronic exposure to citrullinated proteins at periodontitis sites may also predispose susceptible individuals to the development of autoantibodies and the initiation of RA.  In this review, we discuss evidence that PPAD may represent a mechanistic link between periodontitis and RA, diseases that are known to be significantly associated at the epidemiological level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRec_aWYOizrNj_Vg2vObihfW6udTcc2ebx5oFA0gjBsbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2czovFGmsQ%253D%253D&md5=9fe703574164ad0b5dd9b69e0e8f204f</span></div><a href="/servlet/linkout?suffix=cit13d&amp;dbid=16384&amp;doi=10.1007%2Fs11926-014-0408-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11926-014-0408-9%26sid%3Dliteratum%253Aachs%26aulast%3DKoziel%26aufirst%3DJ.%26aulast%3DMydel%26aufirst%3DP.%26aulast%3DPotempa%26aufirst%3DJ.%26atitle%3DThe%2520link%2520between%2520periodontal%2520disease%2520and%2520rheumatoid%2520arthritis%253A%2520an%2520updated%2520review%26jtitle%3DCurr.%2520Rheumatol.%2520Rep.%26date%3D2014%26volume%3D16%26spage%3D408%26doi%3D10.1007%2Fs11926-014-0408-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit13e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Trabocchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pala, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krimmelbein, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menchi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guarna, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sechi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dreker, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scozzafava, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supuran, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carta, F.</span></span> <span> </span><span class="NLM_article-title">Peptidomimetics as protein arginine deiminase 4 (PAD4) inhibitors</span>. <i>J. Enzyme Inhib. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">466</span>– <span class="NLM_lpage">471</span>, <span class="refDoi"> DOI: 10.3109/14756366.2014.947976</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.3109%2F14756366.2014.947976" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=25198885" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFGlsbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2015&pages=466-471&author=A.+Trabocchiauthor=N.+Palaauthor=I.+Krimmelbeinauthor=G.+Menchiauthor=A.+Guarnaauthor=M.+Sechiauthor=T.+Drekerauthor=A.+Scozzafavaauthor=C.+T.+Supuranauthor=F.+Carta&title=Peptidomimetics+as+protein+arginine+deiminase+4+%28PAD4%29+inhibitors&doi=10.3109%2F14756366.2014.947976"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13eR"><div class="casContent"><span class="casTitleNuber">13e</span><div class="casTitle"><span class="NLM_cas:atitle">Peptidomimetics as protein arginine deiminase 4 (PAD4) inhibitors</span></div><div class="casAuthors">Trabocchi, Andrea; Pala, Nicolino; Krimmelbein, Ilga; Menchi, Gloria; Guarna, Antonio; Sechi, Mario; Dreker, Tobias; Scozzafava, Andrea; Supuran, Claudiu T.; Carta, Fabrizio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">466-471</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">The protein arginine deiminase 4 (PAD4) is a calcium-dependent enzyme, which catalyzes the irreversible conversion of peptidyl-arginines into peptidyl-citrullines and plays an important role in several diseases such as in the rheumatoid arthritis, multiple sclerosis, Alzheimer's disease, Creutzfeldt-Jacob's disease and cancer.  In this study, the authors report the inhibition profiles and computational docking toward the PAD4 enzyme of a series of 1,2,3-triazole peptidomimetic-based derivs. incorporating the β-phenylalanine and guanidine scaffolds.  Several effective, low micromolar PAD4 inhibitors are reported in this study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgnjqFPrxaT7Vg90H21EOLACvtfcHk0liqcgw50d_cFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFGlsbvE&md5=3524acfe15eeb79049a7bceb6dd1b6e7</span></div><a href="/servlet/linkout?suffix=cit13e&amp;dbid=16384&amp;doi=10.3109%2F14756366.2014.947976&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F14756366.2014.947976%26sid%3Dliteratum%253Aachs%26aulast%3DTrabocchi%26aufirst%3DA.%26aulast%3DPala%26aufirst%3DN.%26aulast%3DKrimmelbein%26aufirst%3DI.%26aulast%3DMenchi%26aufirst%3DG.%26aulast%3DGuarna%26aufirst%3DA.%26aulast%3DSechi%26aufirst%3DM.%26aulast%3DDreker%26aufirst%3DT.%26aulast%3DScozzafava%26aufirst%3DA.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26aulast%3DCarta%26aufirst%3DF.%26atitle%3DPeptidomimetics%2520as%2520protein%2520arginine%2520deiminase%25204%2520%2528PAD4%2529%2520inhibitors%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2015%26volume%3D30%26spage%3D466%26epage%3D471%26doi%3D10.3109%2F14756366.2014.947976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit13f"><span><span class="NLM_label">(f) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Witalison, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofseth, L. J.</span></span> <span> </span><span class="NLM_article-title">Protein arginine deiminases and associated citrullination: physiological functions and diseases associated with dysregulation</span>. <i>Curr. Drug Targets</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">700</span>– <span class="NLM_lpage">710</span>, <span class="refDoi"> DOI: 10.2174/1389450116666150202160954</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.2174%2F1389450116666150202160954" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13f&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=25642720" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFSht7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2015&pages=700-710&author=E.+E.+Witalisonauthor=P.+R.+Thompsonauthor=L.+J.+Hofseth&title=Protein+arginine+deiminases+and+associated+citrullination%3A+physiological+functions+and+diseases+associated+with+dysregulation&doi=10.2174%2F1389450116666150202160954"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13fR"><div class="casContent"><span class="casTitleNuber">13f</span><div class="casTitle"><span class="NLM_cas:atitle">Protein Arginine Deiminases and Associated Citrullination: Physiological Functions and Diseases Associated with Dysregulation</span></div><div class="casAuthors">Witalison, Erin E.; Thompson, Paul R.; Hofseth, Lorne J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">700-710</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Human proteins are subjected to more than 200 known post-translational modifications (PTMs) (e.g., phosphorylation, glycosylation, ubiquitination, S-nitrosylation, methylation, Nacetylation, and citrullination) and these PTMs can alter protein structure and function with consequent effects on the multitude of pathways necessary for maintaining the physiol. homeostasis.  When dysregulated, however, the enzymes that catalyze these PTMs can impact the genesis of countless diseases.  In this review, we will focus on protein citrullination, a PTM catalyzed by the Protein Arginine Deiminase (PAD) family of enzymes.  Specifically, we will describe the roles of the PADs in both normal human physiol. and disease.  The development of PAD inhibitors and their efficacy in a variety of autoimmune disorders and cancer will also be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdv_o7-kOsurVg90H21EOLACvtfcHk0liqcgw50d_cFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFSht7vJ&md5=9d0072b3b5e23308858bb4cd4ed0cab7</span></div><a href="/servlet/linkout?suffix=cit13f&amp;dbid=16384&amp;doi=10.2174%2F1389450116666150202160954&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389450116666150202160954%26sid%3Dliteratum%253Aachs%26aulast%3DWitalison%26aufirst%3DE.%2BE.%26aulast%3DThompson%26aufirst%3DP.%2BR.%26aulast%3DHofseth%26aufirst%3DL.%2BJ.%26atitle%3DProtein%2520arginine%2520deiminases%2520and%2520associated%2520citrullination%253A%2520physiological%2520functions%2520and%2520diseases%2520associated%2520with%2520dysregulation%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2015%26volume%3D16%26spage%3D700%26epage%3D710%26doi%3D10.2174%2F1389450116666150202160954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Maddur, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miossec, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaveri, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayry, J.</span></span> <span> </span><span class="NLM_article-title">Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies</span>. <i>Am. J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>181</i></span>,  <span class="NLM_fpage">8</span>– <span class="NLM_lpage">18</span>, <span class="refDoi"> DOI: 10.1016/j.ajpath.2012.03.044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.1016%2Fj.ajpath.2012.03.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=22640807" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFOitbbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=181&publication_year=2012&pages=8-18&author=M.+S.+Maddurauthor=P.+Miossecauthor=S.+V.+Kaveriauthor=J.+Bayry&title=Th17+cells%3A+biology%2C+pathogenesis+of+autoimmune+and+inflammatory+diseases%2C+and+therapeutic+strategies&doi=10.1016%2Fj.ajpath.2012.03.044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14aR"><div class="casContent"><span class="casTitleNuber">14a</span><div class="casTitle"><span class="NLM_cas:atitle">Th 17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies</span></div><div class="casAuthors">Maddur, Mohan S.; Miossec, Pierre; Kaveri, Srini V.; Bayry, Jagadeesh</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">181</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">8-18</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Th17 cells that secrete the cytokines IL-17A and IL-17F and express lineage-specific transcription factor RORC (RORγt in mice) represent a distinct lineage of CD4+ T cells.  Transforming growth factor-β and inflammatory cytokines, such as IL-6, IL-21, IL-1β, and IL-23, play central roles in the generation of Th17 cells.  Th17 cells are crit. for the clearance of extracellular pathogens, including Candida and Klebsiella.  However, under certain conditions, these cells and their effector mols., such as IL-17, IL-21, IL-22, GM-CSF, and CCL20, are assocd. with the pathogenesis of several autoimmune and inflammatory diseases, such as rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis, psoriasis, inflammatory bowel disease, and allergy and asthma.  This review discusses these disease states and the various therapeutic strategies under investigation to target Th17 cells, which include blocking the differentiation and amplification of Th17 cells, inhibiting or neutralizing the cytokines of Th17 cells, and suppressing the transcription factors specific for Th17 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8EspukaEizbVg90H21EOLACvtfcHk0liqcgw50d_cFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFOitbbF&md5=15b79f41578ef7eaef6798a93e175c16</span></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.1016%2Fj.ajpath.2012.03.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ajpath.2012.03.044%26sid%3Dliteratum%253Aachs%26aulast%3DMaddur%26aufirst%3DM.%2BS.%26aulast%3DMiossec%26aufirst%3DP.%26aulast%3DKaveri%26aufirst%3DS.%2BV.%26aulast%3DBayry%26aufirst%3DJ.%26atitle%3DTh17%2520cells%253A%2520biology%252C%2520pathogenesis%2520of%2520autoimmune%2520and%2520inflammatory%2520diseases%252C%2520and%2520therapeutic%2520strategies%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2012%26volume%3D181%26spage%3D8%26epage%3D18%26doi%3D10.1016%2Fj.ajpath.2012.03.044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit14b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Skapenko, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leipe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lipsky, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulze-Koops, H.</span></span> <span> </span><span class="NLM_article-title">The role of the T cell in autoimmune inflammation</span>. <i>Arthritis Res. Ther</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">S4</span>– <span class="NLM_lpage">S14</span>, <span class="refDoi"> DOI: 10.1186/ar1703</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.1186%2Far1703" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=15833146" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=S4-S14&author=A.+Skapenkoauthor=J.+Leipeauthor=P.+E.+Lipskyauthor=H.+Schulze-Koops&title=The+role+of+the+T+cell+in+autoimmune+inflammation&doi=10.1186%2Far1703"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.1186%2Far1703&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Far1703%26sid%3Dliteratum%253Aachs%26aulast%3DSkapenko%26aufirst%3DA.%26aulast%3DLeipe%26aufirst%3DJ.%26aulast%3DLipsky%26aufirst%3DP.%2BE.%26aulast%3DSchulze-Koops%26aufirst%3DH.%26atitle%3DThe%2520role%2520of%2520the%2520T%2520cell%2520in%2520autoimmune%2520inflammation%26jtitle%3DArthritis%2520Res.%2520Ther%26date%3D2005%26volume%3D7%26spage%3DS4%26epage%3DS14%26doi%3D10.1186%2Far1703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit14c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kanda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokota, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohno, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komagata, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimada, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mimura, T.</span></span> <span> </span><span class="NLM_article-title">Effects of low-dosage simvastatin on rheumatoid arthritis through reduction of Th1/Th2 and CD4/CD8 ratios</span>. <i>Mod. Rheumatol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">364</span>– <span class="NLM_lpage">368</span>, <span class="refDoi"> DOI: 10.3109/s10165-007-0589-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.3109%2Fs10165-007-0589-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=17929126" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFGgs7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=364-368&author=H.+Kandaauthor=K.+Yokotaauthor=C.+Kohnoauthor=T.+Sawadaauthor=K.+Satoauthor=M.+Yamaguchiauthor=Y.+Komagataauthor=K.+Shimadaauthor=K.+Yamamotoauthor=T.+Mimura&title=Effects+of+low-dosage+simvastatin+on+rheumatoid+arthritis+through+reduction+of+Th1%2FTh2+and+CD4%2FCD8+ratios&doi=10.3109%2Fs10165-007-0589-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14cR"><div class="casContent"><span class="casTitleNuber">14c</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of low-dosage simvastatin on rheumatoid arthritis through reduction of Th1/Th2 and CD4/CD8 ratios</span></div><div class="casAuthors">Kanda, Hiroko; Yokota, Kazuhiro; Kohno, Chieko; Sawada, Tetsuji; Sato, Kojiro; Yamaguchi, Masao; Komagata, Yoshinori; Shimada, Kota; Yamamoto, Kazuhiko; Mimura, Toshihide</div><div class="citationInfo"><span class="NLM_cas:title">Modern Rheumatology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">364-368</span>CODEN:
                <span class="NLM_cas:coden">MROHA4</span>;
        ISSN:<span class="NLM_cas:issn">1439-7595</span>.
    
            (<span class="NLM_cas:orgname">Springer Japan</span>)
        </div><div class="casAbstract">The objective of this study was to assess both the anti-inflammatory and immunomodulatory effects of low-dosage simvastatin on rheumatoid arthritis (RA).  In each patient, simvastatin at 10 mg/day was administered for 12 wk.  The other treatments were unchanged at least 3 mo before simvastatin administration to the end of the study.  Patients were assessed for the improvement in clin., lab., and immunol. parameters of RA and for adverse events.  Twenty-four patients with RA were enrolled.  Clin. symptoms, including patient's assessment of pain and disease activity on visual analog scale (VAS), the swollen joint and tender joint counts, and handgrip strength significantly improved.  Physician's assessment of disease activity on VAS, a period of morning stiffness and modified health assessment questionnaire showed a tendency of improving after administration of low-dosage of simvastatin.  Of special interest was that the median levels of erythrocytes sedimentation rate, C-reactive protein, and rheumatoid factor were significantly decreased from 54.0 mm/h to 45.5 mm/h, from 1.50 mg/dL to 0.85 mg/dL, and from 57.0 IU/mL to 28.0 IU/mL, resp., after administration of simvastatin.  ACR20 and ACR50 responses were achieved in 62% and 38%, resp., of simvastatin-treated patients for 12 wk.  Immunol. assessment in peripheral blood revealed that the Th1/Th2 and CD4/CD8 ratios were significantly reduced by simvastatin.  No adverse events were reported during simvastatin treatment.  Immunomodulation through the alteration of Th1/Th2 and CD4/CD8 ratios may be a pharmacol. mechanism in the anti-rheumatic effect of low-dosage simvastatin.  Although it is necessary to evaluate the long-term effects of statins, low-dosage statins appear to be good as addnl. therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo71tTjmt1TOLVg90H21EOLACvtfcHk0lgais7KOe4iHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFGgs7rL&md5=d2d8b418160109620bb7ec906003c2b9</span></div><a href="/servlet/linkout?suffix=cit14c&amp;dbid=16384&amp;doi=10.3109%2Fs10165-007-0589-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252Fs10165-007-0589-4%26sid%3Dliteratum%253Aachs%26aulast%3DKanda%26aufirst%3DH.%26aulast%3DYokota%26aufirst%3DK.%26aulast%3DKohno%26aufirst%3DC.%26aulast%3DSawada%26aufirst%3DT.%26aulast%3DSato%26aufirst%3DK.%26aulast%3DYamaguchi%26aufirst%3DM.%26aulast%3DKomagata%26aufirst%3DY.%26aulast%3DShimada%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DK.%26aulast%3DMimura%26aufirst%3DT.%26atitle%3DEffects%2520of%2520low-dosage%2520simvastatin%2520on%2520rheumatoid%2520arthritis%2520through%2520reduction%2520of%2520Th1%252FTh2%2520and%2520CD4%252FCD8%2520ratios%26jtitle%3DMod.%2520Rheumatol.%26date%3D2007%26volume%3D17%26spage%3D364%26epage%3D368%26doi%3D10.3109%2Fs10165-007-0589-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit14d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Leipe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grunke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dechant, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reindl, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerzendorf, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulze-Koops, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skapenko, A.</span></span> <span> </span><span class="NLM_article-title">Role of Th17 cells in human autoimmune arthritis</span>. <i>Arthritis Rheum.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">2876</span>– <span class="NLM_lpage">2885</span>, <span class="refDoi"> DOI: 10.1002/art.27622</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.1002%2Fart.27622" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=20583102" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVSqtrrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2010&pages=2876-2885&author=J.+Leipeauthor=M.+Grunkeauthor=C.+Dechantauthor=C.+Reindlauthor=U.+Kerzendorfauthor=H.+Schulze-Koopsauthor=A.+Skapenko&title=Role+of+Th17+cells+in+human+autoimmune+arthritis&doi=10.1002%2Fart.27622"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14dR"><div class="casContent"><span class="casTitleNuber">14d</span><div class="casTitle"><span class="NLM_cas:atitle">Role of Th17 cells in human autoimmune arthritis</span></div><div class="casAuthors">Leipe, Jan; Grunke, Mathias; Dechant, Claudia; Reindl, Christiane; Kerzendorf, Ulrike; Schulze-Koops, Hendrik; Skapenko, Alla</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2876-2885</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">To delineate the role of Th17 cells in the pathogenesis of autoimmune arthritides.  Th17 cells were analyzed in well-defined homogeneous cohorts of patients with the prototypical autoimmune arthritides rheumatoid arthritis (RA) and psoriatic arthritis (PsA), grouped according to patients who had very early active RA (n = 36; mean disease duration 2.8 mo, Disease Activity Score in 28 joints 5.0) and those who had very early active PsA (n = 20; mean disease duration 2.3 mo), none of whom had received treatment with glucocorticoids or disease-modifying antirheumatic drugs, as well as patients with established RA (n = 21; mean disease duration 68 mo) who were considered either responders or nonresponders to therapy.  Groups of healthy individuals and patients with osteoarthritis (a noninflammatory arthritis) were used as control cohorts.  Expression of T lineage-specific transcription factors (RORC, T-bet, GATA-3, and FoxP3) and the response of CD4 T cells to Th17 cell-inducing conditions were analyzed in vitro.  The frequencies of Th17 cells and levels of interleukin-17 strongly correlated with systemic disease activity at both the onset and the progression of RA or PsA.  The values were reduced to control levels in patients with treatment-controlled disease activity.  Th17 cells were enriched in the joints, and increased frequencies of synovial Th17 cells expressed CCR4 and CCR6, indicative of selective migration of Th17 cells to the joints.  The intrinsically elevated expression of RORC, accompanied by biased Th17 cell development, and the resistance of Th17 cells to a natural cytokine antagonist in patients with RA and patients with PsA were suggestive of the underlying mol. mechanisms of uncontrolled Th17 activity in these patients.  Th17 cells play an important role in inflammation in human autoimmune arthritides, both at the onset and in established disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp62F0RUDGaUrVg90H21EOLACvtfcHk0lgais7KOe4iHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVSqtrrK&md5=922bf3cabf3d6ad57ebeb90c07def4c2</span></div><a href="/servlet/linkout?suffix=cit14d&amp;dbid=16384&amp;doi=10.1002%2Fart.27622&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.27622%26sid%3Dliteratum%253Aachs%26aulast%3DLeipe%26aufirst%3DJ.%26aulast%3DGrunke%26aufirst%3DM.%26aulast%3DDechant%26aufirst%3DC.%26aulast%3DReindl%26aufirst%3DC.%26aulast%3DKerzendorf%26aufirst%3DU.%26aulast%3DSchulze-Koops%26aufirst%3DH.%26aulast%3DSkapenko%26aufirst%3DA.%26atitle%3DRole%2520of%2520Th17%2520cells%2520in%2520human%2520autoimmune%2520arthritis%26jtitle%3DArthritis%2520Rheum.%26date%3D2010%26volume%3D62%26spage%3D2876%26epage%3D2885%26doi%3D10.1002%2Fart.27622" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit14e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Souza-Moreira, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campos-Salinas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez-Rey, E.</span></span> <span> </span><span class="NLM_article-title">Neuropeptides as pleiotropic modulators of the immune response</span>. <i>Neuroendocrinology</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">89</span>– <span class="NLM_lpage">100</span>, <span class="refDoi"> DOI: 10.1159/000328636</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.1159%2F000328636" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=21734355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1yltbzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2011&pages=89-100&author=L.+Souza-Moreiraauthor=J.+Campos-Salinasauthor=M.+Caroauthor=E.+Gonzalez-Rey&title=Neuropeptides+as+pleiotropic+modulators+of+the+immune+response&doi=10.1159%2F000328636"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14eR"><div class="casContent"><span class="casTitleNuber">14e</span><div class="casTitle"><span class="NLM_cas:atitle">Neuropeptides as pleiotropic modulators of the immune response</span></div><div class="casAuthors">Souza-Moreira, Luciana; Campos-Salinas, Jenny; Caro, Marta; Gonzalez-Rey, Elena</div><div class="citationInfo"><span class="NLM_cas:title">Neuroendocrinology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">89-100</span>CODEN:
                <span class="NLM_cas:coden">NUNDAJ</span>;
        ISSN:<span class="NLM_cas:issn">0028-3835</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">A review.  Although necessary to eliminate pathogens, inflammation can lead to serious deleterious effects in the host if left unchecked.  During the inflammatory response, further damage may arise from potential autoimmune responses occurring when the immune cells and mols. that respond to pathogen-derived antigens also react to self-antigens.  In this sense, the identification of endogenous factors that control exacerbated immune responses is a key goal for the development of new therapeutic approaches for inflammatory and autoimmune diseases.  Some neuropeptides that are produced during the ongoing inflammatory response have emerged as endogenous anti-inflammatory agents that could collaborate in tuning the balanced steady state of the immune system.  These neuropeptides participate in maintaining immune tolerance through two distinct mechanisms: by regulating the balance between pro-inflammatory and anti-inflammatory factors, and by inducing the emergence of regulatory T cells with suppressive activity against autoreactive T cell effectors.  Indeed, a functioning neuropeptide system contributes to general health, and alterations in the levels of these neuropeptides and/or their receptors lead to changes in susceptibility to inflammatory and autoimmune diseases.  Recently, we found that some neuropeptides also have antimicrobial and antiparasitic actions, suggesting that they could act as primary mediators of innate defense, even in the most primitive organisms.  In this review, we use the vasoactive intestinal peptide as example of an immunomodulatory neuropeptide to summarize the most relevant data found for other neuropeptides with similar characteristics, including adrenomedullin, urocortin, cortistatin and ghrelin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroOMkNxl3ofbVg90H21EOLACvtfcHk0lgais7KOe4iHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1yltbzJ&md5=948602015c5ab1cda2af2c4b6f7c2ea8</span></div><a href="/servlet/linkout?suffix=cit14e&amp;dbid=16384&amp;doi=10.1159%2F000328636&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000328636%26sid%3Dliteratum%253Aachs%26aulast%3DSouza-Moreira%26aufirst%3DL.%26aulast%3DCampos-Salinas%26aufirst%3DJ.%26aulast%3DCaro%26aufirst%3DM.%26aulast%3DGonzalez-Rey%26aufirst%3DE.%26atitle%3DNeuropeptides%2520as%2520pleiotropic%2520modulators%2520of%2520the%2520immune%2520response%26jtitle%3DNeuroendocrinology%26date%3D2011%26volume%3D94%26spage%3D89%26epage%3D100%26doi%3D10.1159%2F000328636" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit14f"><span><span class="NLM_label">(f) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Delgado, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganea, D.</span></span> <span> </span><span class="NLM_article-title">Anti-inflammatory neuropeptides: a new class of endogenous immunoregulatory agents</span>. <i>Brain, Behav., Immun.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1146</span>– <span class="NLM_lpage">1151</span>, <span class="refDoi"> DOI: 10.1016/j.bbi.2008.06.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.1016%2Fj.bbi.2008.06.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=1146-1151&author=M.+Delgadoauthor=D.+Ganea&title=Anti-inflammatory+neuropeptides%3A+a+new+class+of+endogenous+immunoregulatory+agents&doi=10.1016%2Fj.bbi.2008.06.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14f&amp;dbid=16384&amp;doi=10.1016%2Fj.bbi.2008.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbi.2008.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DDelgado%26aufirst%3DM.%26aulast%3DGanea%26aufirst%3DD.%26atitle%3DAnti-inflammatory%2520neuropeptides%253A%2520a%2520new%2520class%2520of%2520endogenous%2520immunoregulatory%2520agents%26jtitle%3DBrain%252C%2520Behav.%252C%2520Immun.%26date%3D2008%26volume%3D22%26spage%3D1146%26epage%3D1151%26doi%3D10.1016%2Fj.bbi.2008.06.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gassani, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rezende, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paiva-Lima, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferreira-Alves, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">dos Reis, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakhle, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Francischi, J. N.</span></span> <span> </span><span class="NLM_article-title">Is the sulphonamide radical in the celecoxib molecule essential for its analgesic activity?</span>. <i>Pharmacol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">439</span>– <span class="NLM_lpage">443</span>, <span class="refDoi"> DOI: 10.1016/j.phrs.2010.06.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.1016%2Fj.phrs.2010.06.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=20600917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1Wmt7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2010&pages=439-443&author=B.+C.+Gassaniauthor=R.+M.+Rezendeauthor=P.+Paiva-Limaauthor=D.+L.+Ferreira-Alvesauthor=W.+G.+dos+Reisauthor=Y.+S.+Bakhleauthor=J.+N.+de+Francischi&title=Is+the+sulphonamide+radical+in+the+celecoxib+molecule+essential+for+its+analgesic+activity%3F&doi=10.1016%2Fj.phrs.2010.06.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Is the sulphonamide radical in the celecoxib molecule essential for its analgesic activity?</span></div><div class="casAuthors">Gassani, Beatriz Carvalho Andraus; Rezende, Rafael Machado; Paiva-Lima, Patricia; Ferreira-Alves, Dalton L.; Pimenta dos Reis, Webster Glayser; Bakhle, Y. S.; Nogueira de Francischi, Janetti</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">439-443</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">In a model of peripherally induced inflammatory pain in rats, selective inhibitors of cyclooxygenase (COX)-2 raised nociceptive thresholds above basal values, an effect referred to as "hypoalgesia".  However other, non-selective, inhibitors of COX (indomethacin, piroxicam) or a selective inhibitor of COX-1 did not induce hypoalgesia in this model, implying that COX inhibition was not causally related to the hypoalgesic effect.  Here, we have assessed whether other COX-2 inhibitors or other sulfonamides, apart from celecoxib could exhibit hypoalgesia in our model of inflammatory pain.  Inflammation was induced in one hind paw of rats by intraplantar injection of carrageenan (250 μg).  Nociceptive thresholds to mech. stimulation were measured in the inflamed and contralateral paws for 6 h after carrageenan.  Three sulfonamides, celecoxib itself, furosemide (a loop diuretic), acetazolamide (a carbonic anhydrase inhibitor), or a selective COX-2 inhibitor lacking the sulfonamide group, lumiracoxib, were injected s.c., 30 min before the pro-inflammatory stimulus.  Naltrexone, a non-selective opioid antagonist was also administered s.c., 30 min before test drugs.  Furosemide and acetazolamide dose-dependently induced hypoalgesia in the inflamed paw, as did celecoxib.  However, lumiracoxib only produced anti-hyperalgesia.  Pre-treatment with naltrexone completely prevented the hypoalgesia induced by the sulfonamides, but only partially prevented the anti-hyperalgesic effect of lumiracoxib.  Taken together, our results suggest that the sulfonamide group in the structure of celecoxib is more crit. for the development of hypoalgesia in our model than its ability to inhibit COX-2.  Further, other sulfonamides lacking significant COX inhibition were also able to exhibit hypoalgesic effects, mediated by the endogenous opioid system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAIBl7KrzaJrVg90H21EOLACvtfcHk0lgN1MMqno2D9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1Wmt7nJ&md5=a98b9b5b264740d23c2fa74b711cf244</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2010.06.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2010.06.007%26sid%3Dliteratum%253Aachs%26aulast%3DGassani%26aufirst%3DB.%2BC.%26aulast%3DRezende%26aufirst%3DR.%2BM.%26aulast%3DPaiva-Lima%26aufirst%3DP.%26aulast%3DFerreira-Alves%26aufirst%3DD.%2BL.%26aulast%3Ddos%2BReis%26aufirst%3DW.%2BG.%26aulast%3DBakhle%26aufirst%3DY.%2BS.%26aulast%3Dde%2BFrancischi%26aufirst%3DJ.%2BN.%26atitle%3DIs%2520the%2520sulphonamide%2520radical%2520in%2520the%2520celecoxib%2520molecule%2520essential%2520for%2520its%2520analgesic%2520activity%253F%26jtitle%3DPharmacol.%2520Res.%26date%3D2010%26volume%3D62%26spage%3D439%26epage%3D443%26doi%3D10.1016%2Fj.phrs.2010.06.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bozdag, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carta, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scozzafava, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenna, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supuran, C. T.</span></span> <span> </span><span class="NLM_article-title">A class of 4-sulfamoylphenyl-ω-aminoalkyl ethers with effective carbonic anhydrase inhibitory action and antiglaucoma effects</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">9673</span>– <span class="NLM_lpage">9686</span>, <span class="refDoi"> DOI: 10.1021/jm501497m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501497m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVensLrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9673-9686&author=M.+Bozdagauthor=M.+Pinardauthor=F.+Cartaauthor=E.+Masiniauthor=A.+Scozzafavaauthor=R.+McKennaauthor=C.+T.+Supuran&title=A+class+of+4-sulfamoylphenyl-%CF%89-aminoalkyl+ethers+with+effective+carbonic+anhydrase+inhibitory+action+and+antiglaucoma+effects&doi=10.1021%2Fjm501497m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">A Class of 4-Sulfamoylphenyl-ω-aminoalkyl Ethers with Effective Carbonic Anhydrase Inhibitory Action and Antiglaucoma Effects</span></div><div class="casAuthors">Bozdag, Murat; Pinard, Melissa; Carta, Fabrizio; Masini, Emanuela; Scozzafava, Andrea; McKenna, Robert; Supuran, Claudiu T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9673-9686</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report a series of 4-sulfamoylphenyl-ω-aminoalkyl ethers as carbonic anhydrase (CA, EC 4.2.1.1) inhibitors.  The structure-activity relationship was drawn for the inhibition of four physiol. relevant isoforms: hCA I, II, IX, and XII.  Many of these compds. were highly effective, low nanomolar inhibitors of all CA isoforms, whereas several isoform-selective were also identified.  X-ray crystal structures of two new sulfonamides bound to the physiol. dominant CA II isoform showed the tails of these derivs. bound within the hydrophobic half of the enzyme active site through van der Waals contacts with Val135, Leu198, Leu204, Trp209, Pro201, and Pro202 amino acids.  One of the highly water-sol. compd. (as trifluoroacetate salt) showed effective IOP lowering properties in an animal model of glaucoma.  Several fluorescent sulfonamides incorporating either the fluorescein-thiourea (7a-c) or tetramethylrhodamine-thiourea (9a,b) moieties were also obtained and showed interesting CA inhibitory properties for the tumor-assocd. isoforms CA IX and XII.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHHbJ45OcmhLVg90H21EOLACvtfcHk0lgN1MMqno2D9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVensLrP&md5=d8ccf7da4a68a95cbd2c060afea9f515</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm501497m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501497m%26sid%3Dliteratum%253Aachs%26aulast%3DBozdag%26aufirst%3DM.%26aulast%3DPinard%26aufirst%3DM.%26aulast%3DCarta%26aufirst%3DF.%26aulast%3DMasini%26aufirst%3DE.%26aulast%3DScozzafava%26aufirst%3DA.%26aulast%3DMcKenna%26aufirst%3DR.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DA%2520class%2520of%25204-sulfamoylphenyl-%25CF%2589-aminoalkyl%2520ethers%2520with%2520effective%2520carbonic%2520anhydrase%2520inhibitory%2520action%2520and%2520antiglaucoma%2520effects%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D9673%26epage%3D9686%26doi%3D10.1021%2Fjm501497m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khalifah, R. G.</span></span> <span> </span><span class="NLM_article-title">The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1971</span>,  <span class="NLM_volume"><i>246</i></span>,  <span class="NLM_fpage">2561</span>– <span class="NLM_lpage">2573</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.1016%2FS0021-9258%2818%2962326-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=4994926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A528%3ADyaE3MXhtlGmu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=246&publication_year=1971&pages=2561-2573&author=R.+G.+Khalifah&title=The+carbon+dioxide+hydration+activity+of+carbonic+anhydrase.+I.+Stop-flow+kinetic+studies+on+the+native+human+isoenzymes+B+and+C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Carbon dioxide hydration activity of carbonic anhydrase.  I.  Stop-flow kinetic studies on the native human isoenzymes B and C</span></div><div class="casAuthors">Khalifah, Raja G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1971</span>),
    <span class="NLM_cas:volume">246</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2561-73</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">The kinetics of catalysis of carbon dioxide hydration by human carbonic anhydrases B and C (EC 4.2.1.1) has been reinvestigated with the use of an improved pH indicator stop-flow approach that was checked by studying the uncatalyzed rate of hydration, with Michaelis-Menten parameters being detd. between pH 5.8 and 8.8 in noninhibitory buffers.  For both isoenzymes, Km was independent of pH, whereas Vmax increased with increasing pH with results being similar to the finding of others on bovine carbonic anhydrase, but differing from earlier reports of Gibbons and Edsall (1964) in the finding that Km was pH-independent.  Despite the differences between the low and high activity forms of the enzyme, there were close kinetic similarities between them that indicated underlying similarities in active site structure.  Imidazole (I) (0.22-1.32M) inhibited the B enzyme, apparently competitively, and had no effect on the C enzyme.  N-Methyl substitution of I abolished its inhibitory effect.  Nitrous oxide (11-45mM) did not inhibit catalysis of carbon dioxide hydration by either of the 2 human isoenzymes, or by bovine carbonic anhydrase.  The enzyme-catalyzed hydration of carbon dioxide probably requires not only water activation by a basic group, but also charge neutralization in the transition state by an electron acceptor function.  The zinc-bound water in carbonic anhydrase could be involved in both donor and acceptor roles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGri57EkpgPMx7Vg90H21EOLACvtfcHk0lgN1MMqno2D9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3MXhtlGmu7k%253D&md5=2764970fcd4f08250b28b9e8e9474681</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2FS0021-9258%2818%2962326-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0021-9258%252818%252962326-9%26sid%3Dliteratum%253Aachs%26aulast%3DKhalifah%26aufirst%3DR.%2BG.%26atitle%3DThe%2520carbon%2520dioxide%2520hydration%2520activity%2520of%2520carbonic%2520anhydrase.%2520I.%2520Stop-flow%2520kinetic%2520studies%2520on%2520the%2520native%2520human%2520isoenzymes%2520B%2520and%2520C%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1971%26volume%3D246%26spage%3D2561%26epage%3D2573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Joullié, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lassen, K. M.</span></span> <span> </span><span class="NLM_article-title">Evolution of amide bond formation</span>. <i>ARKIVOC</i> <span class="NLM_year" style="font-weight: bold;">2010</span>, (<span class="NLM_issue">viii</span>),  <span class="NLM_fpage">189</span>– <span class="NLM_lpage">250</span>, <span class="refDoi"> DOI: 10.3998/ark.5550190.0011.816</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.3998%2Fark.5550190.0011.816" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&pages=189-250&issue=viii&author=M.+M.+Joulli%C3%A9author=K.+M.+Lassen&title=Evolution+of+amide+bond+formation&doi=10.3998%2Fark.5550190.0011.816"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.3998%2Fark.5550190.0011.816&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3998%252Fark.5550190.0011.816%26sid%3Dliteratum%253Aachs%26aulast%3DJoulli%25C3%25A9%26aufirst%3DM.%2BM.%26aulast%3DLassen%26aufirst%3DK.%2BM.%26atitle%3DEvolution%2520of%2520amide%2520bond%2520formation%26jtitle%3DARKIVOC%26date%3D2010%26issue%3Dviii%26spage%3D189%26epage%3D250%26doi%3D10.3998%2Fark.5550190.0011.816" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Makhija, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somani, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chavan, A. V.</span></span> <span> </span><span class="NLM_article-title">Synthesis and pharmacological evaluation of antiinflammatory mutual amide prodrugs</span>. <i>Indian J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">353</span>– <span class="NLM_lpage">357</span>, <span class="refDoi"> DOI: 10.4103/0250-474X.117399</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.4103%2F0250-474X.117399" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=24082352" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1agsb3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2013&pages=353-357&author=D.+T.+Makhijaauthor=R.+R.+Somaniauthor=A.+V.+Chavan&title=Synthesis+and+pharmacological+evaluation+of+antiinflammatory+mutual+amide+prodrugs&doi=10.4103%2F0250-474X.117399"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and pharmacological evaluation of antiinflammatory mutual amide prodrugs</span></div><div class="casAuthors">Makhija, D. T.; Somani, R. R.; Chavan, A. V.</div><div class="citationInfo"><span class="NLM_cas:title">Indian Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">353-357</span>CODEN:
                <span class="NLM_cas:coden">IJSIDW</span>;
        ISSN:<span class="NLM_cas:issn">0250-474X</span>.
    
            (<span class="NLM_cas:orgname">Medknow Publications and Media Pvt. Ltd.</span>)
        </div><div class="casAbstract">The amide prodrugs of nonsteroidal antiinflammatory drugs viz. ibuprofen, diclofenac and flurbiprofen were synthesized by coupling reaction with sulfonamides like sulfamethoxazole and sulfanilamide.  The synthesized prodrugs were screened for their analgesic and antiinflammatory activity using Eddy's hot plate, acetic acid-induced writhing and carrageenan-induced rat paw edema method, resp.  These prodrugs were also evaluated for their ulcerogenic potential.  All synthesized prodrugs were found to be less ulcerogenic than their parent nonsteroidal antiinflammatory drugs and showed better activity profile in terms of analgesic and antiinflammatory activity as compared to their resp. parent drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp18mvHHk7VW7Vg90H21EOLACvtfcHk0lhY-75GXnsOqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1agsb3P&md5=8d55792e72d97a5254630a2da8a6cc27</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.4103%2F0250-474X.117399&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4103%252F0250-474X.117399%26sid%3Dliteratum%253Aachs%26aulast%3DMakhija%26aufirst%3DD.%2BT.%26aulast%3DSomani%26aufirst%3DR.%2BR.%26aulast%3DChavan%26aufirst%3DA.%2BV.%26atitle%3DSynthesis%2520and%2520pharmacological%2520evaluation%2520of%2520antiinflammatory%2520mutual%2520amide%2520prodrugs%26jtitle%3DIndian%2520J.%2520Pharm.%2520Sci.%26date%3D2013%26volume%3D75%26spage%3D353%26epage%3D357%26doi%3D10.4103%2F0250-474X.117399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lai, C.</span>; <span class="NLM_string-name">Wang, T.</span></span> <span> </span><span class="NLM_article-title">Modified Forms of Nonsteroidal Antiinflammatory Drugs (NSAIDs) Having Reduced Side Effects</span>. U.S. Pat. Appl. Publ. <span class="NLM_year">2003</span>, <span class="NLM_patent">U.S. 20030220468 A1</span>, 20031127.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=C.+Lai&author=T.+Wang&title=Modified+Forms+of+Nonsteroidal+Antiinflammatory+Drugs+%28NSAIDs%29+Having+Reduced+Side+Effects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLai%26aufirst%3DC.%26atitle%3DModified%2520Forms%2520of%2520Nonsteroidal%2520Antiinflammatory%2520Drugs%2520%2528NSAIDs%2529%2520Having%2520Reduced%2520Side%2520Effects%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Winum, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carta, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langdon, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cecchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scozzafava, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunkler, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supuran, C. T.</span></span> <span> </span><span class="NLM_article-title">Ureido-substituted sulfamates show potent carbonic anhydrase IX inhibitory and antiproliferative activities against breast cancer cell lines</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">4681</span>– <span class="NLM_lpage">4685</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.05.083</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.1016%2Fj.bmcl.2012.05.083" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=4681-4685&author=J.+Y.+Winumauthor=F.+Cartaauthor=C.+Wardauthor=P.+Mullenauthor=D.+Harrisonauthor=S.+P.+Langdonauthor=A.+Cecchiauthor=A.+Scozzafavaauthor=I.+Kunklerauthor=C.+T.+Supuran&title=Ureido-substituted+sulfamates+show+potent+carbonic+anhydrase+IX+inhibitory+and+antiproliferative+activities+against+breast+cancer+cell+lines&doi=10.1016%2Fj.bmcl.2012.05.083"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.05.083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.05.083%26sid%3Dliteratum%253Aachs%26aulast%3DWinum%26aufirst%3DJ.%2BY.%26aulast%3DCarta%26aufirst%3DF.%26aulast%3DWard%26aufirst%3DC.%26aulast%3DMullen%26aufirst%3DP.%26aulast%3DHarrison%26aufirst%3DD.%26aulast%3DLangdon%26aufirst%3DS.%2BP.%26aulast%3DCecchi%26aufirst%3DA.%26aulast%3DScozzafava%26aufirst%3DA.%26aulast%3DKunkler%26aufirst%3DI.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DUreido-substituted%2520sulfamates%2520show%2520potent%2520carbonic%2520anhydrase%2520IX%2520inhibitory%2520and%2520antiproliferative%2520activities%2520against%2520breast%2520cancer%2520cell%2520lines%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D4681%26epage%3D4685%26doi%3D10.1016%2Fj.bmcl.2012.05.083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">D’Ambrosio, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smaine, F. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carta, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Simone, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winum, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supuran, C. T.</span></span> <span> </span><span class="NLM_article-title">Development of potent carbonic anhydrase inhibitors incorporating both sulfonamide and sulfamide groups</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">6776</span>– <span class="NLM_lpage">6783</span>, <span class="refDoi"> DOI: 10.1021/jm300818k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300818k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6776-6783&author=K.+D%E2%80%99Ambrosioauthor=F.+Z.+Smaineauthor=F.+Cartaauthor=G.+De+Simoneauthor=J.+Y.+Winumauthor=C.+T.+Supuran&title=Development+of+potent+carbonic+anhydrase+inhibitors+incorporating+both+sulfonamide+and+sulfamide+groups&doi=10.1021%2Fjm300818k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm300818k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300818k%26sid%3Dliteratum%253Aachs%26aulast%3DD%25E2%2580%2599Ambrosio%26aufirst%3DK.%26aulast%3DSmaine%26aufirst%3DF.%2BZ.%26aulast%3DCarta%26aufirst%3DF.%26aulast%3DDe%2BSimone%26aufirst%3DG.%26aulast%3DWinum%26aufirst%3DJ.%2BY.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DDevelopment%2520of%2520potent%2520carbonic%2520anhydrase%2520inhibitors%2520incorporating%2520both%2520sulfonamide%2520and%2520sulfamide%2520groups%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6776%26epage%3D6783%26doi%3D10.1021%2Fjm300818k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pala, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Micheletto, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sechi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aggarwal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carta, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenna, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supuran, C. T.</span></span> <span> </span><span class="NLM_article-title">Carbonic Anhydrase inhibition with benzenesulfonamides and tetrafluorobenzenesulfonamides obtained via click chemistry</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">927</span>– <span class="NLM_lpage">930</span>, <span class="refDoi"> DOI: 10.1021/ml500196t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500196t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=927-930&author=N.+Palaauthor=L.+Michelettoauthor=M.+Sechiauthor=M.+Aggarwalauthor=F.+Cartaauthor=R.+McKennaauthor=C.+T.+Supuran&title=Carbonic+Anhydrase+inhibition+with+benzenesulfonamides+and+tetrafluorobenzenesulfonamides+obtained+via+click+chemistry&doi=10.1021%2Fml500196t"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fml500196t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500196t%26sid%3Dliteratum%253Aachs%26aulast%3DPala%26aufirst%3DN.%26aulast%3DMicheletto%26aufirst%3DL.%26aulast%3DSechi%26aufirst%3DM.%26aulast%3DAggarwal%26aufirst%3DM.%26aulast%3DCarta%26aufirst%3DF.%26aulast%3DMcKenna%26aufirst%3DR.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DCarbonic%2520Anhydrase%2520inhibition%2520with%2520benzenesulfonamides%2520and%2520tetrafluorobenzenesulfonamides%2520obtained%2520via%2520click%2520chemistry%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D927%26epage%3D930%26doi%3D10.1021%2Fml500196t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kilkenny, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Browne, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuthill, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emerson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altman, D. G.</span></span> <span> </span><span class="NLM_article-title">Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research</span>. <i>J. Pharmacol. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">94</span>– <span class="NLM_lpage">99</span>, <span class="refDoi"> DOI: 10.4103/0976-500X.72351</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.4103%2F0976-500X.72351" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=21350617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A280%3ADC%252BC3M3hvVyksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=94-99&author=C.+Kilkennyauthor=W.+J.+Browneauthor=I.+C.+Cuthillauthor=M.+Emersonauthor=D.+G.+Altman&title=Improving+bioscience+research+reporting%3A+the+ARRIVE+guidelines+for+reporting+animal+research&doi=10.4103%2F0976-500X.72351"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research</span></div><div class="casAuthors">Kilkenny Carol; Browne William J; Cuthill Innes C; Emerson Michael; Altman Douglas G</div><div class="citationInfo"><span class="NLM_cas:title">Journal of pharmacology & pharmacotherapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">94-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTFwcJ9W7T-OWyYR5VtavbzfW6udTcc2eYxnZo-NcYoTLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M3hvVyksg%253D%253D&md5=adb67f1d88a6f9cf879d5b5bab56dd40</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.4103%2F0976-500X.72351&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4103%252F0976-500X.72351%26sid%3Dliteratum%253Aachs%26aulast%3DKilkenny%26aufirst%3DC.%26aulast%3DBrowne%26aufirst%3DW.%2BJ.%26aulast%3DCuthill%26aufirst%3DI.%2BC.%26aulast%3DEmerson%26aufirst%3DM.%26aulast%3DAltman%26aufirst%3DD.%2BG.%26atitle%3DImproving%2520bioscience%2520research%2520reporting%253A%2520the%2520ARRIVE%2520guidelines%2520for%2520reporting%2520animal%2520research%26jtitle%3DJ.%2520Pharmacol.%2520Pharmacother.%26date%3D2010%26volume%3D1%26spage%3D94%26epage%3D99%26doi%3D10.4103%2F0976-500X.72351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Butler, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godefroy, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besson, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weil-Fugazza, J.</span></span> <span> </span><span class="NLM_article-title">A limited arthritic model for chronic pain studies in the rat</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">73</span>– <span class="NLM_lpage">81</span>, <span class="refDoi"> DOI: 10.1016/0304-3959(92)90133-V</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.1016%2F0304-3959%2892%2990133-V" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1738577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A280%3ADyaK387ltVSqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=1992&pages=73-81&author=S.+H.+Butlerauthor=F.+Godefroyauthor=J.+M.+Bessonauthor=J.+Weil-Fugazza&title=A+limited+arthritic+model+for+chronic+pain+studies+in+the+rat&doi=10.1016%2F0304-3959%2892%2990133-V"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">A limited arthritic model for chronic pain studies in the rat</span></div><div class="casAuthors">Butler S H; Godefroy F; Besson J M; Weil-Fugazza J</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">73-81</span>
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    </div><div class="casAbstract">Freund's adjuvant induced polyarthritis in rats has been used extensively to study pain processes of long duration.  There are limitations of this model for chronic studies of pain/arthritis since the severe systemic changes provoke ethical concerns and also affect behaviour, physiology and biochemistry.  Attempts to limit adjuvant-induced arthritis by plantar injection of the inoculum have been made.  In this model, however, the process evolved to produce widespread polyarthritis if followed for the 6-plus-weeks necessary for chronic studies.  Therefore, although it offers the researcher a reliable limited model of inflammation and nociception at the outset, for longer studies it may have all the disadvantages of the polyarthritic rat.  The purpose of the present study was to produce a limited arthritic process in rats, stable over 6 weeks and suitable for behavioural and neurochemical studies of various chronic pain treatment methods.  Injection (0.05 ml) of complete adjuvant containing 300 micrograms Mycobacterium butyricum in the tibio-tarsal joint produces a predictable monoarthritis, stable clinically and behaviourly from weeks 2 through 6 post injection.  As revealed by clinical observations and X-ray examinations, the arthritis produced was limited anatomically, pronounced, prolonged and stable.  A marked increase in sensitivity to paw pressure was seen in the affected limb.  Animals gained weight and remained active, indicating little systemic disturbance as opposed to polyarthritic rats.  We propose this limited model of arthritis as a suitable alternative to the polyarthritic rat for prolonged studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT8JqpNUe2Bd9XdcedVHT5tfW6udTcc2eYxnZo-NcYoTLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK387ltVSqug%253D%253D&md5=3e5b40828514fb38a83a8ca180f889b3</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2F0304-3959%2892%2990133-V&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0304-3959%252892%252990133-V%26sid%3Dliteratum%253Aachs%26aulast%3DButler%26aufirst%3DS.%2BH.%26aulast%3DGodefroy%26aufirst%3DF.%26aulast%3DBesson%26aufirst%3DJ.%2BM.%26aulast%3DWeil-Fugazza%26aufirst%3DJ.%26atitle%3DA%2520limited%2520arthritic%2520model%2520for%2520chronic%2520pain%2520studies%2520in%2520the%2520rat%26jtitle%3DPain%26date%3D1992%26volume%3D48%26spage%3D73%26epage%3D81%26doi%3D10.1016%2F0304-3959%2892%2990133-V" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di
Cesare Mannelli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bani, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bencini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandi, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calosi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantore, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carossino, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghelardini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valtancoli, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Failli, P.</span></span> <span> </span><span class="NLM_article-title">Therapeutic effects of the superoxide dismutase mimetic compound MnIIMe2DO2A on experimental articular pain in rats</span>. <i>Mediators Inflammation</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>2013</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">11</span>, <span class="refDoi"> DOI: 10.1155/2013/905360</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.1155%2F2013%2F905360" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2013&publication_year=2013&pages=1-11&author=L.+Di%0ACesare+Mannelliauthor=D.+Baniauthor=A.+Benciniauthor=M.+L.+Brandiauthor=L.+Calosiauthor=M.+Cantoreauthor=A.+M.+Carossinoauthor=C.+Ghelardiniauthor=B.+Valtancoliauthor=P.+Failli&title=Therapeutic+effects+of+the+superoxide+dismutase+mimetic+compound+MnIIMe2DO2A+on+experimental+articular+pain+in+rats&doi=10.1155%2F2013%2F905360"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1155%2F2013%2F905360&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2013%252F905360%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BCesare%2BMannelli%26aufirst%3DL.%26aulast%3DBani%26aufirst%3DD.%26aulast%3DBencini%26aufirst%3DA.%26aulast%3DBrandi%26aufirst%3DM.%2BL.%26aulast%3DCalosi%26aufirst%3DL.%26aulast%3DCantore%26aufirst%3DM.%26aulast%3DCarossino%26aufirst%3DA.%2BM.%26aulast%3DGhelardini%26aufirst%3DC.%26aulast%3DValtancoli%26aufirst%3DB.%26aulast%3DFailli%26aufirst%3DP.%26atitle%3DTherapeutic%2520effects%2520of%2520the%2520superoxide%2520dismutase%2520mimetic%2520compound%2520MnIIMe2DO2A%2520on%2520experimental%2520articular%2520pain%2520in%2520rats%26jtitle%3DMediators%2520Inflammation%26date%3D2013%26volume%3D2013%26spage%3D1%26epage%3D11%26doi%3D10.1155%2F2013%2F905360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di Cesare Mannelli, L.</span>; <span class="NLM_string-name">Micheli, L.</span>; <span class="NLM_string-name">Cinci, L.</span>; <span class="NLM_string-name">Maresca, M.</span>; <span class="NLM_string-name">Vergelli, C.</span>; <span class="NLM_string-name">Pacini, A.</span>; <span class="NLM_string-name">Quinn, M.
T.</span>; <span class="NLM_string-name">Giovannoni, M. P.</span>; <span class="NLM_string-name">Ghelardini, C.</span></span> <i>Effects of the Neutrophil Elastase Inhibitor EL-17 in Rat Adjuvant-Induced Arthritis</i>; <span class="NLM_publisher-name">Rheumatology</span>: <span class="NLM_publisher-loc">Oxford</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.1093%2Frheumatology%2Fkew055" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=L.+Di+Cesare+Mannelli&author=L.+Micheli&author=L.+Cinci&author=M.+Maresca&author=C.+Vergelli&author=A.+Pacini&author=M.%0AT.+Quinn&author=M.+P.+Giovannoni&author=C.+Ghelardini&title=Effects+of+the+Neutrophil+Elastase+Inhibitor+EL-17+in+Rat+Adjuvant-Induced+Arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1093%2Frheumatology%2Fkew055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1093%252Frheumatology%252Fkew055%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BCesare%2BMannelli%26aufirst%3DL.%26btitle%3DEffects%2520of%2520the%2520Neutrophil%2520Elastase%2520Inhibitor%2520EL-17%2520in%2520Rat%2520Adjuvant-Induced%2520Arthritis%26pub%3DRheumatology%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leighton, G.
E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, J.</span></span> <span> </span><span class="NLM_article-title">κ-Opioid agonist produce antinociception after i.v. and i.c.v. but not intrathecal administration in the rat</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>93</i></span>,  <span class="NLM_fpage">553</span>– <span class="NLM_lpage">560</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.1988.tb10310.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.1111%2Fj.1476-5381.1988.tb10310.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=2836010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A528%3ADyaL1cXhvVSjtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1988&pages=553-560&author=G.%0AE.+Leightonauthor=R.+E.+Rodriguezauthor=R.+G.+Hillauthor=J.+Hughes&title=%CE%BA-Opioid+agonist+produce+antinociception+after+i.v.+and+i.c.v.+but+not+intrathecal+administration+in+the+rat&doi=10.1111%2Fj.1476-5381.1988.tb10310.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">κ-Opioid agonists produce antinociception after i.v. and i.c.v. but not intrathecal administration in the rat</span></div><div class="casAuthors">Leighton, G. E.; Rodriguez, R. E.; Hill, R. G.; Hughes, J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">553-60</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    </div><div class="casAbstract">Following i.v. administration to rats, PD117302, U50488, U69593, and morphine produced steep parallel dose-response curves indicating antinociceptive activity when evaluated in the paw-pressure test.  When U50488 and U69593 were tested at a single dose of 3.3 mg/kg no effect was seen in the tail-flick test.  When given by the intrathecal route, only morphine was effective at increasing the nociceptive threshold.  PD117302, U50488 and U69593 were without effect in either the paw-pressure or tail-flick tests at ≤100 μg per rat.  PD117302 caused flaccid paralysis of the hindlimbs following intrathecal administration at the top dose tested.  This effect was not reversible by naloxone.  All 3 κ-opioid receptor agonists produced naloxone-reversible antinociception in the paw-pressure test, and to a lesser extent in the tail-flick test, when injected directly into the 3rd cerebral ventricle with the max. effect occurring between 5 and 10 min after administration and declining back to control levels by 60 min.  Morphine had a much slower onset of action with the peak effect being obsd. 30 min after dosing.  The antinociceptive effects of κ-agonists are likely to operate via an action at a supraspinal rather than a spinal site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRnCwR2n4YdLVg90H21EOLACvtfcHk0lhkwyCj9JeSGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXhvVSjtLo%253D&md5=a07f811b47c181c8d06a9abf42fbf83e</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1988.tb10310.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1988.tb10310.x%26sid%3Dliteratum%253Aachs%26aulast%3DLeighton%26aufirst%3DG.%2BE.%26aulast%3DRodriguez%26aufirst%3DR.%2BE.%26aulast%3DHill%26aufirst%3DR.%2BG.%26aulast%3DHughes%26aufirst%3DJ.%26atitle%3D%25CE%25BA-Opioid%2520agonist%2520produce%2520antinociception%2520after%2520i.v.%2520and%2520i.c.v.%2520but%2520not%2520intrathecal%2520administration%2520in%2520the%2520rat%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1988%26volume%3D93%26spage%3D553%26epage%3D560%26doi%3D10.1111%2Fj.1476-5381.1988.tb10310.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bove, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calcaterra, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brooker, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman, R. E.</span></span> <span> </span><span class="NLM_article-title">Weight bearing as a measure of disease progression and efficacy of anti-inflammatory compounds in a model of monosodium iodoacetate-induced osteoarthritis</span>. <i>Osteoarthritis and Cartilage</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">821</span>– <span class="NLM_lpage">830</span>, <span class="refDoi"> DOI: 10.1016/S1063-4584(03)00163-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.1016%2FS1063-4584%2803%2900163-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=14609535" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A280%3ADC%252BD3srjt1KitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=821-830&author=S.+E.+Boveauthor=S.+L.+Calcaterraauthor=R.+M.+Brookerauthor=C.+M.+Huberauthor=R.+E.+Guzman&title=Weight+bearing+as+a+measure+of+disease+progression+and+efficacy+of+anti-inflammatory+compounds+in+a+model+of+monosodium+iodoacetate-induced+osteoarthritis&doi=10.1016%2FS1063-4584%2803%2900163-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Weight bearing as a measure of disease progression and efficacy of anti-inflammatory compounds in a model of monosodium iodoacetate-induced osteoarthritis</span></div><div class="casAuthors">Bove S E; Calcaterra S L; Brooker R M; Huber C M; Guzman R E; Juneau P L; Schrier D J; Kilgore K S</div><div class="citationInfo"><span class="NLM_cas:title">Osteoarthritis and cartilage</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">821-30</span>
        ISSN:<span class="NLM_cas:issn">1063-4584</span>.
    </div><div class="casAbstract">OBJECTIVE:  To describe an in vivo model in the rat in which change in weight distribution is used as a measure of disease progression and efficacy of acetaminophen and two nonsteroidal anti-inflammatory drugs (NSAIDs) in a model of monosodium iodoacetate (MIA)-induced osteoarthritis (OA).  METHODS:  Intra-articular injections of MIA and saline were administered to male Wistar rats (175-200 g) into the right and left knee joints, respectively.  Changes in hind paw weight distribution between the right (osteoarthritic) and left (contralateral control) limbs were utilized as an index of joint discomfort.  Acetaminophen and two archetypal, orally administered NSAIDs, naproxen and rofecoxib, were examined for their ability to decrease MIA-induced change in weight distribution.  RESULTS:  A concentration-dependent increase in change in hind paw weight distribution was noted after intra-articular injection of MIA.  Both naproxen and rofecoxib demonstrated the capacity to significantly (P<0.05) decrease hind paw weight distribution in a dose-dependent fashion, indicating that the change in weight distribution associated with MIA injection is susceptible to pharmacological intervention.  CONCLUSION:  The determination of differences in hind paw weight distribution in the rat MIA model of OA is a technically straightforward, reproducible method that is predictive of the effects of anti-inflammatory and analgesic agents.  This system may be useful for the discovery of novel pharmacologic agents in human OA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSXM-0hOfBxH_6xYuD7tu2XfW6udTcc2ea_7hz-frxIhrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3srjt1KitA%253D%253D&md5=12ee3d4de4609d794d4e4f4b176f25a3</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2FS1063-4584%2803%2900163-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1063-4584%252803%252900163-8%26sid%3Dliteratum%253Aachs%26aulast%3DBove%26aufirst%3DS.%2BE.%26aulast%3DCalcaterra%26aufirst%3DS.%2BL.%26aulast%3DBrooker%26aufirst%3DR.%2BM.%26aulast%3DHuber%26aufirst%3DC.%2BM.%26aulast%3DGuzman%26aufirst%3DR.%2BE.%26atitle%3DWeight%2520bearing%2520as%2520a%2520measure%2520of%2520disease%2520progression%2520and%2520efficacy%2520of%2520anti-inflammatory%2520compounds%2520in%2520a%2520model%2520of%2520monosodium%2520iodoacetate-induced%2520osteoarthritis%26jtitle%3DOsteoarthritis%2520and%2520Cartilage%26date%3D2003%26volume%3D11%26spage%3D821%26epage%3D830%26doi%3D10.1016%2FS1063-4584%2803%2900163-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Yelin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lubeck, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epstein, W.</span></span> <span> </span><span class="NLM_article-title">The impact of rheumatoid arthritis and osteoarthritis: the activities of patients with rheumatoid arthritis and osteoarthritis compared to controls</span>. <i>J. Rheumatol.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">710</span>– <span class="NLM_lpage">717</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=3668977" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A280%3ADyaL1c%252FjsFyksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1987&pages=710-717&author=E.+Yelinauthor=D.+Lubeckauthor=H.+Holmanauthor=W.+Epstein&title=The+impact+of+rheumatoid+arthritis+and+osteoarthritis%3A+the+activities+of+patients+with+rheumatoid+arthritis+and+osteoarthritis+compared+to+controls"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30aR"><div class="casContent"><span class="casTitleNuber">30a</span><div class="casTitle"><span class="NLM_cas:atitle">The impact of rheumatoid arthritis and osteoarthritis: the activities of patients with rheumatoid arthritis and osteoarthritis compared to controls</span></div><div class="casAuthors">Yelin E; Lubeck D; Holman H; Epstein W</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of rheumatology</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">710-7</span>
        ISSN:<span class="NLM_cas:issn">0315-162X</span>.
    </div><div class="casAbstract">We measured the impact of rheumatoid arthritis (RA) and osteoarthritis (OA) by comparing the activities of patients with these illnesses to controls matched for age, sex, and community of residence.  Our results indicate that patients with RA experience more losses than controls in every domain of human activity and that patients with OA experience more losses in the performance of household chores, shopping and errands, and leisure activities.  The methods described here provide a simple, reliable way to assess the impacts of illness in the same terms for all dimensions of human activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQI2S3ZhUeOWw5nADWVYHg1fW6udTcc2ea_7hz-frxIhrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1c%252FjsFyksw%253D%253D&md5=6f0e79449f64d6cca2b7d928a130941e</span></div><a href="/servlet/linkout?suffix=cit30a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYelin%26aufirst%3DE.%26aulast%3DLubeck%26aufirst%3DD.%26aulast%3DHolman%26aufirst%3DH.%26aulast%3DEpstein%26aufirst%3DW.%26atitle%3DThe%2520impact%2520of%2520rheumatoid%2520arthritis%2520and%2520osteoarthritis%253A%2520the%2520activities%2520of%2520patients%2520with%2520rheumatoid%2520arthritis%2520and%2520osteoarthritis%2520compared%2520to%2520controls%26jtitle%3DJ.%2520Rheumatol.%26date%3D1987%26volume%3D14%26spage%3D710%26epage%3D717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit30b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Yelin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henke, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epstein, W.</span></span> <span> </span><span class="NLM_article-title">The work dynamics of the person with rheumatoid arthritis</span>. <i>Arthritis Rheum.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">507</span>– <span class="NLM_lpage">512</span>, <span class="refDoi"> DOI: 10.1002/art.1780300504</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.1002%2Fart.1780300504" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=3593434" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A280%3ADyaL2s3ktFOmsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1987&pages=507-512&author=E.+Yelinauthor=C.+Henkeauthor=W.+Epstein&title=The+work+dynamics+of+the+person+with+rheumatoid+arthritis&doi=10.1002%2Fart.1780300504"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30bR"><div class="casContent"><span class="casTitleNuber">30b</span><div class="casTitle"><span class="NLM_cas:atitle">The work dynamics of the person with rheumatoid arthritis</span></div><div class="casAuthors">Yelin E; Henke C; Epstein W</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis and rheumatism</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">507-12</span>
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    </div><div class="casAbstract">This paper traces the work history of patients with rheumatoid arthritis (RA) from the year of diagnosis to 1985.  The paper also describes the risk factors for work loss among patients with RA.  It uses data from a panel of 698 RA patients, observed for 4 years, from the practices of a random sample of northern California rheumatologists.  Of these 698, 353 had worked for pay at some point in their lives.  Three hundred six of the 353 had worked when diagnosed as having RA.  Of these 306, 157 (51%) were no longer working in 1985.  Forty-seven individuals started working after the onset of illness, but of these, approximately one-third had stopped working by 1985.  In all, 50% of RA patients with some work experience stopped working within a decade of diagnosis, 60% within 15 years, and 90% within 30 years.  We found that the probability of work loss is lessened among persons in jobs that have few physical requirements, among those with high levels of discretion over the pace and activities of work, and among those who were able to stay on the job held when the diagnosis was made.  The probability of work loss is increased among service workers.  The findings of this longitudinal study, showing that work characteristics profoundly alter the probability of work loss among persons with RA, are consistent with the findings of our earlier cross-sectional studies of work outcome and RA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQOCSTunNuI7A20zIbnCCI3fW6udTcc2eaLc04Xl5i6Ybntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2s3ktFOmsg%253D%253D&md5=139f479967b8d4b6435044c279ca6814</span></div><a href="/servlet/linkout?suffix=cit30b&amp;dbid=16384&amp;doi=10.1002%2Fart.1780300504&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.1780300504%26sid%3Dliteratum%253Aachs%26aulast%3DYelin%26aufirst%3DE.%26aulast%3DHenke%26aufirst%3DC.%26aulast%3DEpstein%26aufirst%3DW.%26atitle%3DThe%2520work%2520dynamics%2520of%2520the%2520person%2520with%2520rheumatoid%2520arthritis%26jtitle%3DArthritis%2520Rheum.%26date%3D1987%26volume%3D30%26spage%3D507%26epage%3D512%26doi%3D10.1002%2Fart.1780300504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendrickson, C. L.</span></span> <span> </span><span class="NLM_article-title">High-resolution mass spectrometers</span>. <i>Annu. Rev. Anal. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">579</span>– <span class="NLM_lpage">599</span>, <span class="refDoi"> DOI: 10.1146/annurev.anchem.1.031207.112945</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=10.1146%2Fannurev.anchem.1.031207.112945" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=20636090" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFygsLzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2008&pages=579-599&author=A.+G.+Marshallauthor=C.+L.+Hendrickson&title=High-resolution+mass+spectrometers&doi=10.1146%2Fannurev.anchem.1.031207.112945"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">High-resolution mass spectrometers</span></div><div class="casAuthors">Marshall, Alan G.; Hendrickson, Christopher L.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Analytical Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">579-599</span>CODEN:
                <span class="NLM_cas:coden">ARACFU</span>;
        ISSN:<span class="NLM_cas:issn">1936-1327</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Over the past decade, mass spectrometry has been revolutionized by access to instruments of increasingly high mass-resolving power.  For small mols. up to ∼400 Da (e.g., drugs, metabolites, and various natural org. mixts. ranging from foods to petroleum), it is possible to det. elemental compns. (CcHhNnOoSsPp...) of thousands of chem. components simultaneously from accurate mass measurements (the same can be done up to 1000 Da if addnl. information is included).  At higher mass, it becomes possible to identify proteins (including posttranslational modifications) from proteolytic peptides, as well as lipids, glycoconjugates, and other biol. components.  At even higher mass (∼100,000 Da or higher), it is possible to characterize posttranslational modifications of intact proteins and to map the binding surfaces of large biomol. complexes.  Here we review the principles and techniques of the highest-resoln. anal. mass spectrometers (time-of-flight and Fourier transform ion cyclotron resonance and orbitrap mass analyzers) and describe some representative high-resoln. applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEujA9fN7IGLVg90H21EOLACvtfcHk0ljTebTRa85sjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFygsLzI&md5=f4da150f5e6a8448f8313466ef8f9e08</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1146%2Fannurev.anchem.1.031207.112945&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.anchem.1.031207.112945%26sid%3Dliteratum%253Aachs%26aulast%3DMarshall%26aufirst%3DA.%2BG.%26aulast%3DHendrickson%26aufirst%3DC.%2BL.%26atitle%3DHigh-resolution%2520mass%2520spectrometers%26jtitle%3DAnnu.%2520Rev.%2520Anal.%2520Chem.%26date%3D2008%26volume%3D1%26spage%3D579%26epage%3D599%26doi%3D10.1146%2Fannurev.anchem.1.031207.112945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i65"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00420">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_11627"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b00420">10.1021/acs.jmedchem.8b00420</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Enzymatic activity curves of compounds <b>5A, 2B, 3C, 3D, 3E</b> and <b>AAZ</b> on hCAs I, II, IV, IX and XII (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00420/suppl_file/jm8b00420_si_001.pdf">PDF</a>)</p></li><li><p class="inline">SMILES representation for compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00420/suppl_file/jm8b00420_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00420/suppl_file/jm8b00420_si_001.pdf">jm8b00420_si_001.pdf (753.96 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00420/suppl_file/jm8b00420_si_002.csv">jm8b00420_si_002.csv (2.66 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b00420&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b00420%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-11%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b00420" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-b425991822a79ada59b3.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-fb88834b824b41b135ad.js"></script>

<script type="text/javascript" src="/wro/ke1q~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6679888be8ff2290","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.6.0","si":10}'></script>
</body>
</html>
